vancomycin has been researched along with Gram-Positive Bacterial Infections in 1375 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.07) | 18.7374 |
| 1990's | 439 (31.93) | 18.2507 |
| 2000's | 351 (25.53) | 29.6817 |
| 2010's | 400 (29.09) | 24.3611 |
| 2020's | 184 (13.38) | 2.80 |
| Authors | Studies |
|---|---|
| Hsueh, PR; Huang, YT; Liao, CH; Teng, LJ | 2 |
| Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
| Cohen, MA; Ellsworth, E; Gage, JW; Gibson, GW; Gracheck, SJ; Hanna, DL; Huband, MD; Skerlos, LA; Stier, MA; Sulavik, MC; Zurack, M | 1 |
| Arias, CA; Murray, BE; Panesso, D; Singh, KV | 1 |
| Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
| Amsler, K; Heep, M; Noel, GJ; Pypstra, R; Solomkin, JS; Strauss, RS | 1 |
| Montero, CI; Murray, PR; Stock, F | 1 |
| Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
| Fujimoto, K; Hirokawa, Y; Kashimoto, S; Kato, S; Kinoshita, H; Kitadai, N; Kojima, T; Nakata, K; Tanaka, T | 1 |
| Barbachyn, MR; Brickner, SJ; Hutchinson, DK; Manninen, PR | 1 |
| Benton, BM; Draghi, DC; Krause, KM; Pillar, C; Sahm, DF; Thornsberry, C | 1 |
| Benton, BM; Debabov, DV; Difuntorum, S; Krause, KM; Renelli, M; Wu, TX | 1 |
| Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
| Jacobus, NV; McDermott, LA; Snydman, DR | 1 |
| Ike, Y; Inoue, T; Tomita, H; Zheng, B | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Jang, DS; Jang, KP; Kang, H; Kim, CH; Kim, H; Lee, E; Na, SW | 1 |
| Hanaki, H; Hirose, T; Ichioka, M; Kobayashi, Y; Masuma, R; Matsui, H; Matsumoto, A; Nagai, K; Omura, S; Sunazuka, T; Takahashi, Y | 1 |
| Kaul, M; LaVoie, EJ; Parhi, AK; Pilch, DS; Pradhan, P; Saionz, KW; Trivedi, K; Zhang, Y | 1 |
| Gordeev, MF; Yuan, ZY | 1 |
| Aung, TT; Bai, Y; Beuerman, RW; Cao, D; Koh, JJ; Koh, WL; Lakshminarayanan, R; Li, J; Lim, F; Lin, H; Lin, S; Liu, S; Pang, LM; Pervushin, K; Qiu, S; Salleh, SM; Tan, DT; Verma, C; Zhou, L; Zou, H | 1 |
| Aung, TT; Beuerman, RW; Cao, D; Koh, JJ; Lakshminarayanan, R; Li, J; Lim, F; Lin, S; Liu, S; Ren, L; Tan, DT; Verma, C; Wang, L; Wang, Y; Zou, H | 1 |
| Chen, L; Cooper, B; Cushman, M; Mayhoub, A; Mohammad, H; Oldfield, E; Peters, CE; Pogliano, J; Pogliano, K; Seleem, MN; Younis, W; Zhang, J | 1 |
| Abutaleb, NS; Dayal, N; Mohammad, H; Naclerio, GA; Opoku-Temeng, C; Seleem, MN; Sintim, HO | 1 |
| Aggarwal, B; Bajaj, A; Gupta, S; Gupta, SK; Jain, D; Kumar, S; Kumar, Y; Mehta, D; Pal, G; Pal, S; Rajput, K; Ramu, VS; Rana, K; Rani, P; Saini, V | 1 |
| Anderson, AD; Camargo, JF; Khatri, AM | 1 |
| Aslam, S; Christner, M; Coppenhagen-Glazer, S; Fischer, L; Gelman, D; Harbauer, T; Hazan, R; Herden, U; Khalifa, L; Merabishvili, M; Muntau, AC; Nir-Paz, R; Paul, K; Pirnay, JP; Rohde, C; Rohde, H; Schulz-Jürgensen, S; Singer, D; Yerushalmy, O | 1 |
| Fišerová, K; Hricová, K; Htoutou Sedláková, M; Kolář, M; Kučová, P | 1 |
| Bathoorn, E; Chlebowicz-Fliss, MA; Couto, N; Friedrich, AW; Harmsen, HJM; Lisotto, P; Lokate, M; Raangs, EC; Rosema, S; Rossen, JWA; Zhou, X | 1 |
| Beukers, AG; Keighley, CL; McIver, CJ; Pratama, R; Taylor, PC; van Hal, SJ | 1 |
| Côrtes, MF; Costa, SF; de Castro Lima, VAC; Franco, LAM; Levin, AS; Marchi, AP; Martins, RCR; Neto, LVP; Rocha, V; Rossi, F | 1 |
| Brennan, GI; Coleman, DC; Egan, SA; Kavanagh, NL; McManus, BA; Mollerup, S; O'Connell, B; Pinholt, M; Samaniego Castruita, JA; Shore, AC; Westh, H | 1 |
| Guo, XG; Han, MY; Ji, TX; Li, ZL; Lin, ZH; Liu, YL; Luo, QB; Xiao, SS; Zhong, JH | 1 |
| Joshi, S; Shallal, A; Zervos, M | 1 |
| Chang, TH; Chen, CJ; Chung, CR; Horng, JT; Huang, WT; Lee, TY; Lin, TW; Liu, TP; Lu, JJ; Lu, KP; Tseng, YJ; Wang, HY; Wu, MH | 1 |
| Ayobami, O; Brinkwirth, S; Eckmanns, T; Markwart, R | 1 |
| Abdi, A; Basgut, B; Jame, W | 1 |
| Abbas, NH; Aly, SS; Eltahan, A; Hammad, AM; Hassan, HA; Khalifa, E; Shimamoto, T | 1 |
| Boutin, S; Büchler, MW; Eichel, VM; Frank, U; Heeg, K; Heininger, A; Mutters, NT; Nurjadi, D; Weigand, MA | 1 |
| Abu-Lybdeh, O; Assous, MV; Benenson, S; Mann, T; Murik, O; Oster, Y; Wiener-Well, Y; Zeevi, DA | 1 |
| Antonelli, A; Arcangeli, S; Baldi, G; De Joannon, AC; Del Vecchio, A; Giani, T; Riccobono, E; Rossolini, GM; Tellone, V | 1 |
| Androvic, L; Kamenik, Z; Komrskova, K; Kracikova, L; Laga, R; Mazumdar, A; Stefani, T; Sur, VP; Vimberg, V | 1 |
| Braakman-Jansen, LMA; Lokate, M; Stein, A; van Gemert-Pijnen, JEWC; van Niekerk, JM | 1 |
| Bond, K; Gorrie, CL; Grayson, ML; Higgs, C; Horan, K; Howden, BP; Kinsella, P; Kwong, JC; Marshall, C; Seemann, T; Sherry, NL; Stinear, TP; Walpola, H; Williamson, DA | 1 |
| Cavallo, R; Corcione, S; Curtoni, A; De Benedetto, I; De Rosa, FG; Lupia, T; Mornese Pinna, S; Roberto, G; Scabini, S; Scaglione, L; Shbaklo, N | 1 |
| Carmeli, Y; Grisaru-Soen, G; Lellouche, J; Mandel, D; Schechner, V; Schwartz, D; Stepansky, S; Wullfhart, L | 1 |
| Cheung, J; Freedberg, DE; Lynch, E; Nattakom, M; Richardson, M; Wang, HH; Zachariah, P | 1 |
| Chang, SC; Chen, YC; Chuang, YC; Huang, SH; Lin, CY; Tseng, TC; Wang, JT | 1 |
| Dewar, S; Kelly, J; Tysall, L | 1 |
| Bartels, MD; Gisselø, K; Knudsen, MJS; Mollerup, S; Petersen, AM; Pinholt, M; Rubin, IMC; Westh, H | 1 |
| Golding, GR; Hota, SS; Kleinman, DR; McCracken, M; Mitchell, R; Smith, SW | 1 |
| Bujdáková, H; Jozefíková, A; Nováková, E; Šoltys, K; Valček, A | 1 |
| Heselich, V; Huebner, J; Kolberg, L; Meyer-Buehn, M; Muench, HG; Schroepf, S; Trautmannsberger, I; von Both, U; Weber, R; Werner, G | 1 |
| Bobadilla-Del-Valle, M; Lambraño-Castillo, D; Leal-Vega, FJ; Lopez-Luis, BA; Ortiz-Brizuela, E; Ponce-De-León, A; Sifuentes-Osornio, J; Tovar-Calderón, YE | 1 |
| Boumasmoud, M; Chakrakodi, B; Dengler Haunreiter, V; Kouyos, RD; Kühnert, D; Meyer, L; Schreiber, PW; Schweizer, TA; Seidl, K; Zinkernagel, AS | 1 |
| Hammerum, AM; Hasman, H; Ingmer, H; Jensen, CS; Kjerulf, A; Knudsen, JD; Lawaetz, AC; Pinholt, M; Skive, B | 1 |
| Cai, J; Chen, S; Ding, S; Gu, D; Hu, F; Huang, X; Huang, Y; Li, Q; Ma, B; Shen, J; Shen, Z; Sun, H; Wang, H; Yang, Q; Zhang, R; Zhu, K | 1 |
| Baker, A; Broholm, C; Dahl Knudsen, J; Helms, M; Holm, MKA; Kallemose, T; Knudsen, SB; Mollerup, S; Petersen, AM; Pinholt, M; Rubin, IMC; Westh, H | 1 |
| Arpi, M; Blank, SN; Bonten, MJM; Groenwold, RH; Nabuurs-Franssen, MH; Ossewaarde, JM; Pinholt, M; Rottier, WC; Ruijs, GJHM; Tersmette, M; van der Bij, AK; Westh, H | 1 |
| Arias, CA; Axell-House, D; Khan, A; Miller, WR; Munita, JM | 1 |
| Cho, SY; Chung, DR; Ha, S; Huh, HJ; Huh, K; Kang, CI; Ko, JH; Lee, NY; Peck, KR; Song, JH | 1 |
| Abutaleb, NS; An, W; Cao, X; Flaherty, DP; Hewitt, CS; Holly, KJ; Imhoff, RD; Nocentini, A; Seleem, MN; Supuran, CT | 1 |
| Ebdrup, SR; Frimodt-Møller, N; Hertz, FB; Kirkby, NS; Møller, K; Nielsen, C; Nielsen, KL; Olsen, MH | 1 |
| Jalali, M; Jalali, Y; Kolosova, A; Kyselovic, J; Liptakova, A; Payer, J; Sturdik, I | 1 |
| Pintarić, S; Štritof, Z; Tumpa, A | 1 |
| Gu, Y; Hisatsune, J; Horiuchi, H; Inoue, F; Itoga, M; Kayaba, H; Kimura, M; Kitazawa, J; Matsui, M; Minakawa, S; Saito, N; Sugai, M; Suzuki, S; Tsuchiya, J; Yamamoto, T | 1 |
| Elmeskov, C; Frees, D; Mollerup, S; Pedersen, MS; Pinholt, M; Sejersen, TS; Westh, H; Worning, P | 1 |
| He, YH; Lv, Y; Ruan, GJ; Xue, F; Yan, MY; Zheng, B | 1 |
| Araoka, H; Asano-Mori, Y; Ishiwata, K; Kageyama, K; Kaji, D; Makino, S; Mitsuki, T; Nishida, A; Oyama, T; Takagi, S; Taniguchi, S; Taya, Y; Uchida, N; Wake, A; Yamaguchi, K; Yamamoto, G; Yamamoto, H | 1 |
| Gargvanshi, S; Gutheil, WG | 1 |
| De Oliveira, AG; Dos Santos, CTB; Machado, ABF; Mantovani, HC; Paiva, AD; Rodrigues, WF; Rotta, IS | 1 |
| Chen, PL; Fukushige, M; Ko, WC; Lee, NY; Lin, WL; Morikawa, K; Syue, LS | 1 |
| Bastová, V; Chmelař, D; Janošcová, V; Kuzma, J; Palcová, L; Timko, J | 1 |
| Fan, X; Kang, X; Luo, S; Luo, X; Wang, G; Wei, Y; Zhao, S | 1 |
| Hryniewicz, W; Sadowy, E; Wardal, E; Żabicka, D | 1 |
| Bahrs, C; Brehm, TT; Hagel, S; Hanses, F; Heine, V; Hennigs, A; Hitzenbichler, F; Hornuss, D; Huppertz, G; Jacobi, RJ; Rieg, S; Rose, N | 1 |
| Al-Qamari, A; Bardowski, L; Bulger, C; Churyla, A; Fiehler, M; Malczynski, M; Oakley, R; Qi, C; Rathod, SN; Tanna, SD; Tse, I; Zembower, TR | 1 |
| Abiri, R; Ahmadi, K; Alvandi, A; Azizi, M; Hossainpour, H; Kashef, M; Moradi, J; Motamedi, H | 1 |
| Bush, K; Chow, B; Ellison, J; Pfister, TR; Shen, Y | 1 |
| Ceccarelli, G; d'Ettorre, G; Picciarella, A; Russo, A; Russo, R | 1 |
| He, Z; Jin, D; Li, Y; Liu, S; Wang, J; Wang, Y | 1 |
| Leigh, RJ; Lynch, B; McKenna, C; McWade, R; Walsh, F | 1 |
| Dželalija, M; Fredotović, Ž; Goić Barišić, I; Jozić, S; Kalinić, H; Kvesić, M; Maravić, A; Novak, A; Ordulj, M; Šamanić, I; Tonkić, M | 1 |
| Mobarez, AM; Nikkhah, M; Sadaqat, MH | 1 |
| Coombs, GW; Daley, DA; Mowlaboccus, S; Shoby, P | 1 |
| Alegria, W; Bounthavong, M; Deresinski, S; Fox, E; Ha, D; Holubar, M; Meng, L; Mui, E | 1 |
| Behnke, M; Eisenbeis, S; Falgenhauer, JC; Falgenhauer, L; Gastmeier, P; Häcker, G; Higgins, PG; Hölzl, F; Imirzalioglu, C; Käding, N; Kern, WV; Kola, A; Kramme, E; Mischnik, A; Peter, S; Rieg, S; Rohde, AM; Rupp, J; Schneider, C; Schwab, F; Seifert, H; Tacconelli, E; Tobys, D; Trauth, J; Walker, S; Weber, A; Xanthopoulou, K; Zweigner, J | 1 |
| Guo, Y; Han, R; Wu, J; Xu, X; Yang, Y; Zhou, Y | 1 |
| Carruana, G; Flor-Duro, A; Garcia-Garcera, M; Isaac, S; Lopez-Nogueroles, M; Pineda-Lucena, A; Puchades-Carrasco, L; Quirant, A; Ubeda, C | 1 |
| Abella, J; Al Malki, MM; Artz, A; Dadwal, SS; Dickter, J; Forman, SJ; Khambapati, S; Meguro, A; Mokhtari, S; Nakamura, R; O'Hearn, J; Salhotra, A; Sandhu, KS; Smith, E; Spielberger, R; Tegtmeier, B; Yang, D | 1 |
| Chiu, HC; Hsueh, PR; Huang, YT; Lee, TF; Wan, TW; Yeo, HH | 1 |
| Han, Y; Shen, M; Tang, M; Xu, C; Yao, Z; Zeng, W; Zhang, X; Zheng, X; Zhou, T | 1 |
| Dirnberger, L; Fritz, K; Kling, K; Malczynski, M; Polanco, W; Qi, C; Rios, J; Zembower, T | 1 |
| Bolisetty, S; Chiletti, R; Cranswick, N; Curtis, N; Duffull, S; Gardiner, K; Gwee, A; Hunt, R; Lai, T; Malhotra, A; McMullan, B; Mehta, B; Michalowski, J; Popat, H; Ward, M; Wilkins, AL; Zhu, X | 1 |
| Harada, T; Ito, H; Kaga, Y; Kakimoto, K; Kawahara, R; Koshimo, N; Matsui, T; Nishiki, S; Oishi, K; Takahashi, H; Ueda, E; Yamagishi, T | 1 |
| Atkinson, A; Bittel, P; Buetti, N; Casanova, C; D'Incau, S; Jent, P; Kaspar, T; Marschall, J; Piezzi, V; Seth-Smith, HM; Sommerstein, R; Wassilew, N | 1 |
| Feng, M; Huang, G; Jia, C; Li, Y; Liao, S; Teng, L; Wang, Z; Yao, Y; Yin, R; Yue, M | 1 |
| Chang, SC; Chen, YC; Chuang, YC; Huang, SH; Huang, ST; Lin, CY; Wang, JT; Yang, JL | 1 |
| Cumming, V; Leong, KWC; O'Toole, RF; Van Hal, SJ | 1 |
| Arts, M; Beam, JE; Bui, DT; Conlon, BP; Daniel, JM; de Benedetti, S; Kedziora, KM; Parsons, JB; Rowe, SE; Schneider, T; Sidders, AE | 1 |
| Goto, M; Livorsi, DJ; Perencevich, EN; Suzuki, H; Tholany, J | 1 |
| Li, P; Wang, J; Wang, M; Xin, L; Xu, X | 1 |
| Hashimoto, Y; Hirahara, Y; Hirakawa, H; Kobayashi, S; Kurushima, J; Nomura, T; Suzuki, M; Tanimoto, K; Tomita, H | 1 |
| Abbott, IJ; Cairns, KA; Dooley, MJ; Peel, TN; Peleg, AY; Udy, AA | 1 |
| Cho, SY; Chung, DR; Ha, YE; Huh, HJ; Huh, K; Kang, CI; Ko, JH; Lee, NY; Peck, KR; Song, JH | 1 |
| Ballard, SA; Coombs, GW; da Silva, AG; Daley, DA; Hegstad, K; Howden, BP; Janice, J; Mowlaboccus, S; Pang, S; Schulz, M; Stinear, T; Sundsfjord, A; Wagner, TM | 1 |
| Beatson, SA; Forde, BM; Harris, PNA; Henderson, BC; Lindsay, M; Paterson, DL; Permana, B; Playford, EG; Runnegar, N | 1 |
| Colas, A; Conrath, E; Faivre, V; Florentin, A; Lizon, J; Regad, M | 1 |
| Cook, MA; Coombes, BK; Fiebig-Comyn, AA; Koteva, K; Wang, W; Wright, GD; Xu, M | 1 |
| Klaassen, CHW; Severin, JA; Verkaik, NJ; Voor In 't Holt, AF; Vos, MC; Wammes, LJ | 1 |
| Belmar Campos, C; Büttner, H; Christner, M; Franke, G; Klupp, EM; Knobling, B; Knobloch, JK; Maurer, PM | 1 |
| Hammerum, AM; Hansen, F; Hansen, SGK; Hasman, H; Hoegh, SV; Holm, A; Karstensen, KT; Klein, K; Roer, L; Rosenvinge, FS; Skov, MN | 1 |
| Allen, O; Blane, B; Coll, F; Floto, RA; Gouliouris, T; Kappeler, ARM; Pai, S; Peacock, SJ; Raven, K | 1 |
| Bianco, K; Clementino, MM; Farias, BO; Flores, C; Gonçalves-Brito, AS; Magaldi, M; Montenegro, KS; Moreira, TC; Nascimento, APA; Neves, FPG | 1 |
| Brühwasser, C; Dettenkofer, M; Eichel, VM; Götting, T; Grundmann, H; Güldenhöven, H; Last, K; Liese, J; Martin, M; Mutters, NT; Papan, C; Sadaghiani, C; von Baum, H; Wendt, C; Werner, G | 1 |
| Arafa, AA; El-Razik, KAA; Hasanain, MH; Hedia, RH; Ibrahim, ES; Younes, AM | 1 |
| Cervo, A; Chester, J; Dessilani, A; Forghieri, F; Franceschini, E; Guaraldi, G; Kaleci, S; Luppi, M; Meschiari, M; Monica, M; Monte, MD; Mussini, C; Orlando, G; Ricchizzi, E; Santoro, A; Sarti, M; Scialpi, F; Venturelli, C | 1 |
| Dimov, S; Mitov, I; Peykov, S; Savov, E; Sirakov, I; Strateva, T | 1 |
| Daibata, M; Fukuda, K; Fukushima, A; Ishida, W; Kishimoto, T; Matsuzaki, S; Nakajima, I; Suzuki, T; Todokoro, D; Uchiyama, J | 1 |
| Conde-Estévez, D; Echeverria-Esnal, D; Grau, S; Horcajada, JP; Martin-Ontiyuelo, C; Mateu-De Antonio, J; Prim, N; Sorli, L | 1 |
| Batista, ISF; de Almeida, CDC; de Queiroz Oliveira, JA; Gonçalves, JE; Martins, MAP; Nobre, V; Pereira, FH; Simões E Silva, AC | 1 |
| Adachi, K; Asaka, T; Harada, T; Kawahara, R; Kawatsu, K; Komano, J; Miura, M; Terada, S; Tsuchiya, T; Yokota, M | 1 |
| Caniff, K; Dukarevich, Y; Elfessi, Z; Liu, E; Marquez, K; Shabbir, Z | 1 |
| Chu, Y; Jiang, M; Luo, Y; Quan, X; Zhou, B | 1 |
| Domhan, C; Kleist, C; Mier, W; Mühlberg, E; Uhl, P; Umstätter, F | 1 |
| Achonu, C; Garber, G; Johnstone, J; Katz, KC; Li, Y; Ling, R | 1 |
| Brackmann, M; Leib, SL; Schürch, N; Tonolla, M; Wittwer, M | 1 |
| Armin, S; Azimi, L; Rahbar, M; Zahedani, SS | 1 |
| Conn, KM; Lam, W; Ramsey, AC; Staicu, ML | 1 |
| Butler, AM; Ford, CD; Forsyth, S; Healy, R; Hoda, D; Jones, PB; Lopansri, BK; Majers, J; Snow, G; Webb, BJ | 1 |
| Chang, SC; Chen, PY; Chen, YC; Chuang, YC; Sheng, WH; Wang, JT | 1 |
| Bonnefoy, M; Girard, R; Haïne, M; Mathis, B | 1 |
| Adomako, K; Brown, KA; Garber, G; Johnstone, J; Li, Y; Saedi, A; Shing, E | 1 |
| Colodette, SS; Faria, AR; Merquior, VLC; Monteiro da Silva, BN; Morais, JM; Souza, SDSR; Teixeira, LM | 1 |
| Abu Ahmad, W; Amit, S; Averbuch, D; Friedman, G; Masarwa, R; Oster, Y; Stepensky, P; Temper, V | 1 |
| Borges, V; Capelo, JL; Gil, C; Gomes, JP; Igrejas, G; Pinto, L; Poeta, P; Santos, HM; Silva, C; Torres, C; Vieira, L | 1 |
| Bogdan, C; Bollinger, T; Eisenberger, D; Friedrich, P; Höller, C; Hossain, H; Hussein, Z; Lehner-Reindl, V; Liebl, B; Nickel, S; Pöhlmann, C; Tuschak, C; Valenza, G; Werner, M; Würstl, B | 1 |
| Li, F; Sun, L; Wang, X; Wang, Y | 1 |
| Dong, Y; Du, Q; Liu, Y; Sun, D; Wang, T; You, H; Zhang, D; Zhang, T; Zhang, Y | 1 |
| Kaya, H; Mollerup, S; Pedersen, MS; Petersen, AM; Pinholt, M; Rubin, IMC; Westh, H | 1 |
| Ahmed, MO; Baptiste, KE; Brouwer, E; Daw, MA; Elramalli, AK; Top, J; Willems, RJL; Zorgani, A | 1 |
| Buyukcam, A; Buyukeren, M; Celik, HT; Kara, A; Yigit, S; Yurdakok, M | 1 |
| Arias, CA; Carvajal, LP; Diaz, L; Dinh, A; Echeverri, AM; Kolokotronis, SO; Munita, JM; Murray, BE; Narechania, A; Panesso, D; Planet, PJ; Reyes, J; Rincon, S; Rios, R; Tran, TT | 1 |
| Bhat, NR; Dhanashree, B; Shivashankar, SBK | 1 |
| Hardy, P; Heath, PT; Hill, LF; Jacqz-Aigrain, E; Linsell, L; Lutsar, I; Roilides, E; Sharland, M; Turner, MA | 1 |
| Chambers, ST; Chin, PKL; Dalton, SC; Drennan, PG; Gardiner, SJ; Long, M; Metcalf, SCL; Yi, M | 1 |
| Bootsveld, C; Boutin, S; Eichel, V; Frank, U; Heeg, K; Klein, S; Nurjadi, D | 1 |
| Chhabria, M; Kudaravalli, P; Lesho, E; Pendela, VS | 1 |
| Brennan, GI; Coleman, DC; Corcoran, S; Cullen, A; Egan, SA; Fitzpatrick, M; Hoyne, A; McCormack, O; McDermott, H; O'Connell, B | 1 |
| Bootsveld, C; Boutin, S; Heininger, A; Nurjadi, D; Zimmermann, S | 1 |
| Cao, X; Gao, S; Shen, H; Sun, Y; Zhang, C; Zhang, Y; Zhang, Z; Zhou, H; Zhou, W | 1 |
| Bender, JK; Brockmann, D; Einsele, H; Fuchs, S; Kraus, S; Maier, BF; Neumann, B; Semmler, T; Vogel, U; Werner, G; Wieler, LH; Wittig, A | 1 |
| Fukushima, Y; Nakajima, C; Sato, T; Shinagawa, M; Suzuki, Y; Takahashi, S; Wada, T; Yokota, SI | 1 |
| Gao, L; Li, Y; Liu, G | 1 |
| Harada, S; Kanemura, N; Kitagawa, J; Matsumoto, T; Nakamura, H; Nakamura, N; Niwa, T; Ohata, K; Shimizu, M; Suzuki, A; Takahashi-Yamauchi, T | 1 |
| Gastmeier, P; Kola, A; Maechler, F; Schwab, F; Weber, A | 1 |
| Behnke, M; Dinkelacker, AG; Eisenbeis, S; Falgenhauer, J; Falgenhauer, L; Fritzenwanker, M; Gastmeier, P; Gölz, H; Häcker, G; Higgins, PG; Imirzalioglu, C; Käding, N; Kern, WV; Kola, A; Kramme, E; Mischnik, A; Peter, S; Rieg, S; Rohde, AM; Rupp, J; Seifert, H; Tacconelli, E; Tobys, D; Vehreschild, MJGT; Walker, SV; Xanthopoulou, K | 1 |
| Conly, J; Du, T; Embil, J; Golding, G; Hota, S; Johnston, L; McCracken, M; Mitchell, R; Ormiston, D; Parsonage, J; Simor, A; Smith, S; Wong, A | 1 |
| Borgmann, S; Klare, I; Meintrup, D; Rieß, B; Werner, G | 1 |
| Bosman, RJ; Elbers, PWG; Fleuren, LM; Girbes, ARJ; Guo, T; Mathot, RAA; Roggeveen, LF; van der Voort, PHJ; van Hasselt, JGC; van Hest, RM; Zwep, LB | 1 |
| Arroliga, AC; Aslam, W; Brito, V; Ghamande, S; Jones, S; Mathew, NE; Shaver, C | 1 |
| Aygün, G; Balkan, II; Bayramlar, OF; Kaya, A; Kaya, SY; Mete, B; Saltoglu, N; Tabak, ÖF | 1 |
| Chang, SC; Chen, YC; Chen, YH; Chung, PY; Fang, CT; Lin, HJ; Sheng, WH; Tien, KL; Tsan, CY; Wang, JT | 1 |
| Imai, S; Itohara, K; Kondo, M; Matsubara, K; Nakagawa, S; Nakagawa, T; Omura, T; Orii, S; Sato, Y; Sugimoto, M; Yonezawa, A | 1 |
| Casas Deza, D; De Los Mozos Ruano, A; Fuentes Olmo, J; García López, S; Lamuela Calvo, LJ; Sierra Gabarda, O | 1 |
| Anderson, DJ; Kram, BL; Kram, SJ; Kuhrt, MM; McRae, AS; Schultheis, JM | 1 |
| Gaggl, M; Kshirsagar, AV; Layton, JB; Pate, V; Stürmer, T | 1 |
| Fang, L; Gao, P; Hu, Y; Huang, L; Ni, Y; Wang, H; Wang, J; Yang, J; Zhang, L; Zhu, Z | 1 |
| Almatrafi, A; Alqahtani, M; Alqahtani, S; Alsultan, A; Alzamil, F; Asiri, Y; Bin Aydan, N | 1 |
| Blane, B; Brown, NM; Coll, F; Crawley, C; Enoch, DA; Gouliouris, T; Harrison, EM; Ludden, C; Naydenova, P; Parkhill, J; Peacock, SJ; Raven, KE; Török, ME | 1 |
| Akalin, H; Ali, R; Bulbul, EN; Kazak, E; Kirkizlar, O; Kirkizlar, TA; Ozakin, C; Ozboz, ES; Ozkalemkas, F; Ozkocaman, V | 1 |
| Kimura, T; Tanemoto, M; Yokoyama, T | 1 |
| Abdollahi, A; Asadollahi-Amin, A; Hasannezhad, M; Jafari, S; Sabahi, M; Salehi, M; Seifi, A | 1 |
| Brown, CA; Chanderraj, R; Dickson, RP; Falkowski, N; Hinkle, K; Ranjan, P; Woods, RJ | 1 |
| Patel, N; Shorman, MA; Smith, ZA; Veve, MP; Wright, LR; Yeager, SD | 1 |
| Alemayehu, T; Hailemariam, M | 1 |
| Bender, J; Griskaitis, M; Herrmann, E; Hogardt, M; Kempf, VAJ; Kessel, J; Lehn, A; Serve, H; Vehreschild, MJGT; Werner, G; Wichelhaus, TA; Zacharowski, K; Zeuzem, S | 1 |
| Bernabeu, S; Cattoir, V; Dortet, L; Dulac, D; Girlich, D; Laroche, M; Naas, T; Oueslati, S; Plaisance, M; Simon, S; Volland, H | 1 |
| Gray, T; Merlino, J | 1 |
| Lee, CM; Lee, MC; Lee, WY; Lu, CH | 1 |
| Bobadilla-Del-Valle, M; Lambraño-Castillo, D; Leal-Vega, FJ; López-Luis, BA; Ortiz-Brizuela, E; Ponce-de-León, A; Ramírez-Fontes, A; Sifuentes-Osornio, J; Tovar-Calderón, YE | 1 |
| Higgins, PG; Lucaßen, K; Seifert, H; Wille, J; Wille, T; Xanthopoulou, K; Zweigner, J | 1 |
| Chlebowicz-Fliss, MA; Gigengack-Baars, ACM; Nijhuis, RHT; Rossen, JWA; Smilde, AE; Weersink, AJL | 1 |
| Aktas, G | 2 |
| Adams, DJ; Nylund, CM; Stagliano, DR; Susi, A | 1 |
| Aepfelbacher, M; Belmar Campos, C; Both, A; Christner, M; Hansen, JL; Hilgarth, H; Klupp, EM; Maurer, FP; Olearo, F; Rohde, H | 1 |
| Assaous, F; Benamrouche, N; Bentchouala, C; Djennane, F; Guettou, B; Henniche, FZ; Laouar, H; Rahal, K; Tali Maamar, H; Tiouit, D; Yamouni, F; Ziane, H | 1 |
| Buiting, AG; Gast, KB; Murk, JL; Stohr, JJJM; van Oudheusden, AJG; Verweij, JJ | 1 |
| Andersen, L; Antoniadis, P; Detlefsen, M; Hammerum, AM; Holm, A; Kemp, M; Kjær Hansen, S; Roer, L; Skov, MN | 1 |
| Eghlimi, H; Ejtehadi, F; Kazemi, K; Malekhosseini, SA; Moghadami, M; Motazedian, N; Nikeghbalian, S; Nikoupour, H; Shamsaeefar, A; Zare, E | 1 |
| Assanasen, S; Kiratisin, P; Leelaporn, A; Limsrivanichakorn, S; Pattanachaiwit, S; Rattanasirirat, W; Wongnak, K | 1 |
| Cirkovic, I; Grgurevic, A; Janjusevic, A; Markovic Denic, L; Minic, R | 1 |
| Achor, TS; Agarwal, A; Allen, LE; Attum, B; Au, B; Berger, PZ; Bergin, PF; Bishop, JA; Bosse, MJ; Boulton, CL; Boutte, SJ; Brennan, ML; Breslin, MA; Burgos, EJ; Carlini, AR; Caroom, C; Castillo, RC; Choo, AM; Churchill, C; Collins, SC; Connelly, DW; Costales, TG; Crickard, CV; Crisco, MJ; Cuff, JAN; Degani, Y; Donnelly, JM; Ertl, W; Evans, AR; Firoozabadi, R; Frisch, HM; Gajari, V; Gardner, MJ; Gary, JL; Gaski, GE; Gonzales, G; Goodman, JB; Goodspeed, D; Graves, ML; Haaser, S; Haller, JM; Halvorson, JJ; Hayda, R; Hickerson, LE; Higgins, TF; Hill, LC; Hilliard, CL; Holden, MB; Holzman, M; Howe, AL; Howes, CR; Hsu, JR; Huang, Y; Hydrick, JM; Hymes, RA; Jahangir, AA; Jenkins, MD; Jones, CB; Joshi, M; Karia, RA; Karunakar, MA; Kaufman, AM; Kempton, LB; Kimmel, J; Krause, PC; Laljani, V; Lang, GJ; Large, TM; LeBrun, CT; LeCroy, CM; Lee, OC; Lester-Ballard, V; Malekzadeh, AS; Manson, TT; Marinos, DP; Maroto, M; Mascarenhas, DC; McAndrew, CM; McVey, ED; Miller, AN; Mir, HR; Molina, CS; Moloney, GB; Montalvo, RN; Morandi, MM; Mullins, A; Munz, JW; Murray, CK; Nascone, JW; Natoli, RM; Nwachuku, CO; O'Hara, NN; O'Toole, RV; Obremskey, WT; Osborn, PM; Osgood, GM; Phieffer, LS; Pollak, AN; Ramsey, L; Reahl, GB; Rehman, S; Reid, JS; Reilly, RM; Ricci, WM; Riggsbee, C; Ringenbach, K; Rivera, JC; Rodriguez-Buitrago, A; Rothberg, DL; Rowe, CJ; Russell, GV; Sanders, D; Sathy, AK; Scharfstein, DO; Schoonover, CD; Schroder, LK; Schulman, JE; Sciadini, MF; Seymour, RB; Shafiq, B; Sheridan, E; Sietsema, DL; Sims, SH; Siy, AB; Slobogean, GP; Smith, CS; Sorkin, AT; Spitler, CA; Spraggs-Hughes, A; Stawicki, SP; Taylor, TJ; Teague, D; Trochez, KM; Vallier, HA; Vang, S; Virkus, WW; Wagstrom, EA; Weaver, MJ; Weinlein, JC; Weiss, DB; Westberg, J; Whiting, PS; Wojda, TR; Yarboro, SR; Zadnik, M; Zelle, BA; Zura, RD | 1 |
| Dyrkell, F; Fang, H; Giske, CG | 1 |
| Bhardwaj, P; Islam, MZ; Kim, C; Nguyen, UT; Palmer, KL | 1 |
| Cao, M; Chen, M; Gong, Z; Li, P; Li, Y; Qi, Y; Wang, C; Xiao, C | 1 |
| Lo, CK; Sheth, PM | 1 |
| Ahlem, F; Diene, SM; Elhabiri, Y; Hadjadj, L; Rebiahi, SA; Rolain, JM; Sedrati, T; Zerrouki, H | 1 |
| Chen, YH; Chen, YS; Cheng, SH; Hsueh, PR; Ko, WC; Lee, CM; Lee, WS; Lee, YL; Liao, CH; Lin, CY; Liu, CP; Liu, PY; Lu, MC; Lu, PL; Shao, PL; Sheng, WH; Shi, ZY; Tsai, HY; Tseng, SH; Wang, FD; Wang, LS; Wu, TS; Yen, MY | 1 |
| Dos Santos, LDR; Furlan, JPR; Gallo, IFL; Ramos, MS; Savazzi, EA; Stehling, EG | 1 |
| Cho, SY; Choi, JR; Chung, DR; Huh, HJ; Huh, K; Kang, CI; Kim, HM; Lee, MA; Lee, NY; Peck, KR | 1 |
| Akaishi, T; Ishii, T; Kawamura, T; Kikuchi, A; Kohno, J; Takayama, S | 1 |
| Regasa Dadi, B; Solomon, Z; Tesfaye, M | 1 |
| Asai, N; Hagihara, M; Kato, H; Koizumi, Y; Mikamo, H; Okudaira, M; Yamagishi, Y | 1 |
| Abiko, T; Ara, M; Hasegawa, N; Iketani, O; Kurihara, T; Miwa, T; Mori, T; Nanki, K; Shinjoh, M; Takano, Y; Tamura, Y; Uno, S; Uwamino, Y | 1 |
| Chu, Q; Duan, S; Huang, Y; Kang, Y; Li, X; Ren, Z; Song, L; Wu, D; Xiao, Y; Zhu, S | 1 |
| Anderson, DJ; Godfrey, AW; Schaps, D | 1 |
| Al Rubaye, MTS; Bjørnholt, JV; Hegstad, K; Hultström, ME; Jakovljev, A; Janice, J; Sundsfjord, A | 1 |
| Hamanaka, E; Kitagawa, D; Komatsu, M; Maeda, K; Masuo, K; Nakamura, A; Nakamura, F; Oka, M; Sato, M; Suzuki, S | 1 |
| Bae, S; Chang, MS; Choi, SI; Chung, KH; Kim, SH; Kim, T; Kim, YK; Woo, JH; Yoon, CJ | 1 |
| Biggel, M; Nüesch-Inderbinen, M; Raschle, S; Stephan, R; Stevens, MJA | 1 |
| Baquero, F; Coque, TM; Freitas, AR; Lanza, VF; Novais, C; Peixe, L; Rodríguez, CM; Tedim, AP | 1 |
| Alevizakos, M; Detsis, M; Flokas, ME; Karageorgos, SA; Mylonakis, E | 1 |
| Heisel, RW; Lim, SH; Mascara, GP; Oleksiuk, LM; Sutton, RR; Weber, DR; Winger, DG | 1 |
| Burr, Z; Ford, C; Gazdik, M; Healy, R; Hoda, D; Lopansri, B; Majers, J; Petersen, FB; Webb, BJ | 1 |
| Kim, HR; Kim, TH; Kweon, OJ; Lee, MK; Lim, YK | 1 |
| Caballero, S; Carter, RA; Kim, GJ; Kim, S; Leiner, IM; Ling, L; Miller, L; Pamer, EG; Sušac, B | 1 |
| Baroco, AL; Verma, R | 1 |
| Morrad, S; Verma, R; Wirtz, JJ | 1 |
| Armin, S; Azimi, L; Fallah, F; Karimi, A; Rashidan, M; Shirdust, M | 1 |
| Batista, R; Davido, B; Dinh, A; Fessi, H; Salomon, J | 1 |
| Carella, DM; Chopra, A; Cies, JJ; Knoderer, CA; Moore, WS; Nichols, K | 1 |
| Agostinho, A; Bartolone, P; Betz, M; Guanziroli, N; Öztürk, M; Pires, D; Pittet, D; Tscholl, P; Uçkay, I | 1 |
| Gumpert, H; Hammerum, AM; Holzknecht, BJ; Pinholt, M; Westh, H | 1 |
| Amin, HM; Aziz, RK; Essam, TM; Hashem, YA; Yassin, AS | 1 |
| Coombs, J; Ford, CD; Gazdik Stofer, MA; Lopansri, BK; Motyckova, G; Petersen, FB; Webb, BJ | 1 |
| Arhin, FF; Belley, A; Moeck, G; Seguin, DL | 1 |
| Arai, S; Ikeda, M; Koya, J; Kurokawa, M; Matsuda, K; Moriya, K; Nakamura, F; Okugawa, S; Toyama, K | 1 |
| Florou, Z; Hrabak, J; Malli, E; Medvecky, M; Papagiannitsis, CC; Petinaki, E; Sarrou, S | 1 |
| Corey, GR; Dryden, M; File, TM; Hadvary, P; Huang, DB; Shorr, AF; Torres, A; Wilcox, MH | 1 |
| Bo, H; Hui-Min, Y; Lin Liu, Y; Shamsi, BH; Xu-Chun, M; Yan-Ping, W | 1 |
| de Frutos, M; Eiros, JM; López-Urrutia, L; Oteo, J | 1 |
| de Moya, MA; Elshaboury, RH; Lin, H; Newman, K; Sin, JH; Yeh, DD | 1 |
| Cooper, VS; Doi, Y; Guo, Y; Hu, F; McElheny, CL; Rice, LB; Sluis-Cremer, N; Tait-Kamradt, A; Tomich, AD; Wang, M | 1 |
| Lloyd-Smith, P | 1 |
| Benninger, E; Buclin, T; Gautier, E; Guidi, M; Livio, F; Magnin, JL; Rönn, K; Wahl, P | 1 |
| Arhin, FF; Belley, A; Moeck, G | 1 |
| Ahmad, S; Roy, AK; Roy, M | 1 |
| Balakrishna, AM; Bhushan, S; Dip, PV; Grüber, G; Kohlmeier, A; Nartey, W; Pan, A | 1 |
| Bianchi, L; D'Adamio, S; Galluzzo, M; Talamonti, M | 1 |
| Amin, F; Corey, GR; Dryden, M; File, TM; Heller, B; Holland, TL; Huang, DB; McLeroth, P; O'Riordan, W; Overcash, JS; Shukla, R; Torres, A; Wilcox, MH | 1 |
| Hashimoto, Y; Hirakawa, H; Hisatsune, J; Kurushima, J; Liu, J; Nomura, T; Ruan, G; Sugai, M; Tanimoto, K; Tomita, H; Xue, F; Zheng, B | 1 |
| Anderson, DJ; Fletcher, JM; Kram, BL; Kram, SJ; Sarubbi, CB | 1 |
| Bland, CM; Hersey, RM; Jones, BM; Trestman, IJ | 1 |
| Cattoir, V; Fines-Guyon, M; Giard, JC; Guérin, F; Isnard, C; Lesec, L; Sassi, M | 1 |
| Bongiorno, D; Bressan, R; Busetti, M; Campanile, F; Di Santolo, M; Dolzani, L; Knezevich, A; Lagatolla, C; Luzzati, R; Milan, A; Monticelli, J; Santagati, M; Stefani, S; Tonin, EA | 1 |
| Cho, H; Cho, SY; Lee, DG; Oak, HC; Park, DJ; Park, YJ; Yu, JK | 1 |
| Barros, AJ; Lewis, JD; Sifri, CD | 1 |
| Adondakis, MG; Brown, EM; Oliver, MR; Skedros, JG | 1 |
| Abutaleb, NS; Cheng, JX; Hong, W; Karanja, CW; Seleem, MN; Younis, W; Zhang, X | 1 |
| Cattoir, V; Earl, AM; Gilmore, MS; Lebreton, F; Schaufler, K; Valentino, MD | 1 |
| Aderman, CM; Bhisitkul, RB; Chao, DL; Chiu, CS; Obeid, A; Schwartz, DM | 1 |
| Baell, JB; Carter, GP; Harjani, JR; Howden, BP; Li, L; Nong, Y; Pitcher, NP; Riley, TV; Stinear, TP; Williamson, DA | 1 |
| de Jong, A; Dry, M; Garch, FE; Moyaert, H; Rose, M; Simjee, S; Youala, M | 1 |
| Bulanda, M; Jagiencarz-Starzec, B; Odrowąż-Konduracka, D; Paradowska, B; Szczypta, A; Talaga, K; Wolak, Z | 1 |
| Cai, XT; Liu, SL; Wang, LY; Wang, ZL; Xie, YM; Zhou, H | 1 |
| Bedford, L; Brown, NM; Cartwright, EJP; Gouliouris, T; Limmathurotsakul, D; Peacock, SJ; Raven, KE; Török, ME; Warne, B; Weerasuriya, CK | 1 |
| Eshaghi, A; Green, K; Kim, HC; Kohler, P; McGeer, A; Patel, SN; Plevneshi, A; Willey, BM | 1 |
| Beukers, AG; Chen, SC; Ellem, JA; Ferguson, JK; Lee, A; Maley, MW; Newton, PJ; Sintchenko, V; Taylor, P; Timms, VJ; van Hal, SJ | 1 |
| Bak, N; Ballard, SA; Buultjens, AH; Carter, GC; Cheng, A; Coombs, GW; Ferguson, JK; Grabsch, EA; Heffernan, H; Howden, BP; Johnson, PDR; Kotsanas, D; Mahony, AA; Roberts, SA; Seemann, T; Stinear, TP; Stuart, RL; Xie, S | 1 |
| Prince, RA; Raad, II; Reitzel, R; Rolston, KVI; Shelburne, SA; Vargas-Cruz, N | 1 |
| Angele, M; Bauer, A; Guba, M; Hinske, LC; Kinzinger, J; Pratschke, S; Scheiermann, P; Siebers, C; Weig, T; Zoller, M | 1 |
| Aghazadeh, M; Ahangarzadeh Rezaee, M; Dolatyar, A; Hasani, A; Jahansepas, A; Rahnamaye Farzami, M; Sharifi, Y | 1 |
| Bryan, A; Liu, C; MacAllister, TJ; Pergam, SA; Phipps, A; Stohs, E; Whimbey, E | 1 |
| Asai, N; Hagihara, M; Kato, H; Koizumi, Y; Matsuura, K; Mikamo, H; Nishiyama, N; Shibata, Y; Suematsu, H; Yamagishi, Y | 1 |
| Andleeb, S; Mehmood, K; Raza, T; Ullah, SR | 1 |
| Adomako, K; Chen, C; Garber, G; Johnstone, J; Lam, F; Policarpio, ME; Prematunge, C; Rosella, L | 1 |
| Duncan, LR; Flamm, RK; Mendes, RE; Pfaller, MA; Sader, HS | 1 |
| Freedberg, DE; Li, J; Salmasian, H; Yang, YX; Zachariah, P; Zhou, MJ | 1 |
| Berktold, M; Eschertzhuber, S; Fuchs, S; Hinterberger, G; Knabl, L; Kreidl, P; Lass-Flörl, C; Mayr, A; Obwegeser, A; Orth-Höller, D; Posch, W | 1 |
| Buetti, N; Casanova, C; Egli, A; Fietze, Y; Führer, U; Marschall, J; Rolli, E; Seth-Smith, HM; Wassilew, N | 1 |
| Bohra, M; Cwian, D; Peyton, C | 1 |
| Ali, SA; Bin-Asif, H; Hasan, KA; Rehman, M; Zahid, S | 1 |
| Huang, M; Wu, H; Xu, M; Zhou, J; Zhou, S | 1 |
| Abraham, S; Coombs, GW; Lee, T; Pang, S | 1 |
| Abraham, T; Chung, E; Gad, A; Lee, SE; Saad, NN | 1 |
| Colombo, E; Gerstein, W; Harji, F | 1 |
| Buchanan, R; Draz, N; Gourtsoyannis, Y; Mansell, J | 1 |
| Hashimoto, T; Hayakawa, K; Katanami, Y; Kutsuna, S; Mezaki, K; Ohmagari, N; Takeshita, N; Yamamoto, K | 1 |
| Derese, SG; Ferede, ZT; Tullu, KD; Yeshanew, AG | 1 |
| Chang, C; Fan, Y; Fu, F; Hang, J; Huang, Q; Huang, W; Li, H; Liang, X; Lin, Q; Lu, G; Luo, X; Ren, H; Shen, B; Shen, L; Shi, Y; Song, X; Tao, J; Wang, R; Wen, X; Wu, J; Wu, S; Yang, M; Yu, J; Yuan, Q; Zhang, F; Zhang, H; Zhang, J; Zhang, Z | 1 |
| Behnke, M; Gastmeier, P; Kramer, TS; Leistner, R; Remschmidt, C; Schwab, F; Werner, G; Werner, S | 1 |
| Batista, R; Davido, B; Denis, M; Dinh, A; Escaut, L; Fessi, H; Lawrence, C; Michelon, H; Perronne, C; Salomon, J | 1 |
| Alamin, TF; Birkenmaier, C; Capoor, MN; Coscia, MF; Garfin, SR; Jancalek, R; Lochman, J; McDowell, A; Ruzicka, F; Schmitz, JE; Shamie, AN; Slaby, O; Smrcka, M; Solansky, M; Wang, JC; Zapletalova, M | 1 |
| Aguilar, L; Artero, A; Barberan, J; Calleja, JL; Epelde, F; Giménez, MJ; Granizo, JJ; Guerra, JM; Martínez-Gil, I; Mensa, J; Rodriguez, JC; Ruiz-Morales, J | 1 |
| Cox, CR; Kumar, L; Sarkar, SK | 1 |
| Ballard, S; Hughes, A; Marshall, C; Sullivan, S | 1 |
| Freedberg, DE; Zachariah, P | 1 |
| Auletta, JJ; Chen, M; Kim, S; Komanduri, K; Lindemans, C; Papanicolaou, GA; Riches, ML; Ustun, C; Woo Ahn, K; Young, JH | 1 |
| Baines, SL; Ballard, SA; Buising, K; Chan, HT; Douglas, AP; Howden, BP; Madigan, V; Marshall, C; Ritchie, D; Slavin, MA; Szer, J | 1 |
| Buetti, N; Gardiol, C; Marschall, J; Rion, V; Senn, L; Wassilew, N; Widmer, A | 1 |
| Danziger, LH; Harrington, AT; Meyer, K; Wenzler, E; Wu, T | 1 |
| Aguilera, PA; Chica, CE; Corredor, NC; Leal, AL; López, C; Ovalle-Guerro, MV; Pardo-Oviedo, JM; Patarroyo, MA; Prieto, LM; Rodríguez-Leguizamón, G | 1 |
| Huprikar, S; Nellore, A | 1 |
| Arshadi, M; Douraghi, M; Mashhadi, R; Owlia, P; Pourmand, MR; Shokoohizadeh, L; Soltani, S | 1 |
| Adem, MR; Ateba, CN; Bissong, MEA; Foka, FET; Kumar, A; Matlou, DP; Tchatchouang, CK | 1 |
| Carlson, PE; Chatterjee, A; Duerkop, BA; Hullahalli, K; Johnson, CN; Luong, P; McBride, SW; Palmer, KL; Schubert, AM | 1 |
| Arias, CA; De la Hoz, A; Gomez-Villegas, SI; Malek, A; Nowbakht, C | 1 |
| Bitterman, R; Braun, E; Geffen, Y; Manaa, A; Moskovich, O; Nashashibi, L; Neuberger, A; Paul, M; Petersiel, N; Polak, D | 1 |
| Lee, SJ; Lee, SU; Nam, KY; Noh, GM; Park, ID | 1 |
| Gong, N; Jiang, J; Yang, L; Zhou, H | 1 |
| Esfahani, BN; Havaei, SA; Zalipour, M | 1 |
| Baluku, H; Edolu, M; Kateete, DP; Kigozi, E; Kisukye, J; Mwiine, FN; Najjuka, CF | 1 |
| Dancer, SJ; Hunter, IS; Lemonidis, K; Salih, TS; Tucker, NP | 1 |
| Aitken, SL; Dahesh, S; Nizet, V; Sakoulas, G; Tran, TT; Wong, B | 1 |
| Chu, Y; Ji, S; Jiang, M; Luo, Y; Zhou, B | 1 |
| Ayres, AM; Babiker, A; Cooper, VS; Ezeonwuka, C; Harrison, LH; Marsh, JW; Mustapha, MM; Pacey, MP; Pasculle, AW; Saul, MI; Shutt, KA; Snyder, GM; Sundermann, AJ; Van Tyne, D | 1 |
| Branch-Elliman, W; Davis, RB; Schrank, GM; Snyder, GM; Wright, SB | 1 |
| Bender, JK; Fleige, C; Gatermann, S; Hamprecht, A; Klare, I; Kriebel, N; Werner, G | 1 |
| Furlaneto, MC; Furlaneto-Maia, L; Terra, MR; Tosoni, NF | 1 |
| Cheong, HJ; Choi, WS; Heo, JY; Kim, IS; Kim, WJ; Noh, JY; Seo, YB; Song, JY | 1 |
| Alley, M; Flaherty, M; Lisella, J; Papaliodis, D; Rosenbaum, A | 1 |
| Coyle, E; Kapadia, M; Prince, RA; Rolston, KV; Tarrand, J | 1 |
| Choi, M; Karp, NS; Levine, SM; Weichman, KE; Wilson, SC | 1 |
| Alla, F; Athan, E; Chirouze, C; Chu, VH; Erpelding, ML; Hoen, B; Miro, JM; Olaison, L; Ralph Corey, G; Selton-Suty, C | 1 |
| Akhtar, N; Iram, S; Khan, SA; Mannan, A; Yameen, MA | 1 |
| Baquero, F; Coque, TM; Francia, MV; Freitas, AR; Novais, C; Peixe, L; Tedim, AP | 1 |
| Chiou, MJ; Huang, SH; Lee, SC; See, LC; Shih, HJ; Siu, LK; Wu, MS | 1 |
| Chugh, TD; Gaind, R; Jain, S | 1 |
| Ballard, SA; Grayson, ML; Holmes, NE; Howden, BP; Johnson, PD; Lam, MM; Stinear, TP | 1 |
| Rahiman, S; Tantry, BA | 1 |
| Baj, A; Beltramini, GA; Giannì, AB; Laganà, FC | 1 |
| Barajas, G; Malczynski, M; McLaughlin, M; Qi, C; Radetski, J; Scheetz, MH; Zembower, T | 1 |
| Cheah, YK; Mariana, NS; Nazri, AM; Norital, Z; Poh, LW; Rukman, AW | 1 |
| de Oliveira Andrade, A; Fidel, RA; Hirata Junior, R; Lewis, MA; Lins, RX; Williams, DW; Wilson, MJ | 1 |
| Avery, TR; Bartsch, SM; Brown, ST; Christie, R; Epstein, JM; Eubank, S; Huang, SS; Lee, BY; Parker, JI; Song, Y; Wong, KF; Yilmaz, SL | 1 |
| Brielmeier, B; Kang, Y; Landon, E; Parsad, S; Pettit, NN; Pisano, J; Vicente, M | 1 |
| Ballard, S; Coombs, GW; Grayson, ML; Holt, KE; Howden, BP; Johnson, PD; Lam, MM; Seemann, T; Stinear, TP; Tong, SY | 1 |
| Hugo Lee, MH; Lawlor, M; Lee, AJ | 1 |
| Besece, D; Lamp, KC; McConnell, SA; Rolston, KV; White, P; Yoon, M | 1 |
| Antonio, M; Ardanuy, C; Arnan, M; Ayats, J; Bodro, M; Camoez, M; Carratalà, J; Domínguez, MÁ; García-Vidal, C; Gudiol, C; Obed, M | 1 |
| Humphries, RM; Pollett, S; Sakoulas, G | 1 |
| Keynan, Y; Rubinstein, E | 1 |
| Cheung, L; Crane, LM; de Goffau, MC; Francis, KP; Gazendam, JA; Harmsen, HJ; Lim, E; Ntziachristos, V; Ohlsen, K; Olive, M; Schäfer, T; Tsompanidou, E; van Dam, GM; van Dijl, JM; van Oosten, M | 1 |
| Bétrisey, B; Furustrand Tafin, U; Jeddari, S; Maiolo, EM; Oliva, A; Trampuz, A | 1 |
| Chen, GY; Kuo, CH; Lin, SW; Sun, HY; Tsai, IL | 1 |
| Bo, J; Huang, WR; Jing, Y; Li, HH; Wang, QS; Wang, SH; Zhao, Y | 1 |
| Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kim, SH; Kwon, JC; Lee, DG; Park, SH; Park, YJ; Yoo, JH | 1 |
| Tang, HL; Ye, ZK; Zhai, SD | 1 |
| Brandt, C; Frank, U; Mersch-Sundermann, V; Mutters, NT; Mutters, R; Schneider-Brachert, W | 1 |
| Aptel, F; Boisset, S; Brillat-Zaratzian, E; Bron, A; Chiquet, C; Cornut, PL; Maurin, M; Romanet, JP; Vandenesch, F | 1 |
| Crozier, JA; Palmer, WC; Petrucelli, OM | 1 |
| Coombs, GW; Daley, D; Ingram, PR; Pearson, JC | 1 |
| Hossion, AM; Sasaki, K | 1 |
| Berger, C; Boggian, K; Bucheli, E; Cusini, A; Garzoni, C; Khanna, N; Koller, MT; Kralidis, G; Manuel, O; Meylan, PR; Mueller, NJ; van Delden, C; Weisser, M | 1 |
| Du, XX; Ji, JS; Qu, TT; Shi, KR; Wei, ZQ; Yang, Q; Yu, YS | 1 |
| Anjum, R; Babar, N; Gilani, M; Gill, MM; Latif, M; Munir, T; Usman, J | 1 |
| Choi, HJ; Chung, WS; Hong, KS; Kong, KA; Lee, EJ; Lee, M; Oh, SJ | 1 |
| Caierão, J; d'Azevedo, PA; Dias, CA; Narvaez, GA; Prates, JG; Resende, M | 1 |
| Eshaghi, A; Kalan, L; Low, DE; McConnell, MJ; McGeer, A; Patel, SN; Shahinas, D; Szakacs, TA; Wright, GD | 1 |
| Coburn, B; Eshaghi, A; Low, DE; McGeer, A; Patel, SN; Poutanen, SM; Shahinas, D; Willey, BM | 1 |
| Jenkins, SG; Racanelli, AC; Satlin, MJ; Shore, TB; Soave, R; van Besien, K; Walsh, TJ | 1 |
| Giske, CG; Haldorsen, B; Hegstad, K; Kahlmeter, G; Leegaard, TM; Matuschek, E; Schønning, K; Sundsfjord, A | 1 |
| Chater, M; Foo, H; Maley, M; van Hal, SJ | 2 |
| Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Nikitina, OV; Reĭ, SI | 1 |
| Avila-Morales, J; Garcia-G, MC; Leo-Amador, GE; Sanchez-Corona, J; Zaldívar-Lelo de Larrea, G | 1 |
| Barber, KE; Hall Snyder, A; Rybak, MJ; Sakoulas, G; Werth, BJ | 1 |
| Coyle, E; Nesher, L; Prince, RA; Rolston, K; Shelburne, S; Wang, W | 1 |
| Boehm, J; Coombs, GW; Flexman, J; Ingram, PR; Kay, I; Perry, P; Pryce, T; Wijesuriya, TM | 1 |
| Miller, MA; Popiel, KY | 1 |
| Abuzaid, A; Akturk, HK; Bittner, M; Smer, A | 1 |
| Aguado, JM; Andrés, A; Fernández-Ruiz, M; López-Medrano, F; Morales, JM | 1 |
| Arias, CA; Carvajal, LP; Díaz, L; Munita, JM; Panesso, D; Reyes, J; Rincón, S | 1 |
| Giemza, M; Hryniewicz, W; Markowska, K; Mik, E; Połowniak-Pracka, H; Sadowy, E; Wardal, E; Woźniak, A; Wróblewska, M; Zabicka, D | 1 |
| Conde-Estévez, D; Grau, S | 1 |
| Escosa-García, L; García-Gil, V; Gómez-Gil, MR; Hierro-Llanillo, L | 1 |
| Chen, C; Guo, Q; Hu, F; Li, G; Liu, Q; Qu, T; Wang, M; Xu, X; Ying, C; Yu, Y; Zhu, D | 1 |
| Jung, YH; Kim, HS; Kim, O; Lee, SY; Lee, YS; Yoo, JI; Yoo, JS; Yu, JY | 1 |
| Kudo, M; Nomura, T; Tanimoto, K; Tomita, H; Yomoda, S | 1 |
| Aggarwal, H; Ahmed, S; Edwards, P; Gao, H; Kuruvilla, O; Li, Y; Qiao, X; Yee, DC | 1 |
| Chen, Z; Cheng, H; Deng, QW; Pan, WG; Yang, WZ; Yu, ZJ; Zheng, JX | 1 |
| Abdala, E; Costa, SF; D'Albuquerque, LA; Galvao, FH; Levin, AS; Lopes, CG; van der Heijden, IM; van der Heijden, KM | 1 |
| Diekema, DJ; Kaye, KS; Morgan, DJ | 1 |
| Bubnova, N; Corey, GR; Good, S; Green, S; Heller, B; Jiang, H; Keech, R; Manos, P; Moeck, G; O'Riordan, W; Singh, R; Wikler, M | 1 |
| Adam, HJ; Baxter, MR; Karlowsky, JA; Walkty, AJ; Zhanel, GG | 1 |
| Hsu, AJ; Tamma, PD | 1 |
| Agudelo, M; Gonzalez, JM; Rodriguez, CA; Vesga, O; Zuluaga, AF | 1 |
| Gallagher, JC; Patel, R | 1 |
| Aitken, SL; Garey, KW; Hemmige, VS; Koo, HL; Lasco, TM; Vuong, NN | 1 |
| Camargo, IL; Dabul, AN; Merlo, TP | 1 |
| Alpfidan, I; Demir, LS; Goktas, S; Kurtoglu, MG; Omeroglu, E; Ozcimen, M; Ozcımen, S; Saglam, F; Sakarya, R; Sakarya, Y; Yener, HI | 1 |
| Barber, KE; King, ST; Pogue, JM; Stover, KR | 1 |
| Atıcı, S; Bakır, M; Cerit, K; Kadayifci, EK; Karaaslan, A; Sarmış, A; Söyletir, G; Soysal, A | 1 |
| Dunne, MW; Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Sader, HS | 1 |
| Azzalis, LA; Bacci, MR; Bruniera, FR; Campos Junqueira, VB; da Luz Gonçalves Pedreira, M; Feder, D; Ferreira, FM; Fonseca, FL; Saviolli, LR; Sorgini Peterlini, MA | 1 |
| Boyd, DA; Golding, GR; Lévesque, S; Picard, AC | 1 |
| Hangai, M; Oda, T; Okada, A | 1 |
| Arıca, D; Aydın, D; Demirel, N; Gedik, H; Kantürk, A; Şimşek, F; Yıldırmak, T; Yokuş, O | 1 |
| Adam, H; Baxter, M; Gilmour, MW; Golding, G; Hoban, DJ; Karlowsky, JA; Lagacé-Wiens, P; McCracken, M; Nichol, K; Simner, PJ; Zhanel, GG | 1 |
| Courvalin, P; Depardieu, F; Mejean, V | 1 |
| Aoki, Y; Fukuoka, M; Hamada, Y; Kusaba, K; Magarifuchi, H; Nagasawa, Z; Oho, M; Urakami, T; Yamakuchi, H | 1 |
| Banh, P; Desjardins, M; Eshaghi, A; Kariyawasam, R; Li, A; Melano, RG; Patel, SN; Shahinas, D | 1 |
| Boerma, EC; Brinkman, I; Buter, H; Veeger, N; Verstappen, G | 1 |
| Acikgoz, ZC; Aydogan, S; Celikbilek, N; Coskun-Ari, FF; Durmaz, R; Gozalan, A; Guven, T; Kirca, F; Muderris, T; Ozdem, B; Unaldi, O | 1 |
| Baek, JY; Cho, SY; Chung, DR; Ha, YE; Kang, CI; Kim, SH; Ko, JH; Lee, JY; Lee, NY; Lee, WJ; Peck, KR; Song, JH | 1 |
| Nathwani, D; Tsoulas, C | 1 |
| Chen, CH; Xu, XG | 1 |
| Akova Budak, B; Baykara, M; Cicek, S; Kıvanç, SA; Yilmaz, H | 1 |
| Inđić, N; Jovanović, M; Milošević, B; Mioljević, V; Stevanović, G; Tošić, T; Velebit, B; Zervos, M | 1 |
| Duszynska, W; Hurkacz, M; Kübler, A; Taccone, FS; Wiela-Hojenska, A | 1 |
| Bonten, MJ; De Brauwer, EI; Penders, RJ; Top, J; van der Linden, CJ; Wagenvoort, JH; Willems, RJ | 1 |
| Assmann, C; Beleites, C; Hey, J; Kirchhoff, J; Kostudis, S; Neugebauer, U; Pfister, W; Popp, J; Schlattmann, P | 1 |
| Jacqz-Aigrain, E; Leroux, S; Sharland, M; van den Anker, JN; Zhao, W | 1 |
| Barriere, SL; Corey, GR; Hardin, TC; Lacy, MK; Luke, DR; Nogid, B; Shorr, AF; Stryjewski, ME; Wang, W | 1 |
| Anastassiou, ED; Doudoulakakis, A; Drougka, E; Giormezis, N; Kolonitsiou, F; Konsolakis, C; Koutsia, C; Lebessi, E; Marangos, M; Papadimitriou-Olivgeris, M; Petinaki, E; Sarrou, S; Spiliopoulou, I; Vourli, S; Zerva, L | 1 |
| Ikeda, M; Moriya, K; Okazaki, M; Okugawa, S; Tatsuno, K; Yagihara, Y | 1 |
| Cao, G; Chen, Y; Huang, J; Liang, X; Liu, X; Wu, J; Yu, J; Zhang, J; Zhang, Y; Zhou, Y | 1 |
| Downing, MA; Eshaghi, A; Johnstone, J; McGeer, A; Patel, SN; Xiong, J | 1 |
| Chen, Y; Gao, P; Hu, J; Shen, X; Wang, Y; Xu, H; Xu, Q; Zhang, H; Zhang, L | 1 |
| Iwanaga, N; Izumikawa, K; Kajihara, T; Kohno, N; Kohno, S; Miyazaki, T; Nakamura, S; Oshima, K; Takazono, T; Yanagihara, K | 1 |
| Barber, KE; Raut, A; Rybak, MJ; Smith, JR | 1 |
| Al Hamal, Z; Chaftari, AM; El Zakhem, A; Gagel, A; Garoge, K; Granwehr, B; Hachem, R; Jiang, Y; Jordan, M; Mulanovich, V; Raad, I; Reitzel, R; Viola, GM; Yousif, A | 1 |
| Carfagna, P; Falcone, M; Goldoni, P; Iraci, F; Russo, A; Venditti, M; Vullo, V | 1 |
| Fili, S; Hayvazov, S; Kohlhaas, M; Kontopoulou, K; Schilde, T | 1 |
| Dabiri, H; Emaneini, M; Heidari, H; Jabalameli, F | 1 |
| Guo, L; Jiang, Y; Luo, Y; Ma, Y; Yang, J; Ye, L | 1 |
| Borgert, SJ; Klinker, KP | 1 |
| Gilmore, MS; Saavedra, JT; Wurster, JI | 1 |
| Hadelova, D; Literak, I; Oravcova, V | 1 |
| Albini, TA; Flynn, HW; Kuriyan, AE; Miller, D; Pathengay, A; Relhan, N | 1 |
| Ghafourian, S; Hatami, V; Mohammadi, F; Mohebi, R; Pakzad, I; Sadeghifard, N; Taherikalani, M; Valadbeigi, H | 1 |
| Acar, M; Akgun Karapınar, B; Akturk, H; Aydin, D; Cihan, R; Çoban, A; Ince, Z; Salman, N; Somer, A; Sutcu, M | 1 |
| Banach, DB; Dembry, LM; Emre, S; Fortune, BE; Peaper, DR | 1 |
| Raut, A; Rybak, MJ; Smith, JR; Yim, J | 1 |
| Chen, H; Chen, Y; Han, W; Huang, X; Liu, D; Liu, K; Tian, J; Wang, F; Wang, Y; Xu, L; Xu, Z; Yan, C; Zhang, X; Zhang, Y | 1 |
| Delap, JH; Marzluff, JM; No, DB; Roberts, MC; Turner, R | 1 |
| Melhus, Å; Starlander, G; Tellgren-Roth, C | 1 |
| Heath, PT; Hill, LF; Lestner, JM; Sharland, M | 1 |
| Bender, JK; Fleige, C; Fuchs, S; Kalmbach, A; Klare, I; Werner, G | 1 |
| Barman, J; Nath, R; Saikia, L | 1 |
| Haldar, J; Samaddar, S; Sarkar, P; Yarlagadda, V | 1 |
| Desplaces, N; Lambert, T; Le Monnier, A; Mizrahi, A; Mohamed-Hadj, A; Pilmis, B; Wolff, S | 1 |
| Akkoc, G; Atici, S; Bakir, M; Karaaslan, A; Kepenekli Kadayifci, E; Ocal Demir, S; Sarmis, A; Soysal, A; Ulger Toprak, N; Yakut, N | 1 |
| Fitzpatrick, F; Looby, S; O'Connell, K; O'Connor, C | 1 |
| Karino, S; Kaye, KS; Koppula, S; Martin, ET; Murray, KP; Mynatt, RP; Navalkele, B; Nishan, B; Pervaiz, A; Pogue, JM; Rybak, MJ; Salim, M; Shaikh, H; Solanki, S; Tashtoush, N | 1 |
| Boyd, DA; Golding, GR; Lalancette, C; Lévesque, S | 1 |
| Bulanda, M; Talaga, K | 1 |
| Chu, CM; Lee, CW; Lee, SC; Liu, YC; See, LC; Shih, TC | 1 |
| Carse, E; Lister, DM; Stuart, RL; Tan, K | 1 |
| Absar, MM; Al-Ahdal, MN; Al-Mohizea, MM; Al-Qahtani, AA; Fatani, AJ; Ridha, AM; Senok, AC; Somily, AM | 1 |
| Adams, B; Ford, CD; Gazdik, MA; Hoda, D; Lopansri, BK; Petersen, FB; Snow, GL; Webb, B | 1 |
| Chau, PH; Chen, JH; Cheng, VC; Chuang, VW; Ho, PL; Lai, CK; So, SY; Tai, JW; Tsang, DN; Wong, SC; Yuen, KY | 1 |
| Jeleńska, A; Paluszak, Z; Skowron, K; Szala, B | 1 |
| Bojić, EF; Hukić, M; Ibrišimović, MA; Jakovac, S; Ostojić, M; Tutiš, B | 1 |
| Li, S; Starkey, ES | 1 |
| Akhtar, N; Nizamuddin, S; Sultan, F; Zafar, W | 1 |
| Göçmen, JS; Saba Çopur, Ş; Şahin, F | 1 |
| Brodrick, HJ; Parkhill, J; Peacock, SJ; Raven, KE; Reuter, S; Reynolds, R; Russell, JE; Török, ME | 1 |
| Abat, C; Bentorki, AA; Bourafa, N; Boutefnouchet, N; Loucif, L; Olaitan, AO; Rolain, JM | 1 |
| Cheng, DH; Liu, TT; Lu, H; Qin, XL; Wei, WX | 1 |
| Fisher, D; Isenman, H | 1 |
| Fang, J; Li, JJ; Shang, EN; Tang, L; Wang, SN; Weng, XH | 1 |
| Chang, WH; Fu, CY; Lee, GB; Lee, MS; Lee, WB; Wang, CH; You, HL | 1 |
| Icgen, B; Nakipoglu, M; Yilmaz, F | 1 |
| Al-Kali, A; Alkhateeb, HB; Damlaj, M; Gastineau, DA; Hashmi, SK; Hefazi, M; Hogan, WJ; Litzow, MR; Partain, DK; Patel, R; Patnaik, MM; Razonable, RR | 1 |
| Carroll, K; Romagnoli, M; Simner, PJ; Wang, F; Workneh, M | 1 |
| Chen, Z; Guo, Y; Li, D; Lv, J; Qi, X; Wang, L; Wang, S; Yu, F; Zhang, X | 1 |
| Escudero, L; Olea, JL; Ramírez, C; Tarragó, R | 1 |
| Chu, CI; Fang, Y; Jiang, HL; Li, YH; Wang, LS; Zhou, Z | 1 |
| Aitken, SL; Arias, CA; DiPippo, AJ; Munita, JM; Shelburne, SA; Tarrand, JJ; Tran, TT; Tverdek, FP | 1 |
| Arhin, FF; Belley, A; Moeck, G; Pillar, CM; Shinabarger, DL; Stoneburner, A; Sweeney, D | 1 |
| Aiken, SS; Angus, EM; Bishop, JY; Cooper, JJ; Frapwell, CJ; Howlin, RP; Stoodley, P; Webb, JS; Winnard, C | 1 |
| Hattori, N; Hirano, K; Iwanaga, N; Izumikawa, K; Kajihara, T; Kohno, N; Kohno, S; Miyazaki, T; Miyazaki, Y; Mukae, H; Nakamura, S; Oshima, K; Yanagihara, K | 1 |
| Fennell, J; Gunning, H; Lavin, P; Mellotte, G; Murphy, P; Smyth, A; Taylor, G; Wall, C | 1 |
| Humphreys, H | 1 |
| Caeiro, JP; Hernández, D; Laborie, M; Lipari, F; Martínez, M | 1 |
| Aubry, JM; Belmessieri, D; Duclos, MC; Duguet, N; Dumitrescu, O; Gozlan, C; Lemaire, M; Lina, G; Molinier, V; Redl, A | 1 |
| Keshavarz Valian, S; Mahmoudi, S; Mamishi, S; Movahedi, Z; Pourakbari, B; Sabouni, F | 1 |
| Anastasiou, D; Arnold, SR; Arrieta, A; Bokesch, P; Bradley, J; Congeni, B; Daum, RS; Glasser, C; Kojaoghlanian, T; Patino, H; Wolf, DJ; Yoon, M | 1 |
| Hendrickx, APA; Martin, NI; van Harten, RM; Willems, RJL | 1 |
| Gilmore, MS; Van Tyne, D | 1 |
| Ahn, K; Hwang, GY; Hyun, S; Uh, Y; Yoon, KJ | 1 |
| Darazam, IA; Ghasemnejad, M; Javadi, A; Rouhani, M; Shokouhi, S | 1 |
| Britt, NS; Patel, N; Potter, EM; Steed, ME | 1 |
| Akpaka, PE; Golding, GR; Jayaratne, P; Kissoon, S; Smith, A; Wilson, C | 1 |
| Rybak, MJ; Smith, JR; Yim, J | 1 |
| Chen, KJ; Chen, TL; Lai, CC; Sun, MH | 1 |
| Henard, S; Jouzeau, N; Rabaud, C; Villaume, M | 1 |
| Fortineau, N; Leclercq, R; Maugat, S; Robert, J | 1 |
| Chung, GE; Kim, BH; Kim, EC; Kim, W; Kim, YJ; Lee, HS; Lee, JH; Myung, SJ; Yoon, JH | 1 |
| Cao, B; Li, R; Liu, Y; Song, S; Wang, C; Wang, H | 1 |
| Croos-Dabrera, RV; Ijzerman, MM; Lin, DF; Miao, JZ; Shen, HH; Sheng, RY; Sheng, W; Wang, F; Wu, JF; Zhang, YY; Zheng, JC; Zheng, LY; Zhou, X | 1 |
| Cao, B; Du, XL; Li, BB; Li, F; Liu, YM; Qu, SS; Wang, H; Wang, QT; Wang, SS; Yang, CX | 1 |
| Babinchak, T; Beuran, M; Bochan, M; Cooper, CA; Dartois, N; Dimov, R; Dukart, G; Ellis-Grosse, EJ; Fichev, G; Florescu, I; Gandjini, H; Razbadauskas, A | 1 |
| Weese, JS | 1 |
| Koplin, RS; Rau, G; Ritterband, DC; Seedor, JA; Shah, MK | 1 |
| Chong, TW; Evans, HL; Hedrick, TL; McElearney, ST; Pruett, TL; Sawyer, RG; Scheld, WM; Smith, RL; Swenson, BR | 1 |
| Kenney, B; Tormey, CA | 1 |
| Cheung, BM; Kwok, AK; Liu, F | 1 |
| Arias, CA; Contreras, GA; Cortes, L; Díaz, L; DiazGranados, CA; Murray, BE; Panesso, D; Prada, G; Reyes, J; Rincón, S; Vanegas, S | 1 |
| de Vries, R; Pechlivanoglou, P; Postma, MJ; Sancar, AA; Simsek, N; Unal, S; Yegenoglu, S | 1 |
| Akduman, D; Aktaş, E; Aydemir, H; Celebi, G; Oztoprak, N; Pişkin, N | 1 |
| Florescu, D; Hill, L; Iwen, PC; Sudan, D | 1 |
| Bert, F; Bourdon, N; Le Grand, J; Leflon-Guibout, V; Nicolas-Chanoine, MH | 1 |
| Decazes, JM | 1 |
| Duarte, RS; Merquior, VL; Neves, FP; Ribeiro, RL; Teixeira, LM | 1 |
| Coque, TM; Hammerum, AM; Hope, R; Hryniewicz, W; Johnson, A; Klare, I; Kristinsson, KG; Leclercq, R; Lester, CH; Lillie, M; Novais, C; Olsson-Liljequist, B; Peixe, LV; Sadowy, E; Simonsen, GS; Top, J; Vuopio-Varkila, J; Werner, G; Willems, RJ; Witte, W; Woodford, N | 1 |
| Aguinaga, A; Alonso, M; Del Pozo, JL; Hernaez, S; Leiva, J; Serrera, A | 1 |
| Gonzalez-Ruiz, A; Richardson, J | 1 |
| Goldman, DL; Janow, G; Lambert, B; Rosen, O; Scheiner, M; Soghier, L | 1 |
| Chlebicki, MP; Kurup, A | 1 |
| Carias, LL; Hutton, R; Lakticová, V; Marshall, SH; Rice, LB; Rudin, S | 1 |
| Nandi, K; Rishi, E; Rishi, P; Shroff, D; Therese, KL | 1 |
| Linden, PK | 3 |
| Bouza, E; Croos-Dabrera, RV; Herr, DL; Ijzerman, MM; Knirsch, C; Kunkel, MJ; Ruf, BR; Tack, KJ; Wilcox, MH | 1 |
| Hitomi, S; Koganemaru, H | 1 |
| Gregson, PA; Jones, RS; Warren, RE; Whittaker, JP | 1 |
| Billeter, M; Craig, W; Dalovisio, JR; Levine, DP; Lomaestro, B; Moellering, R; Rotschafer, JC; Rybak, M | 1 |
| Chiquet, C; Cornut, PL | 1 |
| Hapnes, N; Knowles, S; Twomey, A | 1 |
| Ramsey, AM; Zilberberg, MD | 1 |
| Amyes, SG; Dobay, O; Ghidán, A; Kaszanyitzky, EJ; Nagy, K; Rozgonyi, F; Samu, P | 1 |
| Hryniewicz, W; Kuch, A; Ozorowski, T; Stefaniuk, E | 1 |
| Abranches, J; Chávez, V; Garsin, DA; Kajfasz, JK; Lemos, JA; Martinez, AR | 1 |
| Cheong, HJ; Choi, WS; Heo, JY; Jo, YM; Kim, WJ; Noh, JY; Song, JY | 1 |
| Abu-Alfa, AK; Brewster, UC; Hall, I; Huen, SC; Mahnensmith, RL; Topal, J | 1 |
| Coffin, SE; Gerber, JS; Gross, K; McGowan, KL; Nolan, SM; Prasad, P; Reilly, AF; Rettig, S; Zaoutis, T | 1 |
| Chen, KJ; Sun, CC; Yang, KJ; Yeung, L | 1 |
| Echols, M; Keeley, EC; McGuire, DK; Memon, N; Parikh, SV; Shah, J | 1 |
| Mittal, MK; Zimmerman, RA | 1 |
| Jhaveri, R; Lopez Marti, MG | 1 |
| Bou, G; Camba, V; Coque, TM; Pérez, S; Rodríguez-Baño, J; Torres, E; Villanueva, R; Vindel, A | 1 |
| Cadé, S; Enouf, V; Fabre, M; Foissaud, V; Mac Nab, C; Samson, T; Soler, C; Surcouf, C | 1 |
| Chang, CK; Chen, YL; Cheng, CK; Peng, CH | 1 |
| Dominguez-Gil, A; Fernández de Gatta, Mdel M; García, MJ; Sánchez Navarro, A; Santos Buelga, D | 1 |
| Kolson, DL; Kranick, SM; Vinnard, C | 1 |
| Chow, KM; Chung, KY; Kwan, BC; Law, MC; Leung, CB; Li, PK; Pang, WF; Szeto, CC | 1 |
| Higa, M; Kisanuki, K; Nakasone, I; Shiohira, CM; Yamane, N | 1 |
| Baba, H; Kuzuya, T; Nabeshima, T; Yamada, K; Yamamoto, M | 1 |
| Drusano, GL; Lodise, TP; Lomaestro, BM; Patel, N; Rodvold, KA | 1 |
| Lesens, O | 1 |
| Cao-Huu, T; Chanet, P; Henard, S; Kessler, M; Loos-Ayav, C; Rabaud, C | 1 |
| Cao-Huu, T; Chanet, P; Diguio, N; Hartemann, P; Hautemanière, A; Kessler, M | 1 |
| García Madero, R; García Zubiri, C; Gil Navarro, M; Laguna Del Estal, P | 1 |
| Bertics, PJ; Wiepz, GJ | 1 |
| Auzou, M; Bourdon, N; Cattoir, V; Huynh, TM; Leclercq, R | 1 |
| Dohlman, CH; Durand, ML | 1 |
| Chan, D; Hsu, LY; Koh, TH; Krishnan, P; Leo, N; Lin, RT; Low, BS; Nadarajah, M; Ong, KH; Toh, SL | 1 |
| Callery, S; Simor, AE; Vearncombe, M; Williams, VR | 1 |
| Chua, K; Howden, BP | 1 |
| Eliopoulos, GM | 5 |
| Ampe, E; Berthoin, K; Carryn, S; Tulkens, PM | 1 |
| Arias, CA; Eliopoulos, GM; Galloway-Peña, JR; Murray, BE; Nallapareddy, SR | 1 |
| Chang, CM; Chen, PL; Chung, CH; Hung, YP; Ko, WC; Lee, CC; Lee, HC; Lee, NY; Wu, CJ | 1 |
| Chen, YG; Li, LJ; Qu, TT; Wei, ZQ; Yu, YS; Zhang, JL; Zhou, ZH | 1 |
| Adadyński, L; Buczkowska, T; Chmura, A; Durlik, M; Grzybowska, W; Kwiatkowski, A; Mlynarczyk, A; Mlynarczyk, G; Mrowka, A; Paczek, L; Pazik, J; Tyski, S | 1 |
| Beibei, L; Mengli, C; Nan, B; Rui, W; Xuhong, Y; Yun, C | 1 |
| Nailor, MD; Sobel, JD | 1 |
| McBride, SJ; Roberts, SA; Upton, A | 1 |
| Hryniewicz, W; Kawalec, M; Konopka, L; Ozorowski, T; Zaleska, M | 1 |
| de Jesus Castro Lima, M; Levin, AS; Müller, PR; Pereira, GH; Torchio, DS; Zanella, RC | 1 |
| Al-Kofide, H; Al-Naim, L; Zaghloul, I | 1 |
| Ellermann-Eriksen, S; Kristensen, L; Rathe, M; Schumacher, H; Thomsen, MK | 1 |
| Muñoz, P | 1 |
| Sahl, HG; Schneider, T | 1 |
| Bonet, A; de Batlle, J; de la Torre, M; Motjé, M; Piñeiro, L; Sirvent, JM | 1 |
| Hadji-nejad, S; Mehrgan, H; Rahbar, M | 1 |
| Bayraktar, M; Ozgönül, A; Tekin Koruk, S; Tümer, S | 1 |
| Allon, M; Taylor, ME | 1 |
| Jones, DB | 1 |
| Desai, RU; Pass, AB; Saffra, NA; Sharma, S | 1 |
| Bacigalupo, A; Boni, L; Cappellano, P; Del Bono, V; Dominietto, A; Gualandi, F; Lamparelli, T; Mikulska, M; Prinapori, R; Raiola, AM; Van Lint, MT; Viscoli, C | 1 |
| Aspevall, O; Erntell, M; Hedin, G; Heimer, D; Hokeberg, I; Kidd-Ljunggren, K; Melhus, A; Olsson-Liljequist, B; Sjogren, I; Smedjegard, J; Soderblom, T; Struwe, J; Sylvan, S; Tegmark-Wisell, K; Thore, M | 1 |
| Abdujamilova, N; Bartlett, P; Donabedian, SM; Gordoncillo, MJ; Naqvi, A; Perri, MB; Reyes, KC; Zervos, MJ | 1 |
| Ballard, SA; Grabsch, EA; Grayson, ML; Howden, BP; Johnson, PD; Seemann, T; Stinear, TP; Young, HL | 1 |
| Barriere, SL; Benton, BM; Kitt, MM; Krause, KM | 1 |
| Arhin, FF; Draghi, DC; Moeck, G; Pillar, CM; Sahm, DF | 1 |
| Akcay, MN; Altoparlak, U; Koca, O; Ozkurt, Z | 1 |
| Chu, CC; Hsueh, PR; Huang, YT; Lai, CC; Lee, PI; Lee, YL; Lu, CL; Tan, CK; Wang, CY | 1 |
| Bowker, KE; Elliott, HC; MacGowan, AP; Noel, AR; Tomaselli, S | 1 |
| Ang, JY; Deville, JG; Equils, O; Huang, DB | 1 |
| Cattoir, V; Leclercq, R | 1 |
| Bookstaver, PB; Hashem, MG; Iqbal, R; James, CL; Le, J; Rudisill, CN; Sakoulas, G | 1 |
| Jones, RN; Mendes, RE; Pfaller, MA; Rhomberg, PR; Sader, HS | 1 |
| Alangaden, GJ; Bharadwaj, R; Chandrasekar, PH; Fairfax, MR; Painter, TM; Salimnia, H | 1 |
| Balne, PK; Bhatia, K; Mathai, A; Reddy, AK; Reddy, BV; Sambhav, K | 1 |
| Álvarez Lerma, F; García Simón, M; González Pérez, MI; Rodriguez Colomo, O; Sirvent, JM | 1 |
| Anacarso, I; Bondi, M; de Niederhäusern, S; Iseppi, R; Manicardi, G; Messi, P; Sabia, C | 1 |
| Agkus, C; Kocyigit, I; Oymak, O; Unal, A; Utas, C | 1 |
| Bonten, MJ; De Brauwer, EI; Penders, RJ; Top, J; Wagenvoort, JH; Willems, RJ | 1 |
| Dhaliwal, DK; Eller, AW; Farhi, P; Kowalski, RP | 1 |
| Boldrin, C; De Canale, E; Fallico, L; Franchin, E; Grossato, A; Manganelli, R; Palù, G; Parisi, SG; Tommasini, T | 1 |
| Kim, IH; Kim, KS; Kim, NA; Kim, SJ; Lee, JI; Oh, BC; Park, CG | 1 |
| Fitzgibbons, LN; Forrest, GN; Mackay, K; Puls, DL | 1 |
| Alexiou, K; Matschke, K; Reichenspurner, H; Tugtekin, SM; Wilbring, M | 1 |
| Fasih, N; Hasan, R; Jabeen, K; Khan, E; Zafar, A | 1 |
| Bourdon, N; Cattoir, V; Coignard, B; Fines-Guyon, M; Leclercq, R; Maugat, S; Thiolet, JM | 1 |
| Amaya-Villar, R; de la Torre, MV; Garnacho-Montero, J; Gómez-Grande, ML; Jerez, V; Lorente-Ramos, L; Loza, A; Martínez, A; Ortiz, C; Pomares, J; Pozo, JC; Sierra, R | 1 |
| Chung, DR; Kang, CI; Ki, CS; Kim, PW; Lee, JH; Lee, NY; Peck, KR; Seo, JY; Song, JH | 1 |
| Mercuri, LG; Psutka, D | 1 |
| Barberán, J | 1 |
| Cercenado, E | 1 |
| Brescini, L; Cirioni, O; Dawgul, M; Ghiselli, R; Giacometti, A; Guerrieri, M; Kamysz, W; Myszka, H; Orlando, F; Silvestri, C | 1 |
| Matana Kaštelan, Z; Matana, A; Žagar, D | 1 |
| Almyroudis, N; Forrest, A; Jarkowski, A; Segal, BH; Sweeney, RP; Tan, W; Wang, ES; Wetzler, M | 1 |
| Leung, W; Nguyen, GC; Weizman, AV | 1 |
| Bahr, MH; Behrman, SW; Dickson, PV; Zarzaur, BL | 1 |
| Tarchini, G | 1 |
| Augustine, D; Dinesh, KR; Karim, S; Kumar, A; Kurian, AM; Philip, R; Sudhindran, S | 1 |
| Chewning, JH | 1 |
| Callegan, MC; Griffin, G; Guess, S; Leonard, R; Wheatley, NR; Wiskur, BJ; Woods, DC | 1 |
| Kim, HJ; Kim, JY; Kim, MJ; Lee, J; Lee, SE; Park, DW; Sohn, JW; Yoon, YK | 1 |
| Fang, H; Jiang, GX; Ohlsson, AK; Ullberg, M | 1 |
| Cho, OH; Choi, SH; Chong, YP; Jeong, JY; Kim, MN; Kim, SH; Kim, YS; Lee, SO; Na, S; Park, HJ; Park, KH; Sung, H; Woo, JH | 1 |
| Gazin, M; Goossens, H; Lammens, C; Malhotra-Kumar, S | 1 |
| De Bacquer, D; De Vriese, AS; Vandecasteele, SJ | 1 |
| Brown, M; Cuhaci, B; Gracely, EJ; Polisetty, R; Schlecht, HP | 1 |
| Bicking, K; Desai, S; King, EA; McCoy, D; Nyirenda, T | 1 |
| da Costa Darini, AL; Levy, CE; Palazzo, IC; Pitondo-Silva, A | 1 |
| Garcia-Migura, L; Jensen, LB; Sanchez-Valenzuela, AJ | 1 |
| Farrell, DJ; Jones, RN; Sader, HS | 1 |
| Betrisey, B; Corvec, S; Furustrand Tafin, U; Majic, I; Trampuz, A; Zalila Belkhodja, C; Zimmerli, W | 1 |
| Cleveland, KO; Gelfand, MS; Holloway, K; King, ST; Koeth, L; Usery, JB | 1 |
| Jenkins, SG; Raskoshina, L; Schuetz, AN | 1 |
| El-Amin, NM; Faidah, HS | 1 |
| Beloborodov, VB; Gruver, KP; Kuz'menko, TN | 1 |
| Cuervo, J; Gil-Parrado, S; Grau, S; Rebollo, P | 1 |
| Fujita, N; Ichiyama, S; Iinuma, Y; Ito, Y; Matsumura, Y; Matsushima, A; Nagao, M; Shimizu, T; Shirano, M; Takakura, S; Yamamoto, M | 1 |
| Jureen, R; Krishnan, P; Lin, RT; Teo, JW | 1 |
| Cataldo, MA; Grilli, E; Pea, F; Petrosillo, N; Tacconelli, E | 1 |
| Kelesidis, T | 1 |
| Ak, O; Kadanali, A; Karagoz, G; Ozer, S | 1 |
| Lenoble, M | 1 |
| Boucher, HW; Rivera, AM | 1 |
| Aghazadeh, M; Ghotaslou, R; Hasani, A; Milani, M; Sharifi, Y; Soroush, MH; Varshochi, M | 1 |
| Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Oreshkina, TD | 1 |
| Friedrich, AW; Gounaris, A; Kimouli, M; Koumaki, V; Papadopoulou, M; Petropoulou, D; Tsakris, A; Vrioni, G | 1 |
| Farrell, DJ; Jones, RN; Mendes, RE; Sader, HS; Woosley, LN | 1 |
| Ascaso, FJ; Espinet, R; Huerva, V | 1 |
| Ahn, SH; Jin, HY; Jung, MK; Lee, WG; Park, IJ | 1 |
| Bellissimo-Rodrigues, F; Carlotti, AP; Carmona, F; Gaspar, GG; Martinez, R; Matsuno, AK; Prado, SI; Silva, MF | 1 |
| Cheong, HJ; Kee, SY; Kim, WJ; Kwon, YJ; Lee, JE; Park, CW; Pyo, HJ | 1 |
| Boger, DL; James, RC; Okano, A; Pierce, JG; Xie, J | 1 |
| Bathina, P; Bheemreddy, S; Chalana, IK; Hasan, A; Hayakawa, K; Kamatam, S; Kaye, KS; Kotra, H; Ku, K; Kumar, S; Lee, DW; Lephart, PR; Marchaim, D; Martin, ET; Nanjireddy, P; Patel, S; Pogue, JM; Pulluru, H; Rybak, MJ; Sheth, P; Sunkara, B; Swan, J; Tiwari, N; Vahia, A; Yee, V; Yousuf, A | 1 |
| Arias, CA; Murray, BE | 1 |
| Falagas, ME; Mavros, MN; Roussos, N; Vardakas, KZ | 1 |
| Álvarez-Lerma, F; Gimeno Costa, R; Gracia Arnillas, MP; Insausti Ordeñana, J; López Pueyo, MJ; Olaechea Astigarraga, P; Palomar Martínez, M; Seijas Betolaza, I | 1 |
| Cai, Y; Chan, JP; Fisher, DA; Hsu, LY; Koh, TH; Krishnan, P; Kwa, AL; Tan, TY; Tee, NW | 1 |
| Bauer, J; Bauer-Unkauf, I; Bischoff, M; Hölzel, C; Hörmansdorfer, S; Kämpf, P; Mölle, G; Preikschat, P; Schwaiger, K | 1 |
| Iribarren, JA; Llinares, P | 1 |
| Chang, CM; Chou, CH; Ko, WC; Lee, CC; Lee, HC; Lee, NY | 1 |
| Aksu, N; Baran, I; Coşkun, FA; Kanyılmaz, D; Karahan, ZC; Kurşun, S; Mumcuoğlu, I; Tekeli, FA; Us, E | 1 |
| Dasari, P; Maurya, DK | 1 |
| Balm, MN; Dancer, SJ; Fisher, DA; Jureen, R; Lin, RT; Teo, C; Yeoh, AE | 1 |
| Kim, EC; Kim, HB; Kim, TS; Kwon, HL; Park, KU; Song, J; Song, KH; Song, SH | 1 |
| Clark, NM; Grim, SA; Janda, WM; Layden, JE; Lee, TA; Santayana, EM | 1 |
| Jain, N; Mathur, P; Misra, MC | 1 |
| Akpabie, A; Aubry, A; Barbut, F; Brossier, F; Brun-Buisson, C; Chedhomme, FX; Fortineau, N; Fournier, S; Gillaizeau, F; Jarlier, V; Kassis-Chikhani, N; Lucet, JC; Robert, J; Seytre, D; Simon, I; Vanjak, D; Zahar, JR | 1 |
| de Magalhaes Silverman, M; Gingrich, RD; Wudhikarn, K | 1 |
| Adams, CA; Cioffi, WG; Connolly, MD; Gregg, S; Heffernan, DS; Monaghan, SF; Stephen, A; Thakkar, RK | 1 |
| Bisquert, J; Chacón, P; Lainez, S; Sáez-Nieto, JA; Solís, S; Tena, D; Torralba, M; Valdezate, S | 1 |
| Chien, HY; Leu, WJ; Lin, YM; Liu, HP; Liu, YC; Wang, HW | 1 |
| da Costa Darini, AL; da Silva, LP; Martinez, R; Pitondo-Silva, A | 1 |
| Arnold, JC; Bradley, J; Cannavino, CR; Miller, TC; Riffenburgh, RH; Ross, MK; Westley, B | 1 |
| Gopal, L; Jambulingam, M; Madhavan, HN; Rishi, E; Rishi, P; Sengupta, S; Therese, KL | 1 |
| Chen, M; Costello, AJ; Jones, RN; Li, G; Liu, Y; Mendes, RE; Sun, H; Wang, H; Xu, Y | 1 |
| Degener, JE; Feik, D; Mortensen, JE; Rams, TE; van Winkelhoff, AJ | 1 |
| Hazelton, BJ; Iredell, JR; Thomas, LC; Unver, T | 1 |
| Bheemreddy, S; Biedron, C; Chalana, IK; Collins, V; Hayakawa, K; Ho, K; Judge, T; Kamatam, S; Kaye, KS; Khammam, V; Lephart, PR; Marchaim, D; Martin, ET; Nanjireddy, P; Parveen, S; Pogue, JM; Reddy, SM; Rybak, MJ; Tiwari, N; Tumma, RS; Yousuf, A | 1 |
| Kardén-Lilja, M; Koskela, M; Salmenlinna, S; Tissari, P; Vuopio, J | 1 |
| Lo, WB; Patel, M; Solanki, GA; Walsh, AR | 1 |
| Bommarito, S; Chaudhry, A; Farhat, M; Hayakawa, K; Ho, K; Jagadeesh, KK; Kaye, KS; Lephart, PR; Marchaim, D; Martin, ET; Moshos, JA; Mroue, R; Nanjireddy, P; Obeid, T; Parveen, S; Pogue, JM; Rybak, MJ; Singla, M; Sunkara, B; Vadlamudi, G | 1 |
| Elshaug, EK; Ingram, PR; Manning, L; Rawlins, MD; Ridley, BL | 1 |
| Mehta, J; Pi, J; Trifilio, SM | 1 |
| Descourouez, JL; Jorgenson, MR; Rose, WE; Wergin, JE | 1 |
| Barshes, NR; Bechara, CF; Darouiche, RO; Kougias, P; Lin, PH; Pisimisis, G; Poi, MJ | 1 |
| Abdelhadii, A; Beumier, M; Covajes, C; de Backer, D; Jacobs, F; Ocampos-Martinez, E; Penaccini, L; Scolletta, S; Taccone, FS; Vincent, JL | 1 |
| Ikeuchi, H; Ishihara, M; Nakajima, K; Takahashi, Y; Takesue, Y; Takubo, S; Tsuchida, T; Uchino, M | 1 |
| Ahmed, F; Ajamoughli, M; Bathina, P; Hayakawa, K; Ho, K; Jagadeesh, KK; Kamatam, S; Kaye, KS; Khan, A; Lee, KP; Levine, M; Marchaim, D; Martin, ET; Moshos, JA; Mustapha, M; Omotola, AM; Patel, D; Pogue, JM; Reddy, SM; Rybak, MJ; Suhrawardy, U; Sunkara, B; Willis, LB | 1 |
| Cekin, Y; Colak, D; Dönmez, L; Mutlu, D; Oğünç, D; Ongüt, G; Ozhak Baysan, B; Sepin Özen, N | 1 |
| Boulinguez, S; Viraben, R | 1 |
| Carmeli, Y; Eliopoulos, GM; Samore, MH | 1 |
| Bruinsma, N; Driessen, C; London, N; Stobberingh, EE; van den Bogaard, AE; van Santen-Verheuvel, M; Willems, RJ | 1 |
| Bangsberg, DR; Chambers, HF; Charlebois, ED; Felt, SC; Gerberding, JL; Perdreau-Remington, F; Rosen, JI; Steele, L; Winston, LG; Wong, M | 1 |
| Bertolissi, M; Di Silvestre, A; Furlanut, M; Giordano, F; Pea, F; Poz, D | 1 |
| Gillespie, RS; McDonald, RA; Symons, JM | 1 |
| Esber, E; Fogel, EL; Kalayci, C; Lehman, GA; Rerknimitr, R; Sherman, S | 1 |
| Cieslak, PR; Fleming, DW; Strausbaugh, LJ; Thomas, AR | 1 |
| Donabedian, SM; English, LL; Hayes, JR; McDermott, PF; Simjee, S; Wagner, DD; Walker, RD; White, DG; Zervos, MJ | 1 |
| Pigrau, C | 1 |
| Allen, NE; Nicas, TI | 1 |
| Borkowski, J; Czaban, SL; Krajewski, JP; Lebkowski, WJ | 1 |
| Ahmadi, MA; Esmaeli, B; Holz, ER; Krathen, RA; Raad, II | 1 |
| Agamah, E; Goodrich, J; Kanchanapoom, T; Khardori, N; Koirala, J | 1 |
| Chang, KH; Chong, Y; Kim, JM; Kim, MS; Lee, K; Shin, JW; Yong, D | 1 |
| Fukuda, M; Hanazome, I; Sasaki, K | 1 |
| Fujimoto, S; Ike, Y; Murakami, M; Takahashi, A; Yomoda, S | 1 |
| Gold, HS; Inglima, K; Pillai, SK; Press, RA; Rahim, S; Venkataraman, L | 1 |
| Boneca, IG; Chiosis, G | 1 |
| Boehm, I; Christiansen, KJ; Costa, AM; Flexman, JP; Kay, ID; Lambert, EJ; Palladino, S | 1 |
| Bernstein, JM; Bogard, L; Clarridge, JE; Neef, PA; Polenakovik, H; Saklayen, M | 1 |
| Kauffman, CA | 1 |
| Christiansen, KJ; Douglas, CR; Heath, CH; Khinsoe, CH; Kosaras, FP; Lee, RC; Orrell, CT; Pearman, JW; Perry, PL; Peterson, AM | 1 |
| Chen, DC; Du, B; Liu, DW | 1 |
| Sunagawa, M; Ueda, Y | 1 |
| Calfee, DP; Durbin, LJ; Farr, BM; Germanson, TP; Giannetta, ET | 1 |
| Adler, S; Bruss, JB; Deville, JG; Edge-Padbury, B; Kaplan, SL; Morfin, MR; Naberhuis-Stehouwer, S; Wu, E; Yogev, R | 1 |
| Gunel, E; Schreiber, JM; Slain, D; Stamatakis, MK | 1 |
| Almeida, SC; Bokermann, S; Brandileone, MC; Moreira, Mde F; Pignatari, AC; Salomão, R; Valdetaro, F; Villins, M; Vitório, F; Zanella, RC | 1 |
| Barefoot, L; Hansjosten, K; Martínez, JA; Ruthazer, R; Snydman, DR | 1 |
| Noskin, GA; Paule, S; Peterson, LR; Price, CS | 1 |
| Alcalá, MA; Alvarez Lerma, F; Blanco, A; Insausti, J; Olaechea, P; Palomar, M | 1 |
| Clark, NM; Hershberger, E; Lynch, JP; Zervosc, MJ | 1 |
| Matoba, AY | 1 |
| Adler, S; Azimi, PH; Beltran, S; Bruss, JB; Deville, JG; Edge-Padbury, B; Jantausch, BA; Morfin, MR; Naberhuis-Stehouwer, S | 1 |
| Adler, S; Bruss, JB; Deville, J; Edge-Padbury, B; Jantausch, BA; Lopez, P; Morfin, MR; Naberhuis-Stehouwer, S | 1 |
| Adler, S; Bruss, JB; Edge-Padbury, B; Kaplan, SL; Martin, A; Morfin, MR; Naberhuis-Stehouwer, S; Patterson, LE; Yogev, R | 1 |
| Bruss, JB; Edge-Padbury, B; Kaplan, SL; Meissner, HC; Morfin, MR; Naberhuis-Stehouwer, S; Townsend, T; Wenman, W | 1 |
| Courvalin, P; Depardieu, F; Fantin, B; Garry, L; Lefort, A | 1 |
| Benjamin, WH; Chavers, LS; Chavers, P; Funkhouser, E; Moser, SA; Stamm, AM; Waites, KB | 1 |
| Alpízar, A; Bustamante, W; Caballero, M; García, F; Hernández, S; Herrera, ML; Pacheco, A; Vargas, A; Vargas, N | 1 |
| Blok, HE; Bonten, MJ; Jalink, KP; Kamp-Hopmans, TE; Mascini, EM; Troelstra, A; Verhoef, J | 1 |
| Schwartz, MD; Shaikh, ZH; Shive, DK | 1 |
| Avni, I; Barequet, IS; Ben Simon, GJ; Cahane, M; Diamanstein-Weiss, L; Goller, O; Grinbaum, A; Rubinstein, E | 1 |
| Arthur, M; Chau, F; Courvalin, P; Depardieu, F; Fantin, B; Lefort, A; Pouzet, C | 1 |
| Cammarata, SK; Croos-Dabrera, RV; Kollef, MH; Rello, J; Wunderink, RG | 1 |
| Dalsgaard, A; Guardabassi, L | 1 |
| Balasubramaniam, M; Donabedian, SM; Hershberger, E; Oprea, SF; Zaidi, N; Zervos, MJ | 1 |
| Andersen, JS; Emborg, HD; Seyfarth, AM; Wegener, HC | 1 |
| Bradford, PA; Dushin, RG; Petersen, PJ; Wang, TZ | 1 |
| Domínguez, L; Fernández-Garayzábal, JF; Herrero, IA; Moreno, MA | 1 |
| D'Alessandro, A; Kalayoglu, M; Knechtle, SJ; Lucey, MR; Maki, DG; Musat, A; Pirsch, J; Safdar, N; Said, A | 1 |
| Billheimer, D; Calder, C; Frangoul, H; Manes, B; Tsiatis, AC; Wilkerson, KS | 1 |
| Claverie-Martín, F; Delgado, T; Flores, C; Lorenzo-Díaz, F; Méndez-Alvarez, S; Reyes-Darias, JA; Sierra, A; Villar, J | 1 |
| Busse-Johnston, L; Leisenring, W; Limaye, AP; Novicki, TJ; Schapiro, JM; Sebeste, A; Swanson, KM; Swanzy, SR; Ulness, BK | 1 |
| Appleman, MD; Citron, DM; Kwok, R | 1 |
| Babalola, CP; Nicolau, DP; Nightingale, CH; Patel, KB | 1 |
| Rao, N; Santa, ER; Wagener, MM; Yu, VL; Ziran, BH | 1 |
| Fisman, DN; Harris, AD; Lipsitch, M; Morris, JG; Perencevich, EN; Smith, DL | 1 |
| Farr, BM | 2 |
| Crews, JH; Isler, CM; Magann, EF; Martin, JN; Rinehart, BK; Terrone, DA | 1 |
| Bergeret, M; Boisset, S; Denis, F; Ducancelle, A; Garnier, F; Pineiro, A; Raymond, J | 1 |
| Bonten, MJ; Leavis, HL; Mascini, EM; Vandenbroucke-Grauls, CM; Willems, RJ | 1 |
| Fukue, H; Hitomi, S; Oishi, T; Shibuya, S | 1 |
| D'Antonio, D; Di Bonaventura, G; Di Giovanni, P; Fiorilli, MP; Fioritoni, G; Francione, A; Manna, A; Parruti, G; Piccolomini, R; Romano, F; Rotolo, S; Savini, V; Schioppa, F; Staniscia, T | 1 |
| Bonora, MG; Bragagnolo, L; De Fatima, M; Fontana, R; Goglio, A; Guazzotti, GC; Ligozzi, M | 1 |
| Hegde, SS; Judice, JK; Kaniga, K; McCullough, J; Obedencio, G; Pace, J; Reyes, N; Shaw, JP; Skinner, R; Thomas, R; Vanasse, N; Wiens, T | 1 |
| Lundstrom, TS; Sobel, JD | 2 |
| Abad, JL; Alió, JL; Ferrer, C; Rodríguez-Prats, JL | 1 |
| Maki, DG; Marx, JA; Tambyah, PA | 1 |
| Baquero, F; Coque, TM; Novais, C; Peixe, L; Sousa, JC | 1 |
| Blum-Menezes, D; Bratfich, OJ; Duboc, GM; Levi, C; Levin, AS; Moretti, ML; Stucchi, RB; Vormittag, E | 1 |
| Van Bambeke, F | 1 |
| Manome, I; Nagasawa, Z; Nagayama, A | 1 |
| Currie, BP; Lemos-Filho, L | 1 |
| Assal, M; Bernard, L; Boffi El Amari, E; Denormandie, P; Hoffmeyer, P; Stern, R; Vuagnat, A | 1 |
| Bondi, M; de Niederhäusern, S; Guerrieri, E; Manicardi, G; Messi, P; Sabia, C | 1 |
| Peetermans, WE; Rijnders, BJ; Stas, M; Van Wijngaerden, E; Vandecasteele, SJ | 1 |
| Fougnot, S; Lozniewski, A; Mory, F; Rabaud, C; Schuhmacher, H | 1 |
| Corso, A; Faccone, D; Gagetti, P; Galas, M; Lopardo, H; Melano, R; Rodriguez, M; Rodríguez, V; Togneri, A | 1 |
| Fincher, ME; Forsyth, M; Rahimi, SY | 1 |
| Burleigh, WA; Comess, BE; Cone, LA; Dreisbach, L; Potts, BE | 1 |
| Fang, CT; Hsueh, PR; Liao, CH; Teng, LJ; Tseng, SP | 1 |
| Au Eong, KG; Chee, CK; Lee, JJ; Teoh, SC | 1 |
| Coyle, EA; Lewis, RE; Prince, RA; Raad, II; Wiederhold, NP | 1 |
| Barriere, SL; Cabell, CH; Chu, VH; Corey, GR; Dunbar, LM; Fowler, VG; Kitt, MM; Lau, WK; O'Riordan, WD; Pien, FD; Spencer, E; Stryjewski, ME; Vallee, M | 1 |
| Aksoy, A; Kaçmaz, B | 1 |
| Fritsche, TR; Jones, RN; Sader, HS; Streit, JM | 1 |
| Caron, HN; Kremer, LC; van de Wetering, MD; van Woensel, JB | 1 |
| Coque, TM; Novais, C; Peixe, LV; Sousa, JC | 1 |
| Chen, KH; Hsu, WM; Hwu, JJ; Lai, JY; Li, YS | 1 |
| Alves, EM; Castelo Branco, R; de Gouvea, EF; Ferreira, AL; Halpern, M; Monteiro, RC; Moreira, BM; Ribeiro-Filho, J; Santoro-Lopes, G | 1 |
| Emmanuel, R; Khudaier, BY; Rani, P; Sharma, M; Sharma, SK; Taneja, N; Tewari, R | 1 |
| Eisner, A; Feierl, G; Gorkiewicz, G; Kessler, HH; Köfer, J; Leitner, E; Marth, E | 1 |
| Apley, MD; Fox, LE; Pressel, MA; Simutis, FJ | 1 |
| Hurley, JC | 1 |
| Käser, L; Kolyvanos Naumann, U; Nigg, C; Vetter, W | 1 |
| Christidou, A; Dima, S; Gikas, A; Haliotis, G; Kartali, S; Kioumis, J; Kritsotakis, EI; Levidiotou, S; Maltezos, E; Metalidis, S; Nikolaidis, P; Papageorgiou, N; Roumbelaki, M; Scoulica, E; Skoutelis, A; Tselentis, Y | 1 |
| Allen, A; Fraser, TG; Stosor, V; Wang, Q; Zembower, TR | 1 |
| Jones, RN | 1 |
| Agnihotri, H; Dubey, D; Marothi, YA | 1 |
| Chenoweth, CE; Fontana, RJ; Kauffman, CA; Mackin, ML; Magee, JC; Malani, PN; McNeil, SA; Punch, JD | 1 |
| Baldelli, F; Malincarne, L; Mancini, GB; Marroni, M; Morosi, S; Pasticci, MB; Stagni, G | 1 |
| Green, GR; Nadarajah, K; Naglak, M | 1 |
| Akiyama, O; Hagiwara, K; Matsuno, H; Sato, T | 1 |
| Eiferman, RA; Hamrah, P; Ritterband, D; Seedor, J | 1 |
| Hartman, CS; Jaksic, B; Leonard, LB; Martinelli, G; Perez-Oteyza, J; Tack, KJ | 1 |
| Biedenbach, DJ; Fritsche, TR; Goldstein, BP; Jones, RN | 1 |
| Heritage, J; Sandoe, JA; West, AP; Wilcox, MH; Wysome, J | 1 |
| Argaud, L; Descloux, E; Le Scanff, J; Mohammedi, I; Robert, D | 1 |
| Benson, CE; Haddock, M; Nunamaker, DM; Orsini, JA; Ramberg, CF; Snooks-Parsons, C; Stine, L | 1 |
| Barriere, SL; Chu, VH; Corey, GR; Dunbar, LM; Fowler, VG; Kitt, MM; Morganroth, J; O'Riordan, WD; Stryjewski, ME; Vallée, M; Warren, BL; Young, DM | 1 |
| Chong, Y; Ha, GY; Jeong, SH; Lee, K; Lim, HS; Park, KH; Shin, JH; Yong, D | 1 |
| DiazGranados, CA; Jernigan, JA | 1 |
| Drews, SJ; Gharabaghi, F; Johnson, G; Matlow, A; Richardson, SE; Roscoe, M; Tellier, R | 1 |
| Matar, MJ; Rolston, KV; Safdar, A | 1 |
| Agathe-Nerine, J; Barny, S; Garin, B; Lechevallier, S | 1 |
| Blom, DW; Bonten, MJ; Hayden, MK; Lyle, EA; van de Vijver, DA; Weinstein, RA | 1 |
| Edmond, MB; Major, Y; Marra, AR | 1 |
| Palau, E; Picazo, JJ; Portolés, A; Puerro, M; Vargas, E | 1 |
| Chen, YP; Jiang, KQ; Jin, RJ; Wang, XD; Zheng, B; Zhu, BH | 1 |
| Bamford, KB; Desai, M; Franklin, BD; Holmes, AH; Jacklin, A; Richards, M; Trust, S | 1 |
| Caltenco-Serrano, R; Mojica-Madera, JA; Nava-Ocampo, AA; Villanueva-García, D | 1 |
| Blazick, E; Garrett, JR; Keeling, WB; Maxey, TS; Sommers, KE; Vohra, N | 1 |
| Heo, ST; Ko, KS; Kwon, KT; Lee, NY; Oh, WS; Park, S; Peck, KR; Ryu, SY; Song, JH | 1 |
| Huang, J; Malczynski, M; Noskin, GA; Postelnick, MJ; Qi, C; Scheetz, MH; Warren, JR; Zembower, TR | 1 |
| Cho, DT; Hong, H; Hong, HG; Ike, Y; Lee, DT; Lee, K; Lee, Y; Park, YH; Shin, E | 1 |
| Dobbs, TE; Hoesley, CJ; Moser, SA; Patel, M; Stamm, AM; Waites, KB | 1 |
| Fraser, TG; Hansen, C; Long, JK | 1 |
| Camargo, IL; Darini, AL; Gilmore, MS | 1 |
| Matar, MJ; Raad, I; Rolston, KV; Tarrand, J | 1 |
| Anasetti, C; Green, MR; Greene, JN; Rolfe, NE; Sandin, RL | 1 |
| Al-Dhibi, H; Chaudhry, IA; Khan, AO; Shamsi, FA | 1 |
| Scheinfeld, N | 1 |
| Anastasopoulos, T; Kofteridis, DP; Kontopodis, E; Panagiotakis, S; Samonis, G | 1 |
| Elmallah, MK; Janda, WM; Munir, WM; Tu, EY | 1 |
| Fang, H; Hedin, G; Li, G; Nord, CE; Telander, B | 1 |
| Brauers, J; Kresken, M; Menke, A; Morrissey, I; Orland, A; Weiher, H | 1 |
| Cosgrove, SE; Curtis, AB; Diekema, DJ; Herwaldt, LA; Hinrichsen, VL; Huang, SS; Jernigan, JA; Noskin, GA; Perl, TM; Platt, R; Pottinger, JM; Rifas-Shiman, SL; Tokars, JL; Yokoe, DS; Zembower, TR | 1 |
| Beckius, G; Dib-Hajj, F; Gootz, TD; Kaczmarek, F; Lamb, L; Marra, A; Medina, I; Milici, AJ; Shang, W | 1 |
| Chang, PC; Chuang, YC; Li, HY; Liu, JW; Tang, HJ; Wang, JJ | 1 |
| Chatterjee, I; Iredell, JR; Lipman, J; Woods, M | 1 |
| de Bruin, MA; Riley, LW | 1 |
| Tsuji, A | 2 |
| Starr, JA | 1 |
| Manfredi, R | 1 |
| Cheng, CK; Lee, TS; Tang, CW | 1 |
| Colaert, J; Gheysen, F; Michels, F; Scheerlinck, T | 1 |
| Ptushkin, VV | 1 |
| Bell, JM; Biedenbach, DJ; Fritsche, TR; Jones, RN; Sader, HS; Turnidge, JD | 1 |
| Campodonico, R; Colli, A; Gherli, T | 1 |
| Cheung, KW; Hui, M; Lee, GC; So, RK; You, JH | 1 |
| Seymour, JF; Slavin, MA; Thursky, KA; Worth, LJ | 1 |
| Hur, JA; Kang, MW; Kim, SI; Kim, YJ; Kim, YR; Park, YJ; Wie, SH | 1 |
| Jenkins, I | 1 |
| DiPersio, D; Jerome, RN; Lee, P; Wheeler, AP | 1 |
| Attwood, RJ; LaPlante, KL | 1 |
| Allerberger, F; Dworzak, M; Huhulescu, S; Mayer, B; Schmid, D; Stadlbauer, S; Wewalka, G | 1 |
| Chmura, A; Grzybowska, W; Kawecki, D; Młynarczyk, A; Młynarczyk, G; Rowiński, W; Tyski, S; Łuczak, M | 1 |
| Lalitha, P; Ravichandran, M; Yean, CY; Yin, LS | 1 |
| Caplin, JL; Hanlon, GW; Taylor, HD | 1 |
| Akechi, K; Maeda, Y; Matsuzaki, S; Muraoka, A; Rashel, M; Sugihara, S; Takemura, I; Uchiyama, J; Wakiguchi, H | 1 |
| Cataldo, MA; Tacconelli, E | 1 |
| Guglielmo, BJ; Ngo, PD; Schwartz, BS | 1 |
| Balci, I; Menteş, O | 1 |
| Bagchi, P; Bush, K; Ianus, J; Noel, GJ; Strauss, RS | 1 |
| Jayashree, M; Mathew, JL; Ray, P; Singhi, S | 1 |
| Berrocal, A; Flynn, HW; Miller, D; Miller, JJ; Murray, TG; Scott, IU; Smiddy, WE | 1 |
| Baysan, BO; Colak, D; Ergani-Ozcan, A; Inan, D; Naas, T; Nordmann, P; Ogunc, D | 1 |
| Cunha, BA | 1 |
| Recco, RA | 1 |
| Levine, DP | 1 |
| Callegan, MC; Farrand, AJ; Novosad, BD; Robinson, ML; Wiskur, BJ | 1 |
| Blake, RK; Olivier, CN; Salgado, CD; Steed, LL | 1 |
| Dahlke, J; Franke, G; Heisig, P; Horstkotte, MA; Pothmann, W; Rohde, H; Saager, B; Scherpe, S; Sobottka, I; Timmerbeil, BS | 1 |
| Jadoul, M; Labriola, L | 1 |
| Aguilar, L; Barberán, J; Giménez, M; Prieto, J | 1 |
| Barriere, SL; Corey, GR; Fowler, VG; Friedland, HD; Graham, DR; Hopkins, A; Kitt, MM; Lentnek, A; O'Riordan, W; Ross, DP; Stryjewski, ME; Wilson, SE; Young, D | 1 |
| Carter, JE; Mizell, KN | 1 |
| Dailly, E; Deslandes, G; Jolliet, P; Le Floch, R; Pannier, M | 1 |
| Chang, FY; Chou, YY; Lin, JC; Lin, TY; Peng, MY; Wang, NC | 1 |
| Lamer, C; LeGuillou, JL; Letournel, E; Letournel-Glomaud, C; Moulinié, JP | 1 |
| Bartholomew, WR; Goldstein, E; Parr, T; Vickers, MK | 1 |
| Fiscella, RG | 1 |
| Alfonso, EC; Flynn, HW | 1 |
| Betschel, S; Kreiswirth, B; Low, DE; Willey, BM | 1 |
| Wade, JJ | 2 |
| Arduino, MJ; Banerjee, S; Bland, LA; Jarvis, WR; Maloney, SA; Montecalvo, M; Shay, DK; Wormser, GP | 1 |
| Bohnen, JM; Burnett, RJ; Dellinger, EP; Haverstock, DC; Reinhart, HH; Rotstein, OD; Solomkin, JS; Vogel, SB | 1 |
| Cameron, SB; Dunn, DL; Ferrieri, P; Juni, BA; Mason, KR; Rhame, FS; Wells, CL | 1 |
| Carroll, KC; Leonard, RB; Newcomb-Gayman, PL; Ohlson, S | 1 |
| Dowling, TC; Hebden, JN; Jarvis, W; Johnson, JA; McCarter, RJ; Morris, JG; Perdue, BE; Polish, LB; Schwalbe, RS; Shay, DK | 1 |
| Edmond, MB; Hwang, T; Ober, JF; Pfaller, MA; Sanford, MD; Weinbaum, DL; Wenzel, RP | 1 |
| Murray, BE | 2 |
| Brennan, PJ; Edelstein, PH; Norris, AH; Reilly, JP; Schuster, MG | 1 |
| Brenner, DJ; Facklam, RR; Merquior, VL; Pigott, NE; Steigerwalt, AG; Teixeira, LM | 1 |
| Barlow, JF | 1 |
| Isenberg, HD; Lam, S; Morthland, VH; Pfaller, MA; Singer, C; Tucci, V | 1 |
| Aubertin, J; Brunet, F; Charbonneau, P; Domart, Y; Garaud, JJ; Harding, I | 1 |
| Braden, GL; Germain, MJ; Lipkowitz, GS; Madden, RL; Mulhern, JG; O'Shea, MH | 1 |
| Dova, H; Efremidis, AP; Hajichristou, H; Koumakis, G; Plataniotis, G; Skouteri, H; Vassilomanolakis, M | 1 |
| Borton, D | 1 |
| Barbadora, K; Green, M; Shlaes, DM; Shlaes, JH | 1 |
| Rice, LB; Shlaes, DM | 1 |
| Goldmann, DA; Jarvis, WR; Shay, DK | 1 |
| Baccus, Z; Brown, DF; Jones, BL; Ludlam, HA; Woodford, N | 1 |
| Murphy, S; Pinney, RJ | 1 |
| Elliott, J; Facklam, R; Franklin, R; Pigott, N | 1 |
| Carbonaro, CA; Horowitz, H; Montecalvo, MA; Seiter, K; Wormser, GP | 1 |
| Cooper, I; Noskin, GA; Peterson, LR | 1 |
| Caron, F; Gutmann, L; Humbert, G; Kitzis, MD; Lemeland, JF; Pestel, M | 1 |
| Jacoby, GA | 1 |
| Bucaneve, G; Buelli, M; Carotenuto, M; D'Antonio, D; Gentile, G; Liso, V; Martino, P; Menichetti, F; Nosari, AM; Ricci, P | 1 |
| Larsson, C | 1 |
| Motohiro, T; Nagai, K; Ono, E; Sakata, Y; Yuge, K | 1 |
| Daenen, SM; de Vries-Hospers, HG; Erjavec, Z; Halie, MR; van der Waaij, D; van Kamp, H | 1 |
| Bates, J; Griffiths, DT; Jordens, JZ | 2 |
| Barker, CF; Brayman, KL; Brennan, PJ; Fishman, N; Friedman, AL; Levy, MM; Naji, A; Sastry, V | 1 |
| Lancaster, AD | 1 |
| Ford, M; Gould, FK; Morgan, S; Morrison, D; Orr, KE; Perry, JD; Sisson, PR | 1 |
| Chadwick, PR; Oppenheim, BA | 1 |
| Harousseau, JL; Kergueris, MF; Le Normand, Y; Milpied, N | 1 |
| Jahan, P; Kergueris, MF; Le Normand, Y; Milpied, N | 1 |
| Borja, J; García-Barbal, J; Gratacós, L | 1 |
| Boyce, JM; Carias, LL; Fraimow, H; Giorgio, C; Green, M; Marshall, SH; Medeiros, AA; Mermel, LA; Thorisdottir, AS; Zervos, MJ | 1 |
| Carranza, R; García-Iglesias, MC; Suárez, AI | 1 |
| Boyce, JM; Chow, JW; Fortna, S; Medeiros, AA; Opal, SM; Potter-Bynoe, G; Romulo, RL; Sherman, CB; Zervos, MJ | 1 |
| Haney, PE; Hernandez, JM; Horner, JS | 1 |
| Chin, AT; Elliott, TS; Hastings, JG; Johnson, AP; Morrison, D; Stephenson, JR; Tolley, JL; Woodford, N; Worthington, A | 1 |
| Carbonaro, C; Cook, P; Gedris, C; Horowitz, H; Issah, A; Montecalvo, MA; Tenover, FC; Wormser, GP | 1 |
| Briant, V; Cookson, B; George, RC; Johnson, AP; Morrison, D; Woodford, N | 1 |
| Eisner, W; Faur, Y; Frieden, TR; Kreiswirth, B; Low, DE; Munsiff, SS; Warren, S; Willey, BM; Williams, G | 1 |
| Bates, J; Jordens, Z; Selkon, JB | 1 |
| Cookson, B; George, RC; Johnson, AP; Uttley, AH; Woodford, N | 1 |
| Spencer, RC; Weeks, GR; Wilcox, MH | 1 |
| Biavasco, F; De Sio, G; Maffei, C; Manso, E; Sambo, G; Varaldo, PE | 1 |
| George, RC; Johnson, AP; Sanyal, D; Williams, AJ | 1 |
| Amos, G; Bodey, GP; Elting, L; Fainstein, V; Nguyen, H; Rolston, KV | 1 |
| Alsar, MJ; Chantal, P; Sacristán, JA; Soto, J | 1 |
| Swartz, MN | 1 |
| Hartmann, F; Jackson, MW; Panciera, DL | 1 |
| Dean, JL; Delso, DR; Fraimow, HS; Jungkind, DL; Lander, DW | 1 |
| Brugman, JL; Gebhard, JS | 1 |
| Broun, ER; Hromas, RA; Kneebone, PH; Sundblad, K; Tricot, G; Wheat, JL | 1 |
| Biavasco, F; De Biase, L; Macchiarelli, A; Marino, B; Serra, P; Varaldo, PE; Venditti, M | 1 |
| Landman, D; Mobarakai, NK; Quale, JM | 1 |
| Johnson, CC; Levison, ME; Livornese, LL; Osborne, AJ; Pitsakis, PG; Whitman, MS; Zausner, A | 1 |
| Dick, JD; Karp, JE | 1 |
| Henwick, S; Koehler, M; Patrick, CC | 1 |
| Waldvogel, F | 1 |
| Binczewski, B; Rice, LB; Shlaes, DM | 1 |
| McDonald, GR | 1 |
| Chow, JW; Green, M; Kuritza, A; Sahm, DF; Shlaes, DM; Zervos, MJ | 1 |
| Altarac, D; Handwerger, S; Marchione, S; Monka, J; Murray, BE; Raucher, B; Singh, KV; Walters, B; Wolff, J | 1 |
| Flokowitsch, J; Mullen, DL; Nicas, TI; Preston, DA; Unal, S | 1 |
| Cristóbal, JA; del Buey, MA; Huerva, V; Lanuza, J; Mínguez, E; Palomar, A; Sinués, B | 1 |
| Guiney, M; Urwin, G | 1 |
| Caron, F; Gutmann, L; Humbert, G; Klare, I; Lemeland, JF | 1 |
| Coudron, PE; Lavoie, SR; Markowitz, SM; Williams, DS; Wong, ES | 1 |
| Chow, AW; Jewesson, PJ; Kureishi, A; Phillips, GL | 1 |
| Spencer, RC | 1 |
| Arthur, M; Courvalin, P; Depardieu, F; Molinas, C | 1 |
| Asbury, WH; Buffington, DE; Capers, CC; Darsey, EH; Murphy, JE; Rose, WB | 1 |
| Hayden, MK; Sahm, DF; Schultz, JE; Trenholme, GM | 1 |
| Amsterdam, D; Beam, TR; Gorzynski, EA; Lawrence, T; Rotstein, C | 1 |
| Boyle, JF; Gianarkis, DG; Herrington, JA; Painter, BG; Rendo, A; Soumakis, SA; Thurberg, BE | 1 |
| Hyman, GF | 1 |
| Dever, LL; Eng, RH; Handwerger, S; Smith, SM | 1 |
| Goossens, H; Gordts, B; Ieven, M; Van Landuyt, H; Vandamme, P | 1 |
| Handwerger, S; Skoble, J | 1 |
| Cooper, RD; Flokowitsch, JE; Mullen, DL; Nicas, TI; Preston, DA; Snyder, NJ; Stratford, RE | 1 |
| Crisp, C; Grota, P; Jorgensen, JH; Magnon, K; Melcher, GP; Moreno, F; Patterson, JE | 1 |
| Boyce, JM; Giorgio, C; Medeiros, AA; Mermel, LA; Potter-Bynoe, G; Rice, LB; Zervos, MJ | 1 |
| Guglielmo, BJ; Jacobs, RA; Jordan, M; Luber, AD | 1 |
| Chandrasekar, PH | 1 |
| Hagman, HM; Strausbaugh, LJ | 1 |
| Antony, SJ; Matherin, P; Stratton, C | 1 |
| Jarvis, WR; Maloney, SA; Montecalvo, MA; Patel, P; Shay, DK; Tacsa, L; Wormser, GP | 1 |
| Boyce, JM | 3 |
| Carraher, M; Chung, M; de Lencastre, H; Gedris, C; Montecalvo, MA; VanHorn, K; Wormser, GP | 1 |
| Maezawa, H; Nakazawa, Y; Saitoh, A; Sakai, O; Sakamoto, M; Saruta, K; Shiba, K; Shindo, N; Yoshida, M; Yoshikawa, K | 1 |
| Burns, LA | 1 |
| Fraimow, HS; Shlaes, DM | 1 |
| Fraimow, HS; Jungkind, DL | 1 |
| Veis, JH; Vijayvargiya, R | 1 |
| Dembry, LM; Uzokwe, K; Zervos, MJ | 1 |
| Andremont, A; Barbier, N; Chachaty, E; Dumontier, S; Saulnier, P | 1 |
| Fung, JJ; Kramer, DJ; Kusne, S; Linden, PK; Manez, R; Pasculle, AW; Pinna, AD | 1 |
| Saghafi, D | 1 |
| Dembry, LM; Farrel, P; Tallapragada, S; Weinstein, JW | 1 |
| Bass, SN; Biddle, J; Chico, G; Shekar, R; Strozewski, K | 1 |
| Chia, JK; Lewis, RP; McKee, B; Nakata, MM; Park, SS | 1 |
| Kjerulf, A; Pallesen, L; Westh, H | 1 |
| Franklin, C; Hayden, MK; Hu, TC; Matushek, M; Nathan, C; Rice, T; Slaughter, S; Van Voorhis, J; Weinstein, RA | 1 |
| Cooper, BW; Courvalin, P; Marangos, MN; Nicolau, DP; Nightingale, CH; Patel, KB; Quintiliani, R | 1 |
| Corey, GR; Roe, M; Sanders, L; Sexton, DJ; Thorpe, JJ; Towns, M; Weinstein, JW | 1 |
| Brunton, J; Campbell, I; Conly, J; Dedier, H; Garcia, M; Gillis, G; Hockin, J; Humar, A; Jolley, BA; Kennedy, C; Lior, L; Litt, M | 1 |
| Melhus, A; Tjernberg, I | 1 |
| Ang, SW; Lee, ST; Seah, CS | 1 |
| Ghanekar, K; Ojo, F; Rao, GG | 1 |
| Cobo, J | 1 |
| Belliveau, PP; Maday, CE; Rothman, AL | 1 |
| Gedris, CA; Rodney, KM; van Horn, KG | 1 |
| Benn, RA; Branley, J; Yan, B | 1 |
| Boyle, M; Butt, H; Ferguson, J; Johnson, C | 1 |
| Arnold, KE; Funke, G; Nolte, FS; Sweat, H; Winton, EF | 1 |
| Gedris, CA; Mitchell, JB; Rodney, KM; Van Horn, KG | 1 |
| Dobbin, KR; Dunworth, BA | 1 |
| French, GL; Issack, MI; Power, EG | 1 |
| Chadwick, PR; Elliot, J; Joseph, LA; Keaney, MG; Rowland, P | 1 |
| Faraj, AA | 1 |
| James, JK; Levine, DP; Palmer, SM; Rybak, MJ | 1 |
| Zervos, M | 1 |
| Barie, PS; Bohnen, JM; Davis, JM; Fichtl, RE; Gadaleta, D; Huycke, MM; Wells, CL | 1 |
| Bodnar, UR; Cooper, I; Noskin, GA; Peterson, LR; Reisberg, BE; Suriano, T | 1 |
| De Pauw, BE; Deresinski, SC; Dompeling, EC; Donnelly, JP; Feld, R; Lane-Allman, EF | 1 |
| Dholakia, N; Dvorak, T; Ho, DH; LeBlanc, B; Rolston, KV; Streeter, H | 1 |
| McNeeley, DF; Noel, GJ; Saint-Louis, F | 1 |
| Chesney, PJ; English, BK | 1 |
| Fikrig, M; Finkelstein, FO; Golden, M; Gorban-Brennan, N; Kliger, AS; Troidle, L | 1 |
| Blaser, J; Schwank, S | 1 |
| Goldmann, DA | 2 |
| Armstrong, D; Boone, N; Brown, A; Chung, M; Delencastre, H; Eagan, J; Henning, KJ; Wollner, N | 1 |
| Gielerak, P; Jarvis, WR; Jochimsen, EM; Singer, DA | 1 |
| Arthur, M; Courvalin, P; Reynolds, P | 1 |
| Emre, S; Lou, W; Mendelson, MH; Meyers, BR; Meyers, J; Miller, C; Papanicolaou, GA; Sheiner, P | 1 |
| Hafner, A; John, J; Riley, LW; Roberts, RB; Tornieporth, NG | 1 |
| Concia, E; Cruciani, M; Lazzarini, L; Malena, M; Messori, A; Rampazzo, R; Todeschini, G | 1 |
| Atwood, E; DiTore, V; Landman, D; Patel, K; Quale, J; Saurina, G | 1 |
| Chadwick, PR; Fox, A; Morgenstern, GR; Oppenheim, BA; Scarffe, JH; Woodford, N | 1 |
| Bradley, CR; Fraise, AP | 1 |
| Eltringham, I; Farrag, N; Liddy, H | 1 |
| Fraise, AP | 2 |
| Bonten, MJ; Hayden, MK; Matushek, M; Nathan, C; Rice, T; Slaughter, S; van Voorhis, J; Weinstein, RA | 1 |
| Cormican, MG; Johnson, DM; Jones, RN | 1 |
| Chow, JW; Donahedian, SM; Zervos, MJ | 1 |
| Chow, JW; Davidson, A; Sanford, E; Zervos, MJ | 1 |
| Goldmann, DA; Huskins, WC | 1 |
| Ben, RJ; Chi, WM; Chu, ML; Lu, JJ; Wang, CC; Wang, JC; Young, TG | 1 |
| Dunne, WM; Wang, W | 1 |
| Lipsett, PA; Mainous, MR; O'Brien, M | 1 |
| Kolokithas, D; Ojo, F; Rao, GG | 1 |
| Howarth, F; Poulter, D | 1 |
| Wilks, M | 1 |
| Endtz, HP; van Belkum, A; van Duin, J | 1 |
| Cockerill, FR; Hopkins, MK; Kohner, P; Patel, R; Uhl, JR | 1 |
| Keane, CT; Lavery, A; Morrison, D; Power, A; Rossney, AS | 1 |
| Das, I; Fraise, A; Wise, R | 1 |
| Johnson, JA; Morris, JG; Qaiyumi, S; Roghmann, MC; Schwalbe, R | 1 |
| Brennan, PJ; Lautenbach, E | 1 |
| Demitrovicová, A; Grausová, S; Hal'ko, J; Kral'ovicová, K; Krcméry, V; Krupová, I; Kukucková, E; Netriová, J; Stopková, K; Studená-Mrázová, M; Trupl, J | 1 |
| Courvalin, P; Leclercq, R | 1 |
| Beezhold, DW; Hayden, MK; Matushek, M; Nathan, C; Slaughter, S; Trenholme, GM; Weinstein, RA | 1 |
| Rutala, WA; Weber, DJ | 1 |
| Egnor, M; Nachman, SA; Verma, R | 1 |
| Biavasco, F; Lupidi, R; Manso, E; Miele, A; Varaldo, PE; Vignaroli, C | 1 |
| Casewell, MW; Rolando, N; Wade, JJ; Williams, R | 1 |
| Mariano, N; Rahal, JJ; Sahgal, VS; Turner, J; Urban, C; Weinbaum, F | 1 |
| Hacek, DM; Mekonen, ET; Noskin, GA; Peterson, LR | 1 |
| de Lencastre, H; Mato, R; Roberts, RB; Tomasz, A | 1 |
| Noskin, GA; Peterson, LR; Ristow, TA; Warren, JR | 1 |
| Ford, DS; Hibberd, PL; Hooper, DC; Pegues, CF; Pegues, DA | 1 |
| Anglim, AM; Byers, KE; Farr, BM; Klym, B; Scheld, WM | 1 |
| Cooke, RP; Cookson, BD; Kaufmann, ME; Morrison, D; Stephenson, J | 1 |
| Lai, KK | 1 |
| Bouchard, P; Buisson, Y; Cavallo, JD; Debuysère, H; Hernandez, E | 1 |
| Braun, DK; Nicas, TI; Zeckel, ML | 1 |
| Gutmann, L; Michel, M | 1 |
| Aarestrup, FM; Bager, F; Christensen, J; Madsen, M | 1 |
| Furlong, WB; Rakowski, TA | 1 |
| Chadwick, C; Molyneux, R | 1 |
| Cornish, JM; Howe, RA; Millar, MR; Oakhill, A; Robson, M | 1 |
| Fredlund, H; Myhre, EB; Sjöberg, L; Sundsfjord, A; Torell, E; Törnquist, E | 1 |
| Klare, I; Witte, W | 1 |
| Allerberger, F; Dierich, MP; Haas, G; Hirschl, AM; Klare, I; Lass-Flörl, C; Presterl, E; Witte, W | 1 |
| Espinoza, R; Fung, J; Kusne, S; Pasculle, AW; Rakela, J; Wada, S | 1 |
| Leaver, M | 1 |
| Clark, N; Nolte, FS; Rimland, D; Satake, S; Tenover, FC | 1 |
| Cushion, MT; Perlada, DE; Smulian, AG | 1 |
| Gerding, DN | 1 |
| Jarvis, W; Rosenberg, J; Tenover, FC; Vugia, DJ; Wong, J | 1 |
| Nelson, RR | 2 |
| Beighton, D; Casewell, MW; Hill, RL; Kirk, M | 2 |
| Beighton, D; Casewell, MW; Chen, HY; Hill, RL; Kirk, M | 2 |
| Leclercq, R | 1 |
| Biavasco, F; Facinelli, B; Lupidi, R; Manso, E; Varaldo, PE; Vignaroli, C | 1 |
| Braveny, I; Cremer, J; Elsner, E; Milatovic, D; Wallrauch, C | 1 |
| Haran, MA; Isenberg, HD; Tucci, V | 1 |
| Klare, I; Werner, G; Witte, W | 2 |
| Kirkegaard, P; Mogensen, AM; Rasmussen, A; Strauss, G | 1 |
| Morris, JG; Qaiyumi, S; Roghmann, MC; Schwalbe, R | 1 |
| Chadwick, PR; Cookson, BD; Morrison, D; Woodford, N | 1 |
| Zoppi, G | 1 |
| Bonmarchand, G; Fruchart, C; Gray, C; Lemeland, JF; Martin, E; Salah, A; Stamatoullas, A; Tilly, H | 1 |
| Hirakata, Y; Izumikawa, K; Kaku, M; Kamihira, S; Koga, H; Kohno, S; Matsuda, J; Tomono, K; Yamada, Y; Yamaguchi, T | 1 |
| Witte, W | 1 |
| Hastings, JG | 1 |
| Casali, A; Della Giulia, M; Di Lauro, L; Gionfra, T; Santini, S; Sega, FM; Vici, P | 1 |
| Hinkle, C; Porwancher, R; Remphrey, S; Sheth, A; Taylor, E; Zervos, M | 1 |
| Buiting, AG; Endtz, HP; Kluytmans, JA; Koeleman, JG; Spanjaard, L; van Belkum, A; van den Braak, N; van Duin, A; Vandenbroucke-Grauls, CM; Verbrugh, HA; Voss, A; Weersink, AJ | 1 |
| Bobrowska, M; Ramotar, K; Shymanski, J; Toye, B; Woods, W | 1 |
| Cockerill, FR; Garin, KM; Hopkins, MK; Kohner, PC; Patel, R; Uhl, JR; Wegener, LT | 1 |
| Messick, CR; Pendland, SL | 1 |
| Brewrink, J; Cross, AS; McCarter, RJ; Morris, JG; Roghmann, MC | 1 |
| Cavalieri, SJ; Davis, JC; Dominguez, EA; Langnas, AN; Rupp, ME; Winfield, B | 1 |
| Warnick, F | 1 |
| Cookson, B; Morrison, D; Woodford, N | 1 |
| Cercendado Mansilla, E | 1 |
| Fernández Guerrero, ML; Núñez García, A | 1 |
| Cran, M; Duff, Z; Gill-Morton, P; Main, S; Mercer, J; Robinson, K | 1 |
| Breatnach, F; Butler, K; Byrne, C; Clarke, A; Kaufmann, M; Murphy, H; Nourse, C; O'Meara, A | 1 |
| Bonten, MJ; Hayden, MK; Nathan, C; Rice, TW; Weinstein, RA | 1 |
| Aarestrup, FM; Ahrens, P; Dons, L; Hammerum, AM; Jensen, LB; Jones, RN | 1 |
| Budavari, SM; Crewe-Brown, HH; Khoosal, M; Liebowitz, LD; Saunders, GL | 1 |
| Bacca, D; Balistreri, G; Debbia, EA; Marchese, A; Musolino, B; Schito, GC | 1 |
| Brennen, C; Muder, RR; Wagener, MM | 1 |
| Yoshikawa, TT | 1 |
| Arnow, PM; Bruce, DS; Cronin, DC; Grewal, H; Lissoos, T; Loss, GE; Mead, J; Millis, JM; Newell, KA; Schiano, T; Thistlethwaite, JR; Woodle, ES | 1 |
| Arns da Cunha, C; DeFor, T; Johnson, JR; Pastor, JD; Shu, XO; Weisdorf, D | 1 |
| Marcus, N; Peled, N; Yagupsky, P | 1 |
| China, C; Dever, LL; Eng, RH; Johanson, WG; O'Donovan, C | 1 |
| Noskin, GA; Peterson, LR; Postelnick, M; Stosor, V | 1 |
| Bostic, G; Perri, MB; Silverman, J; Thal, LA; Zervos, MJ | 1 |
| Queenan, E; Whittle, J | 2 |
| Kramer, DJ; Linden, PK; McDevitt, D; Pasculle, AW | 1 |
| Bullough, K; Cox, D; Neuman, K | 1 |
| Chiew, YF | 1 |
| Brown, AE; Chung, M; De Lencastre, H; McNeeley, DF; Noel, GJ | 1 |
| Mundy, LM | 1 |
| Chankova, D; Guirguitzova, B; Minkov, N; Zozikov, B | 1 |
| Haarr, E; Harbo, K; Natås, OB; Olsvik, O; Simonsen, GS; Sundsfjord, A | 1 |
| Antony, SJ; Dummer, SJ; Ladner, J; Raudales, F; Stratton, CW | 1 |
| Severin, A; Severina, E; Tomasz, A | 1 |
| Bartholomew, WR; Horvat, RT; Potter, LM | 1 |
| Appleton, D | 1 |
| Flexner, CW; Lechtzin, N; Lucas, GM; Moore, RD; Puryear, DW; Yau, LL | 1 |
| Moellering, RC | 2 |
| Adal, KA; Anglim, AM; Byers, KE; Durbin, LJ; Farr, BM; Simonton, BM | 1 |
| Brooks, S; Friedeman, L; Griffith, J; Hameed, R; Khan, A; Mukherji, R; Schupf, N; Stoica, D | 1 |
| Andersen, J; Cassileth, PA; Fernandez, H; Goodman, M; Hanlon, J; Koya, R; Smith, R; Spector, N | 1 |
| Bowler, IC; Crook, DW; Davies, GJ; Storr, JA | 1 |
| Klein, G; Louwers, J; Schindler, R; Zill, E | 1 |
| d'Halewyn, MA; Fortin, A; Guay, M; Leblanc, G; Milord, F; Vigeant, P | 1 |
| Huneycutt, S; Phillips, A; Tush, GM; Ward, JD | 1 |
| Endtz, HP; van Belkum, A; van den Braak, N; van Keulen, M; Verbrugh, HA; Vliegenthart, J | 1 |
| Baltch, AL; Bopp, LH; George, M; Rafferty, ME; Schoonmaker, DJ; Smith, RP | 1 |
| Collatz, E; Gutmann, L; Mainardi, JL; Rybkine, T; Sougakoff, W | 1 |
| Bell, JM; Paton, JC; Turnidge, J | 1 |
| Hoban, DJ; Kabani, AM; Karlowsky, JA; Turenne, CY; Zhanel, GG | 1 |
| Carazo, I; Cuesta, I; Lozano, C; Martín, A; Pagola, C; Vázquez, E | 1 |
| Koc, Y; Miller, KB; Schenkein, DS; Snydman, DR | 1 |
| Brewrink, J; Fink, JC; Light, PD; Maker, T; Morris, JG; Polish, L; Roghmann, MC | 1 |
| French, GL | 1 |
| Cornaglia, G; Fontana, R; Ligozzi, M; Mazzariol, A; Veneri, G | 1 |
| Anguita Sánchez, M; Castillo Domínguez, JC; Mesa Rubio, MD; Ramírez Moreno, A; Siles Rubio, JR; Vallés Belsué, F | 1 |
| Debillon, T; Kergueris, MF; Pawlotsky, F; Roze, JC; Thomas, A | 1 |
| Johnson, AP; Livermore, DM; Speller, DC; Warner, M; Woodford, N | 1 |
| Feintzeig, ID; Fogel, MA; Gavin, JP; Hunt, WA; Kim, RC; Nussbaum, PB | 1 |
| Brady, JP; Hasbargen, JA; Snyder, JW | 1 |
| Martone, WJ | 1 |
| Goossens, H | 1 |
| Barbé, G; Bertrand, Y; Philippe, N; Ploton, C; Pondarré, C; Souillet, G | 1 |
| Alshab, D; Chow, JW; Clewell, DB; Dembry, L; Donabedian, S; Robinson-Dunn, B; Thal, L; Zervos, MJ | 1 |
| Hollis, RJ; Kruszynski, JA; Noskin, GA; Peterson, LR; Pfaller, MA; Savor, C | 1 |
| Cockerill, FR; Hopkins, MK; Kline, BC; Kohner, P; Patel, R; Piper, KE; Rouse, MS; Steckelberg, JM; Uhl, JR | 1 |
| Belliveau, PP; Fontecchio, SA; Kelley, AL; Lai, KK; Melvin, ZS | 1 |
| Fisher, MC | 1 |
| Amyes, SG; Brown, AR; Miles, RS; Paton, R; Plant, WD; Stevenson, GM; Winney, RJ | 1 |
| Goodwin, CW; McManus, AT; Pruitt, BA | 1 |
| Harding, I; Pittet, D | 1 |
| Thomas, JR | 1 |
| Messick, CR; Pendland, SL; Woodward, J | 1 |
| Bell, J; Coombs, G; O'Brien, F; Turnidge, J | 1 |
| Bilker, WB; Brennan, PJ; Lautenbach, E; Schuster, MG | 1 |
| Agrawal, M; Bhat, N; Dhawan, VK; Nachum, R; Tolbert, L | 1 |
| Goetz, AM; Muder, RR; Rihs, JD; Wagener, MM | 1 |
| Christenson, JC; Daly, JA; Jenkins, E; Korgenski, EK | 1 |
| Cole, MF; Evans, MK; Pearce, CL; Peters, SM | 1 |
| Hayden, MK; Kim, WJ; Weinstein, RA | 1 |
| Adebiyi, AM; Jensen, LB; Palepou, MF; Tremlett, CH; Woodford, N | 1 |
| Blue, SR; Brinton, BG; Carroll, KC; Hwang, YS; Leonard, RB; Woods, ML | 1 |
| Beilman, GJ; Dahms, RA; Dunn, DL; Johnson, EM; Lee, JT; Statz, CL | 1 |
| Conner-Kerr, TA; Franklin, ME; Gaillard, J; Jones, RM; Sullivan, PK | 1 |
| Matsumura, S; Simor, AE | 1 |
| Bonten, MJ; Hayden, MK; Nathan, C; Slaughter, S; van Voorhis, J; Weinstein, RA | 1 |
| Almeida, AM; Bispo, MA; Costa, IM; Falcão, AC; Falcão, F; Palminha, JM; Reis, E; Silva, R | 1 |
| Campos, JM; Patel, KM; Pikis, A; Singh-Naz, N; Sleemi, A | 1 |
| Grüneberg, RN; Hryniewicz, W | 1 |
| Krcmery, V; Krupova, Y; Mateicka, F; Novotny, J; Sabo, A | 1 |
| Ayats, J; Carratalà, J; Domínguez, MA; Fernández de Sevilla, A; Gudiol, F; Liñares, J; Marron, A | 1 |
| Paterson, DL; Taylor, SE; Yu, VL | 1 |
| Bensoussan, R; Laverdiere, M; Weiss, K | 1 |
| Cirak, MY; Sultan, N | 1 |
| Bronk, M; Hellmann, A; Kur, J; Samet, A | 1 |
| Andersen, BM; Digranes, A; Harthug, S; Jacobsen, T; Lingaas, E; Natås, OB; Olsvik, O; Ringertz, SH; Simonsen, GS; Skulberg, A; Sundsfjord, A; Syversen, G | 1 |
| Hatanaka, K; Hiraoka, A; Hosen, N; Karasuno, T; Kawamoto, S; Masaoka, T; Nakamura, H; Nakao, T; Teshima, H; Ujiie, H; Yagi, T | 1 |
| Anderson, RM; Austin, DJ | 1 |
| Barrett, SP; Cookson, BD; Morrison, D; Sisson, P; Woodford, N | 1 |
| Bow, L; Nicolau, DP; Nightingale, CH; Onyeji, CO | 2 |
| Hanaki, H; Hiramatsu, K; Kuwahara, K | 1 |
| Arduino, MJ; Carson, L; Jarvis, WR; Killum, E; Marston, B; Miller, ER; Rimland, D; Satake, S; Sinkowitz-Cochran, RL; Tenover, FC; Tokars, JI | 1 |
| Crane, VS; Garabedian-Ruffalo, SM | 1 |
| Harris, AA; Hayden, MK | 1 |
| Bryson, HM; Spencer, CM | 1 |
| Kruzynski, J; Noskin, GA; Peterson, LR; Siddiqui, F; Stosor, V | 1 |
| Iakovlev, SV | 1 |
| Cook, GM; Kobayashi, K; Rao, M; Smith, JM | 1 |
| Bertolatti, D; Coombs, GW; Grubb, WB; Kay, ID; Pearman, JW; Steven, RA | 1 |
| Carnevale, KA; Dweck, HS; Gedris, C; Levi, MH; Li, K; Malik, RK; Maw, M; Montecalvo, MA; Munoz, JL; Reale, MR; van Horn, K | 1 |
| Darini, AL; Palepou, MF; Woodford, N | 1 |
| Jayaratne, P; Rutherford, C | 1 |
| Armstrong-Evans, M; Blacklock, A; Cann, D; Gould, R; Liska, S; Litt, M; Low, DE; McArthur, MA; McGeer, A; Nusinowitz, S; Willey, B | 1 |
| Bilker, WB; Brennan, PJ; Lautenbach, E | 1 |
| Greenaway, CA; Miller, MA | 1 |
| Bégué, RE; Pérez Mato, S; Robinson, S | 1 |
| Patel, R; Piper, KE; Rouse, MS; Steckelberg, JM | 1 |
| Anderson, RM; Austin, DJ; Bonten, MJ; Slaughter, S; Weinstein, RA | 1 |
| Benner, KG; Busch, AM; Corless, CL; Flora, KD; Olyaei, AJ; Orloff, SL; Rabkin, JM; Rosen, HR | 1 |
| Aukrust, P; Axelsen, AK; Brinch, L; Gaustad, P; Mathiesen, O; Simonsen, GS; Torfoss, D | 1 |
| Bartlett, ST; Keay, S; McCarter, RJ; Morris, JG; Oldach, DW; Pfundstein, J; Qaiyumi, SQ; Roghmann, MC; Schwalbe, RS; Schweitzer, E | 1 |
| Hiramatsu, K; Imafuku, Y; Sato, A; Sato, T; Yamada, H; Yoshida, H | 1 |
| Donnelly, JP | 1 |
| Aguero, SM; Arduino, MJ; Banerjee, SN; Carson, LA; Hill, BC; Jarvis, WR; Kuehnert, MJ; Quirk, SB; Trick, WE | 1 |
| French, G; Jenkins, SG; Jones, RN; Low, DE; McGeer, A; Nadler, H; Roberts, RB; Willey, BM; Witte, W | 1 |
| Hamilton-Miller, JMT; Shah, S | 1 |
| Bauters, F; Courcol, RJ; Husson, MO; Savage, C; Trivier, D | 1 |
| Cunha, BA; Fishbane, S; Mittal, SK; Ruggian, J; Schoch, PE; Shea, K | 1 |
| Armstrong, D; Brown, AE; Chung, M; de Lencastre, H; Tomasz, A | 1 |
| Floss, H; Krause, C; Löffler, D; Wendt, C; Xander, LU | 1 |
| Chernesky, MA; Groves, D; Luinstra, KE; Mahony, JB; Petrich, AK | 1 |
| Feuillu, A; Kérebel, C; Le Bouquin, V; Le Corre, P; Le Verge, R; Mallédant, Y; Polard, E; Trout, H | 1 |
| Assia, EI; Diamantstein, L; Ferencz, JR; Rubinstein, E | 1 |
| Gedris, C; Horowitz, HW; Jarvis, WR; Montecalvo, MA; Petrullo, C; Rodney, K; Shay, DK; Uman, J; Wormser, GP | 1 |
| Gould, FK; Jones, AL; Perry, JD | 1 |
| Jones, AR; Lipman, J; Venkatesh, B | 1 |
| Abbondi, M; Borgonovi, M; Candiani, G; Parenti, F; Romanò, G | 1 |
| Barriere, SL; Dunn, DL; Graham, DR; Kreter, B; Nichols, RL; Rodgers, A; Wilson, SE; Zervos, M | 1 |
| Ferguson, JK | 1 |
| Abbott, M; Aberline, M; Grabsch, EA; Grayson, ML; Hogg, G; Johnson, PD; Kerr, PG; Li, HY; Olden, D | 1 |
| Collignon, PJ | 1 |
| Brunton, J; Campbell, I; Conly, JM; Dedier, H; Weinstein, MR | 1 |
| Clark, NC; Eliopoulos, GM; Gold, HS; Moellering, RC; Ostrowsky, BE; Samore, MH; Tenover, FC; Thauvin-Eliopoulos, C; Venkataraman, L | 1 |
| Coutlée, F; Faucher, MC; Forest, P; Roger, M; St-Antoine, P | 1 |
| Jacobson, AF; Winslow, EH | 1 |
| Bow, L; Bui, KQ; Nicolau, DP; Nightingale, CH; Onyeji, CO; Quintiliani, R | 1 |
| Feld, R | 1 |
| Gibbons, N; Krumins, I | 1 |
| Louie, L; Louie, M; Matsumura, SO; Simor, AE | 1 |
| Kolho, E; Salmenlinna, S; Suppola, JP; Tarkka, E; Vaara, M; Vuopio-Varkila, J | 1 |
| Eliopoulos, GM; Moellering, RC; Schülin, T; Thauvin-Eliopoulos, C | 1 |
| Landman, D; Manikal, V; Oydna, E; Parola, C; Quale, J; Ruan, Y; Saurina, G; Volkert, F | 1 |
| Aldave, AJ; Deramo, VA; Fischer, DH; Maguire, JI; Shah, GK; Stein, JD | 1 |
| Bordessoule, D; Denis, F; Gambarotto, K; Grélaud, C; Martin, C; Ploy, MC; Turlure, P | 1 |
| Maley, MP; Neely, AN | 1 |
| Brink, A; Dusé, A; Kassel, M; Koornhof, H; McCarthy, K; Meyers, M; Smego, R; van Nierop, W; von Gottberg, A | 1 |
| Carmeli, Y; Huskins, C; Samore, MH | 1 |
| Patel, R | 1 |
| Garbutt, JM; Littenberg, B; Mundy, LM; Ventrapragada, M | 1 |
| Ballow, CH; Bhavnani, SM; Biedenbach, DJ; Deinhart, JA; Drake, JA; Forrest, A; Jones, RN | 1 |
| Ayem, ML; Léone, M; Martin, C | 1 |
| Aarestrup, FM; Fussing, V; Hammerum, AM; Wegener, HC | 1 |
| Ben Abid, H; Hadj Ali, ZB; Hafsia, A; Kaufman, L; Lauwers, S; Meddeb, B; Schots, R; Trullemans, F; Van Camp, B; Van Riet, I | 1 |
| Greenstein, M; Kong, F; Petersen, PJ; Singh, MP; Weiss, WJ | 1 |
| Goldsmith, D; Gransden, W; Melzer, M | 1 |
| Eckert, SJ; McNeeley, DF; Noel, GJ | 1 |
| Aznar, E; Climent, MA; Máiquez, J; Palau, J; Picón, I | 1 |
| Teichmann, KD | 1 |
| Bibashi, E; Gompakis, N; Koliouskas, D; Roilides, E; Sidi, V; Tsakiri, A | 1 |
| Cook, GM; Keis, S; Kobayashi, K; Rainey, FA; Rao, M; Smith, JM | 1 |
| Claverie-Martín, F; Méndez-Alvarez, S; Pérez-Hernández, X | 1 |
| Cross, JM; May, AK; McGwin, G; Melton, SM; Moser, SA; Rue, LW | 1 |
| Flanagan, PG; Penrose-Stevens, A; Pitman, I; Simpson, BA; Tan, TY | 1 |
| Kotetishvili, M; Kreger, A; Morris, JG; Sulakvelidze, A; Turabelidze, D | 1 |
| Eick, S; Glockmann, E; König, K; Pfister, W; Sigusch, B; Teschke, M | 1 |
| Domínguez, L; Garde, J; Herrero, IA; Moreno, MA; Teshager, T | 1 |
| Buescher, ES; Karlowicz, MG; Surka, AE | 1 |
| D'Agata, EM; Green, WK; Li, H; Schaffner, W; Schulman, G; Tang, YW | 1 |
| Biesterveld, S; Dellaglio, F; Knijff, E; Lombardi, A; Torriani, S | 1 |
| Bouza, E; Graninger, W; Schaison, G | 1 |
| Menichetti, F | 2 |
| Endtz, HP; Goessens, W; van Belkum, A; van Den Braak, N; Verbrugh, HA | 1 |
| Hoogkamp-Korstanje, JA; Meis, JF; Schouten, MA; Voss, A | 1 |
| Dahlén, G; Molander, A; Reit, C; Samuelsson, W | 1 |
| Kurup, A; Lin, R; Loo, LH; Tee, WS | 1 |
| Allum, AG; Digranes, A; Harthug, S; Hope, O; Kristiansen, BE; Langeland, N | 1 |
| Bonten, MJ; Gaillard, CA; Mascini, EM; Timmer, GJ; Vandenbroucke-Grauls, CM; Willems, R | 1 |
| Dusé, AG; Ferraz, V; von Gottberg, A | 1 |
| Brink, AJ; Devenish, L; Routier, RJ; van den Ende, J | 1 |
| Courvalin, P; Perichon, B | 1 |
| McGregor, KF; Nolan, C; Palepou, MF; Tysall, L; Woodford, N; Young, HK | 1 |
| Banevicius, MA; Li, J; Nicolau, DP; Nightingale, CH; Onyeji, CO | 1 |
| Bilíková, E; Kovacicová, G; Krcmery, V; Svetlansky, I | 1 |
| Kauffman, CA; Lyons, MJ; Malani, PN; Richardson, LP; Wiseman, SW | 1 |
| Bergh, K; Kolmannskog, S; Skogen, PG | 1 |
| Jones, JB | 1 |
| Duh, RW; Malathum, K; Murray, BE; Singh, KV | 1 |
| DenBesten, K; Gonzales, RD; Graham, MB; Kelkar, S; Quinn, JP; Schreckenberger, PC | 1 |
| Gniadkowski, M; Hryniewicz, W; Kawalec, M; Konopka, L; Ozorowski, T; Zaleska, M | 1 |
| Chiew, YF; Ling, MM; Oon, LL | 1 |
| Chiueh, TS; Ho, MF; Lee, WH; Lu, JJ; Perng, CL | 1 |
| Weinstein, MP | 1 |
| Biavasco, F; Foglia, G; Manso, E; Paladini, C; Varaldo, PE; Vignaroli, C | 1 |
| Riley, LW; Roberts, RB; Webb, M | 1 |
| Mondy, KE; Mundy, LM; Shannon, W | 1 |
| D'Agata, EM; Gouldin, C; Li, H; Tang, YW | 1 |
| Jonas, JB | 1 |
| Lehrer, M; Meenan, G; Smith, C; Sym, D | 1 |
| Fujikawa, T; Kobayashi, I; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
| Courval, JM; Edwards, JR; Fridkin, SK; Gaynes, RP; Hill, H; Lawton, R; McGowan, JE; Tenover, FC | 1 |
| Galdón, F; Llambías, P; Lopardo, GD; Marín, ME; Podestá, O; Romero, RH; Scilingo, VM; Stamboulian, D | 1 |
| Alam, MR; Brown, W; Chow, JW; Donabedian, S; Gordon, J; Hershberger, E; Zervos, MJ | 1 |
| Carbon, C; Courvalin, P; Fantin, B; Lafaurie, M; Lefort, A; Perichon, B | 1 |
| Horowitz, HW; Jarvis, WR; Montecalvo, MA; Petrullo, C; Shay, DK; Uman, J; Wormser, GP | 1 |
| Bertrand, X; Talon, D; Thouverez, M | 1 |
| Fiett, J; Gniadkowski, M; Hryniewicz, W; Kawalec, M; Kedzierska, J; Skotnicki, A | 1 |
| Gibson, K; Grabsch, E; Grayson, ML; Padiglione, AA; Wolfe, R | 1 |
| D'Agata, EM; Gautam, S; Green, WK; Tang, YW | 1 |
| Woodford, N | 1 |
| Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Sánchez-Silos, RM | 1 |
| Chang, SC; Fang, CT; Hsue, PR; Jean, SS; Luh, KT; Wang, HK | 1 |
| Carmeli, Y; Mozaffari, E | 1 |
| Bonten, MJ; Weinstein, RA; Willems, R | 1 |
| Balan, D; Li, Z; Nathwani, D; Rittenhouse, B; Vinken, A; Wilike, R | 1 |
| Bouvet, A; Gerbal, R; Marie, JP; Ombandza-Moussa, E; Schlegel, L; Vekhoff, A | 1 |
| Chow, JW; Donabedian, SM; Hershberger, E; Kauffman, CA; Malani, PN; Robinson-Dunn, B; Thal, L; Zervos, MJ | 1 |
| Hogg, G; Homan, WL; Li, M; Poznanski, S; Spalburg, E; Tribe, D; Van Embden, JD; Willems, RJ | 1 |
| Edwards, JR; Fridkin, SK; Gaynes, RP; Lawton, R; McGowan, JE; Tenover, FC | 1 |
| Mercier, RC; Rybak, MJ; Stumpo, C | 1 |
| Cercenado, E; Eliopoulos, G; Isenberg, HD; Rubin, LG; Tucci, V | 1 |
| Bonadio, M; Maccanti, O | 1 |
| Eliopoulos, GM; Moellering, RC; Thauvin-Eliopoulos, C | 1 |
| Bayer, AS; Eliopoulos, GM; Grayson, ML; Ramos, MC | 1 |
| Baillie, L; Casewell, M; Rolando, N; Wade, J | 1 |
| Abdulla, Y; Cameron, J; French, G; Heathcock, R; Poston, S | 1 |
| Chen, HY; Hall, LM; Williams, RJ | 1 |
| Bhandari, S; Sanyal, D | 1 |
| Bailey, EM; Rybak, MJ; Warbasse, LH | 1 |
| Felmingham, D; Grüneberg, RN; Quintana, AI; Wilson, AP | 1 |
| Cooksey, RC; Facklam, RR; Gordon, S; Hill, BC; Jarvis, WR; Pigott, NE; Swenson, JM; Tenover, FC; Thornsberry, C | 1 |
| Calandra, T; Entenza, JM; Glauser, MP; Malinverni, R; Moosmann, Y | 1 |
| Avril, JL; Donnio, PY; Leclercq, R; Mesnard, R; Pouëdras, P; Sire, JM | 1 |
| Alonso, T; Liñares, J; Pérez, JL | 1 |
| Andremont, A; Azab, M; Boutan-Laroze, A; Droz, JP; Kattan, J; Ribrag, V | 1 |
| Jensen, KT; Pers, C; Schønheyder, H; Thomsen, VF | 1 |
| Cohen, J | 1 |
| Gaynes, R; Hill, BC; Josephson, A; Karanfil, LV; Mandel, L; Murphy, M; Swenson, JM | 1 |
| Dias, S; Kaye, D; Levison, ME; Livornese, LL; May, P; Pitsakis, P; Romanowski, B; Samel, C; Taylor, S; Woods, G | 1 |
| Jones, RN; Perl, TM; Wenzel, RP | 1 |
| Biswell, R; Cevallos, V; Ostler, HB; Sherman, MD | 1 |
| Garau, J; Lite, J; Ortega, L | 1 |
| Casewell, MW; Desai, N; Wade, JJ | 1 |
| Chopra, R; Felmingham, D; Robbins, M; Wilson, AP | 1 |
| Bingen, EH; Denamur, E; Elion, J; Lambert-Zechovsky, NY | 1 |
| Corcoran, GD; Gibbons, N; Mulvihill, TE | 1 |
| Barbadora, K; Green, M; Michaels, M | 1 |
| Cocker, HA; Idika, N; Lawal, SF; Odugbemi, T | 1 |
| Arthur, M; Carbon, C; Duval, J; Fantin, B; Leclercq, R | 1 |
| Green, M; Knight, RG; Sahm, DF; Shlaes, DM; Vincent, S | 1 |
| Carbon, C; Caron, F; Gutmann, L | 1 |
| Cheng, DL; Chiu, ZH; Fung, CP; Liu, CY; Wang, FD; Wang, LS | 1 |
163 review(s) available for vancomycin and Gram-Positive Bacterial Infections
| Article | Year |
|---|---|
Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones | 2008 |
New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bone Marrow Cells; Clinical Trials, Phase I as Topic; Drug Design; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Monoamine Oxidase Inhibitors; Oxazolidinones; Pyridones; Sepsis | 2014 |
Evaluation of GeneXpert vanA/vanB in the early diagnosis of vancomycin-resistant enterococci infection.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Gram-Positive Bacterial Infections; Humans; Sensitivity and Specificity; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Vancomycin-Resistant Enterococci: Epidemiology, Infection Prevention, and Control.
Topics: Antimicrobial Stewardship; Child; Cross Infection; Drug Resistance, Multiple; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Pediatrics; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020.
Topics: Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Hospitals; Humans; Vancomycin; Vancomycin-Resistant Enterococci; World Health Organization | 2021 |
Efficacy and safety of novel glycopeptides versus vancomycin for the treatment of gram-positive bacterial infections including methicillin resistant Staphylococcus aureus: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Glycopeptides; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Treatment Outcome; Vancomycin | 2021 |
The use of core genome multilocus sequence typing to determine the duration of vancomycin-resistant Enterococcus faecium outbreaks.
Topics: Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Antimicrobial Susceptibility Testing for Enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Daptomycin; Enterococcus; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Tetracycline; Vancomycin | 2022 |
A molecular study regarding the spread of vanA vancomycin-resistant Enterococcus faecium in a tertiary hospital in China.
Topics: Bacterial Proteins; Cross Infection; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Tertiary Care Centers; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Vancomycin-resistant Enterococcus faecium and the emergence of new sequence types associated with hospital infection.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Gram-Positive Bacterial Infections; Humans; Linezolid; Sepsis; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Sepsis; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Intermittent vs. continuous vancomycin infusion for gram-positive infections: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Drug Administration Schedule; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Vancomycin | 2020 |
Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Structure-Activity Relationship; Vancomycin; Vancomycin Resistance | 2020 |
Vancomycin-resistant Enterococcus faecium pneumonia in a uremic patient on hemodialysis: a case report and review of the literature.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Renal Dialysis; Treatment Outcome; Uremia; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2020 |
Prevalence of vancomycin-resistant enterococcus in Africa in one health approach: a systematic review and meta-analysis.
Topics: Africa; Anti-Bacterial Agents; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; One Health; Polymerase Chain Reaction; Prevalence; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Carnobacterium inhibens isolated in blood culture of an immunocompromised, metastatic cancer patient: a case report and literature review.
Topics: Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Androgen Antagonists; Anti-Bacterial Agents; Bacteremia; Blood Culture; Canada; Carnobacterium; Ceftriaxone; Food Microbiology; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Male; Pneumonia, Bacterial; Prostatic Neoplasms; Vancomycin | 2021 |
Systematic review and meta-analysis to explore optimal therapeutic range of vancomycin trough level for infected paediatric patients with Gram-positive pathogens to reduce mortality and nephrotoxicity risk.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Renal Insufficiency; Vancomycin | 2021 |
Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Ceftazidime; Child; Child, Preschool; Cross Infection; Gastrointestinal Tract; Gram-Positive Bacterial Infections; Hospitalization; Humans; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2017 |
Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections.
Topics: Animals; Anti-Bacterial Agents; Cost Savings; Gram-Positive Bacterial Infections; Hospitalization; Humans; Length of Stay; Skin Diseases, Bacterial; Teicoplanin; Vancomycin | 2018 |
Vancomycin resistant Enterococci: A brief review.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2018 |
Antimicrobial-resistant CC17 Enterococcus faecium: The past, the present and the future.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Global Health; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance | 2019 |
A current perspective on daptomycin for the clinical microbiologist.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Homeostasis; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus aureus; United States; United States Food and Drug Administration; Vancomycin | 2013 |
Vancomycin-resistant enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2013 |
Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Databases, Bibliographic; Drug Monitoring; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Length of Stay; Male; Nephrotic Syndrome; Odds Ratio; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Vancomycin | 2013 |
Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance.
Topics: Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Germany; Gram-Positive Bacterial Infections; Humans; Hygiene; Incidence; Patient Isolation; Prevalence; Risk Factors; Survival Rate; Vancomycin | 2013 |
Novel quercetin glycosides as potent anti-MRSA and anti-VRE agents.
Topics: Anti-Bacterial Agents; Glycosides; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Patents as Topic; Quercetin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2013 |
[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drugs, Investigational; Genes, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Methicillin-Resistant Staphylococcus aureus; Minocycline; Staphylococcal Infections; Tigecycline; Vancomycin | 2014 |
Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
Topics: Acetamides; Adolescent; Child; Child, Preschool; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Risk Factors; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2014 |
Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2015 |
Therapeutic options for vancomycin-resistant enterococcal bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Clinical Trials as Topic; Drug Therapy, Combination; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Risk Factors; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Virulence | 2015 |
The use of vancomycin with its therapeutic and adverse effects: a review.
Topics: Anti-Bacterial Agents; Cephalosporins; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neutropenia; Vancomycin | 2015 |
Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer?
Topics: Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2015 |
Genetic characteristics of vancomycin resistance gene cluster in Enterococcus spp.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Enterococcus; Gram-Positive Bacterial Infections; Humans; Multigene Family; Vancomycin; Vancomycin Resistance | 2015 |
How to use vancomycin optimally in neonates: remaining questions.
Topics: Anti-Bacterial Agents; Computer Simulation; Dose-Response Relationship, Drug; Drug Monitoring; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Sepsis; Vancomycin | 2015 |
Beyond Vancomycin: The Tail of the Lipoglycopeptides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Lipopeptides; Methicillin-Resistant Staphylococcus aureus; Teicoplanin; Vancomycin; Vancomycin-Resistant Enterococci | 2015 |
Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment.
Topics: Anti-Bacterial Agents; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Oxazolidinones; Penicillins; Tetracyclines; Vancomycin; Vancomycin Resistance; Visual Acuity | 2016 |
Vancomycin toxicity in neonates: a review of the evidence.
Topics: Acute Kidney Injury; Adult; Animals; Anti-Bacterial Agents; Child; Disease Models, Animal; Gram-Positive Bacterial Infections; Hearing Loss; Humans; Infant, Newborn; Mice; Vancomycin | 2016 |
Lactococcus lactis spp lactis infection in infants with chronic diarrhea: two cases report and literature review in children.
Topics: Administration, Intravenous; Animals; Anti-Bacterial Agents; Chronic Disease; Diarrhea; Female; Gram-Positive Bacterial Infections; Humans; Infant; Lactococcus lactis; Male; Vancomycin | 2016 |
What do I need to know about glycopeptide antibiotics?
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Teicoplanin; Vancomycin | 2016 |
Advances in prevention and treatment of vancomycin-resistant Enterococcus infection.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin; Vancomycin Resistance | 2016 |
Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies?
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cell Membrane; Cell Wall; Cross Infection; Depsipeptides; Drug Discovery; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Models, Animal; Nisin; Vancomycin | 2017 |
Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.
Topics: Animals; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Teicoplanin; Vancomycin; Vancomycin Resistance; Virginiamycin | 2017 |
Leuconostoc bacteremia in pediatric patients with short bowel syndrome: case series and review.
Topics: Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Child; Child, Preschool; Enteral Nutrition; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Leuconostoc; Male; Parenteral Nutrition, Total; Penicillin G; Polymerase Chain Reaction; Retrospective Studies; Risk Factors; Sequence Analysis, DNA; Short Bowel Syndrome; Vancomycin; Vancomycin Resistance | 2008 |
[Emergence of vancomycin-dependent enterococci following glycopeptide therapy: case report and review].
Topics: Bacterial Proteins; Bacteriuria; Carbon-Oxygen Ligases; Cecal Diseases; Ceftriaxone; Citrobacter freundii; Codon, Nonsense; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Intestinal Perforation; Liver Transplantation; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Norfloxacin; Peritonitis; Postoperative Complications; Staphylococcal Infections; Teicoplanin; Vancomycin; Vancomycin Resistance | 2009 |
Emergence and spread of vancomycin resistance among enterococci in Europe.
Topics: Disease Outbreaks; Drug Resistance, Bacterial; Enterococcus; Europe; Gram-Positive Bacterial Infections; Humans; Incidence; Population Surveillance; Risk Assessment; Risk Factors; Vancomycin | 2008 |
Are glycopeptides still appropriate and convenient for empiric use?
Topics: Anti-Bacterial Agents; Daptomycin; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Teicoplanin; United Kingdom; Vancomycin | 2008 |
Leuconostoc septicemia in a preterm neonate on vancomycin therapy: case report and literature review.
Topics: Anti-Bacterial Agents; Diagnosis, Differential; Female; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Leuconostoc; Risk Factors; Sepsis; Streptococcal Infections; Vancomycin; Vancomycin Resistance; Viridans Streptococci | 2009 |
Vancomycin-resistant enterococcus: a review from a Singapore perspective.
Topics: Anti-Bacterial Agents; Disease Outbreaks; Disease Transmission, Infectious; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Singapore; Vancomycin; Vancomycin Resistance | 2008 |
Vancomycin resistance: are there better glycopeptides coming?
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Glycopeptides; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2008 |
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.
Topics: Adult; Anti-Bacterial Agents; Drug Monitoring; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Practice Guidelines as Topic; Vancomycin; Vancomycin Resistance | 2009 |
Purulent pericarditis: report of 2 cases and review of the literature.
Topics: Aneurysm, Infected; Aortic Aneurysm, Thoracic; Bacterial Infections; Candida glabrata; Candidiasis; Cardiac Tamponade; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluconazole; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Penicillins; Pericardial Effusion; Pericardial Window Techniques; Pericardiocentesis; Pericarditis; Propionibacterium acnes; Staphylococcal Infections; Streptococcal Infections; Streptococcus agalactiae; Suppuration; Tomography, X-Ray Computed; Vancomycin | 2009 |
Multiresistant enterococci: a rare cause of complicated corneal ulcer and review of the literature.
Topics: Animals; Anti-Bacterial Agents; Cats; Corneal Injuries; Corneal Ulcer; Debridement; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterococcus faecalis; Eye Infections, Bacterial; Eye Injuries; Feces; Female; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Young Adult | 2009 |
Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibiotics.
Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2009 |
Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Teicoplanin; Vancomycin | 2009 |
Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2010 |
Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Peptides, Cyclic; Teicoplanin; Vancomycin; Virginiamycin | 2009 |
Lipid II and other bactoprenol-bound cell wall precursors as drug targets.
Topics: Anti-Bacterial Agents; Cell Wall; Drug Delivery Systems; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Terpenes; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2010 |
Weissella confusa: an unexpected cause of vancomycin-resistant gram-positive bacteremia in immunocompromised hosts.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; DNA, Bacterial; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Transplantation, Homologous; Vancomycin; Vancomycin Resistance; Weissella | 2011 |
[Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient].
Topics: Anti-Bacterial Agents; Critical Care; Critical Illness; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Soft Tissue Infections; Vancomycin; Vancomycin Resistance | 2011 |
[Current treatment of Gram-positive infections: from experimental models to clinical experience after approval of new drugs].
Topics: Animals; Anti-Bacterial Agents; Biofilms; Clinical Trials as Topic; Daptomycin; Drug Approval; Drug Evaluation, Preclinical; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Models, Animal; Osteomyelitis; Prosthesis-Related Infections; Rabbits; Rats; Rats, Wistar; Staphylococcal Infections; Vancomycin | 2010 |
[Update of antimicrobial resistance in Gram-positive microorganisms].
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterococcus; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; United States; Vancomycin | 2010 |
Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Renal Insufficiency; Vancomycin | 2012 |
[Treatment of resistant Gram-positive bacterial infections].
Topics: Animals; Anti-Bacterial Agents; Catheter-Related Infections; Cloxacillin; Daptomycin; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Kidney Diseases; Methicillin-Resistant Staphylococcus aureus; Rats; Staphylococcal Infections; Vancomycin | 2011 |
Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci.
Topics: Anti-Infective Agents; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Penicillin Resistance; Practice Guidelines as Topic; Streptococcus pneumoniae; Vancomycin | 2011 |
The rise of the Enterococcus: beyond vancomycin resistance.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enteritis; Enterococcus faecium; Gastrointestinal Tract; Gram-Positive Bacterial Infections; Humans; Microbial Interactions; Vancomycin; Vancomycin Resistance; Virulence Factors | 2012 |
Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study design.
Topics: Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Humans; Randomized Controlled Trials as Topic; Research Design; Vancomycin | 2012 |
Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat.
Topics: Anti-Bacterial Agents; Bacteremia; Colitis; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Graft vs Host Disease; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Iowa; Opportunistic Infections; Postoperative Complications; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2013 |
Meningitis caused by Abiotrophia defectiva: case report and literature review.
Topics: Abiotrophia; Ampicillin; Anesthesia; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Penicillins; Vancomycin | 2013 |
Changing epidemiology of Clostridium difficile-associated disease during stem cell transplantation.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Aztreonam; Chicago; Ciprofloxacin; Clostridioides difficile; Enterococcus faecium; Enterocolitis, Pseudomembranous; Female; Graft vs Host Disease; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Risk Factors; Survival Rate; Transplantation, Homologous; Vancomycin; Vancomycin Resistance | 2013 |
[Oxazolidinones and glycopeptides].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Biotransformation; Cell Wall; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Histamine Release; Humans; Linezolid; Molecular Structure; Oxazolidinones; Peptidoglycan; Pneumonia, Bacterial; Protein Synthesis Inhibitors; Staphylococcal Infections; Teicoplanin; Vancomycin | 2003 |
Mechanism of action of oritavancin and related glycopeptide antibiotics.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Glycopeptides; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Models, Molecular; Peptidoglycan; Vancomycin; Vancomycin Resistance | 2003 |
[Vancomycin (VCM) resistant enterococci (VRE)].
Topics: Bacteremia; Drug Utilization; Enterococcus faecium; Europe; Gram-Positive Bacterial Infections; Humans; Japan; Opportunistic Infections; Risk Factors; United States; Vancomycin; Vancomycin Resistance | 2003 |
Vancomycin resistance: occurrence, mechanisms and strategies to combat it.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Design; Drug Resistance, Multiple, Bacterial; Enterococcus; Genes, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Models, Biological; Peptidoglycan; Staphylococcal Infections; Staphylococcus aureus; Substrate Specificity; Vancomycin; Vancomycin Resistance | 2003 |
Lactobacillus paracasei continuous ambulatory peritoneal dialysis-related peritonitis and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Humans; Lactobacillus; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 2003 |
Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infections.
Topics: Anti-Bacterial Agents; Cross Infection; Depsipeptides; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Peptides, Cyclic; Vancomycin; Vancomycin Resistance | 2003 |
Antimicrobial resistance among gram-positive organisms in the intensive care unit.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin; Virginiamycin | 2003 |
[Vancomycin resistant enterococci in the Netherlands].
Topics: Disease Outbreaks; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infection Control; Methicillin Resistance; Netherlands; Vancomycin; Vancomycin Resistance; Virulence | 2004 |
Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.
Topics: Anti-Bacterial Agents; Daptomycin; Gram-Positive Bacterial Infections; Humans; Vancomycin; Virginiamycin | 2004 |
Glycopeptides in clinical development: pharmacological profile and clinical perspectives.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Glycopeptides; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic; Structure-Activity Relationship; Teicoplanin; Vancomycin | 2004 |
Recurrent Enterococcus faecalis endophthalmitis after phacoemulsification.
Topics: Amikacin; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Recurrence; Vancomycin; Vitrectomy | 2005 |
Prophylactic antibiotics for preventing early Gram-positive central venous catheter infections in oncology patients, a Cochrane systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Anticoagulants; Antineoplastic Agents; Catheterization, Central Venous; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Heparin; Humans; Neoplasms; Odds Ratio; Randomized Controlled Trials as Topic; Teicoplanin; Vancomycin | 2005 |
Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |
Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains.
Topics: Anti-Bacterial Agents; Bacteremia; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Outcome Assessment, Health Care; Population Surveillance; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
Enterococcal resistance--an overview.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2005 |
Newer antibiotics for serious gram-positive infections.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Vancomycin; Virginiamycin | 2006 |
Dalbavancin: a review for dermatologists.
Topics: Acetamides; Adult; Animals; Catheterization; Clinical Trials, Phase III as Topic; Cross Infection; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Enterococcus; Female; Fever; Gram-Positive Bacterial Infections; Headache; Humans; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Teicoplanin; Treatment Outcome; Vancomycin | 2006 |
The implications of enterococci for the intensive care unit.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Infection Control; Intensive Care Units; Peritonitis; Risk Factors; Vancomycin | 2007 |
Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review.
Topics: Cross Infection; Drug Prescriptions; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance | 2007 |
[Streptogramins and glycopeptides].
Topics: Anti-Bacterial Agents; Dosage Forms; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Staphylococcus aureus; Streptogramins; Teicoplanin; Vancomycin; Vancomycin Resistance | 2007 |
[Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Streptococcus pneumoniae; Teicoplanin; Tigecycline; Time Factors; Vancomycin; Virginiamycin | 2007 |
Approaching and analyzing a large literature on vancomycin monitoring and pharmacokinetics.
Topics: Anti-Bacterial Agents; Catheters, Indwelling; Critical Care; Drug Monitoring; Evidence-Based Medicine; Female; Gram-Positive Bacterial Infections; Humans; Information Storage and Retrieval; Middle Aged; Practice Guidelines as Topic; Vancomycin | 2007 |
Telavancin: a novel lipoglycopeptide antimicrobial agent.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Resistance, Multiple, Bacterial; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Vancomycin | 2007 |
Optimizing therapy for vancomycin-resistant enterococci (VRE).
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin | 2007 |
Vancomycin-resistant enterococci (VRE): transmission and control.
Topics: Communicable Disease Control; Cross Infection; Disinfection; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infectious Disease Transmission, Professional-to-Patient; Vancomycin; Vancomycin Resistance | 2008 |
Vancomycin revisited: a reappraisal of clinical use.
Topics: Anti-Bacterial Agents; Critical Care; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Staphylococcal Infections; Vancomycin | 2008 |
Vancomycin: understanding its past and preserving its future.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Practice Guidelines as Topic; Practice Patterns, Physicians'; Vancomycin | 2008 |
[Improvement of bactericide activity in hospital treatment of gram positive infections].
Topics: Anti-Bacterial Agents; Cross Infection; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Hospitals; Humans; Vancomycin | 2008 |
Controversies in endophthalmitis prevention. The risk for emerging resistance to vancomycin.
Topics: Anti-Bacterial Agents; Drug Resistance; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Postoperative Complications; Risk Factors; Therapeutic Irrigation; Vancomycin | 1995 |
Enterococcis: pathogens of the 90s.
Topics: Abdominal Abscess; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 1994 |
Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
Topics: Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Societies, Hospital; United States; Vancomycin | 1995 |
Recommendations for preventing the spread of vancomycin resistance.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Incidence; Infection Control; Vancomycin | 1995 |
Vancomycin resistance in the enterococcus. Relevance in pediatrics.
Topics: Child; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Pediatrics; Vancomycin | 1995 |
Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci.
Topics: Child; Cross Infection; Drug Resistance, Multiple; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Pediatrics; Vancomycin | 1995 |
Teicoplanin or vancomycin in the treatment of gram-positive infections?
Topics: Cell Wall; Cost-Benefit Analysis; Drug Resistance, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Half-Life; Humans; Teicoplanin; Vancomycin | 1995 |
[Gram-positive cocci (include MRSA)].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1994 |
Hospital-acquired infections: diseases with increasingly limited therapies.
Topics: Candidiasis; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1994 |
Emergence of gram-positive infections: relationship to indwelling catheters and management during chemotherapy-induced aplasia.
Topics: Antineoplastic Agents; Bone Marrow; Catheters, Indwelling; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1993 |
Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children.
Topics: Adolescent; Bacteremia; Ceftazidime; Ceftriaxone; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Micrococcaceae; Neoplasms; Neutropenia; Pneumonia; Respiratory Distress Syndrome; Shock, Septic; Skin Diseases; Vancomycin | 1993 |
Emerging antimicrobial resistance and the immunocompromised host.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Lactams; Staphylococcus; Teicoplanin; Vancomycin | 1993 |
Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Catheterization, Central Venous; Catheters, Indwelling; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Incidence; Kidney Diseases; Leukemia; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Penicillins; Prevalence; Prospective Studies; Sepsis; Superinfection; Teicoplanin; Tobramycin; Treatment Outcome; Vancomycin | 1993 |
Teicoplanin in gram-positive infection: microbiological aspects.
Topics: Catheterization, Central Venous; Catheters, Indwelling; Equipment Contamination; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1993 |
Aminoglycoside resistant enterococcal endocarditis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus; Fluoroquinolones; Gentamicins; Gram-Positive Bacterial Infections; Humans; Lactams; Vancomycin | 1993 |
Glycopeptide resistance in gram-positive pathogens.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Staphylococcus aureus; Vancomycin | 1995 |
First documented isolation of vancomycin-resistant Enterococcus faecium in Sweden.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Heart Valve Prosthesis; Humans; Microbial Sensitivity Tests; Middle Aged; Mitral Valve; Sweden; Vancomycin | 1996 |
[Vancomycin and teicoplanin: differential aspects].
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Endocarditis, Bacterial; Erythema; Gram-Positive Bacterial Infections; Hearing Loss; Humans; Incidence; Infusions, Intravenous; Kidney Diseases; Prospective Studies; Teicoplanin; Vancomycin | 1995 |
Vancomycin-resistant Enterococcus faecium infections in the ICU and quinupristin/dalfopristin.
Topics: Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Vancomycin; Virginiamycin | 1996 |
Glycopeptide resistance in enterococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Ligases; Multigene Family; Peptidoglycan; Vancomycin | 1996 |
Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Macrolides; Neoplasms; Neutropenia; Penicillins; Vancomycin | 1996 |
Enterococcus faecium in hospitals.
Topics: Anti-Bacterial Agents; Carrier State; Cross Infection; Disease Outbreaks; Disease Transmission, Infectious; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1997 |
Resistance to glycopeptides in enterococci.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Genotype; Gram-Positive Bacterial Infections; Humans; Phenotype; Vancomycin | 1997 |
Role of environmental contamination in the transmission of vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Cross Infection; Disinfection; Drug Resistance, Microbial; Enterococcus; Environmental Exposure; Equipment Contamination; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1997 |
Vancomycin-resistant enterococcus. Detection, epidemiology, and control measures.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Transmission, Infectious; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin | 1997 |
Beyond vancomycin: new therapies to meet the challenge of glycopeptide resistance.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Immunization; Immunotherapy; Molecular Structure; Vancomycin | 1997 |
Vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Phenotype; Vancomycin | 1997 |
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
Vancomycin-resistant enterococci: implications for infection control.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Incidence; Infection Control; Vancomycin | 1997 |
[Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Species Specificity; Teicoplanin; Vancomycin | 1997 |
VRE in Australia: when antibiotics fail, what then?
Topics: Anti-Bacterial Agents; Australia; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin | 1997 |
Antibiotic resistance in streptococci and enterococci. Where are we, where are we going? An opening lecture.
Topics: Animals; Cephalosporin Resistance; Community-Acquired Infections; Cross Infection; Disease Reservoirs; Drug Resistance, Multiple; Enterococcus; Gene Transfer Techniques; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Molecular Epidemiology; Penicillin Resistance; Pneumococcal Infections; Staphylococcus; Streptococcus; Streptococcus pneumoniae; Vancomycin | 1997 |
[How great is the potential danger from vancomycin-resistant enterococci?].
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1997 |
Vancomycin-resistant enterococci. Mechanism and clinical relevance.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Risk Factors; Vancomycin | 1997 |
Enterococci as emerging pathogens of humans.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; United Kingdom; Vancomycin | 1997 |
[Enterococcal resistance to glycopeptide antibiotics].
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Genotype; Gram-Positive Bacterial Infections; Humans; Phenotype; Teicoplanin; Vancomycin | 1995 |
[Enterococcal endocarditis, a model of therapeutic difficulty].
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus; Gentamicins; Gram-Positive Bacterial Infections; Humans; Penicillin Resistance; Penicillins; Prospective Studies; Streptomycin; Vancomycin | 1995 |
Vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Macrolides; Vancomycin | 1997 |
Guidelines for the prevention and control of vancomycin resistant enterococci (VRE) in long-term care facilities. Sioux Falls Task Force on Antimicrobial Resistance.
Topics: Anti-Bacterial Agents; Cross Infection; Disinfection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Health Education; Humans; Long-Term Care; Mass Screening; South Dakota; Vancomycin | 1998 |
Vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Nitrofurantoin; Urinary Tract Infections; Vancomycin | 1998 |
Clinical implications of nosocomial gram-positive bacteremia and superimposed antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1998 |
Enterococci and vancomycin resistance.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1998 |
Spread of vancomycin-resistant enterococci: why did it happen in the United States?
Topics: Anti-Bacterial Agents; Carrier State; Cross Infection; Disease Reservoirs; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; United States; Vancomycin | 1998 |
Infective endocarditis and glycopeptides.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Humans; Retrospective Studies; Teicoplanin; Vancomycin | 1998 |
Hospital wards spreading vancomycin-resistant enterococci to intensive care units: returning coals to Newcastle.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Hospital Units; Humans; Infection Control; Intensive Care Units; United States; Vancomycin | 1998 |
Vancomycin-resistant Enterococcus.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 1998 |
[Infections of vancomycin resistant enterococci (VRE) and Staphylococcus aureus (VRSA)].
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1999 |
Confronting antibiotic resistance in enterococcal infections.
Topics: Aminoglycosides; beta-Lactam Resistance; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Drugs, Investigational; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1994 |
Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.
Topics: Cost-Benefit Analysis; Drug Costs; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Teicoplanin; Vancomycin | 1995 |
[Teicoplanin. New treatment potentials for gram-positive infections in the hospital].
Topics: Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 1999 |
Intrinsically vancomycin-resistant gram-positive organisms: clinical relevance and implications for infection control.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Genes, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin | 1999 |
Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: pros and cons.
Topics: Anti-Bacterial Agents; Fever; Gram-Positive Bacterial Infections; Humans; Neoplasms; Neutropenia; Prognosis; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin | 1999 |
The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bias; Case-Control Studies; Confounding Factors, Epidemiologic; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Male; Middle Aged; Odds Ratio; Publishing; Research Design; Risk; Vancomycin; Vancomycin Resistance | 1999 |
[Glycopeptides].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Carboxypeptidases; Critical Care; Depression, Chemical; Drug Design; Drug Interactions; Drug Resistance, Microbial; Drug Utilization; Enzyme Inhibitors; Glycopeptides; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Lipoglycopeptides; Membrane Proteins; Operon; Peptide Synthases; Peptidoglycan; Serine-Type D-Ala-D-Ala Carboxypeptidase; Teicoplanin; Transcription Factors; Vancomycin; Vancomycin Resistance | 2000 |
Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazoles; Oxazolidinones; Teicoplanin; Vancomycin; Virginiamycin | 2000 |
Glycopeptide resistance in enterococci.
Topics: Animals; Anti-Bacterial Agents; Cell Wall; Drug Resistance, Microbial; Drug Synergism; Drug Utilization; Enterococcus; Glycopeptides; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Operon; Peptidoglycan; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Teicoplanin; Vancomycin; Vancomycin Resistance | 2000 |
Teicoplanin in the treatment of serious infection.
Topics: Anti-Bacterial Agents; Bacteremia; Bone Diseases, Infectious; Child; Cross Infection; Drug Administration Schedule; Drug Resistance, Microbial; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Home Care Services; Humans; Intensive Care Units; Joint Diseases; Neutropenia; Staphylococcal Infections; Teicoplanin; Vancomycin | 2000 |
The role of teicoplanin in the treatment of febrile neutropenia.
Topics: Anti-Bacterial Agents; Fever; Gram-Positive Bacterial Infections; Humans; Neutropenia; Teicoplanin; Vancomycin | 2000 |
[What is to be done with vancomycin-resistant enterococcal infections?].
Topics: Anti-Bacterial Agents; Disease Outbreaks; Enterococcus; Genotype; Gram-Positive Bacterial Infections; Humans; Infection Control; Netherlands; Vancomycin; Vancomycin Resistance | 2000 |
Update on vancomycin resistance.
Topics: Anti-Bacterial Agents; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance | 2000 |
[Risk factors and prevention of the acquisition and transmission of glycopeptide resistant enterococci].
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Hospitals; Humans; Risk Factors; Vancomycin | 2001 |
Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Phenotype; Vancomycin; Vancomycin Resistance | 2001 |
Vancomycin-resistant enterococci: why are they here, and where do they come from?
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Disease Outbreaks; Enterococcus; Enterococcus faecium; Europe; Gram-Positive Bacterial Infections; Humans; Infection Control; Membrane Proteins; North America; Vancomycin; Vancomycin Resistance | 2001 |
[Enterococci: acquired antibiotic resistance].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Incidence; Urinary Tract Infections; Vancomycin | 1992 |
[Bacteremia caused by vancomycin-resistant Enterococcus faecalis. Report of 2 cases].
Topics: Aged; Bacteremia; Cross Infection; Daptomycin; Drug Resistance, Microbial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Peptides; Pneumonia; Postoperative Complications; Retrospective Studies; Urinary Tract Infections; Vancomycin | 1991 |
62 trial(s) available for vancomycin and Gram-Positive Bacterial Infections
| Article | Year |
|---|---|
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2008 |
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
No Effect of Lactobacillus rhamnosus GG on Eradication of Colonization by Vancomycin-Resistant Enterococcus faecium or Microbiome Diversity in Hospitalized Adult Patients.
Topics: Adult; Aged; Child; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Lacticaseibacillus rhamnosus; Microbiota; Probiotics; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled tria
Topics: Anti-Bacterial Agents; Clinical Protocols; Dose-Response Relationship, Drug; Equivalence Trials as Topic; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Neonatal Sepsis; Safety; Staphylococcal Infections; Vancomycin | 2020 |
Effect of Intrawound Vancomycin Powder in Operatively Treated High-risk Tibia Fractures: A Randomized Clinical Trial.
Topics: Adult; Anti-Bacterial Agents; Double-Blind Method; Female; Fracture Fixation, Internal; Fractures, Ununited; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intra-Articular Fractures; Male; Middle Aged; Powders; Probability; Prospective Studies; Surgical Wound Dehiscence; Surgical Wound Infection; Tibial Fractures; Time Factors; Vancomycin | 2021 |
A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Pneumonia; Pyrimidines; Treatment Outcome; Vancomycin | 2017 |
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Path
Topics: Administration, Intravenous; Adult; Anti-Bacterial Agents; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Pyrimidines; Skin; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2018 |
Fecal microbiota transplantation to eradicate vancomycin-resistant enterococci colonization in case of an outbreak.
Topics: Aged; Aged, 80 and over; Antibiosis; Clostridium Infections; Disease Eradication; Disease Outbreaks; Dysbiosis; Fecal Microbiota Transplantation; Female; Follow-Up Studies; France; Gram-Positive Bacterial Infections; Humans; Intestines; Male; Middle Aged; Pilot Projects; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |
Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Female; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Male; Middle Aged; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin; Young Adult | 2015 |
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Coinfection; Cross Infection; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Lipoglycopeptides; Male; Middle Aged; Pneumonia, Ventilator-Associated; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2015 |
Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematologic Neoplasms; Humans; Lipoglycopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Pilot Projects; Recurrence; Treatment Outcome; Vancomycin | 2016 |
Daptomycin for Complicated Skin Infections: A Randomized Trial.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clindamycin; Creatine Kinase; Daptomycin; Diarrhea; Drug Administration Schedule; Female; Fever; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Single-Blind Method; Skin Diseases, Bacterial; Vancomycin | 2017 |
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Cross Infection; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2008 |
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2008 |
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Cross Infection; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Vancomycin | 2009 |
Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Critical Care; Critical Illness; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Prospective Studies; Treatment Outcome; Vancomycin | 2010 |
In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Skin; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2010 |
The impact of linezolid and vancomycin treatment on local signs and symptoms of inflammation among pediatric patients with complicated skin and skin structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Infant; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pediatrics; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2011 |
TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bayes Theorem; Critical Illness; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Vancomycin | 2002 |
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
Topics: Acetamides; Bacteremia; Child; Child, Preschool; Confidence Intervals; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple; Female; Follow-Up Studies; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Latin America; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Probability; Severity of Illness Index; Treatment Outcome; United States; Vancomycin | 2003 |
Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Treatment Outcome; Vancomycin | 2003 |
Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2003 |
Linezolid for the treatment of complicated skin and skin structure infections in children.
Topics: Acetamides; Administration, Oral; Age Factors; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2003 |
Hematologic effects of linezolid in young children.
Topics: Acetamides; Administration, Oral; Age Factors; Anemia; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Hemoglobins; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Neutropenia; Oxazolidinones; Thrombocytopenia; Vancomycin | 2003 |
Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation.
Topics: Adult; Bacteremia; Cost Savings; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Teicoplanin; Treatment Outcome; Vancomycin | 2004 |
Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial.
Topics: Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Ceftazidime; Double-Blind Method; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Middle Aged; Time Factors; Vancomycin | 2005 |
Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Male; Middle Aged; Penicillins; Skin Diseases, Bacterial; Soft Tissue Infections; Vancomycin | 2005 |
Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study.
Topics: Adult; Anti-Bacterial Agents; Carrier State; Case-Control Studies; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2006 |
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Female; Fever; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Neoplasms; Neutropenia; Oxazolidinones; Vancomycin | 2006 |
Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Male; Penicillins; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2006 |
A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay.
Topics: Administration, Oral; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Length of Stay; Male; Teicoplanin; Vancomycin | 2006 |
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.
Topics: Aged; Ceftazidime; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2008 |
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms.
Topics: Adult; Aminoglycosides; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Male; Middle Aged; Skin Diseases, Infectious; Treatment Outcome; Vancomycin | 2008 |
Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial.
Topics: Abscess; Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Peritonitis; Prospective Studies; Sepsis; Treatment Failure; Vancomycin | 1995 |
Comparison of "gram-sure" with vancomycin disks in distinguishing between gram-negative and gram-positive rods.
Topics: Bacillaceae Infections; Bacillus; CD13 Antigens; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Moraxella; Neisseriaceae Infections; Vancomycin | 1995 |
Teicoplanin: a well-tolerated and easily administered alternative to vancomycin for gram-positive infections in intensive care patients.
Topics: Adult; Aged; Aged, 80 and over; Critical Care; Cross Infection; Drug Monitoring; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Humans; Kidney Diseases; Male; Middle Aged; Netilmicin; Prospective Studies; Teicoplanin; Vancomycin | 1994 |
Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-course vancomycin prophylaxis.
Topics: Bacteremia; Bone Marrow Transplantation; Catheterization, Central Venous; Gram-Positive Bacterial Infections; Humans; Neoplasms; Prospective Studies; Vancomycin | 1995 |
Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Novobiocin; Vancomycin | 1995 |
Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
Topics: Adolescent; Adult; Aged; Amikacin; Amphotericin B; Bacteremia; Ceftazidime; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Teicoplanin; Vancomycin | 1994 |
Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Aztreonam; Cefuroxime; Drug Therapy, Combination; Female; Fever of Unknown Origin; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tobramycin; Treatment Failure; Vancomycin | 1994 |
Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium.
Topics: Adult; Aged; Aged, 80 and over; Cross Infection; Culture Media; DNA Fingerprinting; Drug Resistance, Microbial; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Restriction Mapping; United Kingdom; Vancomycin | 1994 |
A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer.
Topics: Adult; Aged; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Teicoplanin; Vancomycin | 1994 |
Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation.
Topics: Acyclovir; Adult; Bacteremia; Bone Marrow Transplantation; Female; Fever; Fluconazole; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Norfloxacin; Penicillins; Premedication; Streptococcal Infections; Vancomycin | 1994 |
Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Catheterization, Central Venous; Catheters, Indwelling; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Incidence; Kidney Diseases; Leukemia; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Penicillins; Prevalence; Prospective Studies; Sepsis; Superinfection; Teicoplanin; Tobramycin; Treatment Outcome; Vancomycin | 1993 |
Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Liver Diseases; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Treatment Outcome; Vancomycin | 1996 |
Comparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Cross Infection; Disease Reservoirs; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Rectum; Reproducibility of Results; Sensitivity and Specificity; Vancomycin | 1996 |
A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit.
Topics: Adult; Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Gloves, Surgical; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Protective Clothing; Vancomycin | 1996 |
Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.
Topics: Adult; Anti-Bacterial Agents; Cross-Over Studies; Female; Gram-Positive Bacterial Infections; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Prospective Studies; Serum Bactericidal Test; Staphylococcus aureus; Vancomycin | 1996 |
Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 1996 |
Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Mycoplasma Infections; Neoplasms; Neutropenia; Pefloxacin; Thienamycins; Vancomycin | 1997 |
Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bone Marrow Transplantation; Cefazolin; Child; Child, Preschool; Cohort Studies; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Humans; Infant; Male; Middle Aged; Penicillins; Streptococcal Infections; Time Factors; Vancomycin | 1998 |
Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Drug Resistance, Microbial; Enterococcus faecium; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Treatment Outcome; Vancomycin; Virginiamycin | 1997 |
Constant rate infusion of vancomycin in premature neonates: a new dosage schedule.
Topics: Anti-Bacterial Agents; France; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Metabolic Clearance Rate; Vancomycin | 1998 |
[New quinolone versus vancomycin/tobramycin for intestinal sterilization in patients who undergo allogeneic bone marrow transplantation].
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Child; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Intestines; Middle Aged; Quinolones; Sterilization; Tobramycin; Transplantation Conditioning; Vancomycin | 1999 |
A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Ceftriaxone; Cephalosporins; Chi-Square Distribution; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Pancreas Transplantation; Postoperative Complications; Risk Factors; Statistics, Nonparametric; Treatment Outcome; Vancomycin | 1999 |
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Gr
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitalization; Humans; Male; Middle Aged; Oxacillin; Penicillins; Skin Diseases, Bacterial; Vancomycin; Virginiamycin | 1999 |
Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Staphylococcus aureus; Streptococcus; Teicoplanin; Vancomycin | 2000 |
Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Bacitracin; Double-Blind Method; Enterococcus faecium; Feces; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2001 |
Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin.
Topics: Adult; Anti-Bacterial Agents; Double-Blind Method; Erythema; Female; Gram-Positive Bacterial Infections; Histamine Release; Humans; Male; Syndrome; Teicoplanin; Vancomycin | 1992 |
Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Neoplasms; Neutropenia; Pefloxacin; Piperacillin; Vancomycin | 1992 |
Gram-positive infections in neutropenic patients: glycopeptide antibiotic choice.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Neutropenia; Teicoplanin; Vancomycin | 1992 |
Chromatographically purified vancomycin: therapy of serious infections caused by Staphylococcus aureus and other gram-positive bacteria.
Topics: Adolescent; Adult; Aged; Chromatography; Drug Resistance, Microbial; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Oxacillin; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1988 |
1151 other study(ies) available for vancomycin and Gram-Positive Bacterial Infections
| Article | Year |
|---|---|
Daptomycin susceptibility of unusual gram-positive bacteria: comparison of results obtained by the Etest and the broth microdilution method.
Topics: Culture Media; Daptomycin; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Pyrrolidines; Quinazolinones; Topoisomerase II Inhibitors | 2007 |
Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Synergism; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Streptomycin; Vancomycin Resistance | 2007 |
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes; Vancomycin Resistance; Viridans Streptococci | 2007 |
Mechanisms of resistance to daptomycin in Enterococcus faecium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Leukocyte-Adhesion Deficiency Syndrome; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction; Vancomycin | 2008 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Molecular Structure; Pleuromutilins; Polycyclic Compounds; Solubility; Stereoisomerism; Water | 2008 |
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Prospective Studies; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; United States | 2008 |
In vitro activity of telavancin against resistant gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 2008 |
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2008 |
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Bacteriocins; Blotting, Southern; Conjugation, Genetic; Cross Infection; Culture Media; DNA Nucleotidyltransferases; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Erythromycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Perforin; Pheromones; Plasmids; Vancomycin Resistance | 2009 |
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Europe; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hospitalization; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Staphylococcus aureus; Streptococcus; United States | 2009 |
7-Phenylplatensimycin and 11-methyl-7-phenylplatensimycin: more potent analogs of platensimycin.
Topics: Adamantane; Aminobenzoates; Anilides; Anti-Bacterial Agents; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Staphylococcus aureus; Structure-Activity Relationship | 2010 |
Bottromycin derivatives: efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti-VRE activities.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcaceae; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Peptides, Cyclic; Plasma; Vancomycin | 2010 |
Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Naphthyridines; Quinazolines; Quinoxalines; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
Amino acid modified xanthone derivatives: novel, highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infections.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Cell Membrane; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Rabbits; Structure-Activity Relationship; Unilamellar Liposomes; Xanthones | 2015 |
Symmetrically Substituted Xanthone Amphiphiles Combat Gram-Positive Bacterial Resistance with Enhanced Membrane Selectivity.
Topics: Animals; Anti-Bacterial Agents; Cornea; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Staphylococcal Infections; Surface-Active Agents; Xanthones | 2017 |
Phenylthiazole Antibacterial Agents Targeting Cell Wall Synthesis Exhibit Potent Activity in Vitro and in Vivo against Vancomycin-Resistant Enterococci.
Topics: Animals; Anti-Bacterial Agents; Caenorhabditis elegans; Cell Wall; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Models, Molecular; Thiazoles; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2017 |
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.
Topics: Animals; Anti-Bacterial Agents; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Methicillin; Mice; Microbial Sensitivity Tests; Molecular Structure; Skin Diseases, Bacterial; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin; Wound Infection | 2018 |
Targeting Vancomycin-Resistant
Topics: Anti-Bacterial Agents; Cholic Acid; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Operon; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |
Addition of Oral Fosfomycin to Antimicrobial Salvage Therapy for Persistent Vancomycin-Resistant Enterococcal Bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Salvage Therapy; Vancomycin | 2022 |
Bacteriophage Rescue Therapy of a Vancomycin-Resistant
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Female; Genome, Bacterial; Gram-Positive Bacterial Infections; Humans; Infant; Liver Transplantation; Microbial Sensitivity Tests; Phage Therapy; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2021 |
[Enterococcal infections and their treatment options].
Topics: Anti-Bacterial Agents; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin | 2021 |
Long-read sequencing-based in silico phage typing of vancomycin-resistant Enterococcus faecium.
Topics: Bacteriophage Typing; Computer Simulation; Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
A vanA vancomycin-resistant Enterococcus faecium ST80 outbreak resulting from a single importation event.
Topics: Australia; Bacterial Proteins; Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Phylogeny; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Genetic description of VanD phenotype vanA genotype in vancomycin-resistant Enterococcus faecium isolates from a Bone Marrow Transplantation Unit.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bone Marrow Transplantation; Carbon-Oxygen Ligases; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Phenotype; Vancomycin; Vancomycin Resistance | 2022 |
Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
Topics: Cross Infection; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Humans; Ireland; Multilocus Sequence Typing; Plasmids; Prevalence; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Clinically Applicable System for Rapidly Predicting Enterococcus faecium Susceptibility to Vancomycin.
Topics: Algorithms; Anti-Bacterial Agents; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2021 |
Occurrence, Phenotypic and Molecular Characteristics of Vancomycin-Resistant Enterococci Isolated from Retail Raw Milk in Egypt.
Topics: Animals; Anti-Bacterial Agents; Cattle; Egypt; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Linezolid; Microbial Sensitivity Tests; Milk; Multiplex Polymerase Chain Reaction; Teicoplanin; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |
Impact of discontinuing contact precautions and enforcement of basic hygiene measures on nosocomial vancomycin-resistant Enterococcus faecium transmission.
Topics: Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Hygiene; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Vancomycin-resistant enterococcus bacteraemia in an endemic region: clinical features and genomic analysis: a 12-year cohort.
Topics: Anti-Bacterial Agents; Bacteremia; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Update on activity of dalbavancin and comparators against clinical isolates of Gram-positive pathogens from Europe and Russia (2017-2018), and on clonal distribution of MRSA.
Topics: Anti-Bacterial Agents; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 2022 |
Specific Inhibition of VanZ-Mediated Resistance to Lipoglycopeptide Antibiotics.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Molecular Docking Simulation; Teicoplanin; Vancomycin | 2021 |
Spatiotemporal prediction of vancomycin-resistant Enterococcus colonisation.
Topics: Cross Infection; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |
Optimising genomic approaches for identifying vancomycin-resistant Enterococcus faecium transmission in healthcare settings.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Carbon-Oxygen Ligases; Cross Infection; Delivery of Health Care; Disease Outbreaks; Enterococcus faecium; Genome, Bacterial; Genomics; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; Phylogeny; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2022 |
Clinical and microbiological characteristics of bloodstream infections caused by Enterococcus spp. within internal medicine wards: a two-year single-centre experience.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacteremia; Endocarditis; Enterococcus; Gram-Positive Bacterial Infections; Hospitals; Humans; Internal Medicine; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Carriage of vancomycin-resistant
Topics: Anti-Bacterial Agents; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2023 |
Are There Bad ICU Rooms? Temporal Relationship between Patient and ICU Room Microbiome, and Influence on Vancomycin-Resistant
Topics: Adult; Cross Infection; Gastrointestinal Microbiome; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Prospective Studies; RNA, Ribosomal, 16S; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |
Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Monobactams; Prospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Daptomycin susceptibility testing and therapeutic use in enterococcal bloodstream infection (EBSI) in a setting with high rates of vancomycin-resistant Enterococcus faecium (VREfm).
Topics: Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Sepsis; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Vancomycin-resistant
Topics: Canada; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Multilocus Sequence Typing; Retrospective Studies; Sepsis; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2023 |
Persistence and multi-ward dissemination of vancomycin-resistant Enterococcus faecium ST17 clone in hospital settings in Slovakia 2017-2020.
Topics: Bacterial Proteins; Clone Cells; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Phylogeny; Plasmids; Slovakia; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Epidemiological and genetic characteristics of vancomycin-resistant Enterococcus faecium isolates in a University Children's Hospital in Germany: 2019 to 2020.
Topics: Child; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Universities; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Risk Factors Associated with Failure of Linezolid Therapy in Vancomycin-Resistant
Topics: Anti-Bacterial Agents; Bacteremia; Cohort Studies; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Mexico; Referral and Consultation; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Genomic Surveillance of Vancomycin-Resistant Enterococcus faecium Reveals Spread of a Linear Plasmid Conferring a Nutrient Utilization Advantage.
Topics: Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Humans; Nutrients; Plasmids; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Survival of hospital- and community-associated Enterococcus faecium following exposure to in-use concentrations of the biocide sodium dichloroisocyanurate (NaDCC).
Topics: Chlorine; Cross Infection; Disinfectants; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Triazines; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Collateral sensitivity to pleuromutilins in vancomycin-resistant Enterococcus faecium.
Topics: Animals; Anti-Bacterial Agents; Diterpenes; Drug Collateral Sensitivity; Enterococcus faecium; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Pleuromutilins; Polycyclic Compounds; Vancomycin | 2022 |
Attributable mortality of vancomycin resistance in ampicillin-resistant
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Denmark; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Netherlands; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2022 |
Efficacy of teicoplanin in bloodstream infections caused by Enterococcus faecium: posthoc analysis of a nationwide surveillance.
Topics: Anti-Bacterial Agents; Bacteremia; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 2022 |
Structure-activity relationship studies for inhibitors for vancomycin-resistant
Topics: Acetazolamide; Anti-Bacterial Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Structure-Activity Relationship; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Vancomycin-resistant Enterococcus faecium: should we screen on admission?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prevalence; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Young Adult | 2022 |
First report of nosocomial outbreak of vancomycin-resistant Enterococcus faecium infection among COVID-19 patients hospitalized in a non-intensive care unit ward in Slovakia.
Topics: Anti-Bacterial Agents; COVID-19; Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; SARS-CoV-2; Slovakia; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Prevalence and antimicrobial susceptibility of Enterococcus spp. from urine of dogs and cats in northwestern Croatia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cat Diseases; Cats; Chloramphenicol; Ciprofloxacin; Croatia; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins; Prevalence; Rifampin; Streptomycin; Tetracycline; Vancomycin | 2022 |
Interhospital transmission of vancomycin-resistant Enterococcus faecium in Aomori, Japan.
Topics: Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Japan; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Rapid in vivo development of resistance to daptomycin in vancomycin-resistant Enterococcus faecium due to genomic alterations.
Topics: Anti-Bacterial Agents; Cross Infection; Daptomycin; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
The prevalence and molecular epidemiology of vancomycin-resistant Enterococcus (VRE) carriage in patients admitted to intensive care units in Beijing, China.
Topics: Anti-Bacterial Agents; Beijing; Cross-Sectional Studies; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Prevalence; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Clinical and microbiological characteristics of bacterial meningitis in umbilical cord blood transplantation recipients.
Topics: Anti-Bacterial Agents; Cord Blood Stem Cell Transplantation; Daptomycin; Gram-Positive Bacterial Infections; Humans; Meningitis, Bacterial; Microbial Sensitivity Tests; Vancomycin | 2022 |
Library Screening for Synergistic Combinations of FDA-Approved Drugs and Metabolites with Vancomycin against VanA-Type Vancomycin-Resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Rifabutin; Rifamycins; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Clinical isolates of E. faecalis and E. faecium harboring virulence genes show the concomitant presence of CRISPR loci and antibiotic resistance determinants.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clustered Regularly Interspaced Short Palindromic Repeats; Deoxyribonucleases; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gelatinases; Gram-Positive Bacterial Infections; Humans; Kanamycin Kinase; Microbial Sensitivity Tests; Vancomycin; Virulence; Virulence Factors | 2022 |
Trend in healthcare-associated infections due to vancomycin-resistant Enterococcus at a hospital in the era of COVID-19: More than hand hygiene is needed.
Topics: COVID-19; Cross Infection; Delivery of Health Care; Gram-Positive Bacterial Infections; Hand Hygiene; Hospitals; Humans; Methicillin-Resistant Staphylococcus aureus; Pandemics; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Detection and molecular characterization of VRE isolates in Slovakia from stool samples positive for Clostridioides difficile toxins.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clostridioides difficile; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Slovakia; Teicoplanin; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Analysis of virulence genes, drug resistance detection, and pathogenicity in Enterococcus from farm animals.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Cattle; Cefotaxime; Chickens; Ciprofloxacin; Dogs; Drug Resistance; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Levofloxacin; Mice; Microbial Sensitivity Tests; Sulfamethoxazole; Swine; Vancomycin; Virulence; Virulence Factors | 2022 |
VanA-Enterococcus faecalis in Poland: hospital population clonal structure and vanA mobilome.
Topics: Aminoglycosides; Bacterial Proteins; Carbon-Oxygen Ligases; Ciprofloxacin; DNA Transposable Elements; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Multilocus Sequence Typing; Poland; Teicoplanin; Vancomycin | 2022 |
Short-course versus long-course antibiotic treatment for uncomplicated vancomycin-resistant enterococcal bacteraemia: a retrospective multicentre cohort study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Gram-Positive Bacterial Infections; Humans; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Vancomycin-resistant Enterococcus outbreak in a pre- and post-cardiothoracic transplant population: Impact of discontinuing multidrug-resistant organism surveillance during the coronavirus disease 2019 pandemic.
Topics: Anti-Bacterial Agents; COVID-19; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Pandemics; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Rapid Detection of
Topics: Anti-Bacterial Agents; Cross-Sectional Studies; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Nucleic Acid Amplification Techniques; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
The associated impact of standardized admission screening on vancomycin-resistant
Topics: Alberta; Anti-Bacterial Agents; Bacteremia; Gram-Positive Bacterial Infections; Humans; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Time to Effective Therapy Is an Important Determinant of Survival in Bloodstream Infections Caused by Vancomycin-Resistant
Topics: Anti-Bacterial Agents; Bacteremia; Gram-Positive Bacterial Infections; Humans; Retrospective Studies; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |
Comparative genomics and pangenomics of vancomycin-resistant and susceptible
Topics: Anti-Bacterial Agents; Bacterial Proteins; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Hospitals; Humans; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |
Microbiome profiling and characterization of virulent and vancomycin-resistant Enterococcus faecium from treated and untreated wastewater, beach water and clinical sources.
Topics: Anti-Bacterial Agents; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Microbiota; Sewage; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Wastewater; Water | 2023 |
Curcumin carbon dots inhibit biofilm formation and expression of esp and gelE genes of Enterococcusfaecium.
Topics: Anti-Bacterial Agents; Biofilms; Carbon; Curcumin; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Virulence Factors | 2022 |
Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Surveillance Outcome Program (AESOP).
Topics: Agar; Anti-Bacterial Agents; Bacteremia; COVID-19; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Northern Territory; Vancomycin | 2022 |
Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia.
Topics: Adult; Bacteremia; Case-Control Studies; Gram-Positive Bacterial Infections; Humans; Neutropenia; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |
Vancomycin-resistant Enterococcus faecium: admission prevalence, sequence types and risk factors-a cross-sectional study in seven German university hospitals from 2014 to 2018.
Topics: Animals; Antacids; Anti-Bacterial Agents; Cross Infection; Cross-Sectional Studies; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, University; Prevalence; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Check the melting temperature of the FilmArray BCID panel to avoid missed detection of vanM-type enterococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; China; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Temperature; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Microbiome-mediated fructose depletion restricts murine gut colonization by vancomycin-resistant Enterococcus.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Fructose; Gram-Positive Bacterial Infections; Mice; Microbiota; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Association of pre-transplant vancomycin resistant enterococcus colonization status on long-term outcomes of allogeneic-hematopoietic cell transplantation.
Topics: Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Molecular epidemiology of bacteraemic vancomycin-resistant Enterococcus faecium isolates and in vitro activities of SC5005 and other comparators against these isolates collected from a medical centre in northern Taiwan, 2019-2020.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Molecular Epidemiology; Multilocus Sequence Typing; Taiwan; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2023 |
Evaluation of resazurin microplate method for rapid detection of vancomycin and linezolid resistance in Enterococcus faecalis and Enterococcus faecium clinical isolates.
Topics: Animals; Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Linezolid; Microbial Sensitivity Tests; Vancomycin | 2023 |
Development of a workflow for the detection of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis from rectal swabs using the spectra VRE medium.
Topics: Agar; Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Workflow | 2023 |
Individualized vancomycin dosing in infants: prospective evaluation of an online dose calculator.
Topics: Anti-Bacterial Agents; Child; Female; Gram-Positive Bacterial Infections; Humans; Infant; Male; Prospective Studies; Renal Insufficiency; Retrospective Studies; Vancomycin | 2023 |
Effectiveness of patient and staff cohorting to reduce the risk of vancomycin-resistant enterococcus (VRE) acquisition: a retrospective cohort study during a VRE outbreak in Japan.
Topics: Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Japan; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Nosocomial outbreak of vancomycin-resistant
Topics: Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Switzerland; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Infant food production environments: A potential reservoir for vancomycin-resistant enterococci non-nosocomial infections.
Topics: Anti-Bacterial Agents; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infant Formula; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2023 |
Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Antibiotic-induced accumulation of lipid II synergizes with antimicrobial fatty acids to eradicate bacterial populations.
Topics: Anti-Bacterial Agents; Fatty Acids; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin | 2023 |
The association of infectious diseases consultation and 30-day mortality rates among veterans with enterococcal bacteraemia: a propensity score-matched retrospective cohort study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Enterococcaceae; Female; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Referral and Consultation; Retrospective Studies; Vancomycin; Veterans | 2023 |
Disk diffusion-based method aids in the detection of vanM-positive Enterococcus faecium with low vancomycin minimum inhibitory concentrations.
Topics: Anti-Bacterial Agents; China; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Enterococcal Linear Plasmids Adapt to Enterococcus faecium and Spread within Multidrug-Resistant Clades.
Topics: Anti-Bacterial Agents; Enterococcus; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Plasmids; Vancomycin | 2023 |
Impact of vancomycin resistance in Enterococcus faecium bloodstream infection on mortality: A retrospective analysis of nationwide surveillance data.
Topics: Anti-Bacterial Agents; Bacteremia; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Retrospective Studies; Sepsis; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2023 |
Reversible vancomycin susceptibility within emerging ST1421 Enterococcus faecium strains is associated with rearranged vanA-gene clusters and increased vanA plasmid copy number.
Topics: Anti-Bacterial Agents; Australia; Bacterial Proteins; DNA Copy Number Variations; Enterococcus; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multigene Family; Plasmids; Vancomycin | 2023 |
Using Genomics To Investigate an Outbreak of Vancomycin-Resistant Enterococcus faecium ST78 at a Large Tertiary Hospital in Queensland.
Topics: Australia; Cross Infection; Disease Outbreaks; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Humans; Phylogeny; Queensland; Tertiary Care Centers; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Carbapenemase-producing Enterobacteriaceae and vancomycin-resistant Enterococcus faecium: The value of a computerized monitoring system to limit their spread.
Topics: Carbapenem-Resistant Enterobacteriaceae; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Synthetic Biology Facilitates Semisynthetic Development of Type V Glycopeptide Antibiotics Targeting Vancomycin-Resistant
Topics: Animals; Anti-Bacterial Agents; Glycopeptides; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Synthetic Biology; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Contact tracing for vancomycin-resistant Enterococcus faecium (VRE): evaluation of the Dutch policy of quintuple screening cultures.
Topics: Anti-Bacterial Agents; Contact Tracing; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Tolerance of clinical vancomycin-resistant Enterococcus faecium isolates against UV-C light from a mobile source.
Topics: Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Vancomycin-sensitive
Topics: Bacteremia; Bacterial Proteins; Cross Infection; Denmark; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Multilocus Sequence Typing; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Impact of a new hospital with close to 100% single-occupancy rooms on environmental contamination and incidence of vancomycin-resistant Enterococcus faecium colonization or infection: a genomic surveillance study.
Topics: Cross Infection; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Hospitals; Humans; Incidence; Prospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
First Report of a Wastewater Treatment-Adapted Enterococcus faecalis ST21 Harboring vanA Gene in Brazil.
Topics: Anti-Bacterial Agents; Brazil; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Vancomycin; Vancomycin Resistance | 2023 |
Molecular characterization of tetracycline and vancomycin-resistant Enterococcus faecium isolates from healthy dogs in Egypt: a public health threat.
Topics: Animals; Anti-Bacterial Agents; Dogs; Egypt; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Phylogeny; Public Health; Tetracycline; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Virulence Factors | 2023 |
Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study.
Topics: Case-Control Studies; Cross Infection; Gram-Positive Bacterial Infections; Hospitals; Humans; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2023 |
First detection and characterisation of a VanA-type Enterococcus faecalis clinical isolate from Bulgaria.
Topics: Aged, 80 and over; Bacterial Proteins; Bulgaria; Carbon-Oxygen Ligases; DNA Transposable Elements; Drug Resistance, Bacterial; Enterococcus faecalis; Female; Genotype; Gram-Positive Bacterial Infections; Humans; Vancomycin | 2019 |
Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Disease Models, Animal; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Injections; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Phage Therapy; Vancomycin; Vancomycin Resistance | 2019 |
Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Enterococcus faecium; Female; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Propensity Score; Retrospective Studies; Teicoplanin; Treatment Outcome; Vancomycin | 2019 |
Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Brazil; Female; Follow-Up Studies; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitalization; Humans; Incidence; Male; Middle Aged; Prognosis; Prospective Studies; Vancomycin | 2019 |
First isolation and characterization of vancomycin-resistant Enterococcus faecium harboring vanD5 gene cluster recovered from a 79-year-old female inpatient in Japan.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Enterococcus faecium; Female; Genotype; Gram-Positive Bacterial Infections; Humans; Japan; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Multigene Family; Peptide Synthases; Phenotype; Teicoplanin; Vancomycin; Vancomycin Resistance | 2019 |
Sepsis induced bacterial peritonitis caused by Granulicatella adiacens.
Topics: Adult; Anti-Bacterial Agents; Carnobacteriaceae; Gram-Positive Bacterial Infections; Humans; Male; Peritonitis; Sepsis; Staphylococcus aureus; Vancomycin | 2019 |
Investigating the relationship between vancomycin-resistant Enterococcus control practices and the incidence of health care-associated Clostridioides difficile infections in Ontario.
Topics: Clostridioides; Clostridium Infections; Cross Infection; Delivery of Health Care; Gram-Positive Bacterial Infections; Health Facilities; Hospitals; Humans; Incidence; Infection Control; Ontario; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Antimicrobial resistance classification using MALDI-TOF-MS is not that easy: lessons from vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vancomycin | 2020 |
Prevalence and Resistance Profiles of Vancomycin-resistant Enterococcal Isolates in Iran; An Eight-month Report from Nine Major Cities.
Topics: Anti-Bacterial Agents; Cities; Cross-Sectional Studies; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Iran; Microbial Sensitivity Tests; Prevalence; Vancomycin | 2020 |
Is there a higher prevalence of methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococcus (VRE) colonization in patients with antibiotic allergy labels?
Topics: Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Humans; Hypersensitivity; Methicillin-Resistant Staphylococcus aureus; Prevalence; Retrospective Studies; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2020 |
Antimicrobial Stewardship in a Hematological Malignancy Unit: Carbapenem Reduction and Decreased Vancomycin-Resistant Enterococcus Infection.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Methicillin-Resistant Staphylococcus aureus; Vancomycin | 2020 |
Predictors for vancomycin resistant
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Case-Control Studies; Cephalosporins; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci; Vascular Access Devices | 2019 |
Risk factors for vancomycin-resistant enterococcus acquisition during a large outbreak in patients aged 65 years and older.
Topics: Aged; Aged, 80 and over; Aging; Anti-Bacterial Agents; Cohort Studies; Cross Infection; Disease Outbreaks; Female; France; Gram-Positive Bacterial Infections; Humans; Male; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2019 |
Discontinuing Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) Is Associated With Rising VRE Bloodstream Infection Rates in Ontario Hospitals, 2009-2018: A Quasi-experimental Study.
Topics: Cross Infection; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Ontario; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Expression of VanA-type vancomycin resistance in a clinical isolate of Enterococcus faecium showing insertion of IS19 in the vanS gene.
Topics: Bacterial Proteins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Mutagenesis, Insertional; Protein Kinases; Transcription Factors; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2020 |
Enterococcal Bacteremia in Children With Malignancies and Following Hematopoietic Stem Cell Transplantation: A 15-Year Single-Center Experience.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Infant, Newborn; Retrospective Studies; Tertiary Care Centers; Time Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Multiomics Substrates of Resistance to Emerging Pathogens? Transcriptome and Proteome Profile of a Vancomycin-Resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; Computational Biology; Drug Resistance, Microbial; Enterococcus faecalis; Genome, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Annotation; Phylogeny; Proteome; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stress, Physiological; Transcriptome; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Whole-genome analysis of vancomycin-resistant Enterococcus faecium causing nosocomial outbreaks suggests the occurrence of few endemic clonal lineages in Bavaria, Germany.
Topics: Bacterial Proteins; Cross Infection; Disease Outbreaks; Enterococcus faecium; Genotype; Germany; Gram-Positive Bacterial Infections; Hospitals; Humans; Multilocus Sequence Typing; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
Topics: Aged; Anti-Bacterial Agents; Bayes Theorem; Cohort Studies; Cost-Benefit Analysis; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Economics, Pharmaceutical; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Propensity Score; Prospective Studies; Renal Insufficiency; Risk Factors; Vancomycin | 2020 |
Association between vancomycin-resistant Enterococcus faecium colonization and subsequent infection: a retrospective WGS study.
Topics: Bacterial Proteins; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Whole Genome Sequence Analysis of the First Vancomycin-Resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Libya; Multilocus Sequence Typing; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2020 |
A new use of
Topics: Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Lacticaseibacillus rhamnosus; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population Structure.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Enterococcus faecium; Genomics; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Antibiogram of Urinary
Topics: Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Tertiary Care Centers; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2021 |
Determinants of vancomycin nephrotoxicity when administered to outpatients as a continuous 24-hour infusion.
Topics: Aged; Anti-Bacterial Agents; Biomarkers, Pharmacological; Creatinine; Drug Monitoring; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Outpatients; Renal Insufficiency; Retrospective Studies; Risk Factors; Time Factors; Vancomycin | 2020 |
Challenges in interpretation of WGS and epidemiological data to investigate nosocomial transmission of vancomycin-resistant Enterococcus faecium in an endemic region: incorporation of patient movement network and admission screening.
Topics: Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Case Report: A Polymicrobial Vision-Threatening Eye Infection Associated with Polysubstance Abuse.
Topics: Administration, Ophthalmic; Adult; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Ceftazidime; Cocaine; Cocaine-Related Disorders; Coinfection; Dopamine Uptake Inhibitors; Doxycycline; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Keratitis; Kingella; Linezolid; Moxifloxacin; Neisseriaceae Infections; Ophthalmic Solutions; Prednisone; Propionibacterium acnes; Streptococcal Infections; Streptococcus; Substance Abuse, Intravenous; Tobramycin; Vancomycin; Voriconazole | 2020 |
Hospital outbreak of linezolid-resistant and vancomycin-resistant ST80 Enterococcus faecium harbouring an optrA-encoding conjugative plasmid investigated by whole-genome sequencing.
Topics: Anti-Bacterial Agents; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Ireland; Linezolid; Microbial Sensitivity Tests; Phenotype; Plasmids; RNA, Ribosomal, 23S; Vancomycin; Whole Genome Sequencing | 2020 |
Low prevalence of combined linezolid- and vancomycin-resistant Enterococcus faecium from hospital admission screening in an endemic region in Germany.
Topics: Anti-Bacterial Agents; Enterococcus faecium; Germany; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Prevalence; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Characterization of clinical enterococci isolates, focusing on the vancomycin-resistant enterococci in a tertiary hospital in China: based on the data from 2013 to 2018.
Topics: Anti-Bacterial Agents; China; DNA, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Retrospective Studies; Tertiary Care Centers; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Comprehensive integrated NGS-based surveillance and contact-network modeling unravels transmission dynamics of vancomycin-resistant enterococci in a high-risk population within a tertiary care hospital.
Topics: Algorithms; Anti-Bacterial Agents; Contact Tracing; Cross Infection; Enterococcus faecium; Germany; Gram-Positive Bacterial Infections; High-Throughput Nucleotide Sequencing; Humans; Infection Control; Models, Theoretical; Phylogeny; Population Dynamics; Population Surveillance; Retrospective Studies; Tertiary Care Centers; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Emergence of vancomycin- and teicoplanin-resistant Enterococcus faecium via vanD5-harbouring large genomic island.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Canada; Clostridiales; Enterococcus faecium; Genomic Islands; Gram-Positive Bacterial Infections; Humans; Japan; Microbial Sensitivity Tests; Netherlands; Teicoplanin; Vancomycin | 2020 |
Mandated IOL Removal for Cure of Recurrent Enterococcus Faecalis Endophthalmitis: A Case Report.
Topics: Aged; Anti-Bacterial Agents; Device Removal; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Microscopy, Acoustic; Phacoemulsification; Recurrence; Slit Lamp Microscopy; Vancomycin; Visual Acuity; Vitreous Body | 2021 |
Comparison of breakthrough Gram-positive cocci infection during vancomycin vs teicoplanin therapy in patients receiving haematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Febrile Neutropenia; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Teicoplanin; Vancomycin; Young Adult | 2020 |
Increase of vancomycin-resistant Enterococcus faecium strain type ST117 CT71 at Charité - Universitätsmedizin Berlin, 2008 to 2018.
Topics: Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; Berlin; Cross Infection; Female; Genome, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci; Virulence; Virulence Factors; Whole Genome Sequencing | 2020 |
Vancomycin-resistant Enterococcus faecium colonizing patients on hospital admission in Germany: prevalence and molecular epidemiology.
Topics: Adult; Cross Infection; Enterococcus faecium; Genotype; Germany; Gram-Positive Bacterial Infections; Hospitals; Humans; Molecular Epidemiology; Multilocus Sequence Typing; Prevalence; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Emergence of pstS-Null Vancomycin-Resistant Enterococcus faecium Clone ST1478, Canada, 2013-2018.
Topics: Anti-Bacterial Agents; Canada; Clone Cells; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Long-Lasting Decrease of the Acquisition of
Topics: Anti-Bacterial Agents; beta-Lactamases; Enterococcus faecium; Gram-Negative Bacteria; Gram-Positive Bacterial Infections; Humans; Probiotics; Vancomycin | 2020 |
Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Critical Care; Drug Monitoring; Female; Forecasting; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Models, Biological; Pharmacokinetics; Predictive Value of Tests; Vancomycin | 2020 |
Impact of Inappropriate Antibiotic Therapy in Vancomycin-Resistant Enterococcus Bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Enterococcus; Gram-Positive Bacterial Infections; Humans; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2020 |
Risk factors for development of vancomycin-resistant enterococcal bacteremia among VRE colonizers : A retrospective case control study.
Topics: Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Gram-Positive Bacterial Infections; Humans; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2021 |
Chlorhexidine bathing to prevent healthcare-associated vancomycin-resistant Enterococcus infections: A cluster quasi-experimental controlled study at intensive care units.
Topics: Anti-Infective Agents, Local; Chlorhexidine; Cross Infection; Delivery of Health Care; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Prospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram-Positive Bacterial Infection.
Topics: Adolescent; Anti-Bacterial Agents; C-Reactive Protein; Case-Control Studies; Child; Child, Preschool; Drug Monitoring; Female; Gram-Positive Bacterial Infections; Humans; Infant; Male; Retrospective Studies; Treatment Outcome; Vancomycin | 2020 |
Positron Emission Tomography/Computed Tomography-Based Diagnosis of Endotipsitis.
Topics: Anti-Bacterial Agents; Ascites; Bacteremia; Biomarkers; Diagnosis, Differential; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Vancomycin | 2021 |
VanA rectal swab screening as a predictor of subsequent vancomycin-resistant enterococcal bloodstream infection in critically ill adults.
Topics: Adult; Bacteremia; Bacterial Proteins; Critical Illness; Gram-Positive Bacterial Infections; Humans; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
The comparative risk of acute kidney injury of vancomycin relative to other common antibiotics.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Duration of Therapy; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Male; Middle Aged; Vancomycin | 2020 |
Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies.
Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Asian People; Child; Child Health Services; Child, Preschool; China; Female; Glomerular Filtration Rate; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Infant; Infusions, Intravenous; Male; Retrospective Studies; Vancomycin | 2020 |
Optimization of Vancomycin Dosing Regimen in Cancer Patients using Pharmacokinetic/Pharmacodynamic Modeling.
Topics: Anti-Bacterial Agents; Area Under Curve; Cohort Studies; Female; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Theoretical; Neoplasms; Predictive Value of Tests; Retrospective Studies; Vancomycin | 2020 |
Quantifying acquisition and transmission of Enterococcus faecium using genomic surveillance.
Topics: Adult; Aged; Aged, 80 and over; Alcohols; Anti-Bacterial Agents; Chlorhexidine; Cross Infection; Disease Outbreaks; Disinfectants; Enterococcus faecium; Genome, Bacterial; Gram-Positive Bacterial Infections; Humans; Infection Control; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing; Young Adult | 2021 |
Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; Daptomycin; Enterococcus faecium; Febrile Neutropenia; Female; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Linezolid; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sex Factors; Soft Tissue Infections; Turkey; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2020 |
Complicated peritoneal dialysis-associated peritonitis caused by Brevibacterium.
Topics: Aged; Anti-Bacterial Agents; Brevibacterium; Gram-Positive Bacterial Infections; Humans; Male; Peritoneal Dialysis; Peritonitis; Vancomycin | 2021 |
An Update to Enterococcal Bacteremia: Epidemiology, Resistance, and Outcome.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; Cross-Sectional Studies; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Gut Microbiota Predict
Topics: Anti-Bacterial Agents; Bacterial Physiological Phenomena; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecium; Feces; Female; Gastrointestinal Microbiome; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; RNA, Ribosomal, 16S; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections.
Topics: Adult; Anti-Bacterial Agents; Daptomycin; Endocarditis; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Osteomyelitis; Outpatients; Retrospective Studies; Teicoplanin; Vancomycin | 2020 |
Risk factors and outcomes associated with the carriage of tigecycline- and vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Risk Factors; Tigecycline; Vancomycin | 2021 |
Development and validation of a lateral flow immunoassay for rapid detection of VanA-producing enterococci.
Topics: Bacterial Proteins; Carbon-Oxygen Ligases; Enterococcus; Gram-Positive Bacterial Infections; Humans; Immunoassay; Vancomycin; Vancomycin Resistance | 2021 |
Vancomycin variable Enterococcus (VVE), E. faecium, harbouring the vanA gene complex.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Enterococcus; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 2021 |
Correlation between Nosocomial Carriage of Vancomycin-Resistant Enterococci and Antimicrobial Use in Taiwan.
Topics: Anti-Infective Agents; Carrier State; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Humans; Taiwan; Vancomycin; Vancomycin Resistance | 2020 |
Risk factors and outcomes associated with vancomycin-resistant Enterococcus faecium and ampicillin-resistant Enterococcus faecalis bacteraemia: A 10-year study in a tertiary-care centre in Mexico City.
Topics: Ampicillin; Bacteremia; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Mexico; Risk Factors; Vancomycin | 2021 |
Characterization of a vancomycin-resistant Enterococcus faecium isolate and a vancomycin-susceptible E. faecium isolate from the same blood culture.
Topics: Bacterial Proteins; Blood Culture; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Whole-genome sequencing analysis reveals the spread of a vanB-carrying transposon among different vancomycin-resistant Enterococcus faecium clinical isolates in a non-endemic setting.
Topics: Bacterial Proteins; Disease Outbreaks; DNA Transposable Elements; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; Prospective Studies; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2021 |
Efficacy of Vancomycin with Fosfomycin against Vancomycin-Resistant Enterococcus Strains Using Agar Dilution Method.
Topics: Agar; Anti-Bacterial Agents; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 2021 |
Epidemiology and Outcomes of Vancomycin-Resistant Enterococcus Infections in the U.S. Military Health System.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Humans; Military Health Services; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2021 |
Emergence of linezolid-resistance in vancomycin-resistant Enterococcus faecium ST117 associated with increased linezolid-consumption.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Germany; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Retrospective Studies; RNA, Ribosomal, 23S; Vancomycin; Vancomycin Resistance | 2021 |
Vancomycin-resistant Enterococcus faecium in Algeria: phenotypic and genotypic characterization of clinical isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algeria; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Female; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Teicoplanin; Tigecycline; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Virulence Factors; Young Adult | 2021 |
Successful containment of two vancomycin-resistant Enterococcus faecium (VRE) outbreaks in a Dutch teaching hospital using environmental sampling and whole-genome sequencing.
Topics: Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Multilocus Sequence Typing; Netherlands; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Using core genome multilocus sequence typing (cgMLST) for vancomycin-resistant Enterococcus faecium isolates to guide infection control interventions and end an outbreak.
Topics: Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infection Control; Multilocus Sequence Typing; Vancomycin | 2021 |
Clinical Outcome of Vancomycin-Resistant Enterococcus Colonization Among Liver Transplant Recipients at Shiraz Organ Transplant Center.
Topics: Anti-Bacterial Agents; Female; Gram-Positive Bacterial Infections; Humans; Liver Transplantation; Male; Organ Transplantation; Risk Factors; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
First characterization of Tn1546-like structures of vancomycin-resistant Enterococcus faecium Thai isolates.
Topics: Bacterial Proteins; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; Thailand; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2021 |
Intestinal carriage of vancomycin-resistant Enterococcus spp. among high-risk patients in university hospitals in Serbia: first surveillance report.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Serbia; Vancomycin; Vancomycin-Resistant Enterococci; Virulence; Virulence Factors | 2021 |
Epidemiological typing of ST80 vancomycin-resistant Enterococcus faecium: core genome multilocus sequence typing versus single nucleotide polymorphism-based typing.
Topics: Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; Polymorphism, Single Nucleotide; Vancomycin | 2021 |
ddcP, pstB, and excess D-lactate impact synergism between vancomycin and chlorhexidine against Enterococcus faecium 1,231,410.
Topics: Adenosine Triphosphatases; Anti-Bacterial Agents; Anti-Infective Agents, Local; ATP-Binding Cassette Transporters; Bacterial Proteins; Chlorhexidine; Drug Synergism; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Lactic Acid; Vancomycin | 2021 |
First isolation of vancomycin-resistant Enterococcus faecalis from cattle and swine in Xinjiang, China.
Topics: Animals; Anti-Bacterial Agents; Cattle; China; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Swine; Vancomycin; Vancomycin Resistance | 2021 |
High frequency and diversity of Vancomycin-resistant Enterococci (VRE) in Algerian healthcare settings.
Topics: Adult; Aged; Aged, 80 and over; Algeria; Anti-Bacterial Agents; Female; Gram-Positive Bacterial Infections; Hospitals; Humans; Incidence; Male; Microbiota; Middle Aged; Prevalence; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Young Adult | 2021 |
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resist
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Epidemiological Monitoring; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Taiwan; Tetracyclines; Tetrazoles; Tigecycline; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2021 |
Occurrence of multidrug-resistant Enterococcus faecium isolated from environmental samples.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Environmental Microbiology; Fluoroquinolones; Gram-Positive Bacterial Infections; Linezolid; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Vancomycin; Virulence; Virulence Factors | 2021 |
The impact of vancomycin-resistant
Topics: Bacteremia; Cross Infection; Delivery of Health Care; Gram-Positive Bacterial Infections; Humans; Incidence; Policy; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
A Japanese traditional medicine Hochuekkito promotes negative conversion of vancomycin-resistant Enterococci.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Drugs, Chinese Herbal; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Japan; Male; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Medicine, Kampo; Middle Aged; Probiotics; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Vancomycin resistant Enterococci and its associated factors among HIV infected patients on anti-retroviral therapy in Ethiopia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Retroviral Agents; Cross-Sectional Studies; Ethiopia; Female; Gastrointestinal Tract; Gram-Positive Bacterial Infections; HIV; HIV Infections; Hospitalization; Humans; Male; Middle Aged; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2021 |
Digestive Decolonization of Colorectal Carriage of Vancomycin-resistant Enterococcus faecium in a Japanese Adult.
Topics: Adult; Anti-Bacterial Agents; Colorectal Neoplasms; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Japan; Vancomycin | 2022 |
Stachyose inhibits vancomycin-resistant Enterococcus colonization and affects gut microbiota in mice.
Topics: Animals; Anti-Bacterial Agents; Bacteroidetes; Female; Gastrointestinal Microbiome; Gram-Positive Bacterial Infections; Mice; Oligosaccharides; RNA, Ribosomal, 16S; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Risk of methicillin-resistant
Topics: Ambulances; Cohort Studies; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Propensity Score; Retrospective Studies; Staphylococcal Infections; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |
Novel genomic islands and a new vanD-subtype in the first sporadic VanD-type vancomycin resistant enterococci in Norway.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Enterococcus; Enterococcus faecium; Female; Genomic Islands; Gram-Positive Bacterial Infections; Humans; Middle Aged; Peptide Synthases; Vancomycin; Vancomycin Resistance | 2021 |
Nosocomial infections caused by vancomycin-resistant Enterococcus in a Japanese general hospital and molecular genetic analysis.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, General; Humans; Japan; Molecular Epidemiology; Multilocus Sequence Typing; Vancomycin | 2021 |
Evaluation of copper alloys for reducing infection by methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus faecium in intensive care unit and in vitro.
Topics: Alloys; Copper; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2021 |
Spread of vancomycin-resistant Enterococcus faecium ST133 in the aquatic environment in Switzerland.
Topics: Animals; Bacterial Proteins; Enterococcus faecium; Gram-Positive Bacterial Infections; Phylogeny; Swine; Switzerland; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Fitness cost of vancomycin-resistant Enterococcus faecium plasmids associated with hospital infection outbreaks.
Topics: Bacterial Proteins; Cross Infection; Disease Outbreaks; DNA Transposable Elements; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Plasmids; Vancomycin | 2021 |
Vancomycin-resistant enterococci in acute myeloid leukemia and myelodysplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cephalosporins; Cytarabine; Female; Gram-Positive Bacterial Infections; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid; Male; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2017 |
Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.
Topics: Adult; Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; Cohort Studies; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2017 |
First case of bacteremia caused by Janibacter hoylei.
Topics: Actinobacteria; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; DNA, Bacterial; DNA, Ribosomal; Gram-Positive Bacterial Infections; Humans; Infant; Male; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Treatment Outcome; Vancomycin | 2017 |
Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Physiological Phenomena; Clostridium; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Intestines; Mice; Mice, Inbred C57BL; Microbiota; RNA, Ribosomal, 16S; Symbiosis; Vancomycin; Vancomycin-Resistant Enterococci | 2017 |
Topics: Aged; Ampicillin; Bacteremia; beta-Lactams; Clostridioides difficile; Diagnosis, Differential; Enterococcus faecalis; Gram-Positive Bacterial Infections; Hepatitis A; Humans; Infusions, Intravenous; Male; Vancomycin | 2017 |
Topics: Administration, Intravenous; Anti-Bacterial Agents; Arthritis, Infectious; Arthroplasty, Replacement, Hip; Diabetes Complications; Diabetes Mellitus; Diagnosis, Differential; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Osteoarthritis; Osteomyelitis; Peptostreptococcus; Treatment Outcome; Vancomycin | 2017 |
Genotyping, antimicrobial resistance and virulence factor gene profiles of vancomycin resistance Enterococcus faecalis isolated from blood culture.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Blood Culture; Carbon-Oxygen Ligases; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Peptide Synthases; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Virulence; Virulence Factors | 2017 |
Impact of faecal microbiota transplantation to eradicate vancomycin-resistant enterococci (VRE) colonization in humans.
Topics: Anti-Bacterial Agents; Fecal Microbiota Transplantation; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin-Resistant Enterococci | 2017 |
Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
Topics: Anti-Bacterial Agents; Area Under Curve; Drug Administration Schedule; Extracorporeal Membrane Oxygenation; Female; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Monte Carlo Method; Retrospective Studies; Vancomycin | 2017 |
Enterococci in orthopaedic infections: Who is at risk getting infected?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cohort Studies; Cross Infection; Daptomycin; Enterococcus; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Intraoperative Period; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Orthopedic Procedures; Perioperative Period; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2017 |
Genetic characterisation confirms sporadic occurrence of vancomycin-resistant Enterococcus faecalis in Copenhagen, Denmark.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Denmark; Enterococcus faecalis; Gram-Positive Bacterial Infections; Hospitals; Humans; Phylogeny; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2017 |
Biofilm formation in enterococci: genotype-phenotype correlations and inhibition by vancomycin.
Topics: Anti-Bacterial Agents; Biofilms; Egypt; Enterococcus; Genes, Bacterial; Genetic Association Studies; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Polymerase Chain Reaction; Vancomycin; Virulence Factors | 2017 |
Decrease in Vancomycin-Resistant Enterococcus Colonization After Extensive Renovation of a Unit Dedicated to the Treatment of Hematologic Malignancies and Hematopoietic Stem-Cell Transplantation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Equipment Contamination; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hospital Design and Construction; Humans; Infection Control; Leukemia, Myeloid, Acute; Male; Middle Aged; Molecular Typing; Patients' Rooms; Proportional Hazards Models; Retrospective Studies; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Young Adult | 2017 |
In vitro stepwise selection of reduced susceptibility to lipoglycopeptides in enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Teicoplanin; Vancomycin; Vancomycin Resistance | 2017 |
A therapeutic benefit of daptomycin against glycopeptide-resistant gram-positive cocci bloodstream infections under neutropenia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Chemotherapy-Induced Febrile Neutropenia; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Leuconostoc; Leukemia, Myeloid, Acute; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 2017 |
First description in Europe of the emergence of Enterococcus faecium ST117 carrying both vanA and vanB genes, isolated in Greece.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Carbon-Oxygen Ligases; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Europe; Gene Expression Regulation, Bacterial; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Greece; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Phenotype; Plasmids; Protein Kinases; Teicoplanin; Transcription Factors; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2017 |
Analysis of distribution and antibiotic resistance of pathogens isolated from the paediatric population in Shenmu Hospital from 2011-2015.
Topics: Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fungi; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Infant; Infant, Newborn; Male; Meropenem; Microbial Sensitivity Tests; Mycoses; Penicillins; Retrospective Studies; Thienamycins; Vancomycin | 2018 |
Vancomycin-resistant Enterococcus faecium ST17 outbreak in a Neonatal Unit.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Vancomycin; Vancomycin-Resistant Enterococci | 2018 |
Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration.
Topics: Anti-Bacterial Agents; Critical Illness; Gram-Positive Bacterial Infections; Hemofiltration; Humans; Metabolic Clearance Rate; Nomograms; Prospective Studies; Renal Insufficiency; Tertiary Care Centers; Vancomycin | 2018 |
High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium.
Topics: Alkyl and Aryl Transferases; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Mutation; Pennsylvania; Vancomycin | 2017 |
Controlling for endogeneity in attributable costs of vancomycin-resistant enterococci from a Canadian hospital.
Topics: Aged; Anti-Bacterial Agents; Canada; Cross Infection; Female; Gram-Positive Bacterial Infections; Health Care Costs; Hospital Costs; Hospitals, Urban; Humans; Linear Models; Male; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2017 |
The levels of vancomycin in the blood and the wound after the local treatment of bone and soft-tissue infection with antibiotic-loaded calcium sulphate as carrier material.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Calcium Sulfate; Drug Carriers; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Orthopedic Procedures; Osteomyelitis; Prospective Studies; Prosthesis-Related Infections; Soft Tissue Infections; Vancomycin | 2017 |
Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an
Topics: Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2018 |
Septic arthritis of knee joint due to
Topics: Administration, Intravenous; Anti-Bacterial Agents; Arthritis, Infectious; Arthroscopy; Diagnosis, Differential; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Knee Joint; Male; Middle Aged; Peptostreptococcus; Synovial Fluid; Transplant Recipients; Vancomycin | 2017 |
Atomic structure and enzymatic insights into the vancomycin-resistant Enterococcus faecalis (V583) alkylhydroperoxide reductase subunit C.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Catalytic Domain; Crystallography, X-Ray; Cysteine; Drug Resistance; Enterococcus faecalis; Gram-Positive Bacterial Infections; Homeostasis; Humans; Models, Molecular; Molecular Structure; Mutagenesis, Site-Directed; Oxidation-Reduction; Peroxiredoxins; Protein Conformation; Vancomycin | 2018 |
New colony multiplex PCR assays for the detection and discrimination of vancomycin-resistant enterococcal species.
Topics: Bacterial Proteins; Enterococcus faecalis; Enterococcus faecium; Enterococcus hirae; Gram-Positive Bacterial Infections; Humans; Multiplex Polymerase Chain Reaction; Peptide Synthases; Sensitivity and Specificity; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2018 |
Effectiveness of Vancomycin or Beta-Lactam Therapy in Ampicillin-Susceptible
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 2019 |
Successful treatment of a penicillin-intermediate and ceftriaxone-resistant Granulicatella adiacens presumed prosthetic valve endocarditis with vancomycin.
Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carnobacteriaceae; Ceftriaxone; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Penicillins; Prosthesis-Related Infections; Treatment Outcome; Vancomycin | 2018 |
Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Microbial; Enterococcus faecium; Female; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Gene Transfer Techniques; Gene Transfer, Horizontal; Genotype; Gram-Positive Bacterial Infections; Humans; Interspersed Repetitive Sequences; Microbial Sensitivity Tests; Operon; Phenotype; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Teicoplanin; Vancomycin; Vancomycin Resistance; Whole Genome Sequencing | 2018 |
Spread of Vancomycin-Resistant Enterococcus faecium Isolates Despite Validated Infection Control Measures in an Italian Hospital: Antibiotic Resistance and Genotypic Characterization of the Endemic Strain.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Bacterial Typing Techniques; Cross Infection; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Italy; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2018 |
Comparison of Enterococcus faecium Bacteremic Isolates from Hematologic and Non-hematologic Patients: Differences in Antimicrobial Resistance and Molecular Characteristics.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Multilocus Sequence Typing; Plasmids; Prevalence; Vancomycin; Virulence Factors | 2018 |
Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients.
Topics: Adult; Aged; Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Liver; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2018 |
Topics: Anti-Bacterial Agents; Bursitis; Debridement; Elbow Injuries; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Olecranon Process; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propionibacterium acnes; Soft Tissue Injuries; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2018 |
Antibiotic Susceptibility Determination within One Cell Cycle at Single-Bacterium Level by Stimulated Raman Metabolic Imaging.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Glucose; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Single-Cell Analysis; Spectrum Analysis, Raman; Staphylococcus aureus; Vancomycin | 2018 |
Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Enterococcus faecium; Feces; Genome, Bacterial; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Operon; Phylogeny; Plasmids; Symbiosis; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2018 |
BILATERAL ENTEROCOCCUS FAECALIS ENDOPHTHALMITIS WITH MULTIPLE RECURRENCES.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Lens Capsule, Crystalline; Male; Microscopy, Electron; Recurrence; Secondary Prevention; Ultrasonography; Vancomycin; Visual Acuity; Vitrectomy | 2021 |
1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterococcus faecalis; Enterococcus faecium; Erythrocytes; Gram-Positive Bacterial Infections; Hemolysis; Humans; Kinetics; Microbial Sensitivity Tests; Oxadiazoles; Staphylococcus aureus; Vancomycin; Vancomycin-Resistant Enterococci | 2018 |
Antimicrobial susceptibility of enterococci recovered from healthy cattle, pigs and chickens in nine EU countries (EASSA Study) to critically important antibiotics.
Topics: Abattoirs; Ampicillin; Animals; Anti-Bacterial Agents; Bird Diseases; Cattle; Cattle Diseases; Chickens; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Epidemiological Monitoring; Erythromycin; Europe; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Swine; Swine Diseases; Vancomycin | 2018 |
Typing of Enterococcus spp. strains in 4 hospitals in the Małopolska region in Poland.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitalization; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Poland; Vancomycin; Vancomycin Resistance; Virulence; Virulence Factors | 2018 |
[Clinical features of Enterococcus faecium meningitis in children].
Topics: C-Reactive Protein; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Vancomycin | 2018 |
Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study.
Topics: Adult; Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; Case-Control Studies; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Time Factors; United Kingdom; Vancomycin; Vancomycin Resistance | 2018 |
Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Enterococcus faecium; Genetic Variation; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Middle Aged; Phenotype; Prevalence; Vancomycin; Vancomycin Resistance | 2018 |
Relentless spread and adaptation of non-typeable vanA vancomycin-resistant Enterococcus faecium: a genome-wide investigation.
Topics: Anti-Bacterial Agents; Australia; Bacterial Proteins; Bacterial Typing Techniques; Cross Infection; Disease Outbreaks; Enterococcus faecium; Genome, Bacterial; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; New South Wales; Polymerase Chain Reaction; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2018 |
Vancomycin-resistant
Topics: Australia; Bacterial Proteins; Cross Infection; Enterococcus faecium; Epidemics; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Molecular Epidemiology; New Zealand; Phylogeny; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2018 |
In vitro activity of tedizolid and comparator agents against clinical Gram-positive isolates recovered from patients with cancer.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Tetrazoles; Vancomycin | 2018 |
Effect of Intraoperative Single-Shot Application of Vancomycin in Liver Transplant Recipients on Postoperative Infections With Enterococcus faecium and Enterococcus faecalis.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Enterococcus faecalis; Enterococcus faecium; Female; Germany; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Intraoperative Care; Liver Transplantation; Male; Meropenem; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Vancomycin | 2018 |
Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens in the Northwest of Iran.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Iran; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Vancomycin; Vancomycin-Resistant Enterococci | 2018 |
10-year trends in vancomycin-resistant enterococci among allogeneic hematopoietic cell transplant recipients.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cost of Illness; Female; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Factors; Transplantation, Homologous; United States; Vancomycin; Vancomycin-Resistant Enterococci | 2018 |
Comparative study on safety of linezolid and vancomycin in the treatment of infants and neonates for Gram-positive bacterial infections.
Topics: Anti-Bacterial Agents; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Linezolid; Male; Vancomycin | 2018 |
Patient- and hospital-level predictors of vancomycin-resistant Enterococcus (VRE) bacteremia in Ontario, Canada.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Odds Ratio; Ontario; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2018 |
Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16.
Topics: Anti-Bacterial Agents; Daptomycin; Enterococcus; Enterococcus faecalis; Europe; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Teicoplanin; United States; Vancomycin; Viridans Streptococci | 2018 |
The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Disease Transmission, Infectious; Drug Utilization; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; Prevalence; Rectum; Retrospective Studies; United States; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2019 |
Outbreak report: a nosocomial outbreak of vancomycin resistant
Topics: Adolescent; Aged; Anti-Bacterial Agents; Austria; Child; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Organ Transplantation; Phylogeny; Postoperative Complications; Retrospective Studies; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Young Adult | 2018 |
Outbreak of vancomycin-resistant
Topics: Adult; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Switzerland; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2018 |
Delayed Infection in a Patient After Total Hip Arthroplasty.
Topics: Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Buttocks; Female; Gram-Positive Bacterial Infections; Humans; Laminectomy; Musculoskeletal Pain; Physical Therapy Modalities; Postoperative Complications; Prosthesis Failure; Radiography; Reoperation; Spinal Stenosis; Spondylolisthesis; Time Factors; Vancomycin | 2018 |
The unravelled Enterococcus faecalis zoonotic superbugs: Emerging multiple resistant and virulent lineages isolated from poultry environment.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Interspersed Repetitive Sequences; Microbial Sensitivity Tests; One Health; Phylogeny; Poultry; Poultry Diseases; Random Amplified Polymorphic DNA Technique; Vancomycin; Virulence; Virulence Factors; Zoonoses | 2018 |
Efficacy of Vancomycin on Gram-Positive Bacterial Infection in Elderly Critical Patients and Risk Factors Associated With Nephrotoxicity.
Topics: Aged, 80 and over; Anti-Bacterial Agents; APACHE; China; Creatinine; Critical Illness; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Kidney Diseases; Logistic Models; Male; Multivariate Analysis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Vancomycin | 2018 |
Evaluation of vancomycin target trough attainment with published dosing regimens in the neonatal intensive care unit population.
Topics: Administration, Intravenous; Algorithms; Anti-Bacterial Agents; Clinical Protocols; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Retrospective Studies; Vancomycin | 2019 |
Documented vancomycin-induced severe immune-mediated thrombocytopaenia.
Topics: Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Ceftriaxone; Epistaxis; Gram-Positive Bacterial Infections; Humans; Male; Nail Diseases; Nails; Platelet Count; Postoperative Complications; Propionibacterium acnes; Thrombocytopenia; Treatment Outcome; Vancomycin | 2018 |
Infective endocarditis due to
Topics: Actinobacteria; Adolescent; Anti-Bacterial Agents; Diabetes Mellitus, Type 1; Diagnosis, Differential; Echocardiography, Transesophageal; Endocarditis, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Pulmonary Embolism; Tomography, X-Ray Computed; Tricuspid Valve; Urinary Tract Infections; Vancomycin | 2018 |
[Bacteremia Due to Bacillus subtilis: A Case Report and Clinical Evaluation of 10 Cases].
Topics: Anti-Bacterial Agents; Bacillus subtilis; Bacteremia; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin | 2017 |
Prevalence and antimicrobial susceptibility pattern of Enterococcus species isolated from different clinical samples at Black Lion Specialized Teaching Hospital, Addis Ababa, Ethiopia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Doxycycline; Drug Resistance, Bacterial; Enterococcus; Ethiopia; Female; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Infant; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Vancomycin; Young Adult | 2018 |
A Prospective Multicenter Clinical Observational Study on Vancomycin Efficiency and Safety With Therapeutic Drug Monitoring.
Topics: Adolescent; Aged; Anti-Bacterial Agents; Child; Child, Preschool; China; Dose-Response Relationship, Drug; Drug Monitoring; Female; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prospective Studies; Vancomycin | 2018 |
The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospital Costs; Humans; Length of Stay; Male; Middle Aged; Retrospective Studies; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2018 |
Intervertebral disc penetration by antibiotics used prophylactically in spinal surgery: implications for the current standards and treatment of disc infections.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Gram-Positive Bacterial Infections; Humans; Intervertebral Disc; Intervertebral Disc Degeneration; Intervertebral Disc Displacement; Propionibacterium acnes; Vancomycin | 2019 |
Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Daptomycin; Female; Glomerular Filtration Rate; Gram-Positive Bacterial Infections; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin | 2019 |
Matrix metalloprotease-1 inhibits and disrupts Enterococcus faecalis biofilms.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Colony Count, Microbial; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Matrix Metalloproteinase 1; Microbial Sensitivity Tests; Opportunistic Infections; Proteolysis; Recombinant Proteins; Vancomycin | 2019 |
An outbreak of vanA vancomycin-resistant Enterococcus faecium in a hospital with endemic vanB VRE.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; Bacterial Typing Techniques; Disease Management; Disease Outbreaks; Endemic Diseases; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospital Units; Humans; Infection Control; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2019 |
Vancomycin use in surrounding patients during critical illness and risk for persistent colonization with vancomycin-resistant Enterococcus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carrier State; Cross Infection; Drug Utilization; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Assessment; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2019 |
Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Transplantation Conditioning; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2019 |
Utilizing genomic analyses to investigate the first outbreak of vanA vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; Bacteremia; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Daptomycin; Disease Outbreaks; Enterococcus faecium; Female; Genomics; Genotype; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Oncology Service, Hospital; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2019 |
Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey.
Topics: Anti-Bacterial Agents; Communicable Diseases, Emerging; Gram-Positive Bacterial Infections; Humans; Switzerland; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2019 |
In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci.
Topics: Anti-Bacterial Agents; Bacteremia; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |
An epidemiological and molecular study regarding the spread of vancomycin-resistant Enterococcus faecium in a teaching hospital in Bogotá, Colombia 2016.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Colombia; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |
Vancomycin-resistant Enterococcus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Topics: Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Humans; Organ Transplantation; Practice Guidelines as Topic; Societies, Medical; Transplant Recipients; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |
Epidemiological linkage of vancomycin-resistant Enterococcus faecium from different sources in Ahwaz, Iran.
Topics: Cross Infection; Enterococcus faecium; Genetic Linkage; Gram-Positive Bacterial Infections; Hospitals; Humans; Iran; Microbial Sensitivity Tests; Multilocus Sequence Typing; Vancomycin; Vancomycin Resistance | 2019 |
Virulence profiles of vancomycin-resistant enterococci isolated from surface and ground water utilized by humans in the North West Province, South Africa: a public health perspective.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Groundwater; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Public Health; South Africa; Vancomycin; Vancomycin-Resistant Enterococci; Virulence; Virulence Factors | 2019 |
Bacteriophage Resistance Alters Antibiotic-Mediated Intestinal Expansion of Enterococci.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Biological Therapy; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Intestines; Male; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Vancomycin | 2019 |
Lactococcus garvieae, an unusual pathogen in infective endocarditis: case report and review of the literature.
Topics: Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Echocardiography; Endocarditis, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Heart Valve Prosthesis; Humans; Lactococcus; Male; Microbial Sensitivity Tests; Middle Aged; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vancomycin | 2019 |
β-lactam antibiotics vs. vancomycin for the early treatment of enterococcal bacteraemia: A retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacteremia; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Vancomycin | 2019 |
Recurrent
Topics: Aged; Dexamethasone; DNA, Bacterial; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Glucocorticoids; Gram-Positive Bacterial Infections; Humans; Intravitreal Injections; Recurrence; Vancomycin; Vitreous Body | 2019 |
The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study
.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cefazolin; Ceftriaxone; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Vancomycin; Voriconazole; Young Adult | 2019 |
Phenotypic and genotypic characterization of glycopeptide, aminoglycoside and macrolide resistance among clinical isolates of Enterococcus faecalis: a multicenter based study.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Erythromycin; Female; Genes, Bacterial; Genotype; Gentamicins; Gram-Positive Bacterial Infections; Humans; Iran; Male; Microbial Sensitivity Tests; Phenotype; Vancomycin | 2019 |
Species, antibiotic susceptibility profiles and van gene frequencies among enterococci isolated from patients at Mulago National Referral Hospital in Kampala, Uganda.
Topics: Adult; Carrier State; Cross-Sectional Studies; Female; Gene Frequency; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Referral and Consultation; Secondary Care Centers; Uganda; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Young Adult | 2019 |
Emergence of an Australian-like pstS-null vancomycin resistant Enterococcus faecium clone in Scotland.
Topics: Anti-Bacterial Agents; Australia; Cross Infection; Disease Outbreaks; England; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Scotland; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |
Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus Ampicillin.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |
Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asian People; Child; China; Female; Gram-Positive Bacterial Infections; Humans; Kidney; Male; Middle Aged; Nonlinear Dynamics; Vancomycin; Young Adult | 2020 |
Outbreak of Vancomycin-resistant Enterococcus faecium in Interventional Radiology: Detection Through Whole-genome Sequencing-based Surveillance.
Topics: Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Radiology, Interventional; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
The discontinuation of contact precautions for methicillin-resistant
Topics: Cross Infection; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Comparison of VITEK® 2, three different gradient strip tests and broth microdilution for detecting vanB-positive Enterococcus faecium isolates with low vancomycin MICs.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |
Topics: Anti-Bacterial Agents; Daptomycin; Drug Synergism; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |
Assessment of vancomycin resistance transfer among enterococci of clinical importance in milk matrix.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cattle; Conjugation, Genetic; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Food Contamination; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Milk; Tetracycline Resistance; Vancomycin; Vancomycin Resistance | 2019 |
Clinical and microbiological characteristics of vancomycin-resistant enterococci with the VanD phenotype and vanA genotype.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Case-Control Studies; Enterococcus faecium; Female; Genotype; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Peptide Synthases; Phenotype; Retrospective Studies; Risk Factors; Teicoplanin; Vancomycin; Vancomycin Resistance; Virulence Factors | 2013 |
Bacillus cereus fasciitis: a unique pathogen and clinically challenging sequela of inoculation.
Topics: Anti-Bacterial Agents; Bacillus cereus; Child; Clindamycin; Debridement; Fasciitis; Fasciotomy; Gram-Positive Bacterial Infections; Humans; Lower Extremity; Male; Meropenem; Reoperation; Soft Tissue Infections; Therapeutic Irrigation; Thienamycins; Vancomycin; Wounds, Penetrating | 2013 |
Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Daptomycin; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Oxazolidinones; Prevalence; Vancomycin; Young Adult | 2013 |
Antibiotic selection for the treatment of infectious complications of implant-based breast reconstruction.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Breast Implantation; Breast Implants; Device Removal; Drainage; Drug Resistance, Bacterial; Female; Fluoroquinolones; Free Tissue Flaps; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Injections, Intravenous; Microbial Sensitivity Tests; Middle Aged; Radiography, Interventional; Reoperation; Retrospective Studies; Surgical Wound Infection; Tissue Expansion Devices; Treatment Outcome; Vancomycin | 2013 |
Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study.
Topics: Age Factors; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Endocarditis, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; North America; Prospective Studies; Stroke; Vancomycin | 2013 |
Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilities.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Carrier State; Child; Child, Preschool; Enterococcus faecalis; Enterococcus faecium; Female; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Infant; Intensive Care Units, Pediatric; Male; Microbial Sensitivity Tests; Nose; Pakistan; Perineum; Polymerase Chain Reaction; Prevalence; Tertiary Care Centers; Vancomycin; Vancomycin Resistance | 2013 |
Microevolutionary events involving narrow host plasmids influences local fixation of vancomycin-resistance in Enterococcus populations.
Topics: Anti-Bacterial Agents; DNA Transposable Elements; DNA, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Molecular Sequence Data; Plasmids; Portugal; Vancomycin; Vancomycin Resistance | 2013 |
Identification of vancomycin-resistant enterococci clones and inter-hospital spread during an outbreak in Taiwan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Taiwan; Tertiary Care Centers; Vancomycin; Vancomycin Resistance | 2013 |
In vitro activity of vancomycin and daptomycin against clinical isolates of Staphylococcus aureus and enterococci from India.
Topics: Anti-Bacterial Agents; Daptomycin; Enterococcus; Gram-Positive Bacterial Infections; Humans; India; Microbial Sensitivity Tests; Prospective Studies; Staphylococcus aureus; Vancomycin | 2013 |
Genomic analysis of teicoplanin resistance emerging during treatment of vanB vancomycin-resistant Enterococcus faecium infections in solid organ transplant recipients including donor-derived cases.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Enterococcus faecium; Female; Genome, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Organ Transplantation; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; Teicoplanin; Transplantation; Treatment Failure; Vancomycin | 2013 |
Antibacterial resistance and trend of urinary tract pathogens to commonly used antibiotics in Kashmir Valley.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cephalosporins; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; India; Male; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Vancomycin | 2012 |
Maxillary sinusitis after sinus lift due to Gemella morbillorum: antibiotic and surgical treatment.
Topics: Anti-Bacterial Agents; Bone Transplantation; Drug Hypersensitivity; Endoscopy; Female; Follow-Up Studies; Gemella; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Maxillary Sinusitis; Middle Aged; Penicillins; Reoperation; Rifampin; Sinus Floor Augmentation; Surgical Wound Infection; Vancomycin | 2013 |
Virulence of vancomycin-resistant Enterococcus faecium according to linezolid resistance and clinical outbreak status.
Topics: Acetamides; Animals; Chicago; Disease Models, Animal; Disease Outbreaks; Disk Diffusion Antimicrobial Tests; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 500 and over; Humans; Kaplan-Meier Estimate; Linezolid; Moths; Oxazolidinones; Time Factors; Vancomycin; Vancomycin Resistance | 2013 |
Vancomycin-resistant Enterococcus faecium of multi locus sequence type 18 in Malaysia.
Topics: Bacterial Proteins; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Malaysia; Multilocus Sequence Typing; Vancomycin; Vancomycin Resistance | 2012 |
Antimicrobial resistance and virulence traits of Enterococcus faecalis from primary endodontic infections.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; Dental Pulp Diseases; Drug Resistance, Bacterial; Enterococcus faecalis; Erythromycin; Gelatinases; Gene Expression Profiling; Gram-Positive Bacterial Infections; Membrane Proteins; Microbial Sensitivity Tests; Penicillin G; Phenotype; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tetracycline Resistance; Vancomycin; Virulence; Virulence Factors | 2013 |
Modeling the regional spread and control of vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; California; Computer Simulation; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Prevalence; Vancomycin; Vancomycin Resistance | 2013 |
Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Enterococcus; Female; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Infection Control; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance | 2013 |
Genomic insights to control the emergence of vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chromosome Mapping; Cross Infection; Disease Outbreaks; DNA Transposable Elements; DNA, Bacterial; Enterococcus faecium; Genome, Bacterial; Gram-Positive Bacterial Infections; Hospitals; Humans; Molecular Epidemiology; Molecular Sequence Data; Phylogeny; Sequence Analysis, DNA; Vancomycin; Vancomycin Resistance | 2013 |
Abiotrophia defectiva bleb-associated endophthalmitis confirmed with 16s ribosomal RNA sequencing.
Topics: Abiotrophia; Aged; Anti-Bacterial Agents; Atropine; Ceftazidime; Cephalothin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Mydriatics; Phacoemulsification; Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 16S; Surgically-Created Structures; Trabeculectomy; Vancomycin; Vitreous Body | 2015 |
Daptomycin use in neutropenic patients with documented gram-positive infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Vancomycin | 2014 |
Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Multilocus Sequence Typing; Neoplasms; Patient Outcome Assessment; Prospective Studies; Risk Factors; Vancomycin; Young Adult | 2013 |
Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin.
Topics: Animals; Anti-Bacterial Agents; Benzenesulfonates; Biocompatible Materials; Cadaver; Diagnostic Imaging; Disease Models, Animal; Fluorescent Dyes; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Image Interpretation, Computer-Assisted; Indoles; Mice; Myositis; Time Factors; Vancomycin | 2013 |
Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
Topics: Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Calorimetry; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Foreign Bodies; Fosfomycin; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Vancomycin | 2014 |
Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry.
Topics: Acetonitriles; Anti-Bacterial Agents; Calibration; Chromatography, High Pressure Liquid; Colistin; Daptomycin; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Formates; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Limit of Detection; Protein Denaturation; Reproducibility of Results; Tandem Mass Spectrometry; Teicoplanin; Vancomycin | 2013 |
[Retrospective analysis of the Gram-positive bacteria-infected cases in the Department of Hematology].
Topics: Acetamides; Adult; Aged; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Teicoplanin; Vancomycin | 2013 |
Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Enterococcus; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Vancomycin; Vancomycin Resistance | 2013 |
FRIENDS Group: clinical and microbiological characteristics of post-filtering surgery endophthalmitis.
Topics: Aged; Anti-Bacterial Agents; Aqueous Humor; Ceftazidime; DNA, Bacterial; DNA, Ribosomal; Endophthalmitis; Enterococcus; Eye Infections, Bacterial; Female; Filtering Surgery; Glaucoma; Gram-Positive Bacterial Infections; Humans; Male; Polymerase Chain Reaction; Postoperative Complications; RNA, Ribosomal, 16S; Streptococcal Infections; Streptococcus; Vancomycin; Vitreous Body | 2014 |
23-year-old man with fever and a sore thumb.
Topics: Anti-Bacterial Agents; Bacteremia; Cardiac Surgical Procedures; Diagnosis, Differential; Echocardiography, Transesophageal; Endocarditis; Fever; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Pain; Thumb; Vancomycin; Young Adult | 2013 |
A change in the molecular epidemiology of vancomycin resistant enterococci in Western Australia.
Topics: Alleles; Bacterial Proteins; Carbon-Oxygen Ligases; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Vancomycin; Vancomycin Resistance; Western Australia | 2014 |
Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss transplant cohort study.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; beta-Lactams; Cohort Studies; Enterococcus; Enterococcus faecium; Female; Graft Rejection; Gram-Positive Bacterial Infections; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Lung Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Organ Transplantation; Penicillin Resistance; Penicillins; Prospective Studies; Recombinant Fusion Proteins; Risk Factors; Switzerland; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2014 |
Fosfomycin resistance among vancomycin-resistant enterococci owing to transfer of a plasmid harbouring the fosB gene.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Conjugation, Genetic; DNA Transposable Elements; Drug Resistance, Bacterial; Enterococcus; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Proto-Oncogene Proteins c-fos; Transposases; Vancomycin; Vancomycin Resistance | 2014 |
Frequency and antibiogram of vancomycin resistant enterococcus in a tertiary care hospital.
Topics: Anti-Bacterial Agents; Cross-Sectional Studies; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pakistan; Prevalence; Tertiary Healthcare; Vancomycin; Vancomycin Resistance | 2014 |
Assessment of therapeutic drug monitoring of vancomycin in elderly patients according to new guidelines.
Topics: Aged; Drug Monitoring; Female; Gram-Positive Bacterial Infections; Guidelines as Topic; Half-Life; Humans; Injections, Intravenous; Male; Middle Aged; Vancomycin | 2014 |
Emergence of vanA vancomycin-resistant Enterococcus faecium in a hospital in Porto Alegre, South Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Brazil; Carbon-Oxygen Ligases; Cross Infection; Cross-Sectional Studies; Disease Outbreaks; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2014 |
Outbreak of vancomycin-susceptible Enterococcus faecium containing the wild-type vanA gene.
Topics: Agar; Aged; Anti-Bacterial Agents; Bacterial Proteins; Culture Media; Disease Outbreaks; Enterococcus faecium; Female; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2014 |
Vancomycin-variable Enterococcus faecium: in vivo emergence of vancomycin resistance in a vancomycin-susceptible isolate.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2014 |
The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.
Topics: Adult; Bacteremia; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Neutropenia; Prognosis; Risk Factors; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci | 2014 |
Performance of the EUCAST disk diffusion method, the CLSI agar screen method, and the Vitek 2 automated antimicrobial susceptibility testing system for detection of clinical isolates of Enterococci with low- and medium-level VanB-type vancomycin resistanc
Topics: Agar; Anti-Bacterial Agents; Bacterial Proteins; Culture Media; Disk Diffusion Antimicrobial Tests; Enterococcus faecalis; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Vancomycin; Vancomycin Resistance | 2014 |
Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Australia; Bacteremia; Cohort Studies; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2014 |
[Pattern dynamics of bacteriemia and sepsis pathogens in ICU patients of emergency service].
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Candida; Candidiasis; Carbapenems; Cefoperazone; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Klebsiella pneumoniae; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Sulbactam; Vancomycin | 2013 |
Vancomycin-resistant Enterococcus spp isolated from community acquired infections and colonizations in Querétaro City, Mexico.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Mexico; Vancomycin; Vancomycin Resistance | 2014 |
Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2014 |
In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Neoplasms; Oxazolidinones; Vancomycin | 2014 |
Low vancomycin MICs and fecal densities reduce the sensitivity of screening methods for vancomycin resistance in Enterococci.
Topics: Anti-Bacterial Agents; Culture Media; Enterococcus; Feces; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Vancomycin; Vancomycin Resistance | 2014 |
Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital.
Topics: Bacteremia; Cross Infection; Databases, Factual; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Infection Control; Patient Isolation; Polymerase Chain Reaction; Quebec; Retrospective Studies; Tertiary Care Centers; Vancomycin; Vancomycin-Resistant Enterococci | 2014 |
Are we missing anaerobic infective endocarditis in some acute coronary syndromes?
Topics: Acute Coronary Syndrome; Aged; Anti-Bacterial Agents; Ceftriaxone; Diagnosis, Differential; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Mitral Valve Insufficiency; Myocardial Infarction; Peptostreptococcus; Vancomycin | 2014 |
Enterococcal infection in kidney transplant recipients in a setting of low prevalence of vancomycin resistance.
Topics: Aged; Anti-Bacterial Agents; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Male; Middle Aged; Spain; Vancomycin; Vancomycin Resistance | 2014 |
Molecular analysis of vanA outbreak of Enterococcus faecium in two Warsaw hospitals: the importance of mobile genetic elements.
Topics: Bacterial Proteins; Carbon-Oxygen Ligases; Disease Outbreaks; DNA Transposable Elements; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Hospitals; Humans; Phenotype; Plasmids; Poland; Vancomycin; Virulence | 2014 |
Comment on: Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia.
Topics: Ampicillin; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Vancomycin | 2014 |
Linezolid and vancomycin-resistant Enterococcus faecium peritonitis in a child after liver transplantation.
Topics: Biliary Atresia; Child, Preschool; Coinfection; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Liver Transplantation; Male; Peritonitis; Portoenterostomy, Hepatic; Postoperative Complications; Pseudomonas Infections; RNA, Bacterial; RNA, Ribosomal, 23S; Vancomycin | 2015 |
Prevalence of the fosfomycin-resistance determinant, fosB3, in Enterococcus faecium clinical isolates from China.
Topics: Bacterial Proteins; China; Drug Resistance, Bacterial; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Vancomycin | 2014 |
Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia--authors' response.
Topics: Ampicillin; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Vancomycin | 2014 |
Structure and transfer of the vanA cluster in vanA-positive, vancomycin-susceptible Enterococcus faecium, and its revertant mutant.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Multigene Family; Vancomycin; Vancomycin Resistance | 2014 |
Nosocomial infection caused by vancomycin-susceptible multidrug-resistant Enterococcus faecalis over a long period in a university hospital in Japan.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Genotype; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Japan; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Plasmids; Retrospective Studies; Vancomycin | 2014 |
Intraocular penetration of systemic antibiotics in eyes with penetrating ocular injury.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Corneal Injuries; Endophthalmitis; Eye Injuries, Penetrating; Fluoroquinolones; Gram-Positive Bacterial Infections; Intravitreal Injections; Moxifloxacin; Rabbits; Sclera; Vancomycin; Vitreous Body | 2014 |
Recurrent linezolid-resistant Enterococcus faecalis infection in a patient with pneumonia.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Pneumonia, Bacterial; Recurrence; Vancomycin; Vancomycin Resistance | 2015 |
Intestinal translocation of clinical isolates of vancomycin-resistant Enterococcus faecalis and ESBL-producing Escherichia coli in a rat model of bacterial colonization and liver ischemia/reperfusion injury.
Topics: Animals; Bacteremia; Bacterial Translocation; beta-Lactamases; Disease Models, Animal; Endotoxemia; Enterococcus faecalis; Escherichia coli; Gram-Positive Bacterial Infections; Liver; Male; Rats; Reperfusion Injury; Vancomycin; Vancomycin Resistance | 2014 |
Reconsidering isolation precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
Topics: Cross Infection; Drug Resistance, Bacterial; Endemic Diseases; Enterococcus; Gram-Positive Bacterial Infections; Hand Hygiene; Humans; Infection Control; Methicillin-Resistant Staphylococcus aureus; Patient Isolation; Protective Clothing; Staphylococcal Infections; Vancomycin | 2014 |
In vitro activity of oritavancin against Gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2013.
Topics: Anti-Bacterial Agents; Canada; Drug Resistance, Bacterial; Enterococcus faecalis; Glycopeptides; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Laboratories, Hospital; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin | 2014 |
An optimized mouse thigh infection model for enterococci and its impact on antimicrobial pharmacodynamics.
Topics: Ampicillin; Anaerobiosis; Animals; Anti-Bacterial Agents; Disease Models, Animal; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Mice, Inbred ICR; Microbial Sensitivity Tests; Mucins; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Vancomycin | 2015 |
Real-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship.
Topics: Anti-Bacterial Agents; Bacteremia; Blood; Cohort Studies; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Molecular Diagnostic Techniques; Monte Carlo Method; Nanospheres; Oligonucleotide Array Sequence Analysis; Prospective Studies; Vancomycin | 2015 |
Different VanA Elements in E. faecalis and in E. faecium Suggest at Least Two Origins of Tn1546 Among VRE in a Brazilian Hospital.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carbon-Oxygen Ligases; Clone Cells; Cross Infection; DNA Mutational Analysis; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Gene Expression Regulation, Bacterial; Genetic Variation; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Penicillins; Phylogeny; Plasmids; Vancomycin; Vancomycin Resistance | 2015 |
Daptomycin versus Vancomycin in an Enterococcus faecalis Endophthalmitis Rabbit Model.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Intravitreal Injections; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Vancomycin | 2016 |
Lactococcus lactis Catherter-Related Bloodstream Infection in an Infant: Case Report.
Topics: Animals; Anti-Bacterial Agents; Catheter-Related Infections; Down Syndrome; Gram-Positive Bacterial Infections; Hirschsprung Disease; Humans; Infant; Infant, Newborn; Lactococcus lactis; Male; Sepsis; Treatment Outcome; Turkey; Vancomycin | 2015 |
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin.
Topics: Anti-Bacterial Agents; Biomarkers; Enterococcus; Europe; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus; Teicoplanin; United States; Vancomycin | 2015 |
Vancomycin-resistant Enterococcus faecium harbouring vanN in Canada: a case and complete sequence of pEfm12493 harbouring the vanN operon.
Topics: Anti-Bacterial Agents; Canada; DNA, Bacterial; Enterococcus faecium; Gene Order; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Molecular Sequence Data; Operon; Plasmids; Sequence Analysis, DNA; Vancomycin; Vancomycin Resistance | 2015 |
Bacteremia with an iliopsoas abscess and osteomyelitis of the femoral head caused by Enterococcus avium in a patient with end-stage kidney disease.
Topics: Aged; Bacteremia; C-Reactive Protein; Enterococcus; Femur Head; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Male; Osteomyelitis; Polycystic Kidney Diseases; Psoas Abscess; Renal Dialysis; Suppuration; Treatment Outcome; Vancomycin | 2015 |
Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colony Count, Microbial; Cost-Benefit Analysis; Cross Infection; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Incidence; Male; Mass Screening; Middle Aged; Neutropenia; Retrospective Studies; Turkey; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2014 |
Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Canada; Carbon-Oxygen Ligases; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Public Health Surveillance; Vancomycin; Vancomycin Resistance; Young Adult | 2015 |
Competition between VanU(G) repressor and VanR(G) activator leads to rheostatic control of vanG vancomycin resistance operon expression.
Topics: Bacterial Proteins; DNA Footprinting; Drug Resistance, Microbial; Enterococcus faecalis; Gene Expression Regulation, Bacterial; Gram-Positive Bacterial Infections; Humans; Operon; Peptidoglycan; Transcription Factors; Transcription, Genetic; Vancomycin; Vancomycin Resistance | 2015 |
Clinical features of enterococcal bacteremia due to ampicillin-susceptible and ampicillin-resistant enterococci: An eight-year retrospective comparison study.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vancomycin | 2015 |
Characterization of an Enterococcus gallinarum Isolate Carrying a Dual vanA and vanB Cassette.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Chromosomes, Bacterial; Drug Resistance, Bacterial; Enterococcus; Gene Order; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Plasmids; Teicoplanin; Vancomycin | 2015 |
Evaluation of a vancomycin dosing protocol for intensive care unit patients.
Topics: Aged; Anti-Bacterial Agents; Clinical Protocols; Cohort Studies; Drug Monitoring; Female; Glomerular Filtration Rate; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; Netherlands; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2015 |
Molecular characterization of vancomycin-resistant Enterococcus faecium strains isolated from carriage and clinical samples in a tertiary hospital, Turkey.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Molecular Typing; Tertiary Care Centers; Turkey; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Virulence Factors | 2015 |
Bacteremic meningitis caused by Parvimonas micra in an immunocompetent host.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria, Anaerobic; Ceftriaxone; Dyslipidemias; Firmicutes; Gram-Positive Bacterial Infections; Hepatitis B, Chronic; Humans; Male; Meningitis, Bacterial; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin | 2015 |
Comparing the ocular surface effects of topical vancomycin and linezolid for treating bacterial keratitis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Child, Preschool; Eye; Female; Gram-Positive Bacterial Infections; Humans; Keratitis; Linezolid; Male; Middle Aged; Vancomycin | 2016 |
Molecular typing, pathogenicity factor genes and antimicrobial susceptibility of vancomycin resistant enterococci in Belgrade, Serbia.
Topics: Anti-Bacterial Agents; Cluster Analysis; Electrophoresis, Gel, Pulsed-Field; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Prospective Studies; Serbia; Species Specificity; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Virulence Factors | 2015 |
Continuous vs. intermittent vancomycin therapy for Gram-positive infections not caused by methicillin-resistant Staphylococcus aureus.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Female; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prospective Studies; Sepsis; Vancomycin | 2016 |
Environmental survival of vancomycin-sensitive ampicillin-resistant Enterococcus faecium (AREfm).
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Vancomycin | 2015 |
Identification of vancomycin interaction with Enterococcus faecalis within 30 min of interaction time using Raman spectroscopy.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Spectrum Analysis, Raman; Vancomycin | 2015 |
Activity of vancomycin, linezolid, and daptomycin against staphylococci and enterococci isolated in 5 Greek hospitals during a 5-year period (2008-2012).
Topics: Anti-Bacterial Agents; Daptomycin; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Greece; Hospitals; Humans; Linezolid; Microbial Sensitivity Tests; Staphylococcus; Vancomycin | 2015 |
Clinical characteristics and antimicrobial susceptibility of Bacillus cereus blood stream infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacillus cereus; Bacteremia; Blood; Catheter-Related Infections; Female; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Survival Analysis; Tokyo; Vancomycin; Young Adult | 2015 |
Vancomycin serum trough concentration vs. clinical outcome in patients with gram-positive infection: a retrospective analysis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Monitoring; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Vancomycin | 2015 |
Vancomycin-Variable Enterococcal Bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Carbon-Oxygen Ligases; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Typing; Vancomycin; Vancomycin Resistance | 2015 |
Pharmacokinetic Characteristics and Clinical Outcomes of Vancomycin in Young Children With Various Degrees of Renal Function.
Topics: Anti-Bacterial Agents; Child, Preschool; Female; Glomerular Filtration Rate; Gram-Positive Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 2016 |
Clinical characteristics and risk factors of enterococcal infections in Nagasaki, Japan: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Immunosuppressive Agents; Japan; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Factors; Sex Factors; Vancomycin | 2015 |
Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Staphylococcus aureus; Vancomycin | 2016 |
Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.
Topics: Aged; Anti-Infective Agents; Bacteremia; Candida; Candidiasis; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Coinfection; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Multivariate Analysis; Odds Ratio; Risk Factors; Survival Analysis; Treatment Outcome; Vancomycin | 2016 |
[Low grade endophthalmitis caused by P. acnes : Case report].
Topics: Aged, 80 and over; Amikacin; Combined Modality Therapy; Diagnosis, Differential; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Lenses, Intraocular; Postoperative Complications; Propionibacterium acnes; Vancomycin; Vitrectomy | 2016 |
Virulence factors, antimicrobial resistance pattern and molecular analysis of Enterococcal strains isolated from burn patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antigens, Bacterial; Bacterial Proteins; Burns; Carrier Proteins; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Genetic Variation; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Virulence Factors | 2016 |
Prevalence of Diverse Clones of Vancomycin-Resistant Enterococcus faecium ST78 in a Chinese Hospital.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Carbon-Oxygen Ligases; China; Clone Cells; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Gene Expression; Gene Transfer, Horizontal; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Male; Plasmids; Prevalence; Sequence Analysis, DNA; Vancomycin; Vancomycin-Resistant Enterococci; Virulence Factors | 2016 |
Impact of Antibiotic Use on the Evolution of Enterococcus faecium.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Feces; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 2016 |
Vancomycin-resistant Enterococcus faecium with vanA gene isolated for the first time from wildlife in Slovakia.
Topics: Animals; Animals, Wild; Anti-Bacterial Agents; Bacterial Proteins; Bird Diseases; Carbon-Oxygen Ligases; Crows; Enterococcus faecium; Feces; Genetic Variation; Gram-Positive Bacterial Infections; Prevalence; Slovakia; Vancomycin; Vancomycin Resistance | 2016 |
Enterococcus faecalis as multidrug resistance strains in clinical isolates in Imam Reza Hospital in Kermanshah, Iran.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Erythromycin; Gram-Positive Bacterial Infections; Hospitals; Humans; Iran; Microbial Sensitivity Tests; Polymerase Chain Reaction; Vancomycin; Vancomycin-Resistant Enterococci | 2015 |
Vancomycin-resistant enterococci colonization in a neonatal intensive care unit: who will be infected?
Topics: Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Male; Prospective Studies; Rectum; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2016 |
The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients.
Topics: Anti-Bacterial Agents; Connecticut; Enterococcus; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Liver Diseases; Liver Transplantation; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance | 2016 |
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2016 |
[A comparison of efficacy and safety of linezolid versus vancomycin for the treatment of infections in patients after allogeneic hematopoietic stem cell transplantation].
Topics: Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Linezolid; Vancomycin | 2016 |
Vancomycin resistant Enterococcus spp. from crows and their environment in metropolitan Washington State, USA: Is there a correlation between VRE positive crows and the environment?
Topics: Animals; Animals, Wild; Anti-Bacterial Agents; Bacterial Proteins; Bird Diseases; Carbon-Oxygen Ligases; Crows; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Environment; Feces; Gram-Positive Bacterial Infections; Peptide Synthases; Vancomycin; Vancomycin Resistance; Washington | 2016 |
Fatal acquisition of vanD gene during vancomycin treatment of septicaemia caused by Enterococcus faecium.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Peptide Synthases; Sepsis; Vancomycin; Vancomycin Resistance | 2016 |
Population structure and acquisition of the vanB resistance determinant in German clinical isolates of Enterococcus faecium ST192.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chromosome Mapping; Conjugation, Genetic; Cross Infection; Disease Outbreaks; DNA Transposable Elements; Enterococcus faecium; Gene Expression Regulation, Bacterial; Genome, Bacterial; Germany; Gram-Positive Bacterial Infections; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; Vancomycin; Vancomycin Resistance | 2016 |
Drug resistance in Enterococcus species in a tertiary level hospital in Assam, India.
Topics: Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; India; Tertiary Care Centers; Vancomycin | 2016 |
A Vancomycin Derivative with a Pyrophosphate-Binding Group: A Strategy to Combat Vancomycin-Resistant Bacteria.
Topics: Animals; Anti-Bacterial Agents; Diamines; Diphosphates; Erythrocytes; Gram-Positive Bacterial Infections; Humans; Mice; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance; Zinc | 2016 |
Thumb osteoarthritis caused by Lactobacillus plantarum.
Topics: Amoxicillin; Amputation, Surgical; Arthritis, Infectious; Citrus sinensis; Combined Modality Therapy; Diabetes Complications; Disease Susceptibility; Drug Resistance; Drug Substitution; Finger Phalanges; Gram-Positive Bacterial Infections; Humans; Lacerations; Lactobacillus plantarum; Male; Middle Aged; Osteoarthritis; Thumb; Vancomycin; Wound Infection | 2016 |
Beware of Rim-Enhancing Lesions: A Rare Case of Multiple Scedosporium apiospermum and Vancomycin-Resistant Enterococcus faecium Intra-Cranial Abscesses.
Topics: Brain Abscess; Central Nervous System Fungal Infections; Drug Resistance, Multiple, Bacterial; Drug Resistance, Multiple, Fungal; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Magnetic Resonance Imaging; Retrospective Studies; Scedosporium; Vancomycin | 2016 |
Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Michigan; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2016 |
Characterization of a genomic island harbouring a new vanD allele from Enterococcus faecium N15-508 isolated in Canada.
Topics: Aged, 80 and over; Alleles; Bacterial Proteins; Canada; Enterococcus faecium; Female; Genomic Islands; Gram-Positive Bacterial Infections; Humans; Multiplex Polymerase Chain Reaction; Peptide Synthases; Rectum; Teicoplanin; Vancomycin; Vancomycin Resistance | 2016 |
Are vancomycin-resistant enterococci a problem in Polish hospitals?
Topics: Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Length of Stay; Poland; Prevalence; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2015 |
Identification of subclinical transmission of vancomycin-resistant enterococcus within an intensive care unit in Taiwan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Intensive Care Units; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Multilocus Sequence Typing; Taiwan; Tigecycline; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2016 |
Clearance of infant vancomycin-resistant Enterococcus faecium carriage after a neonatal inpatient outbreak.
Topics: Anti-Bacterial Agents; Cohort Studies; Disease Outbreaks; Enterococcus faecium; Feces; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Inpatients; Vancomycin; Vancomycin Resistance; Victoria | 2016 |
Molecular epidemiology of vancomycin resistant enterococci in a tertiary care hospital in Saudi Arabia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arabia; Bacterial Proteins; Carbon-Oxygen Ligases; Child; Child, Preschool; Disk Diffusion Antimicrobial Tests; Electrophoresis, Gel, Pulsed-Field; Female; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Molecular Epidemiology; Molecular Typing; Polymerase Chain Reaction; Saudi Arabia; Teicoplanin; Tertiary Care Centers; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2016 |
Room contamination, patient colonization pressure, and the risk of vancomycin-resistant Enterococcus colonization on a unit dedicated to the treatment of hematologic malignancies and hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Enterococcus; Environmental Microbiology; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Intensive Care Units; Male; Middle Aged; Patients' Rooms; Vancomycin; Vancomycin Resistance; Young Adult | 2016 |
Successful control of emerging vancomycin-resistant enterococci by territory-wide implementation of directly observed hand hygiene in patients in Hong Kong.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Gram-Positive Bacterial Infections; Hand Hygiene; Hong Kong; Hospitals; Humans; Incidence; Infection Control; Prospective Studies; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2016 |
Prevalence and distribution of VRE (vancomycin resistant enterococci) and VSE (vancomycin susceptible enterococci) strains in the breeding environment.
Topics: Animals; Anti-Bacterial Agents; DNA, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Poland; Prevalence; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Species Specificity; Swine; Swine Diseases; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2016 |
Characteristics of Vancomycin-Resistant Enterococcus Strains in the West Balkans: A First Report.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Bosnia and Herzegovina; Carbon-Oxygen Ligases; Croatia; Enterococcus faecalis; Enterococcus faecium; Gene Expression Regulation, Bacterial; Gene Transfer, Horizontal; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pilot Projects; Plasmids; Prospective Studies; Public Health Surveillance; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2017 |
Risk factors and clinical outcomes for vancomycin-resistant enterococcus bacteraemia in hospitalised cancer patients in Pakistan: A case-control study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Child; Data Interpretation, Statistical; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Neoplasms; Pakistan; Risk Factors; Vancomycin; Vancomycin Resistance | 2016 |
Determination of virulence and multidrug resistance genes with polymerase chain reaction method in vancomycin-sensitive and -resistant enterococci isolated from clinical samples.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Enterococcus; Genes, MDR; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Vancomycin; Virulence | 2016 |
A decade of genomic history for healthcare-associated Enterococcus faecium in the United Kingdom and Ireland.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Evolution, Molecular; Genome, Bacterial; Gram-Positive Bacterial Infections; Humans; Infection Control; Phylogeny; Sequence Analysis, DNA; United Kingdom; Vancomycin | 2016 |
Identification of vancomycin-susceptible major clones of clinical Enterococcus from Algeria.
Topics: Algeria; Anti-Bacterial Agents; Bacterial Typing Techniques; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Vancomycin | 2016 |
Retrospective analysis of vancomycin treatment outcomes in Chinese paediatric patients with suspected Gram-positive infection.
Topics: Anti-Bacterial Agents; Asian People; Child, Preschool; Creatinine; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Infant; Intensive Care Units; Kidney Diseases; Male; Retrospective Studies; Risk Factors; Treatment Failure; Treatment Outcome; Vancomycin | 2016 |
[Clinical efficacy and safety of vancomycin compared with linezolid for the treatment of neonatal gram-positive bacterial sepsis].
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Chi-Square Distribution; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Incidence; Infant, Newborn; Linezolid; Male; Middle Aged; Neonatal Sepsis; Oxazolidinones; Platelet Count; Retrospective Studies; Thrombocytopenia; Treatment Outcome; Vancomycin | 2016 |
A microfluidic device for antimicrobial susceptibility testing based on a broth dilution method.
Topics: Anti-Infective Agents; Biosensing Techniques; Drug Resistance, Bacterial; Enterococcus; Equipment Design; Gram-Positive Bacterial Infections; Humans; Lab-On-A-Chip Devices; Microbial Sensitivity Tests; Point-of-Care Systems; Vancomycin; Vancomycin-Resistant Enterococci | 2017 |
vanA-targeted oligonucleotide DNA probe designed to monitor vancomycin- and teicoplanin-resistant bacteria in surface waters.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; DNA Probes; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Environmental Monitoring; Gram-Positive Bacterial Infections; Humans; Oligonucleotides; Teicoplanin; Vancomycin; Water Microbiology | 2016 |
Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Carbon-Oxygen Ligases; Female; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Polymerase Chain Reaction; Prevalence; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Homologous; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Young Adult | 2016 |
Bypass graft infection and bacteremia caused by Anaerostipes caccae: First report of human infection caused by a recently described gut anaerobe.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anastomosis, Surgical; Anti-Bacterial Agents; beta-Lactams; Blood Culture; Clostridiales; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surgical Wound Infection; Vancomycin | 2016 |
Characteristic of Enterococcus faecium clinical isolates with quinupristin/dalfopristin resistance in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; China; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Prevalence; RNA, Ribosomal, 16S; Vancomycin; Virginiamycin | 2016 |
Endophthalmitis after intravitreal injections. Incidence, management and prognosis.
Topics: Aged, 80 and over; Blindness; Combined Modality Therapy; Diabetes Complications; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Intravitreal Injections; Male; Micrococcus; Middle Aged; Moraxella catarrhalis; Moraxellaceae Infections; Prognosis; Retinal Detachment; Retrospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin; Vitrectomy | 2017 |
The Risk Factors, Costs, and Survival Analysis of Invasive VRE Infections at a Medical Center in Eastern Taiwan.
Topics: Adolescent; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Infant; Length of Stay; Male; Risk Factors; Survival Analysis; Taiwan; Vancomycin; Vancomycin Resistance | 2017 |
Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Leukemia; Linezolid; Male; Middle Aged; Retrospective Studies; Risk Factors; ROC Curve; Vancomycin | 2017 |
Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus; Enterococcus faecalis; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2017 |
Prevention of Propionibacterium acnes biofilm formation in prosthetic infections in vitro.
Topics: Anti-Bacterial Agents; Biofilms; Bone Cements; Calcium Sulfate; Gram-Positive Bacterial Infections; Microscopy, Confocal; Microscopy, Electron, Scanning; Propionibacterium acnes; Prosthesis-Related Infections; Tobramycin; Vancomycin | 2017 |
Comparative efficacies of daptomycin, vancomycin, and linezolid in experimental enterococcal peritonitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Enterococcus; Female; Gram-Positive Bacterial Infections; Linezolid; Mice; Mice, Inbred C57BL; Peritonitis; Vancomycin | 2017 |
An Approach to Optimise Therapeutic Vancomycin Dosage in a Haemodialysis Population.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Bacteremia; Drug Dosage Calculations; Gram-Positive Bacterial Infections; Humans; Prospective Studies; Renal Dialysis; Vancomycin | 2016 |
Measures to Prevent and Control Vancomycin-Resistant Enterococci: Do They Really Matter?
Topics: Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; United States; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2017 |
[Infective endocarditis by Abiotrophia defectiva diagnosed by mass spectrometry (MALDI-TOF MS) in Argentina].
Topics: Abiotrophia; Anti-Bacterial Agents; Endocarditis, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vancomycin | 2016 |
Synthesis, surfactant properties and antimicrobial activities of methyl glycopyranoside ethers.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple; Enterococcus faecalis; Enterococcus faecium; Glucosides; Gram-Positive Bacterial Infections; Humans; Listeria monocytogenes; Listeriosis; Methicillin; Methyl Ethers; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2017 |
High frequency of vancomycin resistant
Topics: Anti-Bacterial Agents; Child, Preschool; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Iran; Male; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2016 |
Raising the Alarmone: Within-Host Evolution of Antibiotic-Tolerant
Topics: Anti-Bacterial Agents; Enterococcus; Enterococcus faecium; Gastrointestinal Tract; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance | 2017 |
Vancomycin Resistance due to vanA Gene Expression in an Aerococcus viridans Isolate: First Case in Korea.
Topics: Aerococcus; Aged; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Gene Expression Regulation, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Republic of Korea; RNA, Ribosomal, 16S; Vancomycin; Vancomycin Resistance | 2017 |
Genotypic Characterization of Vancomycin-Resistant Enterococcus spp. In Tertiary Center, Iran.
Topics: Adult; Anti-Bacterial Agents; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Female; Genotype; Gram-Positive Bacterial Infections; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Vancomycin; Vancomycin Resistance | 2017 |
Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Retrospective Studies; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Veterans | 2017 |
Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from Bermuda.
Topics: Adult; Aged; Anti-Bacterial Agents; Bermuda; Cluster Analysis; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2017 |
Endophthalmitis: antibacterial activity of precipitates of vancomycin and ceftazidime.
Topics: Anti-Bacterial Agents; Ceftazidime; Chemical Precipitation; Endophthalmitis; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Treatment Outcome; Vancomycin | 2008 |
[Vancomycin-resistant enterococcus outbreak in Lorraine].
Topics: Anti-Bacterial Agents; Disease Outbreaks; Enterococcus; France; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance | 2008 |
[Vancomycin-resistant enterococci: ONERBA networks data and results of the national 2006 survey on digestive carriage].
Topics: Digestive System; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; France; Gram-Positive Bacterial Infections; Health Surveys; Humans; Vancomycin | 2008 |
Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Ascites; Cephalosporins; Cohort Studies; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Korea; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis; Retrospective Studies; Treatment Outcome; Vancomycin | 2009 |
First report of clinical and epidemiological characterisation of vancomycin-resistant enterococci from mainland China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Case-Control Studies; China; Cross Infection; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Length of Stay; Multivariate Analysis; Risk Factors; Vancomycin; Vancomycin Resistance | 2008 |
[Molecular characterization of vancomycin-resistant enterococci isolates].
Topics: Enterococcus; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2008 |
Issues regarding the use of vancomycin in companion animals.
Topics: Animals; Dog Diseases; Dogs; Enterococcus; Gram-Positive Bacterial Infections; Humans; Legislation, Drug; Legislation, Veterinary; Methicillin Resistance; Public Health; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2008 |
Incidence and clinical characteristics of enterococcus keratitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Contact Lenses, Hydrophilic; Corneal Transplantation; Corneal Ulcer; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Keratoplasty, Penetrating; Male; Microbial Sensitivity Tests; Middle Aged; New York; Risk Factors; Vancomycin | 2008 |
Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit.
Topics: Acetamides; Anti-Bacterial Agents; Drug Administration Schedule; Enterococcus; General Surgery; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Middle Aged; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Acute vancomycin-dependent immune thrombocytopenia as an anamnestic response.
Topics: Acute Disease; Amputation, Surgical; Anti-Bacterial Agents; Antigens, Human Platelet; Autoantibodies; Bacteremia; Ceftazidime; Drug Therapy, Combination; Foot Diseases; Gram-Positive Bacterial Infections; Humans; Immunoglobulin G; Immunoglobulin M; Immunologic Memory; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Surgical Wound Infection; Vancomycin | 2008 |
The efficacy of intravitreal vancomycin and dexamethasone in the treatment of experimental bacillus cereus endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Bacillus cereus; Choroid Diseases; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Gram-Positive Bacterial Infections; Injections; Iridocyclitis; Rabbits; Treatment Outcome; Vancomycin; Vasculitis; Vitreous Body | 2008 |
Nosocomial outbreak of Enteroccocus gallinarum: untaming of rare species of enterococci.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Colombia; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Species Specificity; Vancomycin; Vancomycin Resistance; Young Adult | 2008 |
Vancomycin vs teicoplanin in the treatment of Gram-positive infections: a pharmacoeconomic analysis in a Turkish University Hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Costs and Cost Analysis; Data Interpretation, Statistical; Drug Costs; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Male; Middle Aged; Retrospective Studies; Teicoplanin; Turkey; Vancomycin; Young Adult | 2008 |
[Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Glomerulonephritis; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin; Vasculitis, Leukocytoclastic, Cutaneous | 2008 |
[Ethical comment].
Topics: Drug Resistance, Bacterial; Enterococcus; Ethics, Medical; Gram-Positive Bacterial Infections; Humans; Informed Consent; Vancomycin | 2008 |
Emergence of the vanA genotype among Enterococcus gallinarum isolates colonising the intestinal tract of patients in a university hospital in Rio de Janeiro, Brazil.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Brazil; Carbon-Oxygen Ligases; Carrier State; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Gastrointestinal Tract; Genotype; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Microbial Sensitivity Tests; Peptide Synthases; Teicoplanin; Vancomycin; Vancomycin Resistance; Young Adult | 2009 |
Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome; Vancomycin | 2009 |
Transferable capacity for gastrointestinal colonization in Enterococcus faecium in a mouse model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Disease Models, Animal; Drug Resistance, Bacterial; Enterococcus faecium; Female; Gastrointestinal Diseases; Gene Expression Regulation, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Selection, Genetic; Vancomycin | 2009 |
Endophthalmitis caused by Enterococcus faecalis: a case series.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy | 2009 |
Bacteremia caused by VanC-type enterococci in a university hospital in Japan: a 6-year survey.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Enterococcus; Female; Gram-Positive Bacterial Infections; Health Surveys; Hospitals, University; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Peptide Synthases; Vancomycin; Vancomycin Resistance | 2008 |
Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Debridement; Drug Administration Routes; Drug Therapy, Combination; Female; Gentamicins; Gram-Positive Bacterial Infections; Hip Prosthesis; Humans; Male; Middle Aged; Prosthesis Design; Prosthesis-Related Infections; Treatment Outcome; Vancomycin | 2009 |
[Intravitreal injection of antibiotics in endophthalmitis].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Blood-Retinal Barrier; Cephalosporins; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Fluoroquinolones; Glycopeptides; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Half-Life; Humans; Injections; Retinal Detachment; Vancomycin; Vitrectomy; Vitreous Body | 2008 |
Persistent vancomycin and high-level gentamicin-resistant Enterococcus faecium bacteremia and intra-aortic thrombus in an extremely low birth-weight infant.
Topics: Aortic Diseases; Bacteremia; Diseases in Twins; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Fatal Outcome; Gentamicins; Gestational Age; Gram-Positive Bacterial Infections; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Male; Thrombosis; Vancomycin | 2009 |
Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anti-Bacterial Agents; Enterococcus; Gram-Positive Bacterial Infections; Hospitalization; Humans; Incidence; Microbial Sensitivity Tests; Middle Aged; United States; Vancomycin; Vancomycin Resistance; Young Adult | 2009 |
Vancomycin resistant enterococci (VRE) still persist in slaughtered poultry in hungary 8 years after the ban on avoparcin.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Hungary; Intestines; Microbial Sensitivity Tests; Poultry; Vancomycin; Vancomycin Resistance | 2008 |
New selective and differential chromogenic agar medium, chromID VRE, for screening vancomycin-resistant Enterococcus species.
Topics: Chromogenic Compounds; Colony Count, Microbial; Culture Media; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance | 2009 |
The molecular alarmone (p)ppGpp mediates stress responses, vancomycin tolerance, and virulence in Enterococcus faecalis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Caenorhabditis elegans; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Guanine Nucleotides; Humans; Ligases; Mutation; Stress, Physiological; Vancomycin; Virulence | 2009 |
Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carrier State; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Korea; Male; Middle Aged; Prevalence; Prospective Studies; Rectum; Risk Factors; Vancomycin; Vancomycin Resistance | 2009 |
Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.
Topics: Adult; Daptomycin; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Injections, Intraperitoneal; Middle Aged; Peritonitis; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2009 |
Outbreak of vancomycin-resistant enterococcus colonization among pediatric oncology patients.
Topics: Adolescent; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, Pediatric; Humans; Infection Control; Male; Oncology Service, Hospital; Philadelphia; Prevalence; Risk Factors; Vancomycin; Vancomycin Resistance | 2009 |
Traumatic endophthalmitis caused by Enterococcus raffinosus and Enterobacter gergoviae.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Endophthalmitis; Enterobacter; Enterobacteriaceae Infections; Enterococcus; Eye Injuries, Penetrating; Gram-Positive Bacterial Infections; Humans; Male; Vancomycin; Wound Infection | 2009 |
Meningitis and epidural abscess related to pansinusitis.
Topics: Bacteroidaceae Infections; Cefotaxime; Ceftriaxone; Child; Combined Modality Therapy; Consciousness Disorders; Diagnostic Imaging; Drug Therapy, Combination; Eikenella; Emergencies; Endoscopy; Epidural Abscess; Female; Fusobacterium Infections; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Meningitis, Bacterial; Metronidazole; Otorhinolaryngologic Surgical Procedures; Peptostreptococcus; Prevotella intermedia; Sinusitis; Staphylococcal Infections; Vancomycin | 2009 |
Bacteremia caused by an Enterococcus faecalis isolate with high-level linezolid resistance in a teenager with Crohn's disease.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Bacteremia; Crohn Disease; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Treatment Outcome; Vancomycin | 2009 |
[Glycopeptide-resistant Enterococcus faecium in a hospital in northern Spain. Molecular characterization and clinical epidemiology].
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Genes, Bacterial; Glycopeptides; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Spain; Vancomycin; Virulence | 2009 |
[Glycopeptide-resistant enterococci carriage: Are actual isolation and identification techniques sufficient?].
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; Carbon-Oxygen Ligases; Carrier State; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus; Feces; Female; France; Glycopeptides; Gram-Positive Bacterial Infections; Hospital Units; Humans; Male; Mass Screening; Middle Aged; Peptide Synthases; Reagent Kits, Diagnostic; Rectum; Species Specificity; Vancomycin; Vancomycin Resistance; Young Adult | 2011 |
Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokinetic/pharmacodynamic analysis.
Topics: Anti-Bacterial Agents; Computer Simulation; Drug Administration Schedule; Drug Dosage Calculations; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Models, Statistical; Monte Carlo Method; Staphylococcus; Vancomycin | 2009 |
Propionibacterium acnes brain abscess appearing 10 years after neurosurgery.
Topics: Aged; Anti-Bacterial Agents; Biopsy; Brain; Brain Abscess; Craniotomy; Disease Progression; Gram-Positive Bacterial Infections; Hematoma, Subdural; Humans; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Propionibacterium acnes; Surgical Wound Infection; Time; Time Factors; Vancomycin | 2009 |
Recurrent and relapsing peritonitis: causative organisms and response to treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Netilmicin; Peritoneal Dialysis; Peritonitis; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2009 |
[Epidemiological search for vancomycin-resistant enterococci in mainland of the Ryukyus].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Enterococcus; Feces; Gram-Positive Bacterial Infections; Humans; Japan; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2008 |
Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clinical Trials as Topic; Creatinine; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Pneumonia, Bacterial; Retrospective Studies; Tissue Distribution; Vancomycin; Young Adult | 2009 |
Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Creatinine; Female; Gram-Positive Bacterial Infections; Humans; Inpatients; Kidney; Kidney Diseases; Male; Middle Aged; New York; Plasma; Retrospective Studies; Time Factors; Vancomycin | 2009 |
[Vancomycin resistant Enterococci (VRE)].
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus faecium; Europe; France; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Infection Control; Vancomycin; Vancomycin Resistance | 2009 |
[Interventions implemented to control an outbreak of vancomycin-resistant enterococci in a university hospital].
Topics: Anti-Bacterial Agents; Carrier State; Cross Infection; Disease Outbreaks; Enterococcus faecium; France; Gram-Positive Bacterial Infections; Hand Disinfection; Hospitals, University; Humans; Infection Control; Practice Guidelines as Topic; Protective Clothing; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2009 |
[Control measures for a VRE outbreak in a haemodialysis unit].
Topics: Anti-Bacterial Agents; Carrier State; Cross Infection; Disease Outbreaks; Disinfection; Enterococcus faecium; Equipment Contamination; France; Gram-Positive Bacterial Infections; Hemodialysis Units, Hospital; Humans; Patient Isolation; Protective Clothing; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2009 |
[Enterococcal meningitis in adults].
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Cerebrospinal Fluid Shunts; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Middle Aged; Treatment Outcome; Vancomycin | 2009 |
New developments with vancomycin-resistant enterococci: E. faecium--friend or foe?
Topics: Anti-Bacterial Agents; Canada; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Inflammation; United States; Vancomycin; Vancomycin Resistance | 2009 |
Trimethoprim resistance genes in vancomycin-resistant Enterococcus faecium clinical isolates from France.
Topics: Anti-Bacterial Agents; Enterococcus faecium; France; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Tetrahydrofolate Dehydrogenase; Trimethoprim; Trimethoprim Resistance; Vancomycin; Vancomycin Resistance | 2009 |
Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Cicatrix; Cornea; Corneal Transplantation; Endophthalmitis; Equipment Design; Eye Burns; Eye Diseases; Follow-Up Studies; Graft Rejection; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Incidence; Mycobacterium Infections, Nontuberculous; Pemphigoid, Benign Mucous Membrane; Prosthesis Implantation; Prosthesis-Related Infections; Retrospective Studies; Stevens-Johnson Syndrome; Time Factors; Treatment Outcome; Vancomycin | 2009 |
Molecular epidemiology of vancomycin-resistant enterococci in Singapore.
Topics: Animals; Chickens; Disease Outbreaks; Enterococcus; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Singapore; Vancomycin; Vancomycin Resistance | 2009 |
Utility of environmental sampling for the prevention of transmission of vancomycin resistant enterococci (VRE) in hospitals.
Topics: Enterococcus; Environmental Restoration and Remediation; Gram-Positive Bacterial Infections; Humans; Infection Control; Patients' Rooms; Vancomycin; Vancomycin Resistance | 2009 |
Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Serum; Vancomycin | 2009 |
Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States.
Topics: Ampicillin Resistance; Bacterial Typing Techniques; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Sequence Analysis, DNA; United States; Vancomycin; Virulence | 2009 |
Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.
Topics: Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Eruptions; Female; Fever; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Taiwan; Teicoplanin; Vancomycin | 2009 |
Heteroresistance to teicoplanin in Enterococcus faecium harboring the vanA gene.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; China; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Molecular Sequence Data; Sequence Analysis, DNA; Sputum; Teicoplanin; Vancomycin; Vancomycin Resistance | 2009 |
Molecular epidemiology of vancomycin-resistant Enterococcus faecalis among patients of transplantology wards.
Topics: DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Liver Transplantation; Organ Transplantation; Polymorphism, Restriction Fragment Length; Postoperative Complications; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2009 |
Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Comorbidity; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals; Humans; Male; Middle Aged; New Zealand; Retrospective Studies; Treatment Outcome; Vancomycin; Young Adult | 2010 |
The effect of an antibiotic policy on the control of vancomycin-resistant enterococci outbreak and on the resistance patterns of bacteria isolated from the blood of patients in a hematology unit.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Enterococcus faecium; Follow-Up Studies; Gram-Positive Bacterial Infections; Guideline Adherence; Hematologic Diseases; Humans; Infection Control; Inpatients; Poland; Practice Guidelines as Topic; Vancomycin; Vancomycin Resistance | 2009 |
Outbreak of vancomycin-resistant enterococci in a tertiary hospital: the lack of effect of measures directed mainly by surveillance cultures and differences in response between Enterococcus faecium and Enterococcus faecalis.
Topics: Anti-Bacterial Agents; Disease Outbreaks; Disinfection; Enterococcus faecalis; Enterococcus faecium; Environmental Monitoring; Epidemiological Monitoring; Feces; Gram-Positive Bacterial Infections; Hand Disinfection; Hospitals, Public; Humans; Infection Control; Microbial Sensitivity Tests; Patient Isolation; Population Surveillance; Tertiary Prevention; Vancomycin; Vancomycin Resistance | 2010 |
Pharmacokinetics of vancomycin in adult cancer patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Body Mass Index; Drug Monitoring; Female; Gram-Positive Bacterial Infections; Half-Life; Humans; Leukemia; Male; Medical Records; Metabolic Clearance Rate; Middle Aged; Neoplasms; Retrospective Studies; Vancomycin; Young Adult | 2010 |
Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Daptomycin; DNA, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Polymerase Chain Reaction; Reproducibility of Results; Tigecycline; Vancomycin; Vancomycin Resistance | 2010 |
Multiply resistant gram-positive bacteria: vancomycin-resistant enterococcus in solid organ transplant recipients.
Topics: Anti-Bacterial Agents; Enterococcus; Gram-Positive Bacterial Infections; Humans; Organ Transplantation; Vancomycin; Vancomycin Resistance | 2009 |
Enhancement of vancomycin activity by phenothiazines against vancomycin-resistant Enterococcus faecium in vitro.
Topics: Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Phenothiazines; Vancomycin; Vancomycin Resistance | 2010 |
[Post-operative bacteremia caused by multidrug-resistant Aerococcus viridans in a patient with gall bladder cancer].
Topics: Aerococcus; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Multiple, Bacterial; Gallbladder Neoplasms; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Vancomycin | 2010 |
Practical vancomycin dosing in hemodialysis patients in the era of emerging vancomycin resistance: a single-center experience.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Staphylococcus aureus; Vancomycin; Young Adult | 2010 |
Emerging vancomycin resistance: what are we waiting for?
Topics: Endophthalmitis; Enterococcus faecium; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Lens Implantation, Intraocular; Phacoemulsification; Vancomycin; Vancomycin Resistance | 2010 |
Vancomycin-resistant enterococcal endophthalmitis.
Topics: Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecium; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Lens Implantation, Intraocular; Phacoemulsification; Vancomycin; Vancomycin Resistance; Vitrectomy | 2010 |
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cephalosporins; Enterococcus; Female; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mucositis; Pharynx; Risk Factors; Transplantation, Homologous; Vancomycin; Young Adult | 2010 |
Alarming spread of vancomycin resistant enterococci in Sweden since 2007.
Topics: Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Population Surveillance; Sweden; Vancomycin | 2010 |
Characterization of vancomycin-resistant Enterococcus faecium isolated from swine in three Michigan counties.
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Camelids, New World; Carrier State; Cattle; Cluster Analysis; DNA Fingerprinting; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Feces; Genotype; Goats; Gram-Positive Bacterial Infections; Horses; Humans; Michigan; Microbial Sensitivity Tests; Sheep; Swine; Vancomycin; Vancomycin Resistance | 2010 |
A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203.
Topics: Anti-Bacterial Agents; Australia; Bacteremia; Bacterial Proteins; Bacterial Typing Techniques; Communicable Diseases, Emerging; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Humans; Incidence; Meropenem; Microbial Sensitivity Tests; Phylogeny; Thienamycins; Vancomycin; Vancomycin Resistance | 2010 |
Longitudinal analysis of the in vitro activity profile of oritavancin and comparator glycopeptides against Gram-positive organisms from Europe: 2005-2008.
Topics: Anti-Bacterial Agents; Europe; Glycopeptides; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 2010 |
Incidence and risk factors of vancomycin-resistant enterococcus colonization in burn unit patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Burn Units; Burns; Child; Child, Preschool; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Pharynx; Prospective Studies; Rectum; Risk Factors; Vancomycin; Vancomycin Resistance; Young Adult | 2011 |
Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Enterococcus; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Staphylococcus aureus; Taiwan; Teicoplanin; Vancomycin | 2011 |
Pharmacodynamics of telavancin studied in an in vitro pharmacokinetic model of infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Culture Media; Enterococcus; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Biological; Staphylococcus aureus; Teicoplanin; Vancomycin | 2011 |
[Enterococci resistant to glycopeptides].
Topics: Chromosomes, Bacterial; Community-Acquired Infections; Cross Infection; Dipeptides; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecium; Europe; France; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Vancomycin | 2010 |
Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
Topics: Acetamides; Aged; Daptomycin; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Meningitis, Bacterial; Middle Aged; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2010 |
Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Drug Resistance, Bacterial; Enterococcus; Exotoxins; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Leukocidins; Lipoglycopeptides; Microbial Sensitivity Tests; Population Surveillance; Skin; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus; Staphylococcus aureus; Streptococcus; Vancomycin | 2010 |
Endogenous endophthalmitis caused by Enterococcus casseliflavus.
Topics: Anti-Bacterial Agents; Base Sequence; DNA, Bacterial; Endophthalmitis; Enterococcus; Eye Infections, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Recurrence; Vancomycin; Vitrectomy; Young Adult | 2011 |
Impact of administration of vancomycin or linezolid to critically ill patients with impaired renal function.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Critical Illness; Female; Gram-Positive Bacterial Infections; Humans; Kidney; Linezolid; Male; Metabolic Clearance Rate; Middle Aged; Oxazolidinones; Renal Insufficiency; Retrospective Studies; Vancomycin | 2011 |
Vancomycin-resistance transferability from VanA enterococci to Staphylococcus aureus.
Topics: Bacterial Proteins; Carbon-Oxygen Ligases; Conjugation, Genetic; Enterococcus; Gene Transfer, Horizontal; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2011 |
Peritoneal dialysis-related peritonitis caused by vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 2011 |
Environmental survival of vancomycin-resistant Enterococcus faecium.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Disease Outbreaks; Drug Resistance, Bacterial; Enterococcus faecium; Environment; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Microbial Viability; Netherlands; Vancomycin | 2011 |
Late capsular block syndrome associated with Propionibacterium acnes.
Topics: Aged; Anti-Bacterial Agents; Body Fluids; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Lens Diseases; Middle Aged; Phacoemulsification; Posterior Capsule of the Lens; Postoperative Complications; Propionibacterium acnes; Vancomycin | 2011 |
Molecular epidemiology of Enterococcus faecium isolates from an Italian hospital.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Italy; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Vancomycin | 2011 |
Acute necrotic stomatitis (noma) associated with methicillin-resistant Staphylococcus aureus infection in a newly acquired rhesus macaque (Macaca mulatta).
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Enterococcus faecalis; Epidermal Growth Factor; Gram-Positive Bacterial Infections; Humans; Macaca mulatta; Male; Methicillin-Resistant Staphylococcus aureus; Monkey Diseases; Mouth; Necrosis; Noma; Oral Surgical Procedures; Plastic Surgery Procedures; Staphylococcal Infections; Stomatitis; Sulbactam; Vancomycin; Wound Healing | 2011 |
Management of gram-positive coccal bacteremia and hemodialysis.
Topics: Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Kidney Failure, Chronic; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Renal Dialysis; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2011 |
Lactococcus garvieae causing zoonotic prosthetic valve endocarditis.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Fisheries; Gentamicins; Gram-Positive Bacterial Infections; Heart Valve Prosthesis; Humans; Lactococcus; Male; Middle Aged; Rifampin; Vancomycin; Zoonoses | 2011 |
Clonal dissemination of vanA positive Enterococcus species in tertiary care hospitals in Karachi, Pakistan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Cross-Sectional Studies; DNA Fingerprinting; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Genotype; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Pakistan; Polymerase Chain Reaction; Prevalence; Vancomycin; Vancomycin Resistance | 2010 |
Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08.
Topics: Bacterial Proteins; Bacterial Typing Techniques; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus; France; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Membrane Proteins; Microbial Sensitivity Tests; Molecular Typing; Multilocus Sequence Typing; Vancomycin; Vancomycin Resistance | 2011 |
Evaluation of PCR-based screening for vancomycin-resistant enterococci compared with a chromogenic agar-based culture method.
Topics: Agar; Anti-Bacterial Agents; Bacteriological Techniques; Chromogenic Compounds; Enterococcus; Gram-Positive Bacterial Infections; Humans; Polymerase Chain Reaction; Prospective Studies; Vancomycin; Vancomycin Resistance | 2011 |
Perioperative, postoperative, and prophylactic use of antibiotics in alloplastic total temporomandibular joint replacement surgery: a survey and preliminary guidelines.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement; Bacitracin; Biofilms; Cefazolin; Cephalosporins; Clindamycin; Device Removal; Disinfection; Gentamicins; Gram-Positive Bacterial Infections; Humans; Joint Prosthesis; Penicillins; Peptostreptococcus; Peroxides; Povidone-Iodine; Practice Guidelines as Topic; Practice Patterns, Dentists'; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Surgical Wound Infection; Temporomandibular Joint; Therapeutic Irrigation; Vancomycin | 2011 |
In vitro activity and in vivo efficacy of the saponin diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside hydrochloride (HSM1) alone and in combination with daptomycin and vancomycin against Gram-positive cocci.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Rodent Diseases; Saponins; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2011 |
Rare case of large double perforated anterior mitral leaflet pseudoaneurysm in a patient with aortic valve endocarditis.
Topics: Aged; Aneurysm, False; Anti-Bacterial Agents; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Cefepime; Cephalosporins; Drug Therapy, Combination; Echocardiography; Echocardiography, Doppler, Color; Echocardiography, Transesophageal; Endocarditis, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve; Mitral Valve Insufficiency; Tricuspid Valve Insufficiency; Vancomycin | 2011 |
Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Female; Gram-Positive Bacterial Infections; Humans; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Models, Biological; Practice Guidelines as Topic; Prospective Studies; Time Factors; Tissue Distribution; Vancomycin | 2012 |
Increased risk of vancomycin-resistant enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States.
Topics: Adult; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospital Costs; Hospitalization; Humans; Inflammatory Bowel Diseases; Length of Stay; Logistic Models; Male; Middle Aged; Odds Ratio; Prevalence; Risk Factors; United States; Vancomycin | 2011 |
The microbiology of secondary and postoperative pancreatic infections: implications for antimicrobial management.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacterial Infections; Cross Infection; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Mycoses; Pancreatectomy; Pancreatic Pseudocyst; Pancreatitis; Pancreatitis, Acute Necrotizing; Reoperation; Retrospective Studies; Risk Factors; Sepsis; Surgical Wound Infection; Tennessee; Vancomycin; Vancomycin Resistance | 2011 |
On a different level: telavancin versus vancomycin for hospital-acquired pneumonia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2011 |
Weissella confusa: a rare cause of vancomycin-resistant Gram-positive bacteraemia.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Bacteremia; DNA, Bacterial; DNA, Ribosomal; Esophageal Neoplasms; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Molecular Sequence Data; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Vancomycin Resistance; Weissella | 2011 |
Vancomycin-resistant Enterococcus faecium bacteremia successfully treated with high-dose ampicillin-sulbactam in a pediatric patient after hematopoietic stem cell transplantation.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Sulbactam; Vancomycin | 2011 |
Efficacy of vitrectomy in improving the outcome of Bacillus cereus endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Bacillus cereus; Combined Modality Therapy; Disease Models, Animal; Electroretinography; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Leukocyte Count; Male; Neutrophils; Rabbits; Retina; Specific Pathogen-Free Organisms; Treatment Outcome; Vancomycin; Vitrectomy; Vitreous Body | 2011 |
Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carrier State; Case-Control Studies; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Korea; Male; Middle Aged; Models, Statistical; Rectum; Retrospective Studies; Risk Factors; Time Factors; Vancomycin; Vancomycin Resistance | 2011 |
Screening for vancomycin-resistant enterococci: an efficient and economical laboratory-developed test.
Topics: Bacterial Proteins; Carbon-Oxygen Ligases; Clinical Laboratory Techniques; DNA, Bacterial; Enterococcus; Feces; Gram-Positive Bacterial Infections; Humans; Limit of Detection; Microbial Sensitivity Tests; Predictive Value of Tests; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Vancomycin; Vancomycin Resistance | 2012 |
Enterococcus avium bacteremia: a 12-year clinical experience with 53 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Child; Child, Preschool; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin; Young Adult | 2012 |
Evaluation of GeneOhm VanR and Xpert vanA/vanB molecular assays for the rapid detection of vancomycin-resistant enterococci.
Topics: Bacterial Proteins; Carbon-Oxygen Ligases; Enterococcus faecalis; Enterococcus faecium; Feces; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sensitivity and Specificity; Vancomycin; Vancomycin Resistance | 2012 |
Implementation of a dose calculator for vancomycin to achieve target trough levels of 15-20 microg/mL in persons undergoing hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Models, Statistical; Plasma; Renal Dialysis; Time Factors; Vancomycin | 2011 |
Weight-based loading of vancomycin in patients on hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Models, Statistical; Plasma; Renal Dialysis; Vancomycin | 2011 |
Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Dose-Response Relationship, Drug; Enterococcus; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Treatment Failure; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2011 |
Changes in vancomycin-resistant Enterococcus faecium causing outbreaks in Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carbon-Oxygen Ligases; Disease Outbreaks; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Molecular Typing; Multilocus Sequence Typing; Polymorphism, Genetic; Protein Kinases; Transcription Factors; Vancomycin; Vancomycin Resistance | 2011 |
Presence of glycopeptide-encoding plasmids in enterococcal isolates from food and humans in Denmark.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Denmark; DNA Transposable Elements; Enterococcus faecalis; Enterococcus faecium; Food Microbiology; Gene Transfer, Horizontal; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Meat; Phenotype; Pheromones; Plasmids; Replicon; Vancomycin; Vancomycin Resistance | 2011 |
Antimicrobial activity of daptomycin tested against gram-positive strains collected in European hospitals: results from 7 years of resistance surveillance (2003-2009).
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Soft Tissue Infections; Vancomycin | 2011 |
Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Male; Microbial Sensitivity Tests; Prosthesis-Related Infections; Vancomycin | 2011 |
Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin | 2011 |
Comparison of performance of the novel chromogenic spectra VRE agar to that of bile esculin azide and Campylobacter agars for detection of vancomycin-resistant enterococci in fecal samples.
Topics: Agar; Anti-Bacterial Agents; Azides; Bacteriological Techniques; Bile; Chromogenic Compounds; Culture Media; Enterococcus; Esculin; Feces; Gram-Positive Bacterial Infections; Humans; Sensitivity and Specificity; Vancomycin; Vancomycin Resistance | 2011 |
Vancomycin-resistant Enterococci. Prevalence and risk factors for fecal carriage in patients at tertiary care hospitals.
Topics: Academic Medical Centers; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Feces; Gram-Positive Bacterial Infections; Humans; Prevalence; Risk Factors; Saudi Arabia; Vancomycin | 2011 |
[Actual aspects of sepsis].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Russia; Sepsis; Vancomycin | 2011 |
[Pharmacoeconomic assessment of daptomycin as first-line therapy for bacteraemia and complicated skin and skin structure infections caused by gram-positive pathogens in Spain].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Daptomycin; Data Interpretation, Statistical; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Oxazolidinones; Salvage Therapy; Skin Diseases, Infectious; Spain; Treatment Failure; Vancomycin; Young Adult | 2011 |
Regional spread and control of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Kyoto, Japan.
Topics: Anti-Bacterial Agents; Carrier State; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Feces; Genotype; Gram-Positive Bacterial Infections; Humans; Infection Control; Japan; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2012 |
Detection of an unusual van genotype in a vancomycin-resistant Enterococcus faecium hospital isolate.
Topics: Anti-Bacterial Agents; DNA, Bacterial; Enterococcus faecium; Female; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Phenotype; Sequence Analysis, DNA; Teicoplanin; Vancomycin; Vancomycin Resistance | 2011 |
Comment on: Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Oxazolidinones; Vancomycin | 2012 |
Vancomycin-resistant enterococci rectal colonization in an intensive care unit: a report from Turkey.
Topics: Anti-Bacterial Agents; Carrier State; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Incidence; Intensive Care Units; Microbial Sensitivity Tests; Prospective Studies; Rectum; Turkey; Vancomycin; Vancomycin Resistance | 2012 |
Vancomycin-resistant enterococci among clinical isolates from north-west Iran: identification of therapeutic surrogates.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Iran; Microbial Sensitivity Tests; Prevalence; Vancomycin; Vancomycin Resistance | 2012 |
[Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units].
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Cefoxitin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Moscow; Oxacillin; Oxazolidinones; Rifampin; Surgery, Plastic; Vancomycin | 2011 |
Two cases of severe sepsis caused by Bacillus pumilus in neonatal infants.
Topics: Anti-Bacterial Agents; Bacillus; Female; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Male; Sepsis; Vancomycin | 2012 |
Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010.
Topics: Anti-Bacterial Agents; Bacteremia; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2012 |
Enterococcal infectious crystalline keratopathy in a wearer bandage contact lens.
Topics: Aged; Anti-Bacterial Agents; Contact Lenses, Hydrophilic; Corneal Diseases; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Treatment Outcome; Vancomycin | 2012 |
Characterization of a vancomycin-resistant Enterococcus faecium outbreak caused by 2 genetically different clones at a neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Carbon-Oxygen Ligases; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Feces; Genotype; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Multilocus Sequence Typing; Vancomycin; Vancomycin Resistance | 2012 |
Vancomycin-resistant enterococcus outbreak in a pediatric intensive care unit: report of successful interventions for control and prevention.
Topics: Anti-Bacterial Agents; Child; Cross Infection; Disease Outbreaks; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Infection Control; Intensive Care Units, Pediatric; Male; Program Evaluation; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2012 |
Healthcare-associated risk factors of vancomycin-resistant Enterococci colonization among outpatients undergoing hemodialysis.
Topics: Aged; Blood Urea Nitrogen; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Feces; Female; Genetic Variation; Gram-Positive Bacterial Infections; Hemoglobins; Hospitalization; Humans; Male; Middle Aged; Platelet Count; Prevalence; Renal Dialysis; Risk Factors; Serum Albumin; Vancomycin; Vancomycin Resistance | 2012 |
Redesign of glycopeptide antibiotics: back to the future.
Topics: Anti-Bacterial Agents; Drug Design; Enterococcus; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Models, Molecular; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2012 |
Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; United States; Vancomycin; Vancomycin Resistance | 2012 |
[Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Critical Care; Critical Illness; Daptomycin; Drug Prescriptions; Drug Resistance, Multiple, Bacterial; Drug Utilization; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Intensive Care Units; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Teicoplanin; Vancomycin | 2012 |
Vancomycin-resistant Enterococci in Singaporean hospitals: 5-year results of a multi-centre surveillance programme.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Hospitals, Public; Humans; Population Surveillance; Singapore; Vancomycin; Vancomycin Resistance | 2012 |
Presence of the resistance genes vanC1 and pbp5 in phenotypically vancomycin and ampicillin susceptible Enterococcus faecalis.
Topics: Ampicillin; Ampicillin Resistance; Animals; Anti-Bacterial Agents; Bacterial Proteins; Enterococcus faecalis; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Phenotype; Phylogeny; Real-Time Polymerase Chain Reaction; Repressor Proteins; Swine; Swine Diseases; Vancomycin; Vancomycin Resistance | 2012 |
[Daptomycin therapy in patients with bacteremia].
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Decision Trees; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2012 |
Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Topics: Acetamides; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Incidence; Linezolid; Male; Middle Aged; Oxazolidinones; Proportional Hazards Models; Retrospective Studies; Risk Factors; Taiwan; Vancomycin; Vancomycin Resistance | 2012 |
[Phenotypic and genotypic traits of vancomycin-resistant enterococci in a public hospital: the first vanB-positive Enterococcus faecium isolates].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Genotype; Gram-Positive Bacterial Infections; Hospitals, Public; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Polymerase Chain Reaction; Teicoplanin; Turkey; Vancomycin; Vancomycin Resistance; Young Adult | 2012 |
The consequences of missing appendicitis during pregnancy.
Topics: Anti-Bacterial Agents; Appendectomy; Appendicitis; Diagnosis, Differential; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Pregnancy; Puerperal Disorders; Ultrasonography; Vancomycin; Young Adult | 2011 |
Hot and steamy: outbreak of Bacillus cereus in Singapore associated with construction work and laundry practices.
Topics: Anti-Bacterial Agents; Bacillus cereus; Cross Infection; Disease Outbreaks; Environmental Microbiology; Gram-Positive Bacterial Infections; Hospital Design and Construction; Hospitals, University; Humans; Laundry Service, Hospital; Singapore; Vancomycin | 2012 |
Real-time PCR surveillance of vanA for vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Real-Time Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2012 |
Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolid.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin; Young Adult | 2012 |
Globicatella sanguinis meningitis in a post head trauma patient: first case report from Asia.
Topics: Aerococcaceae; Aged; Anti-Bacterial Agents; Asia; Bacterial Typing Techniques; Cerebrospinal Fluid; Craniocerebral Trauma; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Microscopy; Treatment Outcome; Vancomycin | 2012 |
Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; France; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 500 and over; Hospitals, Teaching; Humans; Infection Control; Microbial Sensitivity Tests; Practice Guidelines as Topic; Program Evaluation; Prospective Studies; Vancomycin; Vancomycin Resistance | 2012 |
Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Topics: Acetamides; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tazobactam; Treatment Outcome; Vancomycin; Wounds and Injuries | 2013 |
Evaluation of a vancomycin dosing nomogram in achieving high target trough concentrations in Taiwanese patients.
Topics: Aged; Anti-Bacterial Agents; Chi-Square Distribution; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Nomograms; Retrospective Studies; Taiwan; Vancomycin | 2012 |
Genetic features and molecular epidemiology of Enterococcus faecium isolated in two university hospitals in Brazil.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carbon-Oxygen Ligases; Daptomycin; DNA Transposable Elements; DNA, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Vancomycin; Vancomycin Resistance; Virulence Factors | 2012 |
Acute bacterial osteoarticular infections: eight-year analysis of C-reactive protein for oral step-down therapy.
Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Bacterial Agents; Arthritis, Infectious; Biomarkers; C-Reactive Protein; Child; Child, Preschool; Clindamycin; Decision Support Techniques; Drug Administration Schedule; Drug Monitoring; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infant; Infusions, Intravenous; Male; Osteomyelitis; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin | 2012 |
Acute postoperative Bacillus cereus endophthalmitis mimicking toxic anterior segment syndrome.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Aqueous Humor; Bacillus cereus; Ceftazidime; Diagnosis, Differential; Drug Therapy, Combination; Endophthalmitis; Endotoxemia; Eye Evisceration; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Keratoplasty, Penetrating; Lens Implantation, Intraocular; Male; Microbial Sensitivity Tests; Middle Aged; Phacoemulsification; Postoperative Complications; Retrospective Studies; Uveitis, Anterior; Vancomycin | 2013 |
Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China.
Topics: Anti-Bacterial Agents; China; Cluster Analysis; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Genes, Bacterial; Genetic Variation; Genotype; Gram-Positive Bacterial Infections; Hospitalization; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Polymerase Chain Reaction; Teicoplanin; Vancomycin; Vancomycin Resistance | 2012 |
Antibiotic susceptibility of periodontal Enterococcus faecalis.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Chronic Periodontitis; Ciprofloxacin; Clindamycin; Dental Plaque; Drug Resistance, Bacterial; Enterococcus faecalis; Erythromycin; Female; Gingiva; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Periodontal Pocket; Periodontitis; Teicoplanin; Tetracycline Resistance; Vancomycin | 2013 |
Rapid identification of Gram-positive pathogens and their resistance genes from positive blood culture broth using a multiplex tandem RT-PCR assay.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Carbon-Oxygen Ligases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Methicillin; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Penicillin-Binding Proteins; RNA, Ribosomal, 16S; Shock, Septic; Staphylococcus; Streptococcus; Vancomycin; Vancomycin Resistance | 2013 |
Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Comorbidity; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Immunosuppression Therapy; Male; Metronidazole; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Vancomycin; Vancomycin Resistance | 2012 |
Molecular typing of vancomycin-resistant Enterococcus faecium with an automated repetitive sequence-based PCR microbial typing system compared with pulsed-field gel electrophoresis and multilocus sequence typing.
Topics: Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; Polymerase Chain Reaction; Vancomycin | 2013 |
Cerebrospinal fluid shunt infection due to Gemella haemolysans.
Topics: Adolescent; Anti-Bacterial Agents; Causality; Ceftazidime; Central Nervous System Infections; Dandy-Walker Syndrome; Gemella; Gentamicins; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Injections, Spinal; Male; Microbial Sensitivity Tests; Penicillin G; Prosthesis-Related Infections; Treatment Outcome; Vancomycin; Ventriculoperitoneal Shunt | 2013 |
Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Case-Control Studies; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Risk Factors; Treatment Outcome; Vancomycin | 2012 |
Potential utility for nomogram-based vancomycin dosing.
Topics: Anti-Bacterial Agents; Female; Gram-Positive Bacterial Infections; Humans; Male; Nomograms; Vancomycin | 2013 |
Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents.
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Daptomycin; Drug Synergism; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Stents; Urinary Tract; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2013 |
Evaluating effectiveness of antibiotic polymethylmethacrylate beads in achieving wound sterilization and graft preservation in patients with early and late vascular graft infections.
Topics: Administration, Topical; Aged; Aged, 80 and over; Amputation, Surgical; Anti-Bacterial Agents; Antisepsis; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Drug Carriers; Drug Therapy, Combination; Follow-Up Studies; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Limb Salvage; Lower Extremity; Male; Middle Aged; Polymethyl Methacrylate; Prosthesis-Related Infections; Recurrence; Retrospective Studies; Tobramycin; Treatment Outcome; Vancomycin | 2013 |
Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Renal Replacement Therapy; Sepsis; Serum; Vancomycin | 2013 |
Preferable timing of therapeutic drug monitoring in patients with impaired renal function treated with once-daily administration of vancomycin.
Topics: Adult; Aged; Analysis of Variance; Anti-Bacterial Agents; Bacterial Infections; Drug Monitoring; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prospective Studies; Renal Insufficiency; Risk Factors; Staphylococcal Infections; Time Factors; Vancomycin | 2013 |
Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Coinfection; Drug Resistance, Bacterial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Staphylococcal Infections; Vancomycin | 2013 |
[Comparison of Phoenix Automated System, API ID 32 Strep System and LightCycler Enterococcus MGRADE System in the Identification of Clinical Enterococcus Isolates].
Topics: Cross Infection; Enterococcus; Germany; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Streptococcal Infections; Vancomycin | 2013 |
Cutaneous Bacillus cereus infection in an immunocompetent patient.
Topics: Adult; Anti-Bacterial Agents; Bacillus cereus; Female; Gram-Positive Bacterial Infections; Humans; Skin Diseases, Bacterial; Vancomycin | 2002 |
Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Case-Control Studies; Cephalosporins; Enterococcus; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Metronidazole; Middle Aged; Risk Factors; Vancomycin; Vancomycin Resistance | 2002 |
Different levels of genetic homogeneity in vancomycin-resistant and -susceptible Enterococcus faecium isolates from different human and animal sources analyzed by amplified-fragment length polymorphism.
Topics: Algorithms; Animals; Anti-Bacterial Agents; Enterococcus faecium; Feces; Genotype; Gram-Positive Bacterial Infections; Humans; Phenotype; Polymorphism, Restriction Fragment Length; Poultry; Swine; Vancomycin; Vancomycin Resistance | 2002 |
Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban county hospital.
Topics: Adult; Bacterial Typing Techniques; Enterococcus faecium; Female; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Intensive Care Units; Male; Patient Isolation; Risk Factors; Time Factors; Vancomycin; Vancomycin Resistance | 2002 |
Peritonitis due to Leuconostoc species in a child receiving peritoneal dialysis.
Topics: Ampicillin; Anti-Bacterial Agents; Child; Female; Gram-Positive Bacterial Infections; Humans; Immunosuppressive Agents; Leuconostoc; Penicillins; Peritoneal Dialysis; Peritonitis; Vancomycin | 2002 |
Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bile; Child; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Ciprofloxacin; Enterococcus; Escherichia coli Infections; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Stents; Vancomycin | 2002 |
Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a population-based assessment.
Topics: Anti-Bacterial Agents; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Utilization Review; Gram-Positive Bacterial Infections; Health Services Misuse; Humans; Infection Control; Oregon; Organizational Policy; Pharmacy Service, Hospital; Practice Guidelines as Topic; United States; Vancomycin; Vancomycin Resistance | 2002 |
Characterization of Tn1546 in vancomycin-resistant Enterococcus faecium isolated from canine urinary tract infections: evidence of gene exchange between human and animal enterococci.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Conjugation, Genetic; DNA Transposable Elements; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gene Transfer, Horizontal; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Plasmids; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2002 |
[The efficacy of intraventricularly administered vancomycin in the case of central nervous system infection caused by enterococcus faecalis].
Topics: Adult; Anti-Bacterial Agents; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Meningitis, Bacterial; Teicoplanin; Time Factors; Treatment Outcome; Vancomycin | 2002 |
Endogenous endophthalmitis secondary to vancomycin-resistant enterococci infection.
Topics: Aged; Bacteremia; Endophthalmitis; Enterococcus faecium; Eye Enucleation; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance; Vitrectomy | 2003 |
Treatment of central nervous system infection by vancomycin-resistant enterococcus faecium.
Topics: Aged; Brain Neoplasms; Central Nervous System Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus faecium; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Injections, Intralesional; Lymphoma; Male; Opportunistic Infections; Risk Assessment; Treatment Outcome; Vancomycin; Virginiamycin | 2003 |
Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Child, Preschool; Clostridioides difficile; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Enterococcus faecium; Enterocolitis, Pseudomembranous; Female; Gram-Positive Bacterial Infections; Hospitals, Urban; Humans; Korea; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2003 |
The intraocular dynamics of vancomycin hydrochloride ophthalmic ointment (TN-011) in rabbits.
Topics: Administration, Topical; Animals; Aqueous Humor; Bacillus subtilis; Conjunctiva; Cornea; Eye; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Ointments; Ophthalmic Solutions; Pigmentation; Rabbits; Tissue Distribution; Vancomycin | 2003 |
Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid.
Topics: Acetamides; Aged; Cross Infection; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Point Mutation; RNA, Ribosomal, 23S; Vancomycin; Vancomycin Resistance | 2003 |
Rapid detection of vanA and vanB genes directly from clinical specimens and enrichment broths by real-time multiplex PCR assay.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Culture Media; DNA, Bacterial; Enterococcus; Feces; Fluorescence Resonance Energy Transfer; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Polymerase Chain Reaction; Time Factors; Vancomycin; Vancomycin Resistance | 2003 |
Screening and electronic labelling of ward contacts of vancomycin-resistant Enterococcus faecium vanB carriers during a single-strain hospital outbreak and after discharge from hospital.
Topics: Carrier State; Contact Tracing; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Mass Screening; Patient Discharge; Rectum; Risk Factors; Vancomycin | 2003 |
[Efficacy and nephrotoxicity of vancomycin in the treatment of Gram positive infections].
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Female; Gram-Positive Bacterial Infections; Humans; Kidney; Male; Middle Aged; Retrospective Studies; Vancomycin | 2003 |
In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
Topics: Abscess; Acetamides; Ampicillin Resistance; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Dipeptidases; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hexosyltransferases; Kidney; Linezolid; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Multienzyme Complexes; Muramoylpentapeptide Carboxypeptidase; Oxazolidinones; Penicillin-Binding Proteins; Peptidyl Transferases; Vancomycin; Vancomycin Resistance | 2003 |
Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital.
Topics: Anti-Bacterial Agents; Cross Infection; Endemic Diseases; Enterococcus; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Infection Control; Vancomycin; Vancomycin Resistance | 2003 |
Vancomycin administration during dialysis with low-flux polysulfone membranes: traditional versus a supplemental dosage regimen.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Drug Administration Schedule; Endpoint Determination; Female; Gram-Positive Bacterial Infections; Half-Life; Humans; Male; Membranes, Artificial; Middle Aged; Polymers; Renal Dialysis; Sulfones; Vancomycin | 2003 |
Phenotypic and genotypic characterization of VanA Enterococcus isolated during the first nosocomial outbreak in Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carbon-Oxygen Ligases; Cross Infection; DNA Primers; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2003 |
Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.
Topics: Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Intensive Care Units; Length of Stay; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance | 2003 |
Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia.
Topics: Bacteremia; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Male; Middle Aged; Safety Management; Vancomycin; Vancomycin Resistance | 2003 |
[Enterococcal infections in critically ill patients admitted to ICU].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Cross Infection; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Prospective Studies; Urinary Tract Infections; Vancomycin | 2003 |
Polymicrobial keratitis secondary to Burkholderia ambifaria, enterococcus, and staphylococcus aureus in a patient with herpetic stromal keratitis.
Topics: Amikacin; Burkholderia; Burkholderia Infections; Corneal Stroma; Drug Therapy, Combination; Enterococcus; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Keratitis, Herpetic; Levofloxacin; Male; Middle Aged; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecium.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Endocarditis; Enterococcus faecium; Female; Glycopeptides; Gram-Positive Bacterial Infections; Heart Valves; Microbial Sensitivity Tests; Mutation; Peptide Synthases; Rabbits; Teicoplanin; Vancomycin | 2003 |
Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Ceftazidime; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, Urban; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Severity of Illness Index; Vancomycin; Vancomycin Resistance | 2003 |
Predominance of vanA genotype among vancomycin-resistant Enterococcus isolates from poultry and swine in Costa Rica.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cattle; Chickens; Costa Rica; Enterococcus; Feces; Genotype; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Polymerase Chain Reaction; Poultry Diseases; Swine; Swine Diseases; Vancomycin; Vancomycin Resistance | 2003 |
Acquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 500 and over; Hospitals, University; Humans; Male; Middle Aged; Netherlands; Phylogeny; Serotyping; Vancomycin; Vancomycin Resistance | 2003 |
Delayed discovery of linezolid-resistant, vancomycin-resistant Enterococcus faecium: lessons learned.
Topics: Acetamides; Aged; Aged, 80 and over; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2004 |
Human corneal stromal tissue concentration after consecutive doses of topically applied 3.3% vancomycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Corneal Stroma; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Ophthalmic Solutions; Surgical Wound Infection; Vancomycin | 2004 |
Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Disease Models, Animal; Drug Resistance, Bacterial; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gene Expression Regulation, Bacterial; Genes, Bacterial; Gram-Positive Bacterial Infections; Heart; Promoter Regions, Genetic; Rabbits; Teicoplanin; Vancomycin; Vancomycin Resistance | 2004 |
Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Cross Infection; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Logistic Models; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Survival Analysis; Survival Rate; Vancomycin | 2004 |
Occurrence, structure, and mobility of Tn1546-like elements in environmental isolates of vancomycin-resistant enterococci.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Environmental Microbiology; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymorphism, Restriction Fragment Length; Vancomycin; Vancomycin Resistance | 2004 |
Molecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis.
Topics: Confidence Intervals; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance | 2004 |
Relations between the consumption of antimicrobial growth promoters and the occurrence of resistance among Enterococcus faecium isolated from broilers.
Topics: Animal Feed; Animal Husbandry; Animals; Anti-Bacterial Agents; Chickens; Denmark; Drug Administration Schedule; Drug Resistance, Bacterial; Enterococcus faecium; Erythromycin; Gram-Positive Bacterial Infections; Linear Models; Logistic Models; Markov Chains; Microbial Sensitivity Tests; Monte Carlo Method; Oligosaccharides; Poultry Diseases; Time Factors; Vancomycin; Virginiamycin | 2004 |
Comparative in vitro activities of AC98-6446, a novel semisynthetic glycopeptide derivative of the natural product mannopeptimycin alpha, and other antimicrobial agents against gram-positive clinical isolates.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Kinetics; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin | 2004 |
Dogs should be included in surveillance programs for vancomycin-resistant enterococci.
Topics: Animals; Dog Diseases; Dogs; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterococcus; Feces; Gram-Positive Bacterial Infections; Humans; Population Surveillance; Vancomycin | 2004 |
Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention.
Topics: Candidiasis; Case-Control Studies; Cohort Studies; Constriction, Pathologic; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Staphylococcal Infections; Time Factors; Tomography, X-Ray Computed; Vancomycin | 2004 |
Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Infant; Infection Control; Male; Neoplasms; Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2004 |
Characterization of the first VanB vancomycin-resistant Enterococcus faecium isolated in a Spanish hospital.
Topics: Aged; Anti-Bacterial Agents; Base Sequence; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Hospitals; Humans; Male; Molecular Sequence Data; Pressure Ulcer; Sequence Alignment; Sequence Analysis, DNA; Sequence Homology; Spain; Vancomycin; Vancomycin Resistance | 2004 |
Convenient selective differential broth for isolation of vancomycin-resistant enterococcus from fecal material.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Culture Media; Enterococcus faecium; Feces; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Vancomycin; Vancomycin Resistance | 2004 |
Evaluation of the Velogene genomic assay for detection of vanA and vanB genes in vancomycin-resistant Enterococcus species.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; DNA Probes; DNA, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Reagent Kits, Diagnostic; Teicoplanin; Vancomycin; Vancomycin Resistance | 2004 |
Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Synergism; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Streptomycin; Teicoplanin; Vancomycin; Vancomycin Resistance | 2004 |
Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Infective Agents; Drug Combinations; Female; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Linezolid; Male; Middle Aged; Orthopedics; Oxazolidinones; Postoperative Complications; Prospective Studies; Thrombocytopenia; Time; Vancomycin | 2004 |
Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Infection Control; Intensive Care Units; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2004 |
For nosocomial vancomycin-resistant enterococcal infections: the ounce of prevention or the pound of cure?
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2004 |
Septic pelvic thrombophlebitis and preeclampsia are related disorders.
Topics: Anti-Bacterial Agents; Body Mass Index; Chorioamnionitis; Delivery, Obstetric; Female; Fever; Fibrinolytic Agents; Follow-Up Studies; Gram-Positive Bacterial Infections; HELLP Syndrome; Heparin; Humans; Incidence; Maternal Welfare; Mississippi; Pelvic Inflammatory Disease; Pelvis; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Puerperal Infection; Retrospective Studies; Sepsis; Thrombophlebitis; Trial of Labor; Vancomycin | 2004 |
High incidence of vancomycin resistance in Enterococcus faecalis strains in a French hospital.
Topics: Anti-Bacterial Agents; Cross Infection; DNA, Bacterial; Enterococcus faecalis; Enterococcus faecium; France; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Teicoplanin; Vancomycin; Vancomycin Resistance | 2004 |
Surveillance of vancomycin-resistant Enterococcus in hospitals in Ibaraki prefecture.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Enterococcus; Feces; Gram-Positive Bacterial Infections; Hospitals; Japan; Microbial Sensitivity Tests; Peptide Synthases; Population Surveillance; Vancomycin; Vancomycin Resistance | 2004 |
Vancomycin-resistant Enterococcus faecium isolates causing hospital outbreaks in northern Italy belong to the multilocus sequence typing C1 lineage.
Topics: Alleles; Animals; Base Sequence; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Food Microbiology; Gram-Positive Bacterial Infections; Humans; Italy; Meat; Phylogeny; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Poultry; Serotyping; Time Factors; Vancomycin | 2004 |
Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria.
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Endpoint Determination; Female; Gram-Positive Bacterial Infections; Linezolid; Lipoglycopeptides; Methicillin Resistance; Mice; Muscle, Skeletal; Nafcillin; Neutropenia; Oxazolidinones; Protein Binding; Staphylococcal Infections; Subcutaneous Tissue; Vancomycin | 2004 |
Unusual anaerobic bacteria in keratitis after laser in situ keratomileusis: diagnosis using molecular biology methods.
Topics: Bacterial Typing Techniques; Cefazolin; DNA, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Keratitis; Keratomileusis, Laser In Situ; Male; Middle Aged; Polymerase Chain Reaction; Propionibacterium; Vancomycin | 2004 |
Nosocomial infection with vancomycin-dependent enterococci.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 2004 |
Local genetic patterns within a vancomycin-resistant Enterococcus faecalis clone isolated in three hospitals in Portugal.
Topics: Anti-Bacterial Agents; Chromosomes; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Portugal; Reverse Transcriptase Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2004 |
Clonal dissemination of VanA-type glycopeptide-resistant Enterococcus faecalis between hospitals of two cities located 100 km apart.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2004 |
A rapid antimicrobial susceptibility test based on chemiluminescence assay and its application to screening of genotypes in vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Culture Media; Enterococcus; Genotype; Gram-Positive Bacterial Infections; Humans; Luminescent Measurements; Microbial Sensitivity Tests; Polymerase Chain Reaction; Teicoplanin; Time Factors; Vancomycin; Vancomycin Resistance | 2004 |
Evidence for biliary excretion of vancomycin into stool during intravenous therapy: potential implications for rectal colonization with vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bile; Carbon-Oxygen Ligases; Cross-Sectional Studies; Drug Therapy, Combination; Enterococcus; Feces; Fluorescence Polarization Immunoassay; Gentamicins; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Rectum; Vancomycin; Vancomycin Resistance | 2004 |
High versus standard dose vancomycin for osteomyelitis.
Topics: Aged; Aged, 80 and over; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Multivariate Analysis; Osteomyelitis; Probability; Retrospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Vancomycin | 2004 |
Glycopeptide-resistance transferability from vancomycin-resistant enterococci of human and animal source to Listeria spp.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Conjugation, Genetic; DNA, Bacterial; Enterococcus; Gene Expression Regulation, Bacterial; Gene Transfer, Horizontal; Gram-Positive Bacterial Infections; Humans; Listeria; Microbial Sensitivity Tests; Plasmids; Teicoplanin; Vancomycin; Vancomycin Resistance | 2004 |
In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections.
Topics: Acetamides; Cefotaxime; Central Nervous System Infections; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Propionibacterium acnes; Vancomycin; Virginiamycin | 2005 |
First report of VanA Enterococcus gallinarum dissemination within an intensive care unit in Argentina.
Topics: Anti-Bacterial Agents; Argentina; Bacterial Proteins; Carbon-Oxygen Ligases; Conjugation, Genetic; Deoxyribonucleases, Type II Site-Specific; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Gene Transfer, Horizontal; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Peptide Synthases; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Population Surveillance; Vancomycin; Vancomycin Resistance | 2005 |
Successful management of central nervous system infection due to Propionibacterium acnes with vancomycin and doxycycline.
Topics: Aged; Anti-Bacterial Agents; Brain Diseases; Doxycycline; Gram-Positive Bacterial Infections; Humans; Male; Propionibacterium acnes; Vancomycin | 2005 |
Fatal Bacillus cereus endocarditis masquerading as an anthrax-like infection in a patient with acute lymphoblastic leukemia: case report.
Topics: Abscess; Adult; Anthrax; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacillus cereus; Brain Diseases; Diagnosis, Differential; Drug Therapy, Combination; Endocarditis, Bacterial; Fatal Outcome; Gram-Positive Bacterial Infections; Humans; Male; Mitral Valve; Penicillins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Skin Ulcer; Vancomycin | 2005 |
First linezolid- and vancomycin-resistant Enterococcus faecium strain in Taiwan.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Oxazolidinones; Taiwan; Vancomycin | 2005 |
Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous; Colony Count, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Models, Biological; Oxazolidinones; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 2005 |
Antimicrobial resistance of enterococci in Turkey.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood; Body Fluids; Catheterization; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Teicoplanin; Turkey; Urine; Vancomycin; Wounds and Injuries | 2005 |
Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus pneumoniae; Teicoplanin; Vancomycin; Vancomycin Resistance | 2005 |
Molecular characterization of glycopeptide-resistant Enterococcus faecium isolates from Portuguese hospitals.
Topics: Anti-Bacterial Agents; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Portugal; Vancomycin; Vancomycin Resistance | 2005 |
Ocular hypersensitivitiy to topical vancomycin in a case of chronic endophthalmitis.
Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Chronic Disease; Drug Hypersensitivity; Endophthalmitis; Eye Diseases; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Ophthalmic Solutions; Propionibacterium acnes; Vancomycin | 2005 |
Surveillance for vancomycin-resistant enterococci colonization among patients of a liver transplant program.
Topics: Adult; Enterococcus; Female; Fibrosis; Gram-Positive Bacterial Infections; Humans; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Risk Factors; Vancomycin | 2005 |
Nosocomial urinary tract infection due to Leuconostoc mesenteroides at a tertiary care centre in north India.
Topics: Adolescent; Adult; Aged; Animals; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; India; Leuconostoc; Male; Middle Aged; Urinary Catheterization; Urinary Tract Infections; Vancomycin | 2005 |
Identification of glycopeptide-resistant enterococci by VITEK 2 system and conventional and real-time polymerase chain reaction.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Drug Resistance, Microbial; Enterococcus; Evaluation Studies as Topic; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2005 |
Vancomycin for multi-drug resistant Enterococcus faecium cholangiohepatitis in a cat.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cholangitis; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hepatitis, Animal; Male; Time Factors; Vancomycin | 2005 |
Mortality due to vancomycin-resistant enterococcal bacteremia versus vancomycin-susceptible enterococcal bacteremia: an ecological analysis.
Topics: Anti-Bacterial Agents; Bacteremia; Enterococcus; Gram-Positive Bacterial Infections; Humans; Risk Factors; Vancomycin; Vancomycin Resistance | 2005 |
[Infectious endocarditis].
Topics: Adult; Aortic Valve Insufficiency; Blood Vessel Prosthesis Implantation; Combined Modality Therapy; Embolism; Endocarditis; Endocarditis, Bacterial; Endocarditis, Subacute Bacterial; Enterococcus faecalis; Fever of Unknown Origin; Gram-Positive Bacterial Infections; Heart Murmurs; Humans; Male; Mycoses; Penicillins; Vancomycin; Vasculitis | 2005 |
Epidemiology and molecular analysis of intestinal colonization by vancomycin-resistant enterococci in greek hospitals.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Gram-Positive Bacterial Infections; Greece; Hospitals, District; Hospitals, University; Humans; Molecular Epidemiology; Peptide Synthases; Random Allocation; Vancomycin; Vancomycin Resistance | 2005 |
Vancomycin and home health care.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Guideline Adherence; Home Care Services; Humans; Infection Control; Male; Middle Aged; Practice Guidelines as Topic; Retrospective Studies; Vancomycin | 2005 |
Vancomycin-resistant Enterococcus faecium osteoarthritis following Staphylococcus aureus hip infection.
Topics: Aged; Anti-Bacterial Agents; Drug Combinations; Drug Resistance, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hip Prosthesis; Humans; Osteoarthritis, Hip; Prosthesis Failure; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
Clinical outcomes of penicillin skin testing.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Hypersensitivity; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Penicillins; Practice Patterns, Physicians'; Retrospective Studies; Skin Tests; Vancomycin | 2005 |
[Case of congestive heart failure associated with hypereosinophilia developed during antibiotics treatment].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Heart Failure; Humans; Hypereosinophilic Syndrome; Male; Methicillin Resistance; Methylprednisolone; Sepsis; Staphylococcal Infections; Teicoplanin; Treatment Outcome; Vancomycin | 2005 |
Ocular infection secondary to gemella.
Topics: Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Corneal Ulcer; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Staphylococcaceae; Tobramycin; Vancomycin | 2006 |
Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infections.
Topics: Anti-Bacterial Agents; Bacteremia; Catheterization; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic; Teicoplanin; Vancomycin | 2006 |
Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin | 2006 |
Loading dose of vancomycin in critically ill patients: 15 mg/kg is a better choice than 500 mg.
Topics: Aged; Critical Illness; Dose-Response Relationship, Drug; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; Vancomycin | 2006 |
Vancomycin for the treatment of methicillin-resistant staphylococcal and enterococcal infections in 15 horses.
Topics: Aminoglycosides; Animals; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Horses; Infusions, Intravenous; Male; Methicillin Resistance; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2005 |
Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Fluoroquinolones; Gammaproteobacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Population Surveillance; Vancomycin; Vancomycin Resistance | 2006 |
Reply to Nannini and to a previous letter by Hurley.
Topics: Bacteremia; Enterococcus; Gram-Positive Bacterial Infections; Humans; Risk Factors; Vancomycin; Vancomycin Resistance | 2006 |
A 24-hour screening protocol for identification of vancomycin-resistant Enterococcus faecium.
Topics: Automation; Bacterial Proteins; Carbon-Oxygen Ligases; Enterococcus faecium; Feces; Gram-Positive Bacterial Infections; Humans; Polymerase Chain Reaction; Sensitivity and Specificity; Vancomycin; Vancomycin Resistance | 2006 |
Relationship of colonization with vancomycin-resistant enterococci and risk of systemic infection in patients with cancer.
Topics: Anti-Bacterial Agents; Enterococcus; Gram-Positive Bacterial Infections; Humans; Neoplasms; Vancomycin; Vancomycin Resistance | 2006 |
[First case of infection due to vancomycin resistant Enterococcus faecalis in New Caledonia].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Male; Teicoplanin; Vancomycin | 2006 |
Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures.
Topics: Anti-Bacterial Agents; Enterococcus; Gram-Positive Bacterial Infections; Hand Disinfection; Housekeeping, Hospital; Humans; Infection Control; Intensive Care Units; Multivariate Analysis; Practice Guidelines as Topic; Vancomycin; Vancomycin Resistance | 2006 |
Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalis.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Oxazolidinones; Vancomycin | 2006 |
Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cost-Benefit Analysis; Drug Administration Routes; Drug Costs; Drug Monitoring; Drug Utilization; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Hospital Costs; Hospitals, Urban; Humans; Length of Stay; Male; Middle Aged; Phlebitis; Prospective Studies; Renal Dialysis; Spain; Teicoplanin; Vancomycin | 2006 |
[Status and drug resistance surveillance of enterococcus infection in patients with severe hepatitis].
Topics: Aminoglycosides; Ampicillin Resistance; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Hepatitis; Humans; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 2006 |
Antimicrobial therapy and local toxicity of intraventricular administration of vancomycin in a neonate with ventriculitis.
Topics: Anti-Bacterial Agents; Cerebral Ventricles; Cross Infection; Encephalitis; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Infant, Newborn; Injections, Intraventricular; Male; Surgical Wound Infection; Vancomycin; Ventriculoperitoneal Shunt | 2006 |
Bedside modified Clagett procedure for empyema after pulmonary resection.
Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; Cefazolin; Chest Tubes; Clindamycin; Empyema, Pleural; Feasibility Studies; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Pneumonectomy; Point-of-Care Systems; Postoperative Complications; Retrospective Studies; Safety; Thoracostomy; Treatment Outcome; Vancomycin | 2006 |
High frequency of vancomycin-resistant Enterococcus faecium isolates with VanB phenotype and vanA genotype in Korean hospitals.
Topics: Bacterial Proteins; Bacterial Typing Techniques; Carbon-Oxygen Ligases; DNA Transposable Elements; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Korea; Membrane Proteins; Microbial Sensitivity Tests; Protein Array Analysis; Species Specificity; Vancomycin; Vancomycin Resistance | 2006 |
The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
Topics: Academic Medical Centers; Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cohort Studies; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2006 |
VanB-vanA incongruent VRE isolated from animals and humans in 1999.
Topics: Animals; Bacterial Proteins; Carbon-Oxygen Ligases; Chickens; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Mutation; Polymerase Chain Reaction; Protein Kinases; Sequence Analysis, DNA; Transcription Factors; Vancomycin | 2006 |
Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.
Topics: Academic Medical Centers; Acetamides; Adult; Aged; Aged, 80 and over; Alabama; Anti-Infective Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2006 |
Multilocus sequence typing and analysis of putative virulence factors in vancomycin-resistant and vancomycin-sensitive Enterococcus faecium isolates from Brazil.
Topics: Adhesins, Bacterial; Animals; Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carrier State; Cross Infection; Enterococcus faecium; Feces; Gram-Positive Bacterial Infections; Hospitals; Humans; Hyaluronoglucosaminidase; Membrane Proteins; Microbial Sensitivity Tests; Species Specificity; Swine; Vancomycin; Vancomycin Resistance; Virulence Factors | 2006 |
Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.
Topics: Anti-Bacterial Agents; Bacteremia; Enterococcus; Feces; Gram-Positive Bacterial Infections; Humans; Leukemia; Lymphoma; Neoplasms; Predictive Value of Tests; Retrospective Studies; Statistics as Topic; Vancomycin; Vancomycin Resistance | 2006 |
Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans.
Topics: Bone Marrow Transplantation; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Vancomycin; Vancomycin Resistance | 2006 |
Pediatric endogenous bacterial endophthalmitis: case report and review of the literature.
Topics: Anti-Bacterial Agents; Blindness; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Infant; Vancomycin; Vitreous Body | 2006 |
Endocarditis caused by Gemella morbillorum resistant to beta-lactams and aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Staphylococcaceae; Vancomycin | 2006 |
Gemella haemolysans infectious crystalline keratopathy.
Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Corneal Diseases; Epithelium, Corneal; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Keratoplasty, Penetrating; Postoperative Complications; Staphylococcaceae; Vancomycin | 2006 |
Emergence of VanD-type vancomycin-resistant Enterococcus faecium in Stockholm, Sweden.
Topics: Alleles; Anti-Bacterial Agents; Bacterial Proteins; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Liver Transplantation; Peptide Synthases; Postoperative Complications; Sweden; Teicoplanin; Vancomycin; Vancomycin Resistance | 2007 |
Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Improving the assessment of vancomycin-resistant enterococci by routine screening.
Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Carrier State; Cohort Studies; Diagnostic Tests, Routine; Disease Notification; Enterococcus; Gram-Positive Bacterial Infections; Humans; Incidence; Patient-Centered Care; Retrospective Studies; United States; Vancomycin; Vancomycin Resistance | 2007 |
Enterococcal virulence determinants may be involved in resistance to clinical therapy.
Topics: Animals; Aortic Valve; Bacterial Proteins; Biofilms; Colony Count, Microbial; Endocarditis, Bacterial; Enterococcus faecalis; Gelatinases; Gram-Positive Bacterial Infections; Humans; Male; Membrane Proteins; Rats; Rats, Sprague-Dawley; Vancomycin; Vancomycin Resistance; Virulence | 2007 |
In vitro synergy of baicalein and gentamicin against vancomycin-resistant Enterococcus.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Synergism; Enterococcus; Enzyme Inhibitors; Flavanones; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 2007 |
Leuconostoc species-associated endocarditis.
Topics: Anti-Bacterial Agents; Aortic Valve; Drug Resistance, Bacterial; Endocarditis, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Heart Valve Prosthesis Implantation; Humans; Leuconostoc; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin G; Vancomycin | 2007 |
Community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Penicillin G; Vancomycin; Vancomycin Resistance; Vitreous Body | 2007 |
Late prosthetic joint infection due to Rothia mucilaginosa.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Chronic Disease; Comorbidity; Debridement; Diabetes Mellitus, Type 2; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hip Prosthesis; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prosthesis-Related Infections; Reoperation; Risk Assessment; Time Factors; Tooth Extraction; Vancomycin | 2007 |
[Vancomycin resistant enterococci in etiology of neutropenic enterocolitis: prophylaxis, clinical signs and treatment].
Topics: Acetamides; Adolescent; Adult; Anti-Infective Agents; Antineoplastic Agents; Drug Resistance, Bacterial; Enterococcus; Enterocolitis; Feces; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hemorrhage; Humans; Linezolid; Middle Aged; Neutropenia; Oxazolidinones; Vancomycin | 2006 |
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Topics: Anti-Bacterial Agents; Asia; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus; Teicoplanin; Vancomycin | 2007 |
Early switch from vancomycin to oral linezolid for treatment of gram-positive heart valve endocarditis.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Endocarditis, Bacterial; Female; Gram-Positive Bacterial Infections; Health Care Costs; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Vancomycin | 2007 |
Linezolid versus vancomycin for prosthetic joint infections: a cost analysis.
Topics: Acetamides; Administration, Oral; Algorithms; Anti-Bacterial Agents; Costs and Cost Analysis; Gram-Positive Bacterial Infections; Health Care Costs; Home Care Services; Humans; Infusions, Intravenous; Joint Prosthesis; Linezolid; Methicillin Resistance; Oxazolidinones; Prosthesis-Related Infections; Vancomycin | 2007 |
Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk.
Topics: Acute Disease; Adult; Aged; Case-Control Studies; Disease Outbreaks; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Leukemia, Myeloid; Male; Middle Aged; Multivariate Analysis; Risk Factors; Vancomycin; Vancomycin Resistance | 2007 |
Comparison of the MicroScan system and the agar dilution assay for Quinupristin/Dalfopristin susceptibility of Enterococcus faecium.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Reproducibility of Results; Teicoplanin; Vancomycin; Virginiamycin | 2007 |
Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Minocycline; Oxazolidinones; Tigecycline; Treatment Outcome; Vancomycin | 2007 |
Partial teicoplanin dependence in a vancomycin-dependent Enterococcus faecium isolated from an oncology patient 1 month after cessation of teicoplanin therapy, Austria 2007.
Topics: Adult; Anti-Bacterial Agents; Austria; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Teicoplanin; Vancomycin | 2008 |
Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005.
Topics: Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus; Glycopeptides; Gram-Positive Bacterial Infections; Hospitalization; Humans; Poland; Transplantation; Vancomycin | 2007 |
A nanoplex PCR assay for the rapid detection of vancomycin and bifunctional aminoglycoside resistance genes in Enterococcus species.
Topics: Aminoglycosides; Anti-Bacterial Agents; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Retrospective Studies; RNA, Ribosomal, 16S; Sensitivity and Specificity; Vancomycin | 2007 |
Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
Topics: Acetamides; Anti-Infective Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Glycopeptides; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus aureus; Streptococcaceae; Taiwan; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2008 |
Presence of vancomycin and ampicillin-resistant Enterococcus faecium of epidemic clonal complex-17 in wastewaters from the south coast of England.
Topics: Alleles; Ampicillin; Ampicillin Resistance; Animals; Animals, Domestic; England; Enterococcus faecium; Environmental Microbiology; Genes, Bacterial; Gram-Positive Bacterial Infections; Hospitals; Humans; Medical Waste Disposal; Microbial Sensitivity Tests; Polymerase Chain Reaction; Risk Factors; Sewage; Vancomycin; Vancomycin Resistance | 2008 |
Isolation and characterization of a novel Enterococcus faecalis bacteriophage phiEF24C as a therapeutic candidate.
Topics: Amino Acid Sequence; Bacteriophages; Electrophoresis, Polyacrylamide Gel; Enterococcus faecalis; Genome, Viral; Gram-Positive Bacterial Infections; Host-Pathogen Interactions; Microscopy, Electron, Transmission; Species Specificity; Vancomycin; Vancomycin Resistance; Viral Proteins; Virion; Virulence | 2008 |
Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis: impact of protein binding?
Topics: Aged; Daptomycin; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Male; Protein Binding; Treatment Failure; Vancomycin; Vancomycin Resistance | 2008 |
[Enterococcus spp. colonized in the gastrointestinal tract of patients in hemato-oncology and intensive care units and their resistance profiles to vancomycin].
Topics: Anti-Bacterial Agents; Carrier State; Enterococcus; Gastrointestinal Tract; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Oncology Service, Hospital; Vancomycin; Vancomycin Resistance | 2007 |
Nosocomial bloodstream infection in a pediatric intensive care unit.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Incidence; India; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Medical Records; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome; Vancomycin | 2008 |
Endophthalmitis caused by Bacillus species.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacillus; Cephalosporins; Child; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy | 2008 |
Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospital Units; Hospitals, University; Humans; Infant; Infant, Newborn; Male; Turkey; Vancomycin; Vancomycin Resistance | 2008 |
The rise and fall of vancomycin.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Humans; Vancomycin | 2008 |
Toward improving therapeutic regimens for Bacillus endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Bacillus cereus; Biological Availability; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Glucocorticoids; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rabbits; Retina; Vancomycin; Vitreous Body | 2008 |
Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.
Topics: Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Multivariate Analysis; Risk Assessment; Risk Factors; Vancomycin; Vancomycin Resistance | 2008 |
Molecular characterisation of linezolid resistance in two vancomycin-resistant (VanB) Enterococcus faecium isolates using Pyrosequencing.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Genes, Bacterial; Genes, rRNA; Gram-Positive Bacterial Infections; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Linezolid; Microbial Sensitivity Tests; Mucositis; Oxazolidinones; Pancreatitis, Acute Necrotizing; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; Vancomycin; Vancomycin Resistance | 2008 |
New recommendations in the treatment of Gram-positive bacteraemia in dialysis patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Gram-Positive Bacterial Infections; Humans; Renal Dialysis; Thrombocytopenia; Vancomycin | 2008 |
Vancomycin-resistant Enterococcus faecium meningitis successfully treated with linezolid.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Vancomycin | 2008 |
Influence of glomerular filtration rate on the clearance of vancomycin administered by continuous infusion in burn patients.
Topics: Adult; Algorithms; Anti-Bacterial Agents; Burns; Cohort Studies; Female; Glomerular Filtration Rate; Gram-Positive Bacterial Infections; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Vancomycin | 2008 |
Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Taiwan; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2008 |
Nosocomial meningitis caused by multiresistant enterococcus as a life-threatening complication of pelvic injury: case report.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Pelvic Bones; Penicillins; Sacrum; Spinal Fractures; Vancomycin | 1995 |
Are serum levels of vancomycin useful in the first week of therapy?
Topics: Bacteremia; Cost Savings; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Vancomycin | 1995 |
Vancomycin use in ophthalmology.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Utilization; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Ophthalmic Solutions; Ophthalmology; Vancomycin | 1995 |
The emergence of Enterococcus faecium resistant to glycopeptides and other standard agents--a preliminary report.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Drug Resistance, Microbial; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Hospital Units; Humans; Liver Transplantation; Male; Prospective Studies; Risk Factors; Vancomycin | 1995 |
Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections.
Topics: Age Factors; Aged; Anti-Bacterial Agents; APACHE; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Inpatients; Multivariate Analysis; New York City; Patient Compliance; Patient Isolation; Regression Analysis; Time Factors; Vancomycin | 1995 |
Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Male; Vancomycin | 1995 |
Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Critical Care; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Minnesota; Vancomycin | 1995 |
Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center.
Topics: Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Maryland; Prevalence; Regression Analysis; Vancomycin | 1995 |
Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.
Topics: Adult; Aged; Bacteremia; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Risk Factors; Vancomycin | 1995 |
What can we do about vancomycin-resistant enterococci?
Topics: Animals; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1995 |
Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections.
Topics: Adult; Aged; Aged, 80 and over; Chloramphenicol; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin | 1995 |
Correlation between phenotypic characteristics and DNA relatedness within Enterococcus faecium strains.
Topics: Bacterial Proteins; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecium; Glycerol; Gram-Positive Bacterial Infections; Humans; Mannitol; Phenotype; Raffinose; Sorbitol; Species Specificity; Vancomycin | 1995 |
VRE--a more immediate threat than Ebola.
Topics: Drug Resistance, Microbial; Drug Resistance, Multiple; Ebolavirus; Enterococcus; Gram-Positive Bacterial Infections; Hemorrhagic Fevers, Viral; Humans; Teicoplanin; Vancomycin | 1995 |
The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections; Vancomycin | 1995 |
Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients.
Topics: Gram-Positive Bacterial Infections; Humans; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Vancomycin | 1995 |
Keeping your patient safe from VRE.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin | 1995 |
Bacteremia due to vancomycin-dependent Enterococcus faecium.
Topics: Bacteremia; Child, Preschool; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Liver Transplantation; Vancomycin | 1995 |
Linkage of vancomycin and high-level gentamicin resistance genes on the same plasmid in a clinical isolate of Enterococcus faecalis.
Topics: Base Sequence; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Molecular Sequence Data; Nucleic Acid Hybridization; Plasmids; Vancomycin | 1995 |
Evaluation of three disk tests for identification of enterococci, leuconostocs, and pediococci.
Topics: Aminopeptidases; Bacteriological Techniques; Catalase; Drug Resistance, Microbial; Enterococcus; Evaluation Studies as Topic; Gram-Positive Bacterial Infections; Humans; Leuconostoc; Leucyl Aminopeptidase; Pediococcus; Pyrrolidonecarboxylic Acid; Vancomycin | 1995 |
Vancomycin-resistant Enterococcus faecium sepsis following persistent colonization.
Topics: Adult; Drug Resistance, Microbial; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Sepsis; Vancomycin | 1995 |
Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium.
Topics: Animals; Ceftriaxone; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Penicillins; Rabbits; Random Allocation; Recurrence; Teicoplanin; Vancomycin | 1995 |
Urinary tract infection with Enterococcus faecalis.
Topics: Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Urinary Tract Infections; Vancomycin | 1995 |
[Enterococci as a new nosocomial problem. A Vancomycin-resistant strain was isolated in Sweden].
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Sweden; Vancomycin | 1995 |
Enterococcus faecium meningitis in a child.
Topics: Child, Preschool; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Meningitis, Bacterial; Vancomycin | 1994 |
Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man.
Topics: Animals; Animals, Domestic; Cattle; Disease Reservoirs; Dogs; Drug Resistance, Microbial; Enterococcus faecium; Food Microbiology; Gram-Positive Bacterial Infections; Horses; Humans; Meat; Microbial Sensitivity Tests; Polymerase Chain Reaction; Poultry; Sewage; Sheep; Swine; United Kingdom; Vancomycin; Water Microbiology | 1994 |
Vancomycin-resistant enterococci: an emerging pathogen in immunosuppressed transplant recipients.
Topics: Adult; Aged; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Immunosuppression Therapy; Male; Middle Aged; Retrospective Studies; Transplantation Immunology; Vancomycin | 1995 |
Draft guideline published on preventing the spread of VRE infections. Hospital Infection Control Practices Advisory Committee.
Topics: Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin | 1994 |
Therapeutic beds: the Trojan horses of the 1990s?
Topics: Beds; Cross Infection; Enterococcus faecium; Equipment Contamination; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Vancomycin | 1994 |
Vancomycin-resistant enterococci and bedpan washer machines.
Topics: Cross Infection; Disinfection; Drug Resistance, Microbial; Enterococcus faecium; Equipment and Supplies, Hospital; Equipment Contamination; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1994 |
Pharmacokinetic parameters of vancomycin for therapeutic regimens in neutropenic adult patients.
Topics: Adolescent; Adult; Creatinine; Drug Therapy, Computer-Assisted; Female; Gram-Positive Bacterial Infections; Hodgkin Disease; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Metabolic Clearance Rate; Middle Aged; Neutropenia; Vancomycin | 1994 |
Application of USC*PACK clinical programs to vancomycin in neutropenic patients.
Topics: Adolescent; Adult; Bayes Theorem; Creatinine; Drug Therapy, Computer-Assisted; Female; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Kidney; Male; Middle Aged; Neutropenia; Software; Urodynamics; Vancomycin | 1994 |
Vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer.
Topics: Bacteremia; Clinical Trials as Topic; Gram-Positive Bacterial Infections; Humans; Neoplasms; Teicoplanin; Vancomycin | 1994 |
IS6770, an enterococcal insertion-like sequence useful for determining the clonal relationship of clinical enterococcal isolates.
Topics: Amino Acid Sequence; Bacterial Typing Techniques; Base Sequence; Cloning, Molecular; Cross Infection; Disease Outbreaks; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Molecular Epidemiology; Molecular Sequence Data; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA; Vancomycin | 1994 |
[Low-level vancomycin resistance in Enterococcus faecalis].
Topics: Adult; Drug Resistance, Microbial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Urinary Tract Infections; Vancomycin | 1994 |
Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cross Infection; Diarrhea; Disease Outbreaks; Disease Reservoirs; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Middle Aged; Rhode Island; Vancomycin | 1994 |
Vancomycin-resistant enterococcus: an emerging nosocomial pathogen and its implications for the operating room setting.
Topics: Aged; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infection Control; Male; Operating Rooms; Vancomycin | 1993 |
Vancomycin-dependent enterococci in the United Kingdom.
Topics: Anti-Bacterial Agents; Enterococcus faecium; Feces; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; United Kingdom; Vancomycin | 1994 |
Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacteremia; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Vancomycin | 1994 |
Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci.
Topics: Bacterial Proteins; Bacterial Typing Techniques; Base Sequence; Carbon-Oxygen Ligases; DNA Probes; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hemodialysis Units, Hospital; Humans; Molecular Sequence Data; Nucleic Acid Hybridization; Polymorphism, Restriction Fragment Length; RNA, Ribosomal; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Vancomycin | 1993 |
Emergence of vancomycin-resistant enterococci in New York City.
Topics: Aged; Base Sequence; Cross Infection; DNA Probes; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Vancomycin | 1993 |
Evidence for an animal origin of vancomycin-resistant enterococci.
Topics: Animals; Animals, Domestic; Chickens; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Food Microbiology; Gram-Positive Bacterial Infections; Humans; Meat; Sewage; Vancomycin | 1993 |
Vancomycin-resistant enterococci.
Topics: DNA Probes; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1993 |
Vancomycin-resistant enterococci.
Topics: Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Infusions, Intravenous; Teicoplanin; Vancomycin | 1993 |
Vancomycin-resistant enterococci.
Topics: Carrier State; Catheterization, Central Venous; Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Length of Stay; Microbial Sensitivity Tests; Vancomycin | 1993 |
The emergence of vancomycin resistance in renal dialysis.
Topics: Aged; Coagulase; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Lactobacillus; Male; Microbial Sensitivity Tests; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcus; Vancomycin | 1993 |
Correlation of vancomycin clearance and creatinine clearance: unreliability for predicting initial dosing in neutropenic haematological patients.
Topics: Adolescent; Adult; Aged; Creatinine; Female; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Vancomycin | 1993 |
Administration of vancomycin for treatment of ascending bacterial cholangiohepatitis in a cat.
Topics: Animals; Cat Diseases; Cats; Cholangitis; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hepatitis, Animal; Male; Vancomycin | 1994 |
Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth.
Topics: Drug Resistance, Microbial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Urinary Tract Infections; Vancomycin | 1994 |
Percutaneous discectomy for the treatment of bacterial discitis.
Topics: Discitis; Diskectomy, Percutaneous; Gram-Positive Bacterial Infections; Humans; Lumbar Vertebrae; Male; Middle Aged; Postoperative Care; Postoperative Complications; Propionibacterium acnes; Spinal Stenosis; Vancomycin | 1994 |
Catheter-related endocarditis due to glycopeptide-resistant Enterococcus faecalis in a transplanted heart.
Topics: Adult; Catheterization, Central Venous; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Heart; Heart Transplantation; Humans; Male; Middle Aged; Vancomycin | 1993 |
Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 1993 |
Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
Topics: Ampicillin Resistance; Animals; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Rifampin; Vancomycin | 1993 |
[Therapy of resistant gram-positive infection: value of glycopeptide antibiotics vancomycin and teicoplanin].
Topics: Drug Resistance, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Half-Life; Humans; Teicoplanin; Vancomycin | 1993 |
Endocarditis after ciprofloxacin therapy for enterococcal pyelonephritis with bacteremia.
Topics: Aged; Bacteremia; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pyelonephritis; Vancomycin | 1993 |
Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states.
Topics: Bacterial Typing Techniques; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Illinois; Michigan; Plasmids; Species Specificity; Vancomycin | 1993 |
Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin.
Topics: Aged; Analysis of Variance; Chi-Square Distribution; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Infection Control; Intensive Care Units; Male; Microbial Sensitivity Tests; Penicillin Resistance; Restriction Mapping; Risk Factors; Vancomycin | 1993 |
In-vitro synergy and mechanism of interaction between vancomycin and ciprofloxacin against enterococcal isolates.
Topics: Bacterial Outer Membrane Proteins; Cell Membrane; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Electrophoresis, Polyacrylamide Gel; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Weight; Vancomycin | 1993 |
Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; United States; Vancomycin | 1993 |
Levels of vancomycin in aqueous humor after topical eye drops administration.
Topics: Anterior Eye Segment; Aqueous Humor; Biological Availability; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Ophthalmic Solutions; Vancomycin | 1993 |
Frequency and antimicrobial susceptibility of clinical isolates of enterococci.
Topics: Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 1993 |
Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin-and glycopeptide-resistant isolate of Enterococcus faecium.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Rabbits; Vancomycin | 1993 |
Increasing problems in the therapy of enterococcal infections.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gentamicins; Gram-Positive Bacterial Infections; Humans; Penicillin Resistance; Species Specificity; Vancomycin | 1993 |
Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
Topics: Ampicillin; Animals; Aortic Valve; beta-Lactamases; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Rabbits; Sulbactam; Vancomycin | 1993 |
Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.
Topics: Alanine; Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Chromosome Inversion; Conjugation, Genetic; DNA Transposable Elements; Drug Resistance, Microbial; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Lactates; Molecular Sequence Data; Mutagenesis, Insertional; Nucleotidyltransferases; Open Reading Frames; Plasmids; Repetitive Sequences, Nucleic Acid; Replicon; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Transposases; Vancomycin | 1993 |
From the Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; United States; Vancomycin | 1993 |
Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
Topics: Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Models, Biological; Regression Analysis; Retrospective Studies; Vancomycin | 1993 |
In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate.
Topics: Bacterial Proteins; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infant; Middle Aged; Teicoplanin; Vancomycin | 1993 |
In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Depsipeptides; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Oxacillin; Peptides, Cyclic; Teicoplanin; Vancomycin | 1993 |
Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci.
Topics: Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; New York City; Vancomycin | 1993 |
Vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1995 |
Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy.
Topics: Aged; Aged, 80 and over; DNA, Bacterial; Enterococcus faecium; Enterocolitis, Pseudomembranous; Feces; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Vancomycin | 1995 |
Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Hospitals; Humans; Infant, Newborn; Intestinal Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Risk Factors; Vancomycin | 1995 |
Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Chromosomes, Bacterial; Cloning, Molecular; Conjugation, Genetic; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Molecular Sequence Data; New York; Nucleic Acid Hybridization; Plasmids; Restriction Mapping; Vancomycin | 1995 |
Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Staphylococcus; Streptococcus; Vancomycin | 1995 |
Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas.
Topics: Anti-Bacterial Agents; Case-Control Studies; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Molecular Epidemiology; Phenotype; Risk Factors; Texas; Vancomycin | 1995 |
Vancomycin resistant enterococci in hospitals in the United Kingdom.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Incidence; United Kingdom; Vancomycin | 1995 |
Assessment of testing for and completeness of reporting of vancomycin-resistant enterococci--Connecticut, 1994.
Topics: Anti-Bacterial Agents; Connecticut; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 1996 |
Controlling vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; DNA Fingerprinting; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Prospective Studies; Seroepidemiologic Studies; United States; Vancomycin | 1995 |
From the Centers for Disease Control and Prevention. Assessment of testing for and completeness of reporting of vancomycin-resistant enterococci--Connecticut, 1994.
Topics: Anti-Bacterial Agents; Connecticut; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 1996 |
Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci.
Topics: Administration, Oral; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Vancomycin | 1996 |
Use of vancomycin in central venous catheter-related infections.
Topics: Bone Marrow Transplantation; Catheterization, Central Venous; Drug Evaluation; Drug Utilization; Equipment Contamination; Gram-Positive Bacterial Infections; Humans; Incidence; Staphylococcal Infections; Vancomycin | 1996 |
Vancomycin-resistant enterococci. The 'superbug' scourge that's coming your way.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Risk Factors; Vancomycin | 1996 |
Increased bactericidal activity as documented by serum bactericidal titers for a triple combination of cell wall active agents against gentamicin-resistant enterococci.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Imipenem; Penicillins; Serum Bactericidal Test; Thienamycins; Vancomycin | 1995 |
Bloodstream infections with vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Immunocompromised Host; Male; Middle Aged; Retrospective Studies; Vancomycin | 1996 |
Vancomycin-resistant enterococci: pervasive and persistent pathogens.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; United States; Vancomycin | 1995 |
Natural history of colonization with vancomycin-resistant Enterococcus faecium.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cross Infection; DNA Fingerprinting; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Middle Aged; Neoplasms; New York; Oncology Service, Hospital; Patient Isolation; Prevalence; Urinary Tract Infections; Vancomycin | 1995 |
[Two cases of gram-positive sepsis successfully treated with vancomycin in combination with imipenem or cilastatin].
Topics: Adolescent; Cilastatin; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Sepsis; Vancomycin | 1996 |
Protecting your patients from VRE.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infection Control; Intensive Care Units; Surgical Wound Infection; Vancomycin | 1996 |
Vancomycin-dependent Enterococci: a clinical and laboratory assessment.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Phenotype; Vancomycin | 1995 |
Practical management of patients infected with resistant organisms: an infection control perspective.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecium; Gloves, Protective; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 100 to 299; Hospitals, University; Humans; Microbial Sensitivity Tests; Rhode Island; Vancomycin | 1995 |
Antibiotic-resistant endocarditis in a hemodialysis patient.
Topics: Ampicillin; Bacteremia; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Teicoplanin; Vancomycin | 1996 |
Control of endemic glycopeptide-resistant enterococci.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Kidney Diseases; Male; Middle Aged; Prevalence; Prospective Studies; Vancomycin | 1996 |
Random amplified polymorphic DNA typing versus pulsed-field gel electrophoresis for epidemiological typing of vancomycin-resistant enterococci.
Topics: Bacterial Typing Techniques; Base Sequence; Cross Infection; Disease Outbreaks; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Evaluation Studies as Topic; France; Gram-Positive Bacterial Infections; Humans; Molecular Epidemiology; Molecular Sequence Data; Random Amplified Polymorphic DNA Technique; Vancomycin | 1996 |
Use of vancomycin in dialysis patients.
Topics: Anti-Bacterial Agents; Bacteremia; Endocarditis; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Renal Dialysis; Vancomycin | 1996 |
Household transmission of vancomycin-resistant Enterococcus faecium.
Topics: Aged; Drug Resistance, Microbial; Enterococcus faecium; Family Health; Female; Gram-Positive Bacterial Infections; Humans; Male; Vancomycin | 1995 |
Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Bacitracin; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Treatment Outcome; Vancomycin | 1995 |
Vancomycin-resistant enterococci at a large university hospital in Denmark.
Topics: Cross Infection; Denmark; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Vancomycin | 1996 |
Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditis.
Topics: Animals; Anti-Bacterial Agents; Aortic Diseases; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rabbits; Streptomycin; Teicoplanin; Vancomycin | 1996 |
Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital.
Topics: Ampicillin Resistance; Analysis of Variance; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Incidence; Logistic Models; North Carolina; Odds Ratio; Prevalence; Prospective Studies; Risk Factors; Vancomycin | 1996 |
Vancomycin-resistant enterococci on a renal ward in an Ontario hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Male; Middle Aged; Nephrology; Ontario; Vancomycin | 1996 |
Vancomycin resistant enterococci in hospitals in the United Kingdom--1995.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Incidence; United Kingdom; Vancomycin | 1996 |
Vancomycin-resistant Enterococcus in the Singapore National Burns Centre: a case report.
Topics: Accidents, Home; Burn Units; Burns; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Male; Vancomycin | 1996 |
Selective medium for screening for vancomycin-resistant enterococci in faeces.
Topics: Anti-Bacterial Agents; Culture Media; Drug Resistance, Microbial; Enterococcus; Feces; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 1996 |
Limiting vancomycin use to combat vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Utilization Review; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 300 to 499; Hospitals, Teaching; Humans; Infection Control; Massachusetts; Organizational Policy; Pharmacy Service, Hospital; Practice Patterns, Physicians'; Vancomycin | 1996 |
Selective isolation of vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Cross Infection; Culture Media; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1996 |
Vancomycin-resistant Enterococcus faecalis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; New South Wales; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1996 |
Vancomycin-resistant Enterococcus faecium colonisations.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Candidiasis, Oral; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Male; Mycobacterium avium-intracellulare Infection; Vancomycin | 1996 |
Vancomycin-resistant Aureobacterium species cellulitis and bacteremia in a patient with acute myelogenous leukemia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Cellulitis; Drug Resistance, Microbial; Gram-Positive Asporogenous Rods; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Male; Microbial Sensitivity Tests; Vancomycin | 1996 |
Evaluation of commercial vancomycin agar screen plates for detection of vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Culture Media; Drug Resistance, Microbial; Enterococcus; Evaluation Studies as Topic; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 1996 |
Vancomycin-resistant enterococcus: case reviews after transplantation.
Topics: Adult; Anti-Bacterial Agents; Clinical Protocols; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Male; Middle Aged; Organ Transplantation; Vancomycin | 1996 |
Investigation of an outbreak of vancomycin-resistant Enterococcus faecium by random amplified polymorphic DNA (RAPD) assay.
Topics: Adult; Anti-Bacterial Agents; Base Sequence; Child; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Infection Control; Microbial Sensitivity Tests; Molecular Sequence Data; Random Amplified Polymorphic DNA Technique; Vancomycin | 1996 |
Screening patients for glycopeptide-resistant enterococci.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infection Control; Mass Screening; Vancomycin | 1996 |
Streptococcus faecalis disc space infection following transurethral resection of prostate.
Topics: Aged; Anti-Bacterial Agents; Biopsy, Needle; Enterococcus faecalis; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Intervertebral Disc; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Prostatectomy; Prostatic Hyperplasia; Radiography; Spinal Diseases; Vancomycin | 1996 |
Surgical Infection Society position on vancomycin-resistant Enterococcus.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin | 1996 |
Use of in-house studies of molecular epidemiology and full species identification for controlling spread of vancomycin-resistant Enterococcus faecalis isolates.
Topics: Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Vancomycin | 1996 |
In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against gram-positive clinical isolates from cancer patients.
Topics: Anti-Bacterial Agents; Depsipeptides; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Teicoplanin; Vancomycin | 1996 |
Neonatal enterococcal bacteremia: an increasingly frequent event with potentially untreatable pathogens.
Topics: Age Factors; Bacteremia; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; Vancomycin | 1996 |
Infections due to drug-resistant pneumococci, enterococci, and Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Mycobacterium tuberculosis; Pneumococcal Infections; Streptococcus pneumoniae; Tuberculosis, Multidrug-Resistant; Vancomycin | 1996 |
Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci.
Topics: Adult; Aged; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Vancomycin | 1996 |
Once-versus thrice-daily netilmicin combined with amoxicillin, penicillin, or vancomycin against Enterococcus faecalis in a pharmacodynamic in vitro model.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Computer Simulation; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Half-Life; Humans; Netilmicin; Penicillins; Vancomycin | 1996 |
When normal flora turn nasty.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1996 |
Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection.
Topics: Anti-Bacterial Agents; Carrier State; Child; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Oncology Service, Hospital; Risk Factors; Vancomycin | 1996 |
Pseudo-outbreak of Enterococcus durans infections and colonization associated with introduction of an automated identification system software update.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cross Infection; Diagnostic Errors; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Software; Species Specificity; United States; Vancomycin | 1996 |
Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality.
Topics: Anti-Bacterial Agents; Case-Control Studies; Chloramphenicol; Cross Infection; DNA, Bacterial; Doxycycline; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Intensive Care Units; Length of Stay; Liver Transplantation; Male; Regression Analysis; Renal Dialysis; Risk Factors; Vancomycin | 1996 |
Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Drug-Related Side Effects and Adverse Reactions; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Infant; Infant, Newborn; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Risk Factors; Vancomycin | 1996 |
Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci.
Topics: Ampicillin; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Gastrointestinal Diseases; Gram-Positive Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam; Vancomycin | 1996 |
Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit.
Topics: Adult; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; England; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Leukemia; Male; Middle Aged; Vancomycin | 1996 |
Heat and chemical resistance of enterococci.
Topics: Alcohols; Chlorine; Cross Infection; Disinfectants; Disinfection; Drug Resistance, Microbial; Enterococcus; Glutaral; Gram-Positive Bacterial Infections; Hot Temperature; Humans; Vancomycin | 1996 |
Vancomycin-dependent Enterococcus faecalis.
Topics: Anti-Bacterial Agents; Bacteremia; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Vancomycin | 1996 |
The treatment and control of vancomycin resistant enterococci.
Topics: Animals; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Practice Guidelines as Topic; Risk Factors; Vancomycin | 1996 |
Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci.
Topics: Adult; Anti-Bacterial Agents; Cross Infection; Digestive System; Enterococcus; Environmental Microbiology; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; Respiration, Artificial; Skin; Vancomycin | 1996 |
Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species.
Topics: Anti-Bacterial Agents; Drug Combinations; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Vancomycin; Virginiamycin | 1996 |
Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Resistance, Multiple; Echocardiography; Enterococcus faecium; Gram-Positive Bacterial Infections; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1997 |
Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Coronary Artery Bypass; Diabetes Mellitus, Type 1; Drug Hypersensitivity; Endocarditis; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus; Superinfection; Vancomycin; Virginiamycin; Wound Infection | 1997 |
Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide.
Topics: Algorithms; Bacterial Infections; Boston; Cross Infection; Developed Countries; Developing Countries; Drug Resistance, Microbial; Enterococcus; Global Health; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Vancomycin | 1997 |
Clinical isolation of vancomycin-resistant Enterococcus faecalis in Taiwan.
Topics: Aged; Bacteremia; Drug Resistance, Microbial; Enterococcus faecalis; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Pneumonia, Bacterial; Polymerase Chain Reaction; Serotyping; Sputum; Vancomycin | 1996 |
Clonal dissemination and colony morphotype variation of vancomycin-resistant Enterococcus faecium isolates in metropolitan Detroit, Michigan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Carbon-Oxygen Ligases; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Ligases; Michigan; Phenotype; Polymerase Chain Reaction; Vancomycin | 1997 |
Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Microbial; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Recovery Room; Retrospective Studies; Vancomycin | 1997 |
Vancomycin-resistant gram-positive cocci: risk factors for faecal carriage.
Topics: Aged; Anti-Bacterial Agents; Carrier State; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Feces; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Length of Stay; Male; Risk Factors; Vancomycin | 1997 |
Avoparcin ban.
Topics: Animal Diseases; Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Europe; Glycopeptides; Gram-Positive Bacterial Infections; Legislation, Drug; Legislation, Veterinary; Vancomycin | 1997 |
Vancomycin-dependent enterococcus.
Topics: Anti-Bacterial Agents; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1997 |
[Vancomycin-resistant enterococci . Work Group Hospital Infection Epidemiology].
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1997 |
Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; Base Sequence; Carbon-Oxygen Ligases; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus; Evaluation Studies as Topic; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Ligases; Molecular Sequence Data; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Species Specificity; Vancomycin | 1997 |
Incidence and detection of multi-drug-resistant enterococci in Dublin hospitals.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Bacteremia; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Feces; Gentamicins; Gram-Positive Bacterial Infections; Humans; Incidence; Ireland; Microbial Sensitivity Tests; R Factors; Teicoplanin; Vancomycin | 1997 |
Are glycopeptide-resistant enterococci in animals a threat to human beings?
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; European Union; Femoral Fractures; Fracture Fixation, Intramedullary; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Occupational Diseases; Poultry; Vancomycin; Wound Infection | 1997 |
Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Leukemia, Promyelocytic, Acute; Male; Recurrence; Vancomycin | 1997 |
Vancomycin resistance and mortality associated with enterococcal bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1997 |
Do low vancomycine serum levels predict failures of vancomycine therapy in neutropenic cancer patients?
Topics: Anti-Bacterial Agents; Bacteremia; Gram-Positive Bacterial Infections; Humans; Neoplasms; Neutropenia; Retrospective Studies; Treatment Failure; Vancomycin | 1996 |
Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals; Humans; Male; Middle Aged; Rectum; Skin; Vancomycin | 1997 |
Vancomycin-resistant Enterococcus faecium shunt infection in an infant: an antibiotic cure.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infant; Postoperative Complications; Vancomycin; Ventriculoperitoneal Shunt | 1995 |
Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Blotting, Southern; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Enterococcus faecalis; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Ligases; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Plasmids; Polymerase Chain Reaction; Vancomycin | 1996 |
Serious infections caused by multiply-resistant Enterococcus faecium.
Topics: Abdomen; Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Multiple; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Immunocompetence; Liver Transplantation; Male; Recurrence; Sepsis; Vancomycin | 1995 |
Quinupristin/dalfopristin (RP 59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: case report.
Topics: Anti-Bacterial Agents; Arteries; Coronary Artery Bypass; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Vancomycin; Virginiamycin | 1995 |
Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium.
Topics: Aged; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteremia; Diabetes Complications; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Liver Transplantation; Male; Microbial Sensitivity Tests; Penicillins; Vancomycin | 1995 |
Multiplicity of genetic backgrounds among vancomycin-resistant Enterococcus faecium isolates recovered from an outbreak in a New York City hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Blotting, Southern; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA Probes; Drug Resistance, Multiple; Electrophoresis, Polyacrylamide Gel; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Ligases; New York City; Plasmids; Vancomycin | 1996 |
In vitro activity of RP 59500 (quinupristin/dalfopristin) and ramoplanin against vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Depsipeptides; Drug Resistance, Microbial; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Kinetics; Microbial Sensitivity Tests; Peptides, Cyclic; Phenotype; Vancomycin; Virginiamycin | 1995 |
Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Clindamycin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Length of Stay; Male; Massachusetts; Middle Aged; Prospective Studies; Risk Factors; Vancomycin | 1997 |
Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactam Resistance; Cross Infection; Disease Outbreaks; Drug Costs; Drug Prescriptions; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecium; Fever; Follow-Up Studies; Gram-Positive Bacterial Infections; Hospital Administration; Hospital Costs; Hospital Departments; Humans; Medical Audit; Neutropenia; Outcome Assessment, Health Care; Pediatrics; Pharmacology, Clinical; Pharmacy Service, Hospital; Policy Making; Practice Patterns, Physicians'; Surgery Department, Hospital; Surgical Procedures, Operative; Vancomycin | 1997 |
Inter-hospital spread of vancomycin-resistant Enterococcus faecium.
Topics: Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infection Control; Patient Transfer; United Kingdom; Vancomycin | 1997 |
Control of vancomycin-resistant enterococcus.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gloves, Protective; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Protective Clothing; Rectal Diseases; Vancomycin | 1997 |
[Asymptomatic carriers of vancomycin-resistant enterococci in France. Study in an ambulatory population of young subjects].
Topics: Adult; Carrier State; Drug Resistance, Microbial; Enterococcus; France; Gram-Positive Bacterial Infections; Humans; Male; Vancomycin | 1997 |
Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Chickens; Cohort Studies; Denmark; Disease Susceptibility; Drug Resistance, Microbial; Enterococcus faecium; Female; Glycopeptides; Gram-Positive Bacterial Infections; Growth Substances; Male; Poultry; Poultry Diseases; Retrospective Studies; Specific Pathogen-Free Organisms; Swine; Swine Diseases; Vancomycin | 1997 |
Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Prosthesis-Related Infections; Vancomycin; Virginiamycin | 1997 |
Successful use of tetracycline as therapy of an immunocompromised patient with septicaemia caused by a vancomycin-resistant enterococcus.
Topics: Bacteremia; Bone Marrow Transplantation; Child; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Male; Tetracycline; Vancomycin | 1997 |
Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Ligases; Male; Middle Aged; Polymerase Chain Reaction; Sweden; Vancomycin | 1997 |
[Vancomycin resistant enterococci in Austria].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Austria; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Female; Genotype; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Polymerase Chain Reaction; Vancomycin | 1997 |
Leuconostoc bacteremia after liver transplantation: another cause of vancomycin resistant gram-positive infection.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Clindamycin; Debridement; Drug Resistance, Microbial; Fatal Outcome; Fever; Follow-Up Studies; Gentamicins; Gram-Positive Bacterial Infections; Humans; Leuconostoc; Liver Transplantation; Male; Peritonitis; Streptococcal Infections; Vancomycin | 1997 |
Detection of vancomycin-resistant enterococci in fecal samples by PCR.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus; Feces; Gram-Positive Bacterial Infections; Humans; Ligases; Polymerase Chain Reaction; Sensitivity and Specificity; Vancomycin | 1997 |
Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; DNA Probes; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Ligases; Microbial Sensitivity Tests; Molecular Epidemiology; Nucleic Acid Hybridization; Ohio; Polymerase Chain Reaction; Prospective Studies; Vancomycin | 1997 |
Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Humans; Metronidazole; Vancomycin | 1997 |
Are clinical laboratories in California accurately reporting vancomycin-resistant enterococci?
Topics: Ampicillin; California; Disease Notification; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Laboratories; Microbial Sensitivity Tests; Observer Variation; Penicillins; Population Surveillance; Reproducibility of Results; Sensitivity and Specificity; Vancomycin | 1997 |
Screening for vancomycin-resistant gram-positive cocci.
Topics: Anti-Bacterial Agents; Carrier State; Culture Media; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Infection Control; Mass Screening; R Factors; Vancomycin | 1997 |
Isolation of vancomycin-resistant enterococci from supermarket poultry.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Chickens; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Gram-Positive Bacterial Infections; Humans; London; Opportunistic Infections; Teicoplanin; Vancomycin | 1997 |
Epidemiology of vancomycin-resistant Enterococcus faecium infections in a liver transplant unit.
Topics: Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Liver Transplantation; London; Molecular Epidemiology; Opportunistic Infections; Vancomycin | 1997 |
The in-vitro activity of LY333328, a new glycopeptide, against clinical isolates of vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Lipoglycopeptides; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 1997 |
In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Glycopeptides; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 1997 |
[Antibiotic resistance of enterococci in Germany].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Germany; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 1997 |
Epidemiology and control of vancomycin-resistant enterococci in an adult and children's hospital.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, Special; Humans; Incidence; Infection Control; Male; Microbial Sensitivity Tests; New York; Risk Factors; Species Specificity; Vancomycin | 1997 |
Arrangement of the vanA gene cluster in enterococci of different ecological origin.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Carbon-Oxygen Ligases; DNA Primers; DNA Transposable Elements; Drug Resistance, Microbial; Ecosystem; Enterococcus; Enterococcus faecium; Feces; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Meat; Multigene Family; Polymerase Chain Reaction; Sewage; Vancomycin | 1997 |
Staphylococcal scalded skin syndrome in a liver transplant patient.
Topics: Anti-Bacterial Agents; Biopsy; Enterococcus faecium; Fatal Outcome; Gram-Positive Bacterial Infections; Humans; Liver Abscess; Liver Transplantation; Male; Middle Aged; Skin; Staphylococcal Scalded Skin Syndrome; Staphylococcus aureus; Streptococcal Infections; Trachea; Vancomycin | 1997 |
Natural history of colonization with vancomycin-resistant Enterococcus faecium.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enteritis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Vancomycin | 1997 |
Strains of glycopeptide-resistant Enterococcus faecium can alter their van genotypes during an outbreak.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multigene Family; Plasmids; Teicoplanin; Vancomycin | 1997 |
Probiotics and prebiotics in the treatment of infections due to vancomycin-dependent Enterococcus faecalis and of imbalance of the intestinal ecosystem (dysbiosis)
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Intestines; Probiotics; Vancomycin | 1997 |
Lactobacillus species as emerging pathogens in neutropenic patients.
Topics: Adult; Ceftazidime; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Lactobacillus; Male; Middle Aged; Neutropenia; Opportunistic Infections; Penicillins; Vancomycin | 1997 |
In vitro susceptibility studies and detection of vancomycin resistance genes in clinical isolates of enterococci in Nagasaki, Japan.
Topics: Anti-Bacterial Agents; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus; Genotype; Gram-Positive Bacterial Infections; Humans; Incidence; Infection Control; Japan; Microbial Sensitivity Tests; Polymerase Chain Reaction; Urban Health; Vancomycin | 1997 |
Vancomycin resistance.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Genotype; Gram-Positive Bacterial Infections; Humans; Staphylococcal Infections; Staphylococcus; Vancomycin | 1997 |
Antibiotic resistance. Epidemiology of resistance in intensive therapy units (ITUs).
Topics: 4-Quinolones; Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enzyme Induction; Gram-Negative Bacteria; Gram-Positive Bacterial Infections; Humans; Incidence; Intensive Care Units; Methicillin Resistance; Mutation; Prevalence; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; United Kingdom; Vancomycin | 1997 |
Epidemiological study of hospital-acquired infection with vancomycin-resistant Enterococcus faecium: possible transmission by an electronic ear-probe thermometer.
Topics: Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Equipment Contamination; Gram-Positive Bacterial Infections; Hospitals, Community; Hospitals, Teaching; Humans; Thermometers; Vancomycin | 1997 |
Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; Carrier State; Community-Acquired Infections; Cross Infection; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Genotype; Gram-Positive Bacterial Infections; Humans; Netherlands; Polymerase Chain Reaction; Vancomycin | 1997 |
Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype)
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Carrier State; Case-Control Studies; Cross Infection; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Molecular Epidemiology; Ontario; Polymerase Chain Reaction; Prospective Studies; Vancomycin | 1997 |
Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin.
Topics: Agar; Anti-Bacterial Agents; Culture Media; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Evaluation Studies as Topic; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Phenotype; Vancomycin | 1997 |
In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin | 1997 |
Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia.
Topics: Acute Disease; Bacteremia; Clostridioides difficile; Cohort Studies; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Leukemia; Male; Middle Aged; Neutropenia; Risk Factors; Vancomycin | 1997 |
An outbreak of vancomycin-resistant Enterococcus faecium in liver transplant recipients.
Topics: Adolescent; Adult; Aged; Bacteremia; Case-Control Studies; Child; Child, Preschool; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Liver Transplantation; Middle Aged; Risk Factors; Vancomycin | 1997 |
Vancomycin-resistant enterococcus.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Neoplasms; Oncology Nursing; Vancomycin | 1997 |
Managing vancomycin-resistant enterococci. A winning team approach.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Patient Care Team; Vancomycin | 1997 |
Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation.
Topics: Adolescent; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Colony Count, Microbial; Confidence Intervals; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Male; Mass Screening; Odds Ratio; Oncology Service, Hospital; Risk Factors; Vancomycin | 1998 |
Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients.
Topics: Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Enterococcus faecium; Genetic Variation; Genome, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Population Surveillance; Prevalence; Vancomycin | 1998 |
Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Chromosome Mapping; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Europe; Gene Transfer, Horizontal; Gram-Positive Bacterial Infections; Humans; Molecular Epidemiology; Mutagenesis, Insertional; Nucleic Acid Hybridization; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Serine-Type D-Ala-D-Ala Carboxypeptidase; United States; Vancomycin | 1998 |
Emergence of vancomycin-resistant enterococci in South Africa.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; South Africa; Vancomycin | 1997 |
Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Europe; Gram-Positive Bacterial Infections; Humans; Italy; Microbial Sensitivity Tests; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1997 |
Vancomycin-resistant Enterococcus faecium in a long-term care facility.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, Veterans; Humans; Long-Term Care; Male; Prevalence; Vancomycin | 1998 |
VRE, MRSA, PRP, and DRGNB in LTCF: lessons to be learned from this alphabet.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Long-Term Care; Vancomycin | 1998 |
Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Child; Drug Resistance, Microbial; Enterococcus; Gallbladder Diseases; Gram-Positive Bacterial Infections; Humans; Incidence; Liver Transplantation; Postoperative Complications; Renal Insufficiency; Respiratory Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 1998 |
Rapid increase in the prevalence of antimicrobial drug resistance among enterococcal blood isolates in southern Israel.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Blood; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Israel; Penicillins; Prevalence; Vancomycin | 1997 |
Vancomycin-resistant Enterococcus faecium in a Veterans Affairs Medical Center: association with antibiotic usage.
Topics: Analysis of Variance; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Units; Hospitals, Veterans; Humans; Incidence; Infection Control; New Jersey; Regression Analysis; Retrospective Studies; Vancomycin | 1998 |
Enterococcus faecium bacteremia: does vancomycin resistance make a difference?
Topics: Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 1998 |
Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin Resistance; Anti-Bacterial Agents; Carrier State; Community-Acquired Infections; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Feces; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Vancomycin | 1998 |
Vancomycin-resistant enterococci: an emerging health problem.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; United States; Vancomycin | 1997 |
Vancomycin-resistant enterococci: improving treatments.
Topics: Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Utilization; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Vancomycin | 1997 |
Transmission of vancomycin-resistant enterococcus among family members: a case study.
Topics: Community-Acquired Infections; Drug Resistance, Microbial; Enterococcus; Family Health; Female; Gastrointestinal Diseases; Gram-Positive Bacterial Infections; Humans; Middle Aged; Vancomycin | 1998 |
An investigation of vancomycin-resistant Enterococcus faecium within the pediatric service of a large urban medical center.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Intensive Care Units, Pediatric; Vancomycin | 1998 |
Enterococci: susceptibility, resistance, and now dependence on vancomycin.
Topics: Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1998 |
Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Working Party of the British Society for Antimicrobial Chemotherapy.
Topics: Anti-Bacterial Agents; Endocarditis, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Heart Valve Prosthesis; Humans; Microbial Sensitivity Tests; Penicillin G; Prosthesis-Related Infections; Staphylococcal Infections; Streptococcal Infections; Vancomycin | 1998 |
[Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].
Topics: Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriuria; beta-Lactamases; Child; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Penicillin Resistance; Penicillins; Streptomycin; Urinary Tract Infections; Vancomycin | 1998 |
[First infection with vancomycin resistant type VanA enterococci in a Norwegian hospital].
Topics: Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Phenotype; Vancomycin | 1998 |
High-level aminoglycoside-resistant enterococcus causing endocarditis successfully treated with a combination of ampicillin, imipenem and vancomycin.
Topics: Adult; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Treatment Outcome; Vancomycin | 1997 |
Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens.
Topics: Anti-Bacterial Agents; Coagulase; DNA, Bacterial; DNA, Recombinant; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Nisin; Penicillin Resistance; Species Specificity; Staphylococcus; Streptococcus pneumoniae; Transformation, Bacterial; Vancomycin | 1998 |
Clonal dissemination of vancomycin-resistant Enterococci and comparison of susceptibility testing methods.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Streptomycin; Vancomycin | 1998 |
[Nursing care plans for renal hospitalized patients infected with antibiotic resistant enterococci].
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infection Control; Kidney Diseases; Patient Care Planning; Vancomycin | 1998 |
Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Metronidazole; Middle Aged; Multivariate Analysis; Risk Factors; Vancomycin | 1998 |
Number of centers reporting VRE cases in 1996 doubled. CDC survey also shows tuberculosis reappearing.
Topics: Anti-Bacterial Agents; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Population Surveillance; Renal Dialysis; Tuberculosis; United States; Vancomycin | 1998 |
Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Cross Infection; Disinfection; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Patients' Rooms; United States; Vancomycin | 1998 |
Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 300 to 499; Hospitals, Community; Humans; Incidence; Poisson Distribution; Thermometers; United States; Vancomycin | 1998 |
Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Cost-Benefit Analysis; Drug Resistance, Microbial; Female; Fever; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; Vancomycin | 1998 |
Guidelines for the management of patients colonized or infected with vancomycin-resistant enterococci.
Topics: Bacteremia; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Patient Isolation; Practice Guidelines as Topic; Vancomycin | 1998 |
Peritonitis associated with vancomycin-resistant Lactobacillus rhamnosus in a continuous ambulatory peritoneal dialysis patient: organism identification, antibiotic therapy, and case report.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Lactobacillus; Male; Microbial Sensitivity Tests; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Teicoplanin; Vancomycin | 1998 |
First known outbreak of colonizing vancomycin-resistant enterococci in Quebec.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Quebec; Vancomycin | 1998 |
Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection.
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Injections, Intraventricular; Male; Vancomycin; Ventriculoperitoneal Shunt; Virginiamycin | 1998 |
Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in The Netherlands.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Chickens; Chromosome Mapping; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Gram-Positive Bacterial Infections; Hospitalization; Humans; Meat; Microbial Sensitivity Tests; Netherlands; Phylogeny; Polymerase Chain Reaction; Vancomycin | 1998 |
Genetic analysis of multiple vancomycin-resistant Enterococcus isolates obtained serially from two long-term-care patients.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Long-Term Care; Male; Middle Aged; Nucleic Acid Hybridization; Plasmids; Polymerase Chain Reaction; Vancomycin | 1998 |
Penicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of beta-lactam resistance.
Topics: Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Bacterial Proteins; beta-Lactam Resistance; Carrier Proteins; Drug Resistance, Microbial; Enterococcus faecium; Genetic Variation; Gram-Positive Bacterial Infections; Hexosyltransferases; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Muramoylpentapeptide Carboxypeptidase; Penicillin G; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Piperacillin; Sequence Homology, Amino Acid; Vancomycin | 1998 |
Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates.
Topics: Anti-Bacterial Agents; Australia; Bacterial Proteins; Bacterial Typing Techniques; Carbon-Oxygen Ligases; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Phenotype; Polymerase Chain Reaction; Teicoplanin; Vancomycin | 1998 |
Screening of stool samples for identification of vancomycin-resistant Enterococcus isolates should include the methyl-alpha-D-glucopyranoside test to differentiate nonmotile Enterococcus gallinarum from E. faecium.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; DNA, Ribosomal; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Feces; Gram-Positive Bacterial Infections; Humans; Methylglucosides; Molecular Sequence Data; RNA, Ribosomal, 16S; Species Specificity; Vancomycin | 1998 |
[Infectious endocarditis caused by Leuconostoc mesenteroides].
Topics: Aged; Anti-Bacterial Agents; Cardiomyopathy, Dilated; Drug Resistance, Microbial; Endocarditis, Bacterial; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Leuconostoc; Prosthesis Failure; Prosthesis-Related Infections; Rheumatic Heart Disease; Species Specificity; Vancomycin; Virulence | 1998 |
The specter of glycopeptide resistance: current trends and future considerations.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1998 |
A guide to TB, VRE, and MRSA.
Topics: Anti-Bacterial Agents; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Methicillin Resistance; Staphylococcal Infections; Tuberculosis, Pulmonary; United States; Vancomycin | 1998 |
Vancomycin-resistant enterococcal infections in bone marrow transplant recipients.
Topics: Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Transplantation, Homologous; Vancomycin | 1998 |
Colonization with vancomycin-resistant enterococci in chronic hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Colony Count, Microbial; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Odds Ratio; Population Surveillance; Prevalence; Proportional Hazards Models; Renal Dialysis; Risk Factors; Vancomycin | 1998 |
Resistance of enterococci to ampicillin and glycopeptide antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Italy; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 1998 |
[Aneurysm of the anterior mitral valve in a case of aortic endocarditis in a patient with ulcerative colitis].
Topics: Adult; Aneurysm, Infected; Anti-Bacterial Agents; Aortic Valve; Aortic Valve Insufficiency; Colitis, Ulcerative; Echocardiography; Endocarditis, Bacterial; Enterococcus faecium; Follow-Up Studies; Gram-Positive Bacterial Infections; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve; Mitral Valve Insufficiency; Penicillins; Time Factors; Vancomycin | 1998 |
Antibiotic resistance among enterococci causing endocarditis in the UK: analysis of isolates referred to a reference laboratory.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Streptomycin; Teicoplanin; Vancomycin | 1998 |
Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin.
Topics: Ambulatory Care; Anti-Bacterial Agents; Bacteremia; Cefazolin; Cephalosporins; Drug Therapy, Combination; Enterococcus; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Metabolic Clearance Rate; Methicillin Resistance; Microbial Sensitivity Tests; Renal Dialysis; Staphylococcus; Vancomycin; Wound Infection | 1998 |
Vancomycin-resistant enterococcus in end-stage renal disease.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple; Enterococcus; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Microbial Sensitivity Tests; Peritoneal Dialysis; Prospective Studies; Renal Dialysis; Risk Factors; Treatment Outcome; Vancomycin | 1998 |
Spread of vancomycin-resistant enterococci: differences between the United States and Europe.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Cross Infection; Disease Vectors; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Europe; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Practice Patterns, Physicians'; Prevalence; United States; Vancomycin | 1998 |
[Vancomycin-resistant enterococci in pediatric hematology: don't panic!].
Topics: Amikacin; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow Transplantation; Carrier State; Catheterization, Central Venous; Child; Decontamination; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Equipment Contamination; Feces; France; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Home Nursing; Hospitalization; Humans; Hygiene; Imipenem; Immunocompromised Host; Mouth; Mouthwashes; Piperacillin; Premedication; Prospective Studies; Transplantation Conditioning; Vancomycin | 1998 |
Molecular analysis of glycopeptide-resistant Enterococcus faecium isolates collected from Michigan hospitals over a 6-year period.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gene Transfer Techniques; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Michigan; Molecular Epidemiology; Nucleic Acid Hybridization; Plasmids; Vancomycin | 1998 |
Comparison of genomic methods for differentiating strains of Enterococcus faecium: assessment using clinical epidemiologic data.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Chicago; Cross Infection; Deoxyribonuclease HindIII; Deoxyribonucleases, Type II Site-Specific; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Genetic Techniques; Gram-Positive Bacterial Infections; Humans; Infection Control; Molecular Epidemiology; Prohibitins; Vancomycin | 1998 |
Determination of 16S rRNA sequences of enterococci and application to species identification of nonmotile Enterococcus gallinarum isolates.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; Cell Movement; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Molecular Sequence Data; Phylogeny; RNA, Bacterial; RNA, Ribosomal, 16S; Sequence Homology, Amino Acid; Species Specificity; Vancomycin; Virulence | 1998 |
Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 300 to 499; Hospital Costs; Hospitals, University; Humans; Incidence; Infection Control; Massachusetts; Program Evaluation; Protective Clothing; Vancomycin | 1998 |
Control of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus in hospitalized children.
Topics: Anti-Bacterial Agents; Carrier State; Child; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1998 |
Epidemiology and control of vancomycin-resistant enterococci (VRE) in a renal unit.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Hemodialysis Units, Hospital; Humans; Infection Control; Kidney Diseases; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Scotland; Vancomycin | 1998 |
Observations on the risk of resistance with the extended use of vancomycin.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Burns; Cross Infection; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Infection Control; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Vancomycin; Wound Infection | 1998 |
VRE: pay attention to your mom.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Hand Disinfection; Humans; Vancomycin | 1998 |
In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1998 |
Emergence and epidemiology of vancomycin-resistant enterococci in Australia.
Topics: Anti-Bacterial Agents; Australia; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Phenotype; Population Surveillance; Vancomycin | 1998 |
The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Chloramphenicol; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prevalence; Treatment Outcome; Vancomycin | 1998 |
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Bisexuality; Black People; Cephalexin; Cephalosporins; Clarithromycin; Dicloxacillin; Doxycycline; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Homosexuality, Male; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; White People | 1998 |
Infection and colonization with vancomycin-resistant Enterococcus faecium in an acute care Veterans Affairs Medical Center: a 2-year survey.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carrier State; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals, Veterans; Humans; Incidence; Infection Control; Male; Middle Aged; Pennsylvania; Prospective Studies; Risk Factors; Vancomycin | 1998 |
Detection of vancomycin-resistant enterococci colonization in a children's hospital.
Topics: Anti-Bacterial Agents; Carrier State; Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, Pediatric; Humans; Infection Control; Microbial Sensitivity Tests; Prevalence; Serotyping; Utah; Vancomycin | 1998 |
Clonal diversity of vancomycin-resistant enterococci from an outbreak in a tertiary care university hospital.
Topics: Anti-Bacterial Agents; Clone Cells; Cluster Analysis; Cross Infection; Disease Outbreaks; District of Columbia; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Infection Control; Phylogeny; Risk Factors; Serotyping; Vancomycin | 1998 |
The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Carbon-Oxygen Ligases; Chicago; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Genotype; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Longitudinal Studies; Male; Middle Aged; Molecular Epidemiology; Polymerase Chain Reaction; Vancomycin | 1999 |
Molecular analysis of diverse elements mediating VanA glycopeptide resistance in enterococci.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Blotting, Southern; Carbon-Oxygen Ligases; DNA Transposable Elements; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Nucleic Acid Hybridization; Point Mutation; Polymorphism, Restriction Fragment Length; Vancomycin | 1998 |
Investigation of an outbreak of vancomycin-resistant Enterococcus faecium in a low prevalence university hospital.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Male; Middle Aged; Prevalence; Retrospective Studies; Utah; Vancomycin | 1998 |
Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant enterococcus infection.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Multivariate Analysis; Postoperative Complications; Retrospective Studies; Risk Factors; Vancomycin | 1998 |
The effects of ultraviolet radiation on antibiotic-resistant bacteria in vitro.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Infection Control; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Ultraviolet Rays; Vancomycin; Wound Infection | 1998 |
Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination.
Topics: Aged; Doxycycline; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Male; Rifampin; Vancomycin; Virginiamycin | 1998 |
External sources of vancomycin-resistant enterococci for intensive care units.
Topics: Anti-Bacterial Agents; Carrier State; Chicago; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 500 and over; Hospitals, Public; Humans; Infection Control; Intensive Care Units; Length of Stay; Prospective Studies; Risk Factors; Vancomycin | 1998 |
The kinetic profile of vancomycin in neonates.
Topics: Body Weight; Critical Care; Drug Interactions; Female; Gram-Positive Bacterial Infections; Guidelines as Topic; Humans; Indomethacin; Infant; Infant, Newborn; Injections, Intravenous; Male; Metabolic Clearance Rate; Regression Analysis; Retrospective Studies; Tissue Distribution; Vancomycin | 1998 |
Vancomycin-resistant Enterococcus faecium colonization in children.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Hematology; Hospital Units; Hospitals, Pediatric; Humans; Logistic Models; Medical Oncology; Molecular Epidemiology; Population Surveillance; Regression Analysis; Risk Factors; Vancomycin | 1999 |
Clinical relevance of a European collaborative study on comparative susceptibility of gram-positive clinical isolates to teicoplanin and vancomycin.
Topics: Anti-Bacterial Agents; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Laboratories; Microbial Sensitivity Tests; Quality Control; Teicoplanin; Vancomycin | 1998 |
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Studies; Catheters, Indwelling; Ceftazidime; Drug Therapy, Combination; Enterococcus; Female; Fluconazole; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Ofloxacin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Xanthomonas | 1998 |
[Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Vancomycin | 1998 |
Treatment options for chronic prostatitis due to vancomycin-resistant Enterococcus faecium.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Chronic Disease; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Liver Transplantation; Male; Nitrofurantoin; Prostatitis; Rifampin; Urine; Vancomycin | 1998 |
Prevalence of high level aminoglycoside and vancomycin resistance among enterococci in Turkey.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Streptomycin; Turkey; Vancomycin | 1998 |
Isolation and epidemiological study of vancomycin-resistant Enterococcus faecium from patients of a haematological unit in Poland.
Topics: Adult; Anti-Bacterial Agents; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hematology; Hospital Units; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Poland; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Serotyping; Teicoplanin; Vancomycin | 1999 |
Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients.
Topics: Anti-Bacterial Agents; Carrier State; Cross Infection; Drug Resistance, Microbial; Enterococcus; Feces; Gram-Positive Bacterial Infections; Humans; Norway; Prevalence; Vancomycin | 1998 |
Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales.
Topics: Cross Infection; England; Enterococcus; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; New York City; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Wales | 1999 |
DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Plasmids; Polymorphism, Genetic; Vancomycin | 1999 |
Interferon-gamma effects on activities of gentamicin and vancomycin against Enterococcus faecalis resistant to the drugs: an in vitro study with human neutrophils.
Topics: Combined Modality Therapy; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Immunotherapy; In Vitro Techniques; Interferon-gamma; Neutrophils; Vancomycin | 1999 |
The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans' Affairs institution.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; Disease Transmission, Infectious; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Georgia; Gram-Positive Bacterial Infections; Hospitals, Veterans; Humans; Long-Term Care; Male; Middle Aged; Prevalence; Risk Factors; Vancomycin | 1999 |
Current treatment of gram-positive infections: focus on efficacy, safety, and cost minimalization analysis of teicoplanin.
Topics: Cost Savings; Drug Costs; Drug Evaluation; Formularies, Hospital as Topic; Gram-Positive Bacterial Infections; Humans; Safety; Teicoplanin; Treatment Outcome; United States; Vancomycin | 1992 |
Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Vancomycin | 1999 |
Vancomycin resistant enterococci in New Zealand.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Mass Screening; New Zealand; Prevalence; Serotyping; Vancomycin | 1999 |
Should genotypic testing be done on all phenotypically vancomycin- resistant enterococci detected in hospitals?
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Drug Resistance, Microbial; Enterococcus; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Phenotype; Polymerase Chain Reaction; Vancomycin | 1999 |
Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Risk Factors; Vancomycin | 1999 |
Nucleotide sequence of IS1542, an insertion sequence identified within VanA glycopeptide resistance elements of enterococci.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Carbon-Oxygen Ligases; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Molecular Sequence Data; Poultry; Transposases; Vancomycin | 1999 |
Detection of clinically relevant genotypes of vancomycin-resistant enterococci in nosocomial surveillance specimens by PCR.
Topics: Cross Infection; DNA, Ribosomal; Drug Resistance, Microbial; Enterococcus; Genotype; Gram-Positive Bacterial Infections; Humans; Polymerase Chain Reaction; RNA, Ribosomal, 16S; Vancomycin | 1999 |
Control of transmission of vancomycin-resistant Enterococcus faecium in a long-term-care facility.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Costs and Cost Analysis; Cross Infection; Disease Outbreaks; Disease Reservoirs; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Homes for the Aged; Humans; Infection Control; Long-Term Care; Male; Nursing Homes; Ontario; Vancomycin | 1999 |
Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Comorbidity; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Male; Middle Aged; Philadelphia; Retrospective Studies; Risk Factors; Statistics as Topic; Vancomycin | 1999 |
Lack of transmission of vancomycin-resistant enterococci in three long-term-care facilities.
Topics: Aged; Aged, 80 and over; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Long-Term Care; Prevalence; Prospective Studies; Quebec; Vancomycin | 1999 |
Vancomycin-resistant Enterococcus faecium meningitis successfully treated with chloramphenicol.
Topics: Anti-Bacterial Agents; Chloramphenicol; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Meningitis, Bacterial; Vancomycin | 1999 |
In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Penicillin Resistance; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin | 1999 |
Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs.
Topics: Anti-Bacterial Agents; Communicable Disease Control; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Models, Theoretical; Vancomycin | 1999 |
Vancomycin-resistant Enterococcus in liver transplant patients.
Topics: Adult; Anti-Bacterial Agents; Biliary Tract Diseases; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Liver Transplantation; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Vancomycin | 1999 |
Carrier rate of resistant enterococci in a tertiary care hospital in Norway.
Topics: Aged; Anal Canal; Bacterial Proteins; beta-Lactam Resistance; Carbon-Oxygen Ligases; Carrier State; Digestive System Surgical Procedures; Drug Resistance, Microbial; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Hematology; Hospitals; Humans; Male; Middle Aged; Norway; Prevalence; Surgery Department, Hospital; Vancomycin | 1999 |
[A case of lymphocyst infection caused by vanB type VRE].
Topics: Adult; Anti-Bacterial Agents; Cesarean Section; Cysts; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Hysterectomy; Lymph; Postoperative Complications; Pregnancy; Pregnancy Complications, Neoplastic; Retroperitoneal Space; Uterine Cervical Neoplasms; Vancomycin | 1999 |
Commentary on the MAFF technical report: a review of antimicrobial resistance in the food chain. Ministry of Agriculture Fisheries and Food.
Topics: Animal Husbandry; Animal Nutritional Physiological Phenomena; Animals; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Food Chain; Food Contamination; Gram-Positive Bacterial Infections; Humans; Public Health; Vancomycin | 1999 |
Regional dissemination of vancomycin-resistant enterococci resulting from interfacility transfer of colonized patients.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Digestive System; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals, Community; Humans; Iowa; Male; Middle Aged; Patient Transfer; Prevalence; Vancomycin | 1999 |
Practical approach to the identification of clinically relevant Enterococcus species.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Bacteriological Techniques; Cost-Benefit Analysis; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Vancomycin | 1999 |
Identification of clinically isolated vancomycin-resistant enterococci: comparison of API and BBL Crystal systems.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Resistance, Microbial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Reagent Kits, Diagnostic; Rifampin; Streptomycin; Vancomycin | 1999 |
Large conjugative vanA plasmids in vancomycin-resistant Enterococcus faecium.
Topics: Bacterial Proteins; Carbon-Oxygen Ligases; Chromosome Mapping; Conjugation, Genetic; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multigene Family; Plasmids; Restriction Mapping; Vancomycin | 1999 |
[Determination of the nosocomial origin of vancomycin-resistance strains of Enterococcus isolated from stool of patients in a hematology department].
Topics: Adult; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecium; Feces; France; Gram-Positive Bacterial Infections; Hospital Units; Hospitals, University; Humans; Leukemia; Phylogeny; Vancomycin | 1999 |
Vancomycin-resistant enterococci in hemodialysis patients is related to intravenous vancomycin use.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carrier State; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Rectum; Renal Dialysis; Vancomycin | 1999 |
Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City Hospital.
Topics: Anti-Bacterial Agents; Child; Conjugation, Genetic; Cross Infection; DNA Fragmentation; DNA Probes; DNA Transposable Elements; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Units; Hospitals, Urban; Humans; Medical Oncology; Neoplasms; New York City; Nucleic Acid Hybridization; Pediatrics; Vancomycin | 1999 |
Prevalence of colonization with vancomycin-resistant enterococci in various population groups in Berlin, Germany.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Berlin; Carrier State; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prevalence; Risk Factors; Urban Population; Vancomycin | 1999 |
Direct detection of vanA and vanB genes in clinical specimens for rapid identification of vancomycin resistant enterococci (VRE) using multiplex PCR.
Topics: Bacterial Proteins; Carbon-Oxygen Ligases; Drug Resistance, Microbial; Enterococcus; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Polymerase Chain Reaction; Sensitivity and Specificity; Time Factors; Vancomycin | 1999 |
Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Vancomycin | 1999 |
Vancomycin concentration in the vitreous after intravenous and intravitreal administration for postoperative endophthalmitis.
Topics: Anti-Bacterial Agents; Biological Availability; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Vancomycin; Vitrectomy; Vitreous Body | 1999 |
Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting.
Topics: Adult; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Oncology Service, Hospital; Prospective Studies; Vancomycin | 1999 |
Glycopeptide tolerance in bacteria causing endocarditis.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Drug Tolerance; Endocarditis, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Propionibacterium; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1999 |
Vancomycin resistance in gram-positive cocci--old bugs, new tricks, confusing terminology.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1999 |
In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic.
Topics: Animals; Anti-Bacterial Agents; Endocarditis, Bacterial; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Rats; Sepsis; Teicoplanin; Vancomycin | 1999 |
Vancomycin-resistant enterococci: causes and control.
Topics: Anti-Bacterial Agents; Cross Infection; DNA Transposable Elements; Drug Resistance, Microbial; Enterococcus; Gene Amplification; Gene Expression Regulation, Bacterial; Gram-Positive Bacterial Infections; Humans; Selection, Genetic; Vancomycin | 1999 |
Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Colony Count, Microbial; Critical Care; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hospital Units; Humans; Kidney Diseases; Mass Screening; Oncology Service, Hospital; Outcome Assessment, Health Care; Penicillins; Peritoneal Dialysis; Renal Dialysis; Risk Factors; Vancomycin; Victoria | 1999 |
Vancomycin-resistant enterococci and use of avoparcin in animal feed: is there a link?
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Animals, Domestic; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Microbial; Enterococcus; Gene Expression Regulation, Bacterial; Glycopeptides; Gram-Positive Bacterial Infections; Guidelines as Topic; Humans; Serine-Type D-Ala-D-Ala Carboxypeptidase; Vancomycin | 1999 |
Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacitracin; Doxycycline; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Feces; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Vancomycin | 1999 |
A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiology.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; Chromosome Mapping; DNA Primers; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Open Reading Frames; Peptide Synthases; Polymerase Chain Reaction; Sequence Alignment; Sequence Homology, Amino Acid; Vancomycin; Vancomycin Resistance | 1999 |
Evaluation of a vanA-specific PCR assay for detection of vancomycin-resistant Enterococcus faecium during a hospital outbreak.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Feces; Gram-Positive Bacterial Infections; Humans; Polymerase Chain Reaction; Vancomycin | 1999 |
Controlling VRE.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin | 1999 |
Influence of adjunctive interferon-gamma on treatment of gentamicin- and vancomycin-resistant Enterococcus faecalis infection in mice.
Topics: Animals; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Interferon-gamma; Mice; Vancomycin | 1999 |
Stopping the spread of vancomycin-resistant enterococci.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 300 to 499; Humans; Infection Control; Texas; Vancomycin | 1999 |
Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Drug Synergism; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Time Factors; Vancomycin; Vancomycin Resistance; Virginiamycin | 1999 |
vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Enterococcus faecium; Finland; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Polymerase Chain Reaction; Sequence Analysis, DNA; Vancomycin | 1999 |
Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium.
Topics: Abdominal Abscess; Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Linezolid; Male; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Rats; Rats, Sprague-Dawley; Treatment Outcome; Vancomycin | 1999 |
Vancomycin-resistant enterococci in Brooklyn, New York: a moment in time.
Topics: Anti-Bacterial Agents; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; New York; Vancomycin; Vancomycin Resistance | 1999 |
Treatment strategies for postoperative Propionibacterium acnes endophthalmitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Combined Modality Therapy; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Male; Middle Aged; Propionibacterium acnes; Recurrence; Reoperation; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy | 1999 |
Report from the Catalan Agency for Health Technology Assessment (CAHTA). Review of the scientific evidence of the clinical and economic implications of resistance of enterococcus to vancomycin.
Topics: Anti-Bacterial Agents; Enterococcus; Evidence-Based Medicine; Gram-Positive Bacterial Infections; Humans; Infection Control; Population Surveillance; Prevalence; Risk Factors; Spain; Technology Assessment, Biomedical; Vancomycin; Vancomycin Resistance | 1999 |
Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animal Husbandry; Animals; Anti-Bacterial Agents; Carrier State; Cattle; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Feces; France; Gram-Positive Bacterial Infections; Hospitalization; Humans; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Prevalence; Vancomycin; Vancomycin Resistance | 2000 |
Survival of enterococci and staphylococci on hospital fabrics and plastic.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Hospitals; Humans; Methicillin; Methicillin Resistance; Penicillins; Plastics; Polyesters; Polypropylenes; Staphylococcal Infections; Staphylococcus; Textiles; Vancomycin; Vancomycin Resistance | 2000 |
Epidemiology of glycopeptide-resistant enterococci colonizing high-risk patients in hospitals in Johannesburg, Republic of South Africa.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Prevalence; Risk Factors; South Africa; Vancomycin; Vancomycin Resistance | 2000 |
Vancomycin-resistant enterococci in liver transplant recipients.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Infection Control; Liver Transplantation; Postoperative Complications; Vancomycin; Vancomycin Resistance | 2000 |
Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2000 |
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Bacteremia; Case-Control Studies; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Medical Records; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Regression Analysis; Risk Factors; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2000 |
Characterization of vancomycin-resistant and vancomycin-susceptible Enterococcus faecium isolates from humans, chickens and pigs by RiboPrinting and pulsed-field gel electrophoresis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Carbon-Oxygen Ligases; Chickens; Deoxyribonuclease EcoRI; Deoxyribonucleases, Type II Site-Specific; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Poultry Diseases; Restriction Mapping; Swine; Swine Diseases; Vancomycin; Vancomycin Resistance | 2000 |
The clinical impact of early gram-positive bacteremia and the use of vancomycin after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bone Marrow Transplantation; Cohort Studies; Female; Gram-Positive Bacterial Infections; Humans; Kidney Diseases; Male; Middle Aged; Postoperative Complications; Transplantation, Homologous; Vancomycin | 2000 |
Saccharomicins, novel heptadecaglycoside antibiotics produced by Saccharothrix espanaensis: antibacterial and mechanistic activities.
Topics: Actinomycetales; Aminoglycosides; Animals; Anti-Bacterial Agents; Carbohydrate Sequence; Cations; Cell Membrane; Disease Models, Animal; DNA; Drug Interactions; Female; Gram-Positive Bacterial Infections; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Molecular Sequence Data; Protein Biosynthesis; Proteins; Staphylococcus; Vancomycin | 2000 |
Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Osteomyelitis; Oxazolidinones; Renal Dialysis; Spinal Diseases; Spine; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2000 |
Antimicrobial-resistant enterococcal isolates from fluoroquinolone-naive children.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Naphthyridines; Penicillins; Vancomycin | 2000 |
[Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer].
Topics: Amikacin; Antineoplastic Agents; Breast Neoplasms; Drug Costs; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Neutropenia; Penicillanic Acid; Piperacillin; Spain; Tazobactam; Teicoplanin; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Vancomycin | 2000 |
Propionibacterium acnes endophthalmitis requiring intraocular lens removal after failure of medical therapy.
Topics: Anti-Bacterial Agents; Device Removal; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Male; Middle Aged; Phacoemulsification; Propionibacterium acnes; Prosthesis-Related Infections; Reoperation; Vancomycin; Visual Acuity | 2000 |
Enterococci with reduced susceptibility to vancomycin in New Zealand.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Diarrhea; DNA Fingerprinting; DNA, Bacterial; DNA, Ribosomal; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Feces; Glucosides; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; New Zealand; Prevalence; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Vancomycin Resistance | 2000 |
Modulation of efficacies and pharmacokinetics of antibiotics by granulocyte colony-stimulating factor in neutropenic mice with multidrug-resistant Enterococcus faecalis infection.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Granulocyte Colony-Stimulating Factor; Humans; Mice; Neutropenia; Vancomycin; Vancomycin Resistance | 2000 |
Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit.
Topics: Burn Units; Cephalosporins; Clinical Protocols; Cross Infection; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin; Vancomycin Resistance; Wounds and Injuries | 2000 |
Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Injections, Intravenous; Injections, Intraventricular; Injections, Spinal; Linezolid; Middle Aged; Oxazoles; Oxazolidinones; Subarachnoid Hemorrhage; Tomography, X-Ray Computed; Vancomycin; Ventriculoperitoneal Shunt; Virginiamycin | 2000 |
Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Reproducibility of Results; Vancomycin; Vancomycin Resistance | 2000 |
Red light kills bacteria via photodynamic action.
Topics: Anti-Bacterial Agents; Cell Division; Colony Count, Microbial; Color; Dental Caries; Drug Resistance, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Laser Therapy; Light; Periodontitis; Photosensitizing Agents; Porphyrins; Spectrometry, Fluorescence; Subgingival Curettage; Vancomycin | 2000 |
Prevalence of vancomycin-resistant Enterococcus faecium (VREF) in pig faeces from slaughterhouses in Spain.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Enterococcus faecium; European Union; Feces; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Prevalence; Spain; Swine; Swine Diseases; Vancomycin; Vancomycin Resistance | 2000 |
Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy.
Topics: Abnormalities, Multiple; Bacterial Infections; Candidiasis; Comorbidity; Cross Infection; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Meningitis; North Carolina; Oxacillin; Retrospective Studies; Sepsis; Staphylococcal Infections; Vancomycin; Virginia | 2000 |
Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Patient Admission; Prospective Studies; Renal Dialysis; Time Factors; Vancomycin; Vancomycin Resistance | 2001 |
Development of the Specific and Random Amplification (SARA)-PCR for both species identification of enterococci and detection of the vanA gene.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Enterococcus; Food Microbiology; Gene Amplification; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Species Specificity; Teicoplanin; Vancomycin; Vancomycin Resistance | 2001 |
Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Teicoplanin; Transferases; Vancomycin; Vancomycin Resistance | 2001 |
Prevalence of vancomycin-resistant enterococci in Europe.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Enterococcus; Europe; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Vancomycin; Vancomycin Resistance | 2000 |
Identification and antimicrobial susceptibility of enterococci isolated from the root canal.
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Calcium Hydroxide; Clindamycin; Dental Pulp Cavity; Dental Pulp Diseases; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Gram-Positive Bacterial Infections; Humans; Metronidazole; Penicillin G; Penicillin Resistance; Penicillins; Root Canal Filling Materials; Tetracycline; Tetracycline Resistance; Treatment Failure; Vancomycin | 2000 |
Infection of central nervous system by motile Enterococcus: first case report.
Topics: Aged; Central Nervous System Bacterial Infections; Drug Therapy, Combination; Enterococcus; Fever; Gentamicins; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Male; Meningitis; Microbial Sensitivity Tests; Recurrence; Vancomycin; Ventriculoperitoneal Shunt | 2001 |
Vancomycin resistance emerging in a clonal outbreak caused by ampicillin-resistant Enterococcus faecium.
Topics: Aged; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Genotype; Gram-Positive Bacterial Infections; Humans; Incidence; Male; Microbial Sensitivity Tests; Norway; Penicillins; Vancomycin; Vancomycin Resistance | 2000 |
Preventing the spread of vancomycin-resistant enterococci (VRE) in Canada.
Topics: Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Microbial Sensitivity Tests; Risk Factors; Vancomycin; Vancomycin Resistance | 1997 |
Emerging glycopeptide resistance in gram-positive organisms.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Prevalence; Teicoplanin; Vancomycin | 2000 |
A case of vancomycin-resistant enterococcal endocarditis.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Penicillins; Phenotype; Vancomycin; Vancomycin Resistance | 2000 |
Prevalence of the vanB2 gene cluster in vanB glycopeptide-resistant enterococci in the United Kingdom and the Republic of Ireland and its association with a Tn5382-like element.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Enterococcus; Genes, Bacterial; Gram-Positive Bacterial Infections; Ireland; United Kingdom; Vancomycin; Vancomycin Resistance | 2001 |
Effects of adjunctive treatment with combined cytokines in a neutropenic mouse model of multidrug-resistant Enterococcus faecalis septicemia.
Topics: Animals; Anti-Bacterial Agents; Cytokines; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Granulocyte-Macrophage Colony-Stimulating Factor; Interferon-gamma; Mice; Neutropenia; Recombinant Proteins; Sepsis; Vancomycin | 2001 |
Is vancomycin resistance in enterococci predictive of inferior outcome of enterococcal bacteremia?
Topics: Bacteremia; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Neutropenia; Predictive Value of Tests; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2001 |
Effectiveness of a vancomycin restriction policy in changing the prescribing patterns of house staff.
Topics: Antibiotic Prophylaxis; Drug Prescriptions; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Humans; Medication Systems, Hospital; Personnel, Hospital; Practice Guidelines as Topic; Vancomycin; Vancomycin Resistance | 2000 |
Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child.
Topics: Anti-Bacterial Agents; Cefotaxime; Child, Preschool; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Micrococcaceae; Neutropenia; Rifampin; Vancomycin | 2001 |
Postoperative Proprionobacterium acnes endophthalmitis.
Topics: Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Humans; Lens Capsule, Crystalline; Postoperative Complications; Propionibacterium acnes; Retrospective Studies; Therapeutic Irrigation; Vancomycin | 2001 |
In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identification.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Feces; Genes, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Probes; Species Specificity; Vancomycin; Virginiamycin | 2001 |
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Vancomycin | 2001 |
Outbreak of vancomycin-resistant Enterococcus faecium of the phenotype VanB in a hospital in Warsaw, Poland: probable transmission of the resistance determinants into an endemic vancomycin-susceptible strain.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Conjugation, Genetic; Disease Outbreaks; DNA Restriction Enzymes; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, Urban; Humans; Microbial Sensitivity Tests; Poland; Polymorphism, Restriction Fragment Length; Vancomycin; Vancomycin Resistance | 2001 |
Gastrointestinal colonisation of vancomycin-resistant enterococcus in a Singapore teaching hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Digestive System; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Infant; Male; Middle Aged; Singapore; Vancomycin; Vancomycin Resistance | 2001 |
High prevalence of VanB2 vancomycin-resistant Enterococcus faecium in Taiwan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Multigene Family; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Sequence Analysis, DNA; Taiwan; Teicoplanin; Vancomycin; Vancomycin Resistance | 2001 |
Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
Topics: Anti-Bacterial Agents; Bacteremia; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Penicillins; Vancomycin; Vancomycin Resistance | 2001 |
Recovery from a single blood culture of two enterococcus gallinarum isolates carrying both vanC-1 and vanA cluster genes and differing in glycopeptide susceptibility.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Drug Resistance; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Teicoplanin; Vancomycin; Vancomycin Resistance | 2001 |
Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Infant; Infant, Newborn; Length of Stay; Male; Middle Aged; Risk Factors; Vancomycin; Vancomycin Resistance | 2001 |
Clinical and molecular characterization of vancomycin-resistant Enterococcus faecium strains during establishment of endemicity.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cluster Analysis; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Polymerase Chain Reaction; Tennessee; Vancomycin; Vancomycin Resistance | 2001 |
Postoperative proprionibacterium acnes endophthalmitis.
Topics: Cataract Extraction; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Humans; Injections; Lens Capsule, Crystalline; Propionibacterium acnes; Vancomycin | 2001 |
Fluorescence polarization immunoassay: can it result in an overestimation of vancomycin in patients not suffering from renal failure?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Enzyme Multiplied Immunoassay Technique; Female; Fluorescence Polarization Immunoassay; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Treatment Outcome; Vancomycin | 2001 |
Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Translocation; Cyclophosphamide; Drug Therapy, Combination; Enterococcus; Escherichia coli; Gram-Positive Bacterial Infections; Immunosuppressive Agents; Intestines; Kanamycin; Metronidazole; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred ICR; Mice, Nude; Mice, SCID; Neutropenia; Vancomycin; Vancomycin Resistance; Virulence | 2001 |
The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linear Models; Multivariate Analysis; Prevalence; Prospective Studies; Risk Factors; Statistics, Nonparametric; United States; Vancomycin | 2001 |
Summaires for patients. Factors associated with the development of antibiotic-resistant bacteria.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Prevalence; Prospective Studies; Risk Factors; United States; Vancomycin | 2001 |
Detection of carriage of vancomycin-resistant enterococci in an intensive care unit in Buenos Aires.
Topics: Anti-Bacterial Agents; Argentina; Carrier State; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Vancomycin; Vancomycin Resistance | 2001 |
Heteroresistance to vancomycin in Enterococcus faecium.
Topics: Anti-Bacterial Agents; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2001 |
Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rabbits; Teicoplanin; Vancomycin | 2001 |
Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cost Control; Cost Savings; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 500 and over; Hospital Costs; Humans; Infection Control; Length of Stay; New York; Oncology Service, Hospital; Vancomycin; Vancomycin Resistance | 2001 |
Selection of a teicoplanin-resistant Enterococcus faecium mutant during an outbreak caused by vancomycin-resistant enterococci with the vanB phenotype.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Conjugation, Genetic; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gene Transfer, Horizontal; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Poland; Polymorphism, Restriction Fragment Length; Teicoplanin; Vancomycin; Vancomycin Resistance | 2001 |
The prevalence of fecal colonization with VRE among residents of long-term-care facilities in Melbourne, Australia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Disease Outbreaks; Enterococcus faecalis; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Nursing Homes; Prevalence; Vancomycin; Vancomycin Resistance; Victoria | 2001 |
High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci.
Topics: Bacteriological Techniques; Drug Administration Schedule; Enterococcus; Enterococcus faecalis; Enterococcus faecium; False Negative Reactions; Feces; Gastrointestinal Diseases; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Rectum; Sensitivity and Specificity; Skin; Vancomycin; Vancomycin Resistance | 2002 |
Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Incidence; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Spain; Streptomycin; Vancomycin | 2001 |
Differential antimicrobial susceptibility between human and chicken isolates of vancomycin-resistant and sensitive Enterococcus faecium.
Topics: Animals; Anti-Bacterial Agents; Chickens; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2002 |
Invasive infections due to vancomycin-resistant enterococci in adult patients.
Topics: Adult; Aged; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Vancomycin | 2001 |
Use of insurance claims data to assess outpatient antimicrobial therapy for gram-positive infections.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Female; Gram-Positive Bacterial Infections; Home Infusion Therapy; Hospitalization; Humans; Infusions, Intravenous; Insurance Claim Reporting; Male; Middle Aged; United States; Vancomycin | 2002 |
Economic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: a decision analytical model.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Cellulitis; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Utilization Review; Floxacillin; Gram-Positive Bacterial Infections; Hospital Costs; Hospitals, Public; Humans; Infection Control; Infusions, Intravenous; Linezolid; Oxazolidinones; Practice Patterns, Physicians'; United Kingdom; Vancomycin | 2001 |
[Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Critical Care; Cross Infection; Drug Resistance; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Lactams; Male; Middle Aged; Mouth; Neutropenia; Opportunistic Infections; Pneumococcal Infections; Respiratory Distress Syndrome; Shock, Septic; Species Specificity; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae; Streptococcus sanguis; Treatment Outcome; Vancomycin | 2002 |
Molecular analysis of vancomycin-resistant Enterococcus faecalis from Michigan hospitals during a 10 year period.
Topics: Anti-Bacterial Agents; DNA, Bacterial; Electrophoresis; Enterococcus faecalis; Gram-Positive Bacterial Infections; Michigan; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2002 |
Multilocus sequence typing scheme for Enterococcus faecium.
Topics: Alleles; Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Base Sequence; Enterococcus faecium; Genetic Variation; Gram-Positive Bacterial Infections; Humans; Molecular Sequence Data; Recombination, Genetic; Sequence Analysis, DNA; Vancomycin; Vancomycin Resistance | 2002 |
Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Benchmarking; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Intensive Care Units; Methicillin; Quality Assurance, Health Care; Risk Factors; United States; Vancomycin; Vancomycin Resistance | 2002 |
Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faecium.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Culture Media; Enterococcus faecium; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Hydrogen-Ion Concentration; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Time Factors; Vancomycin; Vancomycin Resistance | 2002 |
Vancomycin-resistant enterococci.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; United Kingdom; Vancomycin | 1992 |
Vancomycin-resistant enterococcus faecium: headline news.
Topics: Cross Infection; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1992 |
Vancomycin-resistant Enterococcus faecium in hospitalized children.
Topics: Bacterial Typing Techniques; Case-Control Studies; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitalization; Hospitals, Pediatric; Humans; Infant; Oncology Service, Hospital; Vancomycin | 1992 |
Activity of vancomycin against recently isolated nosocomial gram-positive cocci.
Topics: Cross Infection; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Staphylococcus; Streptococcus; Vancomycin | 1992 |
Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Peptides; Rats; Teicoplanin; Vancomycin | 1992 |
Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Rabbits; Vancomycin | 1992 |
Pristinamycin for Enterococcus faecium resistant to vancomycin and gentamicin.
Topics: Child; Drug Resistance, Microbial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1992 |
Vancomycin resistance in south London.
Topics: Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; London; Vancomycin | 1992 |
Vancomycin-resistant Enterococcus durans.
Topics: Cross Infection; DNA Restriction Enzymes; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Vancomycin | 1992 |
CAPD peritonitis caused by Lactobacillus rhamnosus.
Topics: Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Lactobacillus; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1992 |
Enterococcus species in urinary tract infection.
Topics: Anti-Bacterial Agents; Enterococcus; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Prospective Studies; Teicoplanin; Urinary Tract Infections; Urine; Vancomycin | 1992 |
Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; beta-Lactamases; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospital Bed Capacity; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Prospective Studies; Risk Factors; Teicoplanin; United States; Vancomycin; Virulence | 1992 |
Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Rats; Rats, Wistar; Teicoplanin; Vancomycin | 1992 |
Bacteremia due to vancomycin-resistant Enterococcus faecium of Van B phenotype during prophylaxis with vancomycin.
Topics: Ampicillin; Bacteremia; Drug Resistance, Microbial; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid; Middle Aged; Vancomycin | 1992 |
In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources.
Topics: Animals; Anti-Bacterial Agents; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterococcus; Glycopeptides; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lactobacillus; Leuconostoc; Nocardia; Rhodococcus; Staphylococcus; Teicoplanin; Vancomycin | 1992 |
Empiric use of vancomycin in the febrile neutropenic patient.
Topics: Bacteremia; Gram-Positive Bacterial Infections; Humans; Neutropenia; Vancomycin | 1992 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 23-1992. A 55-year-old man with recurrent pericardial and pleural effusions after aortic-valve replacement.
Topics: Aortic Valve; Cephalosporins; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Penicillins; Pericarditis; Pleural Effusion; Postoperative Complications; Propionibacterium acnes; Suppuration; Vancomycin | 1992 |
A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit.
Topics: Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 300 to 499; Humans; Infection Control; Intensive Care Units; Microbial Sensitivity Tests; New York City; Population Surveillance; Prospective Studies; Retrospective Studies; Risk Factors; Vancomycin | 1992 |
Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Electronics, Medical; Enterococcus faecium; Equipment Contamination; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 300 to 499; Hospitals, Teaching; Humans; Middle Aged; Odds Ratio; Population Surveillance; Risk Factors; Thermometers; Vancomycin | 1992 |
In-vitro activity of LY264826, an investigational glycopeptide antibiotic, against gram-positive bloodstream isolates and selected gram-negative bacilli.
Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 1992 |
Enterococcus faecalis infection in a corneal graft.
Topics: Chloramphenicol; Corneal Ulcer; Drug Therapy, Combination; Enterococcus faecalis; Eye Infections, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Vancomycin | 1992 |
Hygienic hand disinfection for the removal of epidemic vancomycin-resistant Enterococcus faecium and gentamicin-resistant Enterobacter cloacae.
Topics: Adult; Chlorhexidine; Cross Infection; Disease Outbreaks; Drug Evaluation; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Hand Disinfection; Humans; Vancomycin | 1991 |
Enterococcus faecium sensitive to teicoplanin but not vancomycin.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Neutropenia; Teicoplanin; Vancomycin | 1991 |
Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital.
Topics: Adolescent; Child; Child, Preschool; Cross Infection; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Microbial; Enterococcus faecium; Epidemiologic Methods; Female; Gram-Positive Bacterial Infections; Humans; Infant; Male; Phenotype; Polymorphism, Restriction Fragment Length; Vancomycin | 1991 |
Septicaemia caused by Pediococcus pentosaceus: a new opportunistic pathogen.
Topics: Ampicillin; Drug Resistance, Microbial; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Immune Tolerance; Middle Aged; Opportunistic Infections; Pediococcus; Sepsis; Vancomycin | 1991 |
Recovery of vancomycin-resistant gram-positive cocci from pediatric liver transplant recipients.
Topics: Adolescent; Bacteremia; Child; Child, Preschool; Drug Resistance, Microbial; Enterococcus; Feces; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Infant; Liver Transplantation; Time Factors; Vancomycin | 1991 |
Occurrence of Leuconostoc mesenteroides and leuconostoc-like organisms in Lagos, Nigeria.
Topics: Bacterial Typing Techniques; Carrier State; Catalase; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Hospitals; Humans; Leuconostoc; Nigeria; Prevalence; Vancomycin | 1991 |
Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Female; Glycopeptides; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Mutagenesis, Insertional; Rabbits; Teicoplanin; Vancomycin | 1991 |
Vancomycin susceptibility and identification of motile enterococci.
Topics: Bacterial Proteins; Carrier Proteins; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Hexosyltransferases; Humans; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Sequence Homology, Nucleic Acid; Species Specificity; Vancomycin | 1991 |
Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium.
Topics: Animals; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Rabbits; Vancomycin | 1991 |